
<html lang="en"     class="pb-page"  data-request-id="5db50006-a07b-40cb-924f-44cf51c04d9c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm500572b;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-21"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility" /></meta><meta name="dc.Creator" content="László E.  Kiss" /></meta><meta name="dc.Creator" content="Patrício  Soares-da-Silva" /></meta><meta name="dc.Description" content="Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures. CO..." /></meta><meta name="Description" content="Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures. CO..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 2, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500572b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500572b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500572b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500572b" /></link>
        
    
    

<title>Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500572b" /></meta><meta property="og:title" content="Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0022.jpeg" /></meta><meta property="og:description" content="Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures. COMT is a druggable biological target for the treatment of various central and peripheral nervous system disorders, including Parkinson’s disease, depression, schizophrenia, and other dopamine deficiency-related diseases. The purpose of this perspective is fourfold: (i) to summarize the physiological role of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history and perspective of the medicinal chemistry behind the discovery and development of COMT inhibitors; (iii) to discuss how the physicochemical properties of recognized COMT inhibitors are understood to exert influence over their pharmacological properties; and (iv) to evaluate the clinical benefits of the most relevant COMT inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500572b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500572b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-8/abseba.2021.7.issue-8/20210809/abseba.2021.7.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-15/accacs.2021.11.issue-15/20210806/accacs.2021.11.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-31/ascecg.2021.9.issue-31/20210809/ascecg.2021.9.issue-31.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-8/bomaf6.2021.22.issue-8/20210809/bomaf6.2021.22.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-29/cgeabj.2021.99.issue-29/20210809-01/cgeabj.2021.99.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-15/enfuem.2021.35.issue-15/20210805/enfuem.2021.35.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-15/joceah.2021.86.issue-15/20210806/joceah.2021.86.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-30/jpcafh.2021.125.issue-30/20210805/jpcafh.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-30/jpcbfk.2021.125.issue-30/20210805/jpcbfk.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-30/jpccck.2021.125.issue-30/20210805/jpccck.2021.125.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-30/jpclcd.2021.12.issue-30/20210805/jpclcd.2021.12.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-8/jprobs.2021.20.issue-8/20210806/jprobs.2021.20.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-15/orlef7.2021.23.issue-15/20210806/orlef7.2021.23.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-15/orgnd7.2021.40.issue-15/20210809/orgnd7.2021.40.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500572b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500572b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500572b&amp;href=/doi/10.1021/jm500572b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8692-8717</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5003183" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm500823a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Medicinal Chemistry of Catechol <i>O</i>-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=L%C3%A1szl%C3%B3+E.++Kiss">László E. Kiss</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patr%C3%ADcio++Soares-da-Silva">Patrício Soares-da-Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Research & Development, BIAL − Portela & C<sup>a</sup>, S.A., À Avenida da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">MedInUP − Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319 Porto, Portugal</span></div><div class="corresp-info"><strong>*</strong>Tel: +351- 22-9866100. Fax: 351- 22-9866192. E-mail: <a href="/cdn-cgi/l/email-protection#1c707d6f6670733277756f6f5c7e757d70327f7371"><span class="__cf_email__" data-cfemail="e68a87959c8a89c88d8f9595a6848f878ac885898b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500572b&amp;href=/doi/10.1021%2Fjm500572b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8692–8717</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 31, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 April 2014</li><li><span class="item_label"><b>Published</b> online</span>2 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 November 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500572b" title="DOI URL">https://doi.org/10.1021/jm500572b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8692%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DL%25C3%25A1szl%25C3%25B3%2BE.%2BKiss%252C%2BPatr%25C3%25ADcio%2BSoares-da-Silva%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D21%26contentID%3Djm500572b%26title%3DMedicinal%2BChemistry%2Bof%2BCatechol%2BO-Methyltransferase%2B%2528COMT%2529%2BInhibitors%2Band%2BTheir%2BTherapeutic%2BUtility%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8717%26publicationDate%3DNovember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500572b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3008</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">57</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500572b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Medicinal Chemistry of Catechol O-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;László&quot;,&quot;last_name&quot;:&quot;E. Kiss&quot;},{&quot;first_name&quot;:&quot;Patrício&quot;,&quot;last_name&quot;:&quot;Soares-da-Silva&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;8692-8717&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500572b&quot;},&quot;abstract&quot;:&quot;Catechol O-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures. COMT is a druggable biological target for the treatment of various central and peripheral nervous system disorders, including Parkinson’s disease, depression, schizophrenia, and other dopamine deficiency-related diseases. The purpose of this perspective is fourfold: (i) to summarize the physiological role of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history and perspective of the medicinal chemistry behind the discovery and development of COMT inhibitors; (iii) to discuss how the physicochemical properties of recognized COMT inhibitors are understood to exert influence over their pharmacological properties; and (iv) to evaluate the clinical benefits of the most relevant COMT inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500572b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500572b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500572b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500572b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500572b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500572b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500572b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500572b&amp;href=/doi/10.1021/jm500572b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500572b" /></input><a href="/doi/pdf/10.1021/jm500572b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500572b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500572b%26sid%3Dliteratum%253Aachs%26pmid%3D25080080%26genre%3Darticle%26aulast%3DKiss%26date%3D2014%26atitle%3DMedicinal%2BChemistry%2Bof%2BCatechol%2BO-Methyltransferase%2B%2528COMT%2529%2BInhibitors%2Band%2BTheir%2BTherapeutic%2BUtility%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D21%26spage%3D8692%26epage%3D8717%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jmcmar.2014.57.issue-21/20141113/jmcmar.2014.57.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Catechol <i>O</i>-methyltransferase (COMT) is the enzyme responsible for the O-methylation of endogenous neurotransmitters and of xenobiotic substances and hormones incorporating catecholic structures. COMT is a druggable biological target for the treatment of various central and peripheral nervous system disorders, including Parkinson’s disease, depression, schizophrenia, and other dopamine deficiency-related diseases. The purpose of this perspective is fourfold: (i) to summarize the physiological role of COMT inhibitors in central and peripheral nervous system disorders; (ii) to provide the history and perspective of the medicinal chemistry behind the discovery and development of COMT inhibitors; (iii) to discuss how the physicochemical properties of recognized COMT inhibitors are understood to exert influence over their pharmacological properties; and (iv) to evaluate the clinical benefits of the most relevant COMT inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the late 1950s, Marvin Armstrong and co-workers studied the metabolism of norepinephrine in the urine of patients with the adrenaline-forming tumor pheochromocytoma and noted the formation of an O-methylated metabolite (3-methoxy-4-hydroxymandelic acid).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The endogenous origin of this metabolite had been postulated because its excretion was not affected by dietary changes. Following Armstrong’s work, the group of the 1970 Nobel Prize winner for Physiology or Medicine, Julius Axelrod, reported the normal occurrence of the corresponding 3-O-methylated metabolites of dopamine, epinephrine, and norepinephrine in mammals.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The enzyme that is responsible for the regioselective O-methylation of one of the hydroxyl groups of catecholamines was partially purified and characterized from rat liver fractions by the same group and later termed catechol <i>O</i>-methyltransferase (COMT EC 2.1.1.6).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Because catecholamines are important neurotransmitters involved in many biological functions, the inhibition of the COMT enzyme became an attractive strategy for manipulating the levels of endogenous neurotransmitters such as dopamine, epinephrine, and norepinephrine. Although early COMT inhibitors (often classified as “first-generation” inhibitors) prolonged the physiological effect of endogenous neurotransmitters by inhibiting COMT, their efficacy on dopaminergic, adrenergic, and noradrenergic mechanisms was limited.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Furthermore, the role of first-generation COMT inhibitors in the inactivation of neurotransmitters at receptor sites was questioned. COMT began to attract increasing attention in the 1970s, when the involvement of the COMT enzyme in the metabolic degradation of the mainstay antiparkinsonian drug L-DOPA (levodopa) was discovered. Parkinson’s disease (PD) is a chronic degenerative neurological disorder predominantly afflicting the aged population. PD is caused by a reduction in the striatal levels of dopamine associated with the gradual degeneration or death of nigral cells in the brain. L-DOPA can be considered a biological precursor of dopamine that can be used as an “artificial” means to manipulate the cerebral levels of this neurotransmitter.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Despite the beneficial ability of L-DOPA to modulate the cerebral levels of dopamine, one of its major drawbacks is its short in vivo half-life. COMT inhibitors block the unwanted O-methylation of L-DOPA by COMT to 3-<i>O</i>-methyl-L-DOPA (3-OMD) in peripheral tissues, thereby prolonging the pharmacological effect of L-DOPA as well as diminishing the therapeutic dose. Over the last 30 years, efforts from several research groups from both academia and the pharmaceutical industry have focused on optimizing L-DOPA therapy with the objective of providing a more continuous and sustained delivery of dopamine to the striatum by targeting COMT. The search for new COMT inhibitors led to the discovery of “second-generation” inhibitors, which were endowed with improved pharmacokinetic profiles compared with those of the first-generation predecessors. Clinically relevant COMT inhibitors for the adjunctive treatment of PD are exemplified by nitecapone, (<b>31</b>,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> OR-462; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), entacapone (<b>32</b>,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> OR-611; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), tolcapone (<b>37</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Ro40-7592; Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), nebicapone (<b>39</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> BIA 3-202; Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), and opicapone (<b>50c</b>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> BIA 9-1067; Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). Although second-generation COMT inhibitors share the same nitrocatechol pharmacophore, subtle differences do exist in the mode of COMT inhibition. These characteristic properties are thought to be of relevance in terms of the downstream clinical efficacy and safety of PD treatment and will be discussed in this perspective along with the potential therapeutic applications of COMT inhibitors in other dopamine-deficiency related diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Catechol <i>O</i>-Methyltransferase (COMT) Enzyme</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Catechol <i>O</i>-methyltransferase (COMT) is a magnesium-dependent intracellular enzyme that catalyzes the transfer of a methyl group from the common methyl donor <i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine (AdoMet or SAM) to substrates incorporating a dihydroxybenzene (catechol) motif, resulting in the formation of mono-O-methylated products and <i>S</i>-adenosylhomocysteine (AdoHcy or SAH) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COMT catalyzed methylation of simple catechol and pyrogallol substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The enzymatic O-methylation reaction generally takes place with high regioselectivity. Under in vivo experimental conditions, the COMT-mediated metabolic degradation of catecholic substrates almost exclusively results in the formation of the corresponding <i>meta</i>-O-methylated products.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In contrast, under in vitro conditions, some COMT substrates have also been shown to undergo O-methylation reactions at the <i>para</i>-position. The extent of the <i>para</i>-O-methylated product is highly dependent on the nature of the substrate and the experimental conditions, such as the pH of the reaction mixture, but in general accounts for ≤50% of the total amount of methylated metabolites.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Catechols bearing a polar side chain (e.g., dopamine) are O-methylated exclusively at the <i>meta</i> position in vitro, whereas substrates that contain a less polar side chain may also undergo O-methylation reactions at the <i>para</i> position. Modeling studies with the 3D protein structure have also confirmed that COMT favors <i>meta</i>-O-methylation over the <i>para</i>-O-methylation reaction. The binding of the <i>para</i>-hydroxyl group of the catechol nucleus to the methyl donor AdoMet forces the side chain to accommodate an unfavorable position, which results in repulsive interactions with the protein residues.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Vicinal trihydroxybenzenes (e.g., pyrogallol) are methylated on the middle hydroxyl group regardless of the substitution pattern of the middle hydroxyl group (i.e., <i>para</i> or <i>meta</i>) relative to other substituents on the benzene ring.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> COMT is able to methylate only one of the hydroxyl groups, and no dimethylated product is formed.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Function, Substrates, and Distribution of COMT</h3><div class="NLM_p">The main physiological function of COMT is the metabolic inactivation of endogenous catechol neurotransmitters<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and xenobiotic substances.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Furthermore, the physiological functions of several hormones incorporating a catechol pharmacophore are also terminated by COMT. The COMT physiological substrates include dopamine, epinephrine, norepinephrine, 3,4-dihydroxymandelic acid (DOMA), 3,4-dihydroxyphenylacetic acid (DOPAC), ascorbic acid, and catechol estrogens, such as 2-hydroxyestradiol, 4-hydroxyestradiol, 2-hydroxyestrogen, 2-hydroxyestron, and the dihydroxyindolic intermediates of melanin. Several drugs incorporating a dihydroxyphenyl moiety are also substrates of COMT, including amino acid decarboxylase (AADC) inhibitors (carbidopa, <b>1</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and benserazide, <b>2</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>), dopamine agonists (apomorphine, <b>3</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> dobutamine, <b>4</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and fenoldopam, <b>5</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>), the antihypertensive compound α-methyl-L-DOPA, <b>6</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and bronchodilating agents, such as isoprenaline, <b>7</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and rimiterol, <b>8</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Moreover, COMT also plays a key role in the inactivation of exogenous toxic compounds and metabolites bearing catecholic structures.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Drug substrates of COMT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The distribution and cellular localization of COMT have been evaluated in several animal species as well as in humans.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> COMT is considered a ubiquitous enzyme because it can be found in almost all peripheral tissues as well as in the central nervous system (CNS). In peripheral tissues, the COMT enzyme is abundantly expressed in the liver and kidney but is also present in the lung, stomach, spleen, intestines, adrenals, heart, various glands, adipose tissue, uterus, gonads, muscles, and red blood cells (RBCs).<a onclick="showRef(event, 'ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref27">(15, 27)</a> The COMT enzymatic activity in the liver is 3–4-fold higher than that in other peripheral tissues. The extent of COMT protein and enzymatic activity in the brain is significantly lower than that in peripheral tissues. Different brain areas show quite similar COMT protein distributions. The COMT enzyme has been found to be present in two distinct forms;<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> both a soluble form (S-COMT) and a membrane-bound form (MB-COMT) have been cloned and characterized. They are coded by the same gene using two separate promoters.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The gene encoding the human enzyme is located in chromosome 22, band q11.2.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Human S-COMT consists of 221 amino acids, whereas human MB-COMT has a 50-residue-long amino-terminal extension that contains the hydrophobic anchor region. The primary amino acid sequences for different mammalian species exhibit high similarity. For instance, human S-COMT is 81% identical with rat S-COMT and displays an 82% homology with the porcine COMT enzyme.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Although large interspecies differences were found in the relative distribution of S-COMT and MB-COMT, S-COMT is predominant in the periphery, while MB-COMT is predominant in the brain.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The cellular localization of S-COMT is different from that of MB-COMT. S-COMT is mainly expressed in the cytoplasm, whereas MB-COMT is located on intracellular membranes, such as the rough endoplasmic reticulum, oriented toward the cytoplasm. Both the S-COMT and MB-COMT forms are active toward O-methylation reactions, and no difference in substrate specificity has been reported. The primary amino acid sequences of the catalytic sites of S-COMT and MB-COMT are identical, but there is a marked difference in their kinetic behavior. MB-COMT shows a higher substrate affinity (<i>K</i><sub>m</sub>) than does S-COMT, which in turn exhibits a much higher capacity (<i>V</i><sub>max</sub>) than does MB-COMT. These kinetic differences determine the roles of the two isoenzymes. MB-COMT has been considered to be the physiologically more important form of the enzyme because it is able to methylate catecholamines at their physiological concentration.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> S-COMT is important in nonphysiological conditions, such as when the substrate concentration suddenly increases (e.g., during L-DOPA treatment) or when a higher O-methylation reaction rate is needed.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.2 Catalytic Mechanism and Three-Dimensional Crystal Structure of COMT</h3><div class="NLM_p">The methylation of catecholic substrates by the COMT enzyme requires the presence of magnesium(II) ions and the cofactor AdoMet. Early kinetic studies with the partially purified enzyme suggested several different catalytic mechanisms, such as the ping–pong mechanism or the rapid random equilibrium mechanism.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Later, it was concluded by Woodard and co-workers that the mechanism is sequentially ordered and that the methylation reaction proceeds in a single step via a tight S<sub>N</sub>2-type transition state in inversion mode without the involvement of a methylated enzyme intermediate.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Approximately three decades after Axelrod’s pioneering work, the soluble form of recombinant rat COMT in complex with the methyl donor AdoMet, a magnesium(II) ion, and a simple tight-binding nitrocatechol, <b>19</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (3,5-dinitrocatechol, 3,5-DNC) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), was successfully cocrystallized.<a onclick="showRef(event, 'ref13 ref38'); return false;" href="javascript:void(0);" class="ref ref13 ref38">(13, 38)</a> In the last two decades, a number of other crystallographic structures of human and rat S-COMTs bound to various inhibitors have also been determined and comprehensively reviewed.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The analysis of the crystal structures revealed that the structural fold of human and rat S-COMTs is similar.<a onclick="showRef(event, 'ref13 ref40'); return false;" href="javascript:void(0);" class="ref ref13 ref40">(13, 40)</a> The overall structure of rat S-COMT in complex with <b>19</b> and the enlarged view of the catalytic site are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,B, respectively.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat S-COMT in complex with the methyl donor AdoMet, the Mg<sup>2+</sup> ion and ligand <b>19</b>: (A) schematic representation of the three-dimensional structure of the protein; (B) enlarged view of the catalytic site. Figures drawn using program PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">COMT has a single domain, a mixed α/β-protein structure in which the seven-stranded central β-sheet core is surrounded by eight α-helices (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The active site of COMT consists of the AdoMet binding domain and the catalytic region with the magnesium(II) ion. The cofactor AdoMet is located in a more buried cleft, whereas the substrate binding site occupies a shallow groove on the outer surface of the protein (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). It has been found that AdoMet is the first ligand to bind to the enzyme, followed by the magnesium(II) ion and finally by the substrate.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Molecular surface of COMT shown in green with the methyl donor AdoMet and ligand <b>19</b> represented in sticks. The Mg<sup>2+</sup> ion is depicted in magenta. Figure drawn using program PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The major molecular interactions with the protein are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. The adenine ring of AdoMet is hydrogen bounded to Ser119 and Gln120 and makes further van der Waals interactions with residues Ile91, Ala118, and Trp143. The methionine fragment of AdoMet forms hydrogen bonds with residues Val42, Ser72, and Asp141.The magnesium(II) ion is located in the center of the catalytic site and has no interaction with the cofactor AdoMet. It is octahedrally coordinated to the oxygen atoms of the side chains of aspartic acid residues Asp141 and Asp169 and asparagine residue Asn170, while another coordination site is occupied by a molecule of water. The fifth and sixth coordinating orbits of the magnesium(II) ion are chelated to each of the two hydroxyl groups belonging to the catechol substrate. In addition to the excellent coordination to the protein and the catechol substrate, the magnesium(II) ion lowers the substrate p<i>K</i><sub>a</sub>, thereby facilitating the deprotonation of the more acidic hydroxyl group of the catechol nucleus by Lys144; the resultant phenolate anion can be immediately methylated by AdoMet. Further important hydrogen bonding interactions have been identified between the hydroxyls of the catechol ring and the side chains of Glu199 and Lys144. Additional beneficial interactions are provided by the so-called hydrophobic “gatekeeper” residues (Trp38, Trp143, Pro174, and Leu198), which maintain the substrate correctly positioned for methylation by making favorable interactions with the catechol ring. The interaction of the catechol ring with Trp38 was found to be absolutely essential for high binding affinity. Replacement of Trp38 with arginine in pig COMT drastically reduced the binding affinity of the catechol substrate.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">From these observations, several families of inhibitors have been designed and synthesized.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Overall, the analysis of the crystal structures clearly suggest that COMT can interact well with various types of inhibitors incorporating catechol pharmacophore. Because the catechol ring binds to the enzyme in a groove at the surface of the protein, the side chain extends out of the catalytic site cavity toward the solvent region, and it can be a target for optimization of the pharmacokinetic profile of the inhibitor.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">3 Therapeutic Applications of COMT Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">COMT inhibitors are used primarily in the treatment of certain central and peripheral nervous system disorders,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> such as Parkinson’s Disease (PD),<a onclick="showRef(event, 'ref5 ref43'); return false;" href="javascript:void(0);" class="ref ref5 ref43">(5, 43)</a> restless leg syndrome<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (RLS), schizophrenia,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> mood disorder,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> depression,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> cognition improvement,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> the depressive phase of bipolar disorder,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> edema formation state,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> gastrointestinal disturbances,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and other dopamine deficiency-related diseases, such as attention deficit disorder<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> (ADD) and attention deficit hyperactivity disorder<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (ADHD). The following serves as a brief summary of the most important therapeutic applications.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.1 Parkinson’s Disease</h3><div class="NLM_p">Parkinson’s disease (PD) is the most prevalent chronic degenerative neurological disorder of the elderly after Alzheimer’s disease (AD). Dopaminergic neurons are gradually destroyed in a specific region of the CNS (mainly in the <i>substantia nigra</i>), resulting in a reduction in brain dopamine levels, which becomes symptomatic over a certain threshold. The classical symptoms of PD are motor-related and commonly include tremor and rigidity as well as mild to severe difficulty in coordinating physical movements. Dopamine is a neurotransmitter that stimulates motor neurons, which are nerve cells that control the muscles. If dopamine production is depleted, the motor system nerves are unable to control movement and coordination. In the later stages of PD, cognitive and behavioral problems may also arise. When clinical symptoms appear, ∼70–80% of the dopaminergic neurons have already been lost. The etiology of this neuronal destruction is unknown (idiopathic PD), but most likely both genetic and environmental factors contribute.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> PD has an estimated prevalence of 2% in the adult population over 60 years of age. There is currently no cure for PD; however, there are medications that can control the symptoms of the disease. In the early stages of PD, the administration of a dopamine agonist, which mimics the effects of dopamine at the dopaminergic receptors, helps alleviate the symptoms of PD. Alternatively, the administration of a centrally active monoamine oxidase (MAO-B) inhibitor prevents the cerebral breakdown of dopamine by blocking the oxidative deamination of dopamine to DOPAC,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> thereby reducing symptoms and improving the quality of life of parkinsonian patients. In certain cases, direct stimulation of the dopaminergic receptors by surgery in the brain (deep brain stimulation) may also be an option for patients afflicted with PD. However, as PD progresses, the symptoms worsen and conventional treatments (dopamine agonists or MAO-B inhibitors) may not provide satisfactory results. The dopamine precursor L-DOPA (levodopa), the most effective symptomatic treatment available for PD, has been in clinical practice since the 1960s and remains the gold standard.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Orally administered L-DOPA is able to compensate for the shortage of cerebral dopamine by transport across the blood–brain barrier (BBB), followed by conversion to dopamine by decarboxylation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Metabolism and active transport of L-DOPA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a result, L-DOPA can be employed clinically as an artificial source of dopamine. Although the majority of PD patients experience considerable improvements in motor function soon after initiating L-DOPA therapy, a major drawback is that this positive clinical response tends to diminish or fluctuate rather quickly over the following years and eventually reaches a stage where undesirable side effects traceable to the medication, such as motor complications and dyskinesia, are not easily distinguishable from the symptoms of the disease itself. It has also been noted that when L-DOPA is administered orally, ∼70% of the orally administered dose is extensively degraded to dopamine in the peripheral tissues through enzyme-catalyzed decarboxylation, so that only a limited percentage of the administered L-DOPA remains intact for passage into the brain. As a COMT substrate, a small amount of the administered L-DOPA (∼10%) is metabolized by the COMT enzyme to 3-OMD, a compound that has not been shown to exhibit any clinical effects (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). To combat this premature destruction of L-DOPA, a peripheral AADC inhibitor, such as <b>1</b> or <b>2</b>, is administered concomitantly, which reduces the extent of L-DOPA decarboxylation in the periphery, thereby reducing the clinically effective dose of L-DOPA by approximately 70–80%.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> However, due to degradation through the COMT pathway, less than 10% of the orally administered L-DOPA dose reaches the brain.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The plasma concentration of 3-OMD increases due to its long elimination half-life (<i>t</i><sub>1/2</sub> ≥ 15 h) and remains high during chronic therapy.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Moreover, 3-OMD further reduces the bioavailability of L-DOPA by competing with it for transport across the BBB.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Therefore, the inhibition of COMT should help preserve the integrity of L-DOPA by minimizing the degree of detrimental O-methylation of L-DOPA to 3-OMD by COMT in the periphery. The concomitant administration of a COMT inhibitor and an AADC inhibitor lowers the required oral dose of L-DOPA while retaining its clinical benefit.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.2 Psychotic Disorders</h3><div class="NLM_p last">COMT also represents an important target as a susceptibility gene for cognitive dysfunction in schizophrenia as a result of the unique role of the enzyme in regulating dopaminergic function in the prefrontal cortex. Within the coding sequence of COMT is a common G to A polymorphism that produces a valine-to-methionine substitution at codons 108 and 158 of S-COMT and MB-COMT, respectively.<a onclick="showRef(event, 'ref45 ref60'); return false;" href="javascript:void(0);" class="ref ref45 ref60">(45, 60)</a> This functional COMT polymorphism (valine/methionine) predicts performance in tasks of prefrontal executive function and the neurophysiological response measured with electroencephalography and functional magnetic resonance imaging in tasks assessing working memory. Individuals with the valine/valine genotype, which encodes for the high-activity enzyme resulting in lower dopamine concentrations in the prefrontal cortex, perform less well and are less efficient physiologically than methionine/methionine individuals.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> These findings raise the possibility of new pharmacological interventions for the treatment of prefrontal cortex dysfunction and of predicting outcome based on COMT genotype.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> However, recent data suggest a more complex pattern of genetic regulation of COMT function beyond that attributable to the valine/methionine locus. Moreover, it is also clear that there is a complex nonlinear relationship between dopamine availability and brain function. These two factors, allied to phenotypic complexity within schizophrenia, make it difficult to draw strong conclusions regarding COMT in schizophrenia.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.3 Other Potential Indications</h3><div class="NLM_p">Dopamine plays a dual role in the body, occurring in both neurons and non-neuronal cells. Dopamine is a neurotransmitter in brain dopaminergic neurons, and its central role in the regulation of motor function and behavior is well established. In the peripheral nervous system, dopamine is the first catecholamine in the biosynthesis of neurotransmitters such as norepinephrine and epinephrine. The role of dopamine in the sympathetic nervous system is not limited only to providing a means for the synthesis of the neurotransmitter noradrenaline;<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> the amine can also act as a cotransmitter in some circumstances.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Non-neuronal cells capable of producing dopamine are distributed in the kidney and intestine.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These renal tubular and intestinal epithelial cells are endowed with a high capacity to synthesize dopamine from its immediate precursor, L-DOPA, where the amine plays a pivotal role as a local hormone with autocrine and paracrine function, regulating water and electrolyte homeostasis.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The rationale for the usefulness of peripherally selective COMT inhibitors in the treatment of cardiovascular disorders and gastrointestinal medical conditions is based on the considerable O-methylation of dopamine by COMT. In fact, high-sodium diets increased night-time systolic and diastolic blood pressures in wild-type mice, whereas the blood pressures in COMT (−/−) mice remained unaltered.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Furthermore, in the wild-type mice, the sodium-induced increase in blood pressure was completely normalized by treatment with a peripheral-selective COMT inhibitor.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Alternatively, some peripherally selective COMT inhibitors may provide protection against angiotensin II-induced renal damage through antioxidative and anti-inflammatory mechanisms rather than through COMT inhibition-induced changes in renal dopaminergic tone.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In a prospectively followed hypertensive cohort, 174 patients who suffered a myocardial infarction were identified and compared with 348 controls from the same cohort.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Patients homozygous for the low activity COMT genotype had a decreased risk of myocardial infarction compared with those with the high activity genotype, with an odds ratio of 0.65 (95% CI 0.44–0.97, <i>p</i> = 0.033). The protective effect of the low activity genotype was most evident among older patients (>58 years of age), with an odds ratio of 0.43 (95% CI 0.23–0.79, <i>p</i> = 0.006). The serum levels of estradiol were increased (<i>p</i> = 0.006) in males with the low activity genotype. These data suggest that the low activity COMT genotype is protective against myocardial infarction, and one may speculate that the altered estrogen status could be involved in this effect.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Other studies have also described the cardiovascular risk effect of the high activity genotype (valine/valine),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> which presents the possibility of using peripherally selective COMT inhibitors in the treatment of cardiovascular disorders. However, there is evidence in the literature that conflicts with these views,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> namely, with respect to experimental models of hypertension.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p last">The inhibition of peripheral COMT, which prevents the mucosal degradation of dopamine, along with various dopamine receptor agonists ameliorates gastroduodenal mucosal damage. This protective effect was suggested to result from the probable electroneutral component of duodenal mucosal bicarbonate secretion stimulated via peripheral dopamine D<sub>1</sub> receptors.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> This may also explain the increased incidence of diarrhea in patients receiving COMT inhibitors.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In addition, some peripheral-selective COMT inhibitors stimulate cAMP-dependent Cl<sup>–</sup> secretion in the rat colon, and this process is regulated by endogenous prostaglandin and the submucosal enteric nervous system.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> On the other hand, it has also been suggested that the COMT gene 158Met polymorphism might be associated with a reduced risk of developing more severe intestinal metaplasia in <i>Helicobacter pylori</i>-infected older subjects.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4 Medicinal Chemistry of COMT Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The medicinal chemistry of COMT inhibitors has been previously reviewed elsewhere.<a onclick="showRef(event, 'ref42 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref42 ref77 ref78">(42, 77, 78)</a> This perspective is structured into different classes of inhibitors exemplified by the most relevant compounds of each class, followed by summary of reported clinical data, and concludes with a personal perspective on the current state of the field.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.1 Competitive Inhibitors</h3><div class="NLM_p">Following the characterization of COMT, several structurally simple small molecules were reported to inhibit COMT. These early COMT ligands<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> included polyhydroxy compounds containing vicinal-dihydroxy (catechol) or trihydroxybenzene (pyrogallol) motifs (Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), as described further below.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">4.1.1 Simple Catechols and Related Structures</h4><div class="NLM_p">Catechols and simple related derivatives have been shown to inhibit COMT in vitro; representative examples are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. Compounds <b>9</b>–<b>15</b> inhibit COMT in a competitive manner, with inhibition constants in the low micromolar range.<a onclick="showRef(event, 'ref4 ref15'); return false;" href="javascript:void(0);" class="ref ref4 ref15">(4, 15)</a> The binding of <b>9</b>–<b>15</b> is fully reversible through the 1,2-dihydroxy moiety. Catechols <b>9</b>–<b>15</b> are very good substrates for the COMT enzyme, and thus they easily undergo O-methylation reactions after incubation with liver COMT, resulting in the formation of the corresponding O-methylated metabolites in high quantities.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The naturally occurring flavonoid <b>14</b><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> and compound <b>15</b><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> (U-0521) have been reported to be the most potent COMT inhibitors in vitro from this early catechol class of compounds, with inhibitory constants (<i>K</i><sub>i</sub>) of 8.4 and 7.8 μM, respectively. The in vivo efficacy of <b>9</b>–<b>15</b> was found to be limited due to the very short half-lives of these molecules.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> For instance, repeated administration of <b>9</b> was required to prolong the in vivo COMT inhibitory effect. Furthermore, <b>9</b> elicited convulsions in mice after intraperitoneal (ip) administration within a few minutes, which is unrelated to COMT inhibition and may be attributed to the facile penetration of <b>9</b> into the brain.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compound <b>15</b> was reported to effectively diminish plasma and brain levels of 3-OMD in different animal species after ip injection, but its target selectivity was questioned because it inhibited other enzymes involved in the catabolism of catecholamines, such as tyrosine hydroxylase.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Despite its toxicity and unfavorable pharmacokinetic properties, catechol <b>15</b> was administered orally to one parkinsonian patient, but no effect on erythrocyte COMT activity was observed.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representative structures of early catechol-based competitive COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">4.1.2 Pyrogallol and its derivatives</h4><div class="NLM_p">Inhibitor <b>16</b><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> (pyrogallol) and derivatives <b>17</b> and <b>18</b>,<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> similarly to <b>9</b>–<b>15</b>, inhibit the COMT enzyme in a competitive manner because they compete with the substrate for the active site of the enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative structures of early pyrogallol-based competitive COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The parent pyrogallol compound <b>16</b> is one of the most potent competitive COMT inhibitors in vitro within the trihydroxybenzene series, with a <i>K</i><sub>i</sub> value of 13 μM. The higher potency of <b>16</b> over the parent catechol compound <b>9</b> (<i>K</i><sub>i</sub> = 30 μM) may be attributed to the presence of the extra hydroxyl group on the catechol nucleus, which provides beneficial van der Waals interactions with the protein in the catalytic pocket. Nevertheless, <b>16</b> displayed a similar in vivo pharmacological profile to that of <b>9</b>, including limited efficacy and high toxicity. Compound <b>16</b> at a dose of 200 mg/kg was found to be short-acting in rats, and a repeated dose was required to sustain effective inhibition. Although <b>16</b> easily penetrated mice brains at a repeated dose of 50 mg/kg every 30 min, its efficacy on cerebral levels of catecholamines was insufficient. Inhibitor <b>17</b> (gallic acid) is a markedly less potent inhibitor than <b>16</b>, with a <i>K</i><sub>i</sub> value of 70 μM. Although <b>16</b> and <b>17</b> share the same 1,2,3-trihydroxybenzene pharmacophore, they have quite different physicochemical properties, which make <b>17</b> more toxic than <b>16</b>. To test a simple ester of <b>17</b>, namely, compound <b>18</b> (GPA 1714), as a COMT inhibitor appeared to be rational because esters of <b>17</b> have been used as safe food additives due to their antioxidant properties. A few clinical trials were performed with the <i>N</i>-butyl ester <b>18</b>, which showed some beneficial effects at a daily dose of 750 mg in patients afflicted with Huntington’s chorea and spasmodic troticollis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>18</b> has been reported to reduce the dose of L-DOPA by an average of 29% in patients with parkinsonism but failed to show any advantage over AADC inhibitors administered concomitantly with L-DOPA.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Furthermore, in patients afflicted with chronic schizophrenia, compound <b>18</b> failed to provide a beneficial therapeutic effect at a daily dose of 5 g.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p last">Due to their unfavorable pharmacokinetic properties and questionable efficacies against cerebral levels of catecholamines, no compounds from the trihydroxybenzene series have advanced into clinical development.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.2 Tight-Binding Inhibitors</h3><div class="NLM_p">In the mid-1980s, two different industrial research groups, at Orion Corp. and Hoffman-la Roche Ltd., simultaneously discovered that disubstituted catechols bearing strongly electron-withdrawing groups (EWGs) (such as nitro or cyano) at the <i>ortho</i>-position to one of the hydroxyl groups were more potent inhibitors of the COMT enzyme than the previously studied simple catechols <b>9</b>–<b>15</b> and pyrogallols <b>16</b>–<b>18</b>.<a onclick="showRef(event, 'ref37 ref90'); return false;" href="javascript:void(0);" class="ref ref37 ref90">(37, 90)</a> The new derivatives were shown to alter L-DOPA metabolism in vivo and were found to be longer-acting inhibitors than <b>9</b>–<b>18</b>. Moreover, they did not interfere with other enzymes involved in the metabolism of catecholamines, including tyrosine hydroxylase, dopamine-β-hydroxylase (DβH), and MAO. In contrast with the earlier competitive inhibitors <b>9</b>–<b>18</b>, the new type of inhibitors did not undergo extensive O-methylation by COMT, which suggests that they bind to the active site of the enzyme more tightly but conversely are poorer substrates. The presence of an EWG markedly lowers the p<i>K</i><sub>a</sub> values of the adjacent hydroxyl group, thereby decreasing the reactivity of the resulting phenolate anion toward O-methylation through delocalization of the negative charge.</div><div class="NLM_p">In the in vitro screening of different compound collections, <b>19</b> was identified as the most potent hit (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Compound <b>19</b> had an ED<sub>50</sub> of 1.3 mg/kg at 1 h postdose in rats, and concomitant administration of 50 mg/kg of <b>19</b> with L-DOPA and <b>2</b> (100 and 50 mg/kg po, respectively) almost completely suppressed the formation of 3-OMD.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The acute toxicity of <b>19</b> was found to be in the range of 312–625 mg/kg after single oral administration to mice. Despite the outstanding in vivo pharmacological profile of <b>19</b> over catechols <b>8</b>–<b>15</b> and pyrogallols <b>16</b>–<b>18</b>, it was concluded that compound <b>19</b> was not suitable for clinical development due to safety and toxicological concerns.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Preliminary structure–activity relationship (SAR) studies on structure <b>19</b> revealed that the position of the EWG is important, and the best result was obtained with compounds substituted with EWGs at the <i>ortho</i>-position relative to one of the hydroxyl groups of the catechol nucleus (cf. <b>19</b> and <b>20</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>). Replacement of the nitro group with other EWGs, such as cyano (<b>21</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>), aldehyde (<b>22</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>), carboxylic acid ester (<b>23</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>), or carboxyamide (<b>24</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a>) groups, drastically reduced COMT inhibition in vitro. Attempts to replace the nitro group of <b>25</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> with trifluoromethyl or mesyl groups gave the practically inactive compounds <b>26</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> and <b>27</b>,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> respectively. The nitro group located at the furthest place from the catechol hydroxyls in structure <b>19</b> has inspired scientists to try to replace it with other groups to modulate the pharmacokinetic properties of <b>19</b>. The nitrocatechol moiety (1,2-dihydroxy 3-nitrobenzene) has been a standard structural feature on most subsequent COMT inhibitor designs because it exhibits greatly improved in vitro potency over the first-generation inhibitors <b>9</b>–<b>18</b>. Efforts by academic research groups and pharmaceutical companies have led to the identification of several new classes of second-generation (tight-binding) COMT inhibitors with improved pharmacokinetic profiles over <b>19</b> and related structures. Several of these research groups have developed compounds that have reached clinical trials, as described further below.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Examples of Early Second-Generation COMT Inhibitors and IC<sub>50</sub> Values</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0021.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="​" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char="​">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">12<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">442<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">-CN</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">88<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">-CHO</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">162<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">-COOMe</td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">361<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="​">1924<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CHO</td><td class="colsep0 rowsep0" align="char" char="​">24<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CHO</td><td class="colsep0 rowsep0" align="char" char="​">2300<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">-SO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">-H</td><td class="colsep0 rowsep0" align="left">-CHO</td><td class="colsep0 rowsep0" align="char" char="​">20000<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determined in rat brain.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> determined in rat liver.</p></div></div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">4.2.1 <i>meta</i>-Nitrated Catechols</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16">4.2.1.1 Vinylic Derivatives</h5><div class="NLM_p">A series of vinylic compounds disclosed by Orion Corp. and exemplified by <b>28</b>–<b>32</b> showed high in vitro potency (IC<sub>50</sub> < 25 nM) in rat brain tissues more or less independently of the nature of the substituents on the vinyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative examples of vinylic <i>meta</i>-nitrated COMT inhibitors and IC<sub>50</sub> values in rat brain homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitors <b>28</b>–<b>32</b> exhibited a greater than 1000-fold increased specificity for COMT versus tyrosine hydroxylase and a greater than 10000-fold increased specificity versus DβH, MAO-A, and MAO-B enzymes. Compounds <b>28</b>–<b>30</b> were found to significantly reduce the plasma levels of 3-OMD in rats by 89%, 26%, and 49%, respectively, 5 h after oral administration at a dose of 30 mg/kg. The pharmacodynamic interaction of the dicyano derivative <b>28</b> with L-DOPA was also assessed. Compound <b>28</b> provided a 2-fold increase in the plasma levels of L-DOPA 3 h postadministration, which was steadily sustained over the next 2 h. Compounds <b>31</b> and <b>32</b>, which are structurally closely related to <b>28</b>–<b>30</b>, were selected as clinical candidates of Orion for the adjunctive treatment of PD.</div><div class="NLM_p">Inhibitor <b>31</b> has been reported to be a tight-binding inhibitor of COMT, with IC<sub>50</sub> values of 18 and 307 nM in rat brain and liver, respectively. The <i>K</i><sub>i</sub> value of <b>31</b> was calculated to be 23 nM in rat liver.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a> COMT inhibition by <b>31</b> was strictly confined to the periphery, and <b>31</b> was found to be devoid of acute toxicity risk (LD<sub>50</sub> > 2500 mg/kg). The beneficial effect of <b>31</b> on the striatal levels of L-DOPA, dopamine, DOPAC, and 3-OMD in rat lasted for 5 h after the oral administration of <b>31</b> plus L-DOPA and an AADC inhibitor and were found to be dose-dependent (3–30 mg).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Compound <b>31</b> demonstrated relatively modest in vivo efficacy in cynomolgus monkeys after intravenous (iv) administration of L-DOPA/AADC inhibitor <b>1</b> boluses, but when administered to rats at an oral dose of 30 mg/kg concomitantly with L- DOPA and AADC inhibitor <b>1</b>, it inhibited the formation of 3-OMD in serum by 80%.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">Compound <b>32</b> is a fully reversible potent inhibitor of COMT with IC<sub>50</sub> values of 10 and 160 nM in rat duodenum and liver, respectively.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Inhibitor <b>32</b> achieved nearly complete inhibition of duodenal COMT for 1–3 h after an oral dose of 30 mg/kg in rats. Compound <b>32</b> is a longer-acting inhibitor than is <b>31</b>, sustaining significant COMT inhibition up to 6 h postadministration in rats. Compound <b>32</b> was found to be a purely peripheral COMT inhibitor at doses of up to 30 mg/kg. Furthermore, <b>32</b> demonstrated a marked effect on rat plasma 3-OMD and L-DOPA pharmacokinetics in a dose-dependent manner (3–30 mg/kg).<a onclick="showRef(event, 'ref94 ref96'); return false;" href="javascript:void(0);" class="ref ref94 ref96">(94, 96)</a> Although <b>32</b> is the most widely prescribed antiparkinsonian COMT inhibitor, it has limitations in clinical practice. Due to its low to moderate bioavailability (<i>F</i> = 29–46%) and relatively short-acting COMT inhibitory profile, its dosages are elevated (200 mg) and must be repeated up to 8 times per day.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The reason for the limited exposure of <b>32</b> may be related to its inadequate physicochemical properties. Compound <b>32</b> exhibits very low aqueous solubility at low pH (80 μg/mL at pH ≤ 5), which affects its rate of absorption from the acidic environment in the stomach.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> At the higher pH values (pH ≥ 5) found in the small intestine, <b>32</b> exists in the ionized form, which limits its passage through the intestinal wall. The partition coefficient (log <i>P</i>) of the ionized form of <b>32</b> has been determined to be −0.4 in a mixture of 1,2-dichloroethane–water.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The low lipophilicity of <b>32</b> at physiological pH can also explain its limited passage across the BBB. In addition to its low aqueous solubility and lipophilicity, the enzymatic stability of <b>32</b> is also limited. Compound <b>32</b> was found to be extensively metabolized through glucuronidation of its hydroxyls, which resulted in short half-lives in different animal species as well as in humans.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_p last">The therapeutic usefulness of vinylic structures, such as compounds <b>28</b>–<b>32</b>, has been demonstrated primarily in the adjunctive treatment of PD, but other potential therapeutic applications have also been claimed by Orion in several patent applications. In a divisional application of Orion’s initial patent application,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> peripherally selective COMT inhibitors bearing nitrocatechol motifs (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) were indicated to be useful in the treatment of hypertension and heart failure, while depression could be treated with CNS-active COMT inhibitors, though no experimental data were reported.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The effect of COMT inhibitors on the treatment of ulcers and lesions in the gastro-intestinal tract has also been reported.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Compounds <b>19</b> and <b>31</b> significantly reduced both the incidence and the severity of cysteamine-induced duodenal ulcers in rats. In another experiment, the administration of absolute ethanol to rats resulted in severe gastric damage consisting of grossly hemorrhagic and necrotic lesions. An oral dose of 30 mg/kg <b>31</b> and <b>19</b> caused 37% and 77% reductions in the areas of the lesions, respectively. In a separate patent application, Orion reported the anticancer effects of <b>19</b> and <b>32</b> on the MCF-7 human breast cancer cell line.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Both <b>19</b> and <b>32</b> markedly decreased the cell growth of MCF-7 cells at low micromolar concentrations. Compound <b>31</b> has been shown to have an effect on the prevention of diabetic vascular dysfunctions, such as nephropathy, retinopathy, and neuropathy.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The effect of <b>31</b> on the glomerular filtration rate (GFR) and albumin excretion rate (AER) was studied in diabetic rats. Inhibitor <b>31</b> at a dose of 30 mg/kg was found to normalize both GFR and AER compared with noninhibitor <b>31</b> treated animals. In 2001, Aho and Linden reported analgesic effects for COMT inhibitors.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The relationship between COMT inhibition and analgesic effects has remained unclear. However, inhibitors <b>19</b> and <b>31</b>–<b>32</b> displayed significant reductions in the pain thresholds of different pharmacological models, such as in the Randall–Selitto test and the acetic acid-induced writhing test. Interestingly, the same COMT inhibitors (<b>19</b> and <b>31</b>–<b>32</b>) had no effect in a hot plate test, which might be attributed to their peripheral mechanism of action. Orion published two patent applications on the use of COMT inhibitors in combination with L-DOPA and AADC inhibitors for the symptomatic treatment of patients afflicted with restless legs syndrome (RLS)<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> and for the delay of the progression of motor dysfunction in patients afflicted with PD.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> It has been reported that <b>32</b> potentiates the turning behavior induced by L-DOPA and AADC inhibitor <b>1</b> in rats with unilateral nigral lesions.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17">4.2.1.2 Acetylated and Carbamoylated Derivatives</h5><div class="NLM_p">Acetylated and carbamoylated series of compounds were first identified by Hoffmann la Roche Ltd., aimed at the development of an orally bioavailable, reversibly binding, and CNS-active COMT inhibitor for the treatment of PD. Representative examples <b>33</b>–<b>36</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>.<a onclick="showRef(event, 'ref37 ref109'); return false;" href="javascript:void(0);" class="ref ref37 ref109">(37, 109)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative examples of acetylated and carbamoylated <i>meta</i>-nitro COMT inhibitors and their IC<sub>50</sub> values in rat liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among structures <b>33</b>–<b>35</b>, no significant influence of different side chain substituents on in vitro activity has been observed. Despite good in vitro COMT enzymatic activity, compounds <b>33</b>–<b>35</b> showed moderate in vivo efficacy and exhibited considerable toxicity. The ED<sub>50</sub> values of <b>33</b>–<b>35</b> have been determined in rats at 4 h postdose to be 6.7, 5.1, and 3.4 mg/kg, respectively. The optimization of the acetyl substituent of <b>35</b> led to the identification of benzoyl derivative <b>36</b> (Ro41-0960), which was slightly more potent in vitro than was the parent compound <b>35</b>, though it was endowed with markedly enhanced in vivo efficacy over <b>33</b>–<b>35</b>. This o<i>rtho</i>-fluoro analogue <b>36</b> was found to be very potent, with an oral ED<sub>50</sub> of 0.28 mg/kg in rats at 1 h postdose. Moreover, compound <b>36</b> (3–100 mg, po, 2 h) blocked the formation of 3-OMD and homovanillic acid (HVA) in rats in a dose-dependent manner. Concomitant administration of 50 mg/kg <b>36</b> with L-DOPA and <b>2</b> (100 and 50 mg/kg po, respectively) almost completely suppressed the formation of 3-OMD (9% of control).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Despite the favorable pharmacological and toxicological profile of <b>36</b>, Roche has not considered the clinical development of COMT inhibitor <b>36</b>. However, from the same class of compounds, a structurally very close analogue to <b>36</b>, inhibitor <b>37</b>, was chosen for clinical evaluation for the adjunctive treatment of PD.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><div class="NLM_p">Compound <b>37</b> was characterized as a tight-binding and reversible inhibitor of the COMT enzyme and found to be more potent under in vitro experimental conditions than was <b>31</b> or <b>32</b> against rat liver and brain COMT, with IC<sub>50</sub> values of 36 and 2.2 nM, respectively.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Furthermore, <b>37</b> displayed longer duration of action in different animal species and appeared to be more potent than were compounds <b>31</b> and <b>32</b>.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Compound <b>37</b> showed full inhibition in the heart and kidney when dosed to rats (100 mg/kg) at 0.5 h postdose, and the liver COMT was inhibited by over 90% at the same time point. Significant inhibition (≥50%) was maintained up to 8 h (in liver) and 11 h (heart and kidney) after dosing.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The COMT enzymatic activity was fully recovered at 16 h postdose in all tissues. Compound <b>37</b> increased the extracellular levels of L-DOPA, dopamine, and DOPAC in the rat striatum in a dose-dependent manner (3–30 mg), while the levels of 3-OMD were markedly decreased when <b>37</b> was coadministered with L-DOPA and AADC inhibitors. Although <b>37</b> shares with <b>31</b> and <b>32</b> the same nitrocatechol pharmacophore, it displays a different pharmacokinetic profile, which was demonstrated by its cerebral inhibition effect.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> The high permeation of <b>37</b> across the BBB is believed to be due to the presence of the lipophilic 4′-methylbenzoyl side chain. Compound <b>37</b> has been shown to be an equipotent inhibitor of both brain and peripheral COMT, with a cerebral ID<sub>50</sub> of 26–28 mg/kg in rats.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The L-DOPA induced increase in HVA output was attenuated by <b>37</b>, which further confirms the occurrence of central COMT inhibition.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> The beneficial effect of central COMT inhibition has been demonstrated in several pharmacological models. Inhibitor <b>37</b> administered alone has demonstrated antidepressant activity in an animal model of the anhedonic state, but an L-DOPA boost was needed to show a more marked antidepressant effect in two other rat models of depression (the forced swimming test and learned helplessness paradigm).<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114, 115)</a> Compound <b>37</b> has also been shown to increase the exploratory activity of rats after oral administration at a dose of 10 mg/kg and was found to potentiate the hyperactivity and stereotypy induced by amphetamine and nomifensine in rats.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><div class="NLM_p">The acute toxicity of <b>37</b> was found to be low. The oral LD<sub>50</sub> values in rat were higher than 2 g/kg.<a onclick="showRef(event, 'ref110 ref117'); return false;" href="javascript:void(0);" class="ref ref110 ref117">(110, 117)</a> The oral bioavailability of <b>37</b> was demonstrated to be superior (<i>F</i> = 60%) to that of <b>32</b>. Compounds <b>32</b> and <b>37</b> have similar p<i>K</i><sub>a</sub> values and poor aqueous solubility profiles. Experimental log <i>P</i> values for both the neutral (3.17) and ionized (0.2) forms of <b>37</b> were found to be higher than that of <b>32</b> (2.16 and −0.4, respectively), which supports its enhanced intestinal absorption and higher permeation across the BBB over <b>32</b>. During clinical trials, <b>37</b> altered liver enzyme activity in 1–3% of subjects.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Shortly after the launch, the marketing authorization of <b>37</b> was suspended due to liver toxicity concerns highlighted by several postlaunch cases of fatal fulminant hepatitis.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Several possible causes have been postulated for the toxicity of <b>37</b>. In humans, compound <b>37</b> is almost completely metabolized prior to excretion, with less than 1% of an orally administered dose of <b>37</b> excreted unchanged.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Although the reduction of the nitro group to the corresponding catecholic aniline accounted for 8% of the excretion of the administered dose of <b>37</b>, this metabolic pathway could be responsible for forming reactive intermediates arising from the oxidation of the amino metabolite of <b>37</b>. It has also been shown that these reactive intermediates form glutathione adducts in vitro upon incubation with human liver microsomes and may be capable of forming covalent adducts with hepatic proteins, resulting in damage to liver tissue.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Another possible mechanism of toxicity involves the uncoupling of oxidative phosphorylation, which has been observed in vitro and in vivo.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122, 123)</a> Furthermore, <b>37</b> has been shown to be toxic to human neuroblastoma SH-SY5Y cells and caused a profound reduction in ATP synthesis with or without a functional respiratory chain.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p">Limitations in the clinical use of <b>32</b> and <b>37</b> have prompted the discovery of novel COMT inhibitors with improved efficacies (more efficacious than <b>32</b>), peripheral selectivities (more selective than <b>37</b>), and safety profiles (safer than <b>37</b>). To this end, the analogue-based design approach has been taken at BIAL – Portela & C<sup>a</sup>, S.A., to identify new compounds that selectively inhibit COMT in peripheral tissues. A homologous series (<i>n</i> = 1–4) of nitrocatechol structures <b>38</b> have been disclosed, which were derived from the CNS active <b>37</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> It had been speculated that insertion of an aliphatic spacer (<i>n</i> = 1–4) between the carbonyl group and the phenyl ring might result in COMT inhibitors approximately equipotent to the parent <b>37</b> but with improved peripheral selectivity. Compounds with different spacer lengths (<i>n</i> = 1–4) were shown to inhibit in vitro both rat brain and liver COMT with IC<sub>50</sub> values ranging from 3.7 to 12.8 nM and from 696 to 1285 nM, respectively. It has also been shown that compounds with the general formula <b>38</b> (<i>n</i> = 1–4) achieved maximal inhibitory effects within 30 min after their oral administration to rats at a dose of 30 mg/kg. The parent benzophenone derivative (<i>n</i> = 0) showed a similar inhibitory profile against brain and liver COMT, whereas compounds with longer carbon chains (<i>n</i> = 1–4) were less potent at inhibiting brain COMT in comparison with their inhibitory effect on liver COMT. Inhibitor <b>39</b><a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> was found to exhibit the longest duration of action and was endowed with enhanced peripheral selectivity over <b>37</b>. Furthermore, <b>39</b> and <b>37</b> were equally potent inhibitors of liver COMT in the rat, with ED<sub>50</sub> values of 0.7 mg/kg at 1 h postdose. Inhibition by <b>39</b> had a shorter duration than did that by <b>37</b> but a longer duration than did that by <b>32</b>. Compound <b>39</b> displayed weaker brain COMT inhibition than did <b>37</b>, with ED<sub>50</sub> values of 5.3 and 1.6 mg/kg, respectively. Substitution on the phenyl ring of core structure <b>38</b> had no effect on the inhibitory profiles of the parent unsubstituted structures, such as <b>39</b>.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Incubation of <b>39</b> with liver microsomes resulted in the formation of the corresponding <i>meta</i>- and <i>para</i>-O-methylated metabolites. The crystal structures of COMT were used to study the molecular interactions between <b>39</b> and rat S-COMT by unrestrained flexible-docking simulations.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> It has been found that the catechol ring of <b>39</b> can bind in two different orientations to the active site of COMT, which explains the lack of regioselectivity of O-methylation seen in vitro. In contrast, under in vivo conditions <b>39</b> has been shown to undergo O-methylation exclusively at the <i>meta</i>-position relative to the phenylacetyl side chain, as a result of the preferential cytochrome P450-mediated O-demethylation of the <i>para</i>-<i>O</i>-methyl regioisomer.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><div class="NLM_p">The functional relevance of brain COMT inhibition by <b>39</b> was evaluated based on the potentiation of amphetamine-induced hyperactivity. Amphetamine is known to be a potent psychostimulant that, depending on the dose administered, increases locomotion and induces stereotypies. Peripherally selective COMT inhibitors are expected not to alter amphetamine-induced locomotion and stereotypies. Indeed, rats treated (30 mg/kg) with <b>32</b> or <b>39</b> 6 h before amphetamine challenge (4 mg/kg) displayed the same pattern of locomotion and stereotyped behavior as did the corresponding controls. On the basis of the overall pharmacological profile, <b>39</b> entered clinical evaluation as an adjunct to L-DOPA therapy for PD. The clinical development of <b>39</b> was discontinued because its safety profile was not considered sufficiently improved over that of <b>37</b>.</div><div class="NLM_p last">Further efforts to modify <b>37</b> led to the identification of a distinct series of compounds incorporating heteroatom-containing side chains, such as alkyl-phenols, thiophenols, and disubstituted amines (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Compounds from phenoxy and thiophenoxy series <b>40</b> were found to exhibit slightly improved in vitro (in SK-N-SH cells, 100 nM) COMT inhibition (85–94%) over <b>32</b> (77%) but were less efficacious than was <b>37</b> (97%).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The length of the hydrocarbon spacer (<i>n</i> = 1–4) had no effect on the in vitro COMT inhibition. In mice at a dose of 30 mg/kg, compounds from the same class <b>40</b> were shown to be potent liver COMT inhibitors (70–78% inhibition at 1 h) and were reasonably selective for the periphery (20–39% central inhibition at 1 h). In the alkylamino series <b>41</b>,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> compounds containing <i>N</i>-phenyl piperazine side chains were equipotent to <b>37</b>. Substitution with less bulky groups, such as <i>N</i>,<i>N</i>-dimethyl, morpholine, and alkyl-piperazine, led to reductions in COMT inhibition. Thus, systematic modification of <i>N</i>-phenyl piperazine side chains (<i>n</i> = 2) led to the identification of inhibitor <b>42</b><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> (BIA 3-335; Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which was found to be a long-acting peripheral COMT inhibitor retaining 74% inhibition at 6 h postdose (30 mg/kg, mice), while <b>32</b> provided only 26% inhibition in liver tissues. Furthermore, <b>42</b> displayed better peripheral selectivity (14% cerebral inhibition at 1 h) compared with <b>37</b> (99% brain inhibition at 1 h). The poor BBB penetration of <b>42</b> may be attributed to the presence of two piperazinyl nitrogen atoms beyond the customary nitrocatechol motif along with the solvent accessible carbonyl function, which altogether represent an extended hydrophilic surface. Moreover, the hydrogen-bond acceptor atoms have a further negative impact on BBB permeation. In conjunction with 3D structures of COMT in complex with other inhibitors, it has been found that the nitrocatechol ring of <b>42</b> binds to the substrate binding site and the bulky side-chain extends out of the catalytic pocket toward the solvent region without providing beneficial interaction with the protein.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18">4.2.1.3 Heterocyclyl Nitrocatechol Derivatives</h5><div class="NLM_p">Researchers at Hofmann la-Roche Ltd. disclosed the first structurally varied series of COMT inhibitors bearing heterocyclic rings at the <i>meta</i>-position relative to the nitro group.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Representative examples of heterocyclyl <i>meta</i>-nitro COMT inhibitors and their IC<sub>50</sub> values in rat liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Representative examples <b>43</b>–<b>46</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>. In vitro COMT inhibition by compounds <b>43</b>–<b>46</b> ranged from 23 to 39 nM in rat liver tissues. Compounds <b>43</b>–<b>46</b> exhibited low toxicity in mice (LD<sub>50</sub> > 5000 mg/kg), but their in vivo efficacy was found to be weaker than that of <b>37</b>, most likely due to poor gastrointestinal absorption.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> For instance, the benzoxazinone derivative <b>43</b> had an oral ED<sub>50</sub> of 32 mg/kg in rats 4 h postadministration, which corresponds to a more than 10-fold weaker efficacy than that of <b>37</b>. Applying the prodrug approach to compounds <b>43</b>–<b>46</b> resulted in modest improvements in the in vivo potency.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">In another effort to identify novel COMT inhibitors endowed with enhanced in vivo potency over <b>43</b>–<b>46</b>, researchers at BIAL – Portela & C<sup>a</sup>, S.A. have reported the optimization of a screening hit <b>47</b>,<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> identified by preliminary in vitro screening of different compound banks (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The trihydroxybenzene ring of <b>47</b> was replaced with the customary nitrocatechol subunit, leading to the identification of potent COMT inhibitors in vitro, such as <b>48</b><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> (100% inhibition at 3 μM), with limited in vivo inhibitory ability in mice liver (39% inhibition at 30 mg/kg, 6 h postdose). In a subsequent optimization phase, the replacement of the pyrazole ring with oxadiazole rings resulted in compound <b>49</b>,<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> which was found to be equipotent to <b>37</b> in mice (93% liver inhibition at 30 mg/kg, 6 h postdose). Oxadiazole <b>49</b> showed only a 3-fold preference for peripheral COMT inhibition in the rat 3 h postadministration (3 mg/kg). Furthermore, in an in vitro toxicity assay (mouse neuroblastoma cell line at 30 μM), the viable cell count was reduced to 43% after 24 h of exposure to compound <b>49</b>, suggesting that <b>49</b> might be toxic. In a subsequent phase of SAR aimed at reducing toxicity risk and improving tissue selectivity, the replacement of the phenyl ring with heterocyclic rings led to the identification of a series of <i>meta</i>-pyridyl-<i>N</i>-oxides exemplified by <b>50a</b>–<b>c</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Notably, the o<i>rtho</i>- and <i>para</i>-pyridine <i>N</i>-oxide derivatives were generally found to be less potent than were their <i>meta</i>-pyridyl-<i>N</i>-oxide regioisomers. Although the prototype compound <b>50a</b> displayed modest inhibition (33%) in mice at a dose of 3 mg/kg (3 h postdose), it showed very little alteration in the cell viability count (93% of control) after 24 h of exposure to a mouse neuroblastoma cell line at a concentration of 30 μM. Further work on <b>50a</b> demonstrated that the pyridyl <i>N</i>-oxide ring could be substituted with small lipophilic groups (CF<sub>3</sub> in <b>50b</b> or methyl and halogen in <b>50c</b>), which restored its high potency (95–99% inhibition) and reduced its toxicity in a mouse neuroblastoma cell line (87–96% viable cells after 24 h exposure) compared with <b>37</b> (27% viable cells). Based on the presented data, it was not obvious what type of molecular properties might be responsible for the lower toxicity risk of the pyridine <i>N</i>-oxide compounds. Nevertheless, the authors were convinced that the lower lipophilicity (log <i>P</i>) and higher hydrophilic surface area were the key molecular descriptors of the toxicity risk of COMT inhibitors such as <b>50a</b>–<b>c</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The best compound from the pyridine <i>N</i>-oxide series was <b>50c</b>, which is under clinical evaluation for the adjunctive treatment of PD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">In a time course experiment (rat, po, 3 mg/kg), <b>50c</b> achieved the maximum inhibitory (99%) effect within 3 h of oral administration, which was continued by 80–90% inhibition up to 9 h postadministration, followed by a gradual return to lower levels over the next 15 h. Furthermore, <b>50c</b> was shown to modulate the plasma levels of L-DOPA (101% increase) and 3-OMD (43–58% of decrease) at a dose of 3 mg/kg. Compound <b>50c</b> was designed as a hydrophilic 1,2,4-oxadiazole analogue with a pyridine <i>N</i>-oxide residue at position 3 to provide high COMT inhibitory potency and prevent cell toxicity.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Inhibitor <b>50c</b> is endowed with an exceptionally high binding affinity (subpicomolar <i>K</i><sub>d</sub>)<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> that translates into a slow complex dissociation rate constant and a long duration of action in vivo.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In liver and brain homogenates from rats administered <b>50c</b>, <b>37</b>, and <b>32</b> by a gastric tube, compound <b>50c</b> showed a stronger and more sustained COMT inhibitory effect than did the COMT inhibitors <b>37</b> and <b>32</b>. One hour after administration, the COMT inhibition was 99% for <b>50c</b> versus 82% for <b>37</b> and 68% for <b>32</b>. Nine hours after administration, <b>32</b> showed no COMT inhibition, and <b>37</b> produced a minimal inhibitory effect (16%), whereas <b>50c</b> continued to inhibit COMT activity by 91%.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Chronic administration of <b>50c</b> to cynomolgus monkeys resulted in increased L-DOPA bioavailability, both peripheral and central, with a concomitant reduction in 3-OMD formation.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Compound <b>50c</b> increased the L-DOPA exposure (from 2031 to 3352 ng·h/mL) in the dorsal striatum dialysate without changing the L-DOPA <i>C</i><sub>max</sub> values and reduced the exposure to 3-OMD (from 315 to 105 ng·h/mL) with marked decreases in the 3-OMD <i>C</i><sub>max</sub> values (from 29.7 to 7.6 ng/mL). Similar findings were observed in the substantia nigra and prefrontal cortex. Inhibitor <b>50c</b> increased the L-DOPA systemic exposure (from 267627 to 506858 ng·h/mL) without changing the L-DOPA <i>C</i><sub>max</sub> values and reduced the exposure to 3-OMD (from 417304 to 66544 ng·h/mL) with marked decreases in the 3-OMD <i>C</i><sub>max</sub> values (from 1909 to 427 ng/mL). These changes were accompanied by ∼80–85% reductions in the erythrocyte COMT activity.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19">4.2.1.4 Diphenyl Sulfone Scaffolds</h5><div class="NLM_p">Takehiro and collaborators at Kissei Pharmaceuticals reported a new family of COMT inhibitors characterized by the general formula <b>51</b>, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>, where the nitrocatechol pharmacophore is further functionalized at the 5-position with a benzene-sulfonyl group.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> A number of compounds have been synthesized and shown to inhibit the COMT enzyme in vitro at low nanomolar concentrations. In particular, compound <b>52</b><a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> was shown to be endowed with an IC<sub>50</sub> of 6.2 nM.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. COMT inhibitors developed by Kissei Pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A selected series of compounds have been subjected to in vitro cellular toxicity tests in a rat hepatocyte cell line. The EC<sub>50</sub> values (50% of viable cells) were determined for each compound, and the results were compared with those for <b>37</b> and <b>32</b>. It was found that some of the disclosed derivatives (such as compound <b>52</b>) displayed lower toxicity than did either <b>37</b> (EC<sub>50</sub> = 34.3 μM) or <b>32</b> (EC<sub>50</sub> = 111 μM).</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">4.2.2 <i>ortho</i>-Nitrated Catechols</h4><div class="NLM_p">In the early 1990s, Pérez and co-workers disclosed the first example of “<i>ortho</i>-nitrated” catechols, exemplified by <b>53</b>, where the nitro group is located at the <i>ortho</i> position relative to the formyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Compound <b>53</b> exhibited an IC<sub>50</sub> value of 1.5 μM against pig liver COMT, which was slightly superior to that of the corresponding 3,4-dihydroxy-5-nitro regioisomer (IC<sub>50</sub> = 2.0 μM). Further studies by the same group led to the discovery of <b>54</b> (QO IIR2), which incorporated a vinylic side chain at the <i>ortho</i> position.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Compound <b>54</b> was found to be a selective, reversible, tight-binding COMT inhibitor with an apparent inhibition constant (<i>K</i><sub>app</sub>) of 200 nM, which is 3.5-fold lower than that obtained for <b>31</b>.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Compound <b>54</b> modulated the striatal levels of 3-OMD in a dose-dependent fashion after concomitant ip administration with L-DOPA (7.5–60 mg/kg) and AADC inhibitor <b>1</b> (50 mg/kg).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative examples of <i>ortho</i>-nitrated COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">BIAL – Portela & C<sup>a</sup>, S.A., have disclosed a systematic comparative study of regioisomerically nitrated derivatives of common <i>meta</i>-nitrated COMT inhibitors, such as <b>39</b> and <b>42</b>.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> General structures and representative examples of this work are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>. The alkylaryl <b>55</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> and alkylamino <b>56</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> compounds were shown to maintain good in vitro potency in comparison to their <i>meta</i>-nitrated derivatives (<b>39</b> and <b>42</b>), whereas the ring-constrained analogues <b>57</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> exhibited weaker COMT inhibitory potency than did the corresponding open chain derivatives in human neuroblastoma SK-N-SH cells at a concentration of 100 nM. Conversely, the <i>ortho</i>-nitro analogues <b>55</b> and <b>56</b> failed to provide enhanced in vivo inhibition (rat, 30 mg/kg, po) over their <i>meta</i>-nitrated derivatives <b>39</b> and <b>42</b>. Generally, compounds from series <b>55</b> and <b>56</b> displayed much shorter peripheral durations of inhibition than did their <i>meta</i>-nitro regioisomers <b>39</b> and <b>42</b>. Additionally, examples of <b>55</b> and <b>56</b> were endowed with little or no peripheral selectivity. The best inhibitor from the “<i>ortho</i>-nitrated” series was compound <b>58</b><a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> (BIA 8-176), which subsequently advanced into the preclinical phase. Benzophenone analogue <b>58</b> inhibited rat brain and liver COMT with IC<sub>50</sub> values of 3 and 130 nM, respectively. Compound <b>58</b> rapidly (<i>t</i><sub>max</sub> = 0.5 h) achieved the maximum inhibitory effect in rat liver at a dose of 30 mg/kg, and thereafter the inhibitory ability of <b>58</b> had fallen by 50% at 3 h postdose. The profile of central inhibition by <b>58</b> was similar to that of liver inhibition. After the rapid onset (<i>t</i><sub>max</sub> = 0.5 h) of cerebral COMT inhibition (>90%) by <b>58</b>, the inhibitory effect relatively quickly decreased over the next 2.5 h. The shorter-acting effect of <i>ortho</i>-nitrated catechols over the corresponding <i>meta</i>-nitrated compounds may be attributed to their reduced metabolic stability. In vitro metabolic studies with <b>58</b> provided information on its binding orientation. Compound <b>58</b> is predominantly methylated at the <i>ortho</i>- rather than the <i>meta</i>-position (7.5:1). The preferred <i>ortho</i> binding mode was confirmed by molecular modeling studies and X-ray crystallography.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The <i>ortho</i> biding mode is thermodynamically more favorable than the <i>meta</i> orientation. Furthermore, in <i>meta</i> orientation, the nitro group encounters steric conflicts with a hydrophobic side chain of Leu198 and is strongly destabilized by repulsive electrostatic interactions with the negatively charged Glu199.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> In contrast, in <i>ortho</i> binding mode, benzophenone <b>58</b> makes favorable van der Waals interactions contacts with Trp143. The development of <b>58</b> was discontinued due to metabolic stability concerns.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.2.3 Trisubstituted Catechol Derivatives</h4><div class="NLM_p">In a patent application, Orion has claimed that trisubstituted catechol derivatives inhibit the COMT enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative examples of trisubstituted catechol structures of COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The most interesting reported inhibitors from this work are compounds <b>59</b><a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and <b>60</b>,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> with IC<sub>50</sub> values of 15 and 30 nM, respectively, representing improvements over their mononitro analogues. In rats, at a dose of 10 mg/kg, compounds <b>59</b> and <b>60</b> displayed plasma concentrations 0.5 h postdose that were markedly higher than those for <b>31</b>. Both compounds <b>59</b> and <b>60</b> exhibited better bioavailability than did <b>31</b>, but the dicyano derivative <b>59</b> exhibited a shorter plasma half-life than did the dinitro analogue <b>60</b>, which may be attributed to differences in their metabolic stabilities. The compounds have been proposed for use in PD and hypertension. In a very recent patent application, Orion has disclosed a series of isophthalonitriles similar to <b>59</b> exemplified by compound <b>61</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Compound <b>61</b> inhibited human recombinant S-COMT with a <i>K</i><sub>i</sub> value of 190 nM. Additionally, <b>61</b> demonstrated an improved effect on L-DOPA pharmacokinetics over <b>32</b>. The structure of the clinical candidate from this work has not been disclosed to date.</div><div class="NLM_p">In 2009, Kissei pharmaceuticals published a novel series of trisubstituted oxadiazolyl-nitrocatechol derivatives, such as <b>62a</b>.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> The synthesized compounds are structurally quite similar to a previously disclosed oxadiazole compound, <b>62b</b>,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> which can be found in Roche’s patent application.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Compound <b>62a</b> is a potent inhibitor of human COMT, with an IC<sub>50</sub> of 9.4 nM. Moreover, <b>62a</b> was found to possess apparently lower toxicity compared with that of <b>62b</b> in the rat hepatocyte cell line. The pharmacodynamic interaction of oxadiazole <b>62a</b> and the comparator <b>62b</b> with L-DOPA was assessed in rats. Compounds <b>62a</b>,<b>b</b> were administered at a dose of 3 mg/kg, and then L-DOPA (5 mg/kg) was coadministered with AADC inhibitor <b>1</b> (30 mg/kg) at either 4 or 6 h postdose. After 2 h, the L-DOPA was quantified. Compound <b>62a</b> caused a 2-fold increase in the plasma levels of L-DOPA 4 h postadministration, which was steadily sustained over the next 2 h. In contrast, <b>62b</b> provided only a 40% increase in the plasma levels of L-DOPA, and thereafter the L-DOPA levels quickly returned to the baseline at 6 h postadministration. Finally, the potentiation of the efficacy of L-DOPA in unilateral 6-hydroxydopamine-lesioned hemiparkinsonian rats was assessed. Compounds <b>62a</b>,<b>b</b> were orally administered (10 mg/kg) with concomitant oral administration of L-DOPA (5 mg/kg) and AADC inhibitor <b>2</b> (30 mg/kg). Three weeks after the lesion, the potency was measured as the number of contralateral turnings. Oxadiazole <b>62a</b> displayed remarkable potentiation of the drug effects compared with control animals treated only with L-DOPA and inhibitor <b>2</b>. It is unknown whether these new analogues, such as <b>62a</b>, have any advantage over BIAL’s oxadiazolyl COMT inhibitors, such as <b>50c</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">Hiroaki and colleagues at Kissei Pharmaceuticals characterized trisubstituted nitrovanillic amide derivatives as inhibitors of the COMT enzyme, represented by compound <b>63</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Compound <b>63</b> was shown to be equipotent to <b>32</b> (IC<sub>50</sub> = 10 nM) and displayed improved in vitro efficacy over <b>37</b> (IC<sub>50</sub> = 36 nM). Additionally, in the rat hepatocyte cell line, compound <b>63</b> presented a lower toxicity risk than did <b>32</b> and <b>37</b>.</div><div class="NLM_p last">Further efforts to identify novel COMT inhibitors at Kissei Pharmaceuticals led to the discovery of novel trisubstituted COMT inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> A representative structure of this work is compound <b>64</b>,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> which was found to be potent in vitro, with an IC<sub>50</sub> value of 6.2 nM. Compound <b>64</b> is devoid of toxicity in the rat hepatocyte cell line. The in vivo COMT inhibitory profile of <b>64</b> was evaluated in rat liver and brain homogenates at a dose of 10 mg/kg. Compound <b>64</b> was found to achieve a 100% inhibitory effect in the liver 1 h after oral administration and thereafter sustained constant inhibition of COMT over the next 4 h. Conversely, <b>32</b> and <b>37</b> displayed shorter durations in peripheral inhibition. The extent of central COMT inhibition by nitrocatechol <b>64</b> was markedly lower than that of <b>37</b> and remained below the 40% level. Compound <b>64</b> was tested for its potentiation of the efficacy of L-DOPA in unilateral 6-hydroxydopamine lesioned hemiparkinsonian rats. The authors claimed that compound <b>64</b> presented similar potentiation drug effects to those of <b>37</b>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">4.2.4 Fused Nitrocatechol Derivatives</h4><div class="NLM_p">In the early 2000s, Orion’s interest turned to fused bicyclic nitrocatechol structures (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Fused nitrocatechol structures of COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">COMT inhibitors in which the pharmacophore is an appropriately substituted coumarin ring system were published in 2002.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The invention is represented by the 5-nitro analogue <b>65</b><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and 8-nitro derivative <b>66</b>.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Compounds <b>65</b> and <b>66</b> inhibited COMT in the low nanomolar range with IC<sub>50</sub> values of 10 and 35 nM, respectively. The in vivo COMT activity data for the coumarin compounds were not disclosed in the patent application. The second scaffold is based upon naphthalene and isoquinoline derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> The application is represented by compounds <b>67</b><a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> and <b>68</b>.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> The naphthyl derivative <b>67</b> exhibited an IC<sub>50</sub> of 15 nM, while isoquinolinyl example <b>68</b> was shown to have a much weaker COMT inhibitory effect (IC<sub>50</sub> = 140 nM) than the structurally similar naphthyl analogues, such as <b>67</b>. Another “bicyclic” patent application by Orion focused on benzofused five-membered heterocycles with the preferred structures represented by compounds <b>69</b> and <b>70</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Examples <b>69</b> and <b>70</b> exhibited impressive inhibitory constants with <i>K</i><sub><i>i</i></sub> values of 0.5 and 2.0 nM, respectively. Compounds <b>69</b> and <b>70</b> were evaluated in vitro for their ability to uncouple oxidative phosphorylation, which appears to be one of the most important mechanisms of the cell toxicity caused by some nitrocatechol derivatives, such as <b>37</b>.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122, 123)</a> The presented data confirmed that compounds <b>69</b> and <b>70</b> did not uncouple oxidative phosphorylation. Furthermore, compounds <b>69</b> and <b>70</b> were demonstrated to be endowed with enhanced in vitro uridine-5′-diphosphoglucuronic acid (UGDPA) metabolic stability in human liver microsomes over <b>32</b>. However, in a related publication, benzothiophene <b>69</b> was reported to possess poor oral bioavailability and high systemic clearance.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> The exact structure of the clinical candidate for the treatment of PD has not been revealed publicly, but it was later reported that the phase I clinical trial was discontinued due to the conclusion that the clinical candidate pharmacological properties would not outperform those of <b>32</b> or <b>37</b>.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.3 Miscellaneous Inhibitors</h3><div class="NLM_p">In addition to the catechol- and pyrogallol-based inhibitors discussed in sections <a class="ref internalNav" href="#sec4_1" aria-label="4.1">4.1</a> and <a class="ref internalNav" href="#sec4_2" aria-label="4.2">4.2</a>, several structurally “atypical” molecules, which do not share the dihydroxy- or trihydroxybenzene ring, have been reported to show COMT inhibitory activity and are discussed further below.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.3.1 Tropolone-Based Inhibitors</h4><div class="NLM_p">Compound <b>71</b> (tropolone) and its alkylated derivatives <b>72</b> and <b>73</b> inhibit COMT in a competitive fashion, with <i>K</i><sub>i</sub> values of 27.0, 8.9, and 10.1 μM, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Although tropolones <b>71</b>–<b>73</b> do not incorporate a catechol motif in their structure, they are able to interact with COMT through α-keto–enol tautomerism.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Tropolone-based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The binding mode of <b>71</b>–<b>73</b> is reversible, and the strength of the interaction with COMT is relatively weak, which results in short acting in vivo effects in different animal species, such as in rats.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Compound <b>71</b> exhibited high cerebral concentrations 0.5 h after ip administration in rats at a dose of 100 mg/kg. The concentration was markedly reduced in all tissues over the next 2–3 h. Tropolones <b>71</b>–<b>73</b> exerted modest effects on catecholamine levels when administered ip to rats at doses of 40–100 mg/kg. Due to the considerable toxicity of <b>71</b>–<b>73</b>, no clinical development was initiated with tropolone derivatives.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.3.2 Hydroxy-pyridones, -pyrimidones, -quinolinones, and -pyrones</h4><div class="NLM_p">Hydroxy-pyridones, -pyrimidones, -quinolinones, and -pyrones interact with the COMT enzyme in a similar fashion as do tropolones <b>71</b>–<b>73</b>, because they can be considered isosteric compounds of catechol.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> The early prototype compounds <b>74</b>–<b>76</b><a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> share similar pharmacological properties with pyrogallols <b>16</b>–<b>18</b> and catechol derivatives <b>9</b>–<b>15</b>, such as moderate efficacy in vitro, a lack of selectivity, and noticeable toxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>). These characteristics precluded the successful clinical development of any of the early pyridone, quinoline, and pyrone ligands as COMT inhibitors. Despite the unfavorable pharmacodynamic and pharmacokinetic properties of the early ligands <b>74</b>–<b>76</b>, the optimization of pyridone <b>74</b> by scientists at Merck led to the discovery of a novel series of hydroxyl-pyridones, represented by <b>77</b><a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> and <b>78</b><a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>). Pyridones <b>77</b> and <b>78</b> were shown to be potent inhibitors of human MB-COMT, with IC<sub>50</sub> values of 8 and 31 nM, respectively. A structurally similar pyrimidone analogue, <b>79</b>,<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> exhibited lower potency in the same in vitro assay (IC<sub>50</sub> = 93 nM).</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Pyrimidone, pyridone, quinoline, and pyrone based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The compounds disclosed in the patent applications have been claimed to be useful for the symptomatic treatment of certain psychiatric disorders, such as schizophrenia, depression, bipolar disorders, and other dopamine deficiency-related diseases.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.3.3 Bifunctional Inhibitors</h4><div class="NLM_p">Inhibitors bearing two catecholic structures in the same molecule have been synthesized and evaluated for their in vitro COMT inhibitory ability. Representative examples are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Representative examples of bifunctional COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In an early series, the two carboxyamide subunits were separated by different length alkyl spacers.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> The authors concluded that no evidence could be found for a direct correlation between potency and bifunctional nature, although the length of the hydrocarbon spacer influenced the in vitro potency. The most potent catechol compound was <b>80a</b><a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> (<i>n</i> = 3), which displayed a competitive inhibition pattern with a <i>K</i><sub>i</sub> of 0.3 μM. In the trihydroxy series, the most interesting compound, <b>80b</b>,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> also had an <i>n</i>-propyl spacer. Compound <b>80b</b> displayed a <i>K</i><sub>i</sub> of 6.6 μM, and the inhibition mode was found to be uncompetitive. Derivatives with either longer or shorter hydrocarbon chains displayed marked reductions in activity (<b>80c</b>,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a><i>K</i><sub>i</sub> = 136 μM; <b>80d</b>,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a><i>K</i><sub>i</sub> = 26.7 μM). Follow-up work on bifunctional inhibitors led to a novel series of asymmetrical phenol–nitrocatechol type inhibitors exemplified by structures <b>81a</b>–<b>c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Compounds <b>81a</b>–<b>c</b> were found to exhibit higher in vitro potency than did their first generation analogues, with <i>K</i><sub>i</sub> values of 0.64, 0.77, and 0.97 μM, respectively. The in vivo evaluation of bifunctional inhibitors has not been reported in the literature to date.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.3.4 Bisubstrate Inhibitors</h4><div class="NLM_p">The rationale for designing bisubstrate inhibitors was to target simultaneously the catechol and the AdoMet binding sites in the catalytic site of the enzyme. Bisubstrate COMT inhibitors represented by general structure <b>82</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>) were expected to have an advantage over single-substrate-based compounds. The first bisubstrate inhibitor, <b>82a</b>, was developed by structure-based design using the crystal structure of the quaternary complex between the COMT enzyme, the cofactor AdoMet, <b>19</b>, and the magnesium(II) ion.<a onclick="showRef(event, 'ref13 ref160'); return false;" href="javascript:void(0);" class="ref ref13 ref160">(13, 160)</a> The inhibitor <b>82a</b> displayed a modest potency with an IC<sub>50</sub> of 2000 nM. Later, Lerner and co-workers designed two additional analogues (guided by computer modeling studies) with shorter (<b>82b</b>) and conformationally more rigid (<b>82c</b>) linkers between the adenine and catechol moieties.<a onclick="showRef(event, 'ref161 ref162'); return false;" href="javascript:void(0);" class="ref ref161 ref162">(161, 162)</a> Bisubstrate inhibitor <b>82b</b> displayed a 10-fold greater inhibitory potency than did compound <b>82a</b>. The less flexible derivative <b>82c</b> was the most potent bisubstrate inhibitor to date, with an IC<sub>50</sub> of 9 nM.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Kinetic analysis with compound <b>82c</b> displayed competitive inhibition mechanism with respect to the cosubstrate and AdoMet binding site and a more complex inhibition mechanism with respect to the catecholic binding site. Compound <b>82c</b> was successfully cocrystallized with rat S-COMT.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> The crystal structure reveals that inhibitor <b>82c</b> binds to both the AdoMet and the catechol binding sites. Binding of the bisubstrate inhibitor <b>82c</b> to COMT causes little structural changes of the enzyme compared with the protein in complex with a simple nitrocatechol substrate such as <b>19</b> and the cofactor AdoMet.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Bisubstrate inhibitors of the COMT enzyme and structure of AdoMet competitive fragment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scientists at Hoffman la-Roche Ltd. synthesized and characterized analogues of <b>82c</b>. The SAR analyses of the Markush structure <b>83</b> revealed that its potency could be attributed to the nature of the R group.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Incorporation of electron-donating substituents (e.g., R = -<sup>i</sup>Pr) resulted in low micromolar potency inhibitors. In contrast, the presence of EWGs (R<sub>1</sub> = −CN, CF<sub>3</sub>, -(CO)CF<sub>3</sub>, -Cl, aryl, or heteroaryl) was found to be beneficial for in vitro COMT inhibition. The 4-fluoro phenyl analogue <b>84a</b> showed excellent potency, with an IC<sub>50</sub> value of 21 nM.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> No experimental in vivo data for bisubstrate inhibitors have been published to date. The compounds have been proposed for the treatment of various medical conditions, such as PD, depression, and schizophrenia and for cognition improvement. Another attempt to identify important interactions between COMT and bisubstrate inhibitors involved the modification of the ribose and the adenine moieties. Replacement of the hydroxyls of the ribose ring with hydrogen in <b>84a</b> gave derivative <b>84b</b>, which was less active than the parent compound <b>84a</b>.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Further work on inhibitor <b>84b</b> demonstrated that in vitro potency could be restored by inclusion of fluorine (<b>84c</b>).<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> In another study attempts were made to modify the adenine moiety of <b>84a</b> using structure-based design.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The nitrogen atom of the adenine ring at position 1 is crucial for high binding affinity due to hydrogen bonding to the backbone NH of Ser119. The 6-methylpurine derivative <b>84d</b> was found to be the most potent adenine modified analogue.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a></div><div class="NLM_p last">In a very recent report, scientists at Takeda Pharmaceutical Company Ltd. have identified a series of AdoMet competitive fragments, which are structurally unrelated to AdoMet. Successful cocrystallization of <b>85</b> with mouse COMT confirmed its binding to the AdoMet pocket.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Compound <b>85</b> exhibits a <i>K</i><sub>i</sub> value of 16 μM and can serve as starting point for development of novel bisubstrate inhibitors.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.4 Prodrugs and Codrugs</h3><div class="NLM_p">The most clinically relevant COMT inhibitors bear nitrocatechol rings, which greatly determine the overall physicochemical properties of the inhibitor, such as its aqueous solubility and polarity. Inadequate physicochemical properties in nitrocatechol COMT inhibitors may result in limited oral bioavailability. As discussed in section <a class="ref internalNav" href="#sec4_2_1_1" aria-label="4.2.1.1">4.2.1.1</a>, <b>32</b> has limited absorption due to certain molecular properties.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> To tackle this problem, several water-soluble prodrugs of <b>32</b> have been synthesized to improve the oral bioavailability of <b>32</b>. These prodrug derivatives include phosphate ester <b>86</b><a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> and various O-substituted esters <b>87a</b>–<b>i</b><a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> as well as <i>N</i>-alkyl <b>88a</b>–<b>c</b><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> and <i>N</i>,<i>N</i>-dialkyl carbamate esters <b>89a</b>–<b>c</b><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). These prodrugs are expected to release the parent drug <b>32</b> in systemic circulation.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Prodrugs of COMT inhibitors <b>32</b> and <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The phosphate ester <b>86</b> was endowed with greatly improved aqueous solubility (30 mg/mL) over <b>32</b> in a low pH range (1.2–7.4), which represents the full pH scale of the gastrointestinal track. The chemical stability of <b>86</b> was shown to be high, and no significant degradation was observed in a buffered solution at physiological pH and temperature (<i>t</i><sub>1/2</sub> = 2227 h). In human plasma, phosphate ester <b>86</b> was found to also be stable. After incubation with rabbit liver homogenate, <b>86</b> underwent slow enzymatic hydrolysis (over 1 h) to the parent drug <b>32</b> (<i>E</i> isomer) and its <i>Z</i> geometric isomer (<i>E</i>/<i>Z</i> ratio 1:6). Its overly high stability toward enzymatic degradation may be related to the steric hindrance and the strong electron-withdrawing effect of the nitro group, which in turn limit the activity of phosphatase enzymes. Further efforts to enhance the oral absorption of <b>32</b> involved the preparation and characterization of a series of <i>O</i>-acyl, <i>O</i>-acyloxyacyl, and <i>O</i>-alkyloxycarbonyl esters, as well as an <i>O</i>-acyloxy alkyl ether represented by the general structure <b>87</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). It has been postulated that compounds <b>87a</b>–<b>i</b> might be endowed with higher lipophilicity and, in certain cases, with better aqueous solubility over the parent drug <b>32</b>. Although all reported examples of <b>87a</b>–<b>i</b> were found to have higher apparent partition coefficients (log <i>P</i><sub>app</sub> = 1.23–4.0) than that of <b>32</b> (log <i>P</i><sub>app</sub> = 0.65), the di-O-substituted esters <b>87b</b>–<b>f</b> had insufficient solubility. The prodrugs having branched substituents on the catechol hydroxyls, <b>87b</b> and <b>87g</b>–<b>h</b>, displayed greater stability toward chemical hydrolysis than did the straight-alkyl chain analogue <b>87c</b>. Compounds <b>87b</b> and <b>87g</b>–<b>h</b> were shown to be more stable at lower pH values than at neutral pH. The mono substituted esters <b>87a</b> and <b>87i</b> exhibited comparable or superior aqueous solubility (1.62 and 6.99 mg/mL, respectively) at pH 7.4 than did <b>32</b> (1.75 mg/mL). Prodrug <b>87i</b> underwent rapid enzymatic hydrolysis at physiological pH (<i>t</i><sub>1/2</sub> = 0.7 h), but its chemical stability was insufficient due to intramolecular hydrolysis involving the free vicinal hydroxyl group of the catechol nucleus. On the basis of its overall physicochemical properties, the best compound of the above series was the mono-<i>O</i>-pivaloyl ester <b>87a</b>, which failed to provide better oral absorption (<i>F</i> = 7%) over <b>32</b> (<i>F</i> = 10.4%) in rats. The lower absolute oral bioavailability of <b>87a</b> can be attributed to its lower aqueous solubility at low pH values because absorption is likely to take place in the upper part of the gastrointestinal tract, where the environment is more acidic. Further work designing potential new prodrugs resulted in a series of <i>N</i>-alkyl and <i>N</i>,<i>N</i>-dialkyl carbamates (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Prodrugs <b>88a</b>–<b>c</b> and <b>89a</b> were shown to present reasonable chemical stabilities in phosphate buffer (pH = 7.4) with <i>t</i><sub>1/2</sub> values in the range of 14.9–20.7 h. Furthermore, their in vitro enzymatic hydrolysis was rapid (<i>t</i><sub>1/2</sub> = 0.8–2.7) enough to fulfill the prodrug criteria. Unexpectedly, <i>N</i>,<i>N</i>-dialkyl carbamates <b>89a</b>–<b>c</b> failed to release <b>32</b> under in vivo conditions, presumably due to the involvement of other metabolic pathways besides the targeted hydrolytic cleavage. The mono <i>N</i>-alkyl carbamates <b>88a</b>–<b>c</b> were endowed with good to excellent aqueous solubility (≥40, 1.94, and 2.46 mg/mL, respectively), and the log <i>P</i><sub>app</sub> values of <b>88b</b>,<b>c</b> were shown to be 5- and 4-fold higher, respectively, than that of <b>32</b>. When prodrugs <b>88a</b> and <b>88c</b> were administered at doses equivalent to 5.7 mg/kg of <b>32</b>, lower area under the plasma concentration–time curve (AUC<sub>0–2h</sub>) values were obtained (318 and 261 ng·h/mL, respectively) than for the parent compound <b>32</b> (644 ng·h/mL).</div><div class="NLM_p">Prodrugs of another investigational drug candidate molecule, benzothiophene <b>69</b>, have also been disclosed in the literature (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). The carboxylate group of <b>69</b> was esterified with different alcohols to give the corresponding alkyl esters (<b>90a</b>−<b>d</b>), benzyl ester (<b>91a</b>), acyloxyalkyl esters (<b>92a</b>–<b>d</b>), aminoacyloxy alkyl ester (<b>92e</b>), and cyclic carbonate ester (<b>91b</b>).<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> The prepared lipophilic esters (<b>90a</b>–<b>d</b>, <b>91a</b>,<b>b</b> and <b>92a</b>–<b>d</b>) were expected to counterbalance the very polar nature of <b>69</b>, while the aminoacyloxy alkyl ester <b>92e</b> was aimed for use as a substrate for dipeptide intestinal transporters.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Simple alkyl (<b>90a</b>–<b>d</b>) and alkylaryl esters (<b>91a</b>) were shown to be stable in human serum, but in rat liver homogenate they were unstable (<i>t</i><sub>1/2</sub> = 19.8–130.9 min). Diesters <b>92a</b>–<b>d</b>, designed to increase recognition by esterases, were also evaluated. Prodrugs <b>92a</b>–<b>d</b> were prone to quantitative hydrolysis in human serum with <i>t</i><sub>1/2</sub> values ranging from 5.1 to 32.3 h. Furthermore, <b>92a</b>–<b>d</b> underwent rapid hydrolytic degradation to the parent compound <b>69</b> in rat liver homogenate with <i>t</i><sub>1/2</sub> values of less than a minute. Compounds <b>92a</b>, <b>92d</b>,<b>e</b>, and <b>91b</b> were selected for in vivo evaluation in rats at a concentration of 10 μM/kg, but they failed to provide marked improvement over the parent compound <b>69</b>. Only prodrugs <b>91b</b> and <b>92a</b> caused a 2-fold increase in the plasma concentration of benzothiophene <b>69</b>.</div><div class="NLM_p">Another attempt to improve the bioavailability of <b>32</b> involved the preparation of a codrug product of <b>32</b> and L-DOPA, where the two different entities (L-DOPA and <b>32</b>) were linked together to form a single molecule (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> The codrug approach was expected to be an effective way to simplify the administration regime of L-DOPA and <b>32</b> in addition to facilitating their in vivo delivery to the site of action.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structure of codrug of <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Due to chemical stability problems, the most convenient way to link L-DOPA and <b>32</b> is through a carbamate linker between the furthest hydroxyl group from the nitro group in <b>32</b> and the amino group of L-DOPA. Codrug <b>93</b> was found to be quite stable toward chemical hydrolysis at a wide range of pH values (<i>t</i><sub>1/2</sub> = 12.1 h, pH = 1.2; <i>t</i><sub>1/2</sub> = 1.4 h, pH = 5.0; <i>t</i><sub>1/2</sub> = 1.1 h, pH = 7.4).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Nevertheless, <b>93</b> underwent rapid enzymatic hydrolysis in rabbit liver homogenates at physiological pH (<i>t</i><sub>1/2</sub> = 7 min) and released the parent drugs (i.e., <b>32</b> and L-DOPA), demonstrating the bioreversibility of <b>93</b>. No in vivo experiments with codrug <b>93</b> have been reported thus far in the literature. Codrugs of other common COMT inhibitors have also not been published.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">5 COMT Inhibitors in Clinical Trials</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Until the late 1980s, early pyrogallol and catechol-based competitive inhibitors demonstrated poor in vivo efficacy, which precluded their clinical development. The tight-binding COMT inhibitors (i.e., nitrocatechols) were more promising than their competitive pyrogallol and catechol predecessors. The first potent and selective COMT inhibitor in clinical trials was <b>31</b>, followed by <b>32</b> and <b>37</b> and later by <b>39</b> and <b>50c</b>. Their major clinical pharmacology properties are summarized below.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">5.1 Nitecapone</h3><div class="NLM_p last">Compound <b>31</b> was progressed into phase I clinical trials by Orion in 1987 for the adjunctive treatment of PD.<a onclick="showRef(event, 'ref6 ref172'); return false;" href="javascript:void(0);" class="ref ref6 ref172">(6, 172)</a> Twelve healthy volunteers were enrolled in a phase I study with <b>31</b> and received either 100 mg of L-DOPA and 25 mg of AADC inhibitor <b>1</b> alone or the two drugs simultaneously in increasing single doses (10–100 mg) with <b>31</b>. Compound <b>31</b> was rapidly absorbed, with a median <i>t</i><sub>max</sub> of 0.5 h. The plasma peak concentrations and the AUC values increased in a dose-dependent manner. Clinical candidate <b>31</b> exhibited a very short elimination half-life (<i>T</i><sub>1/2</sub> = 30–45 min). Inhibitor <b>31</b> was found to partially inhibit S-COMT in erythrocytes 30 min after drug intake in a dose-dependent manner and had no inhibitory effect on cerebral COMT. Compound <b>31</b> slightly increased the relative bioavailability of L-DOPA. Dose-proportional decreases in 3-OMD and HVA and significant increases in DOPAC were observed. Inhibitor <b>31</b> was found to be well tolerated in a dose range of 10–100 mg, and no side effects related to the use of the compound were reported except for the discoloration of urine, which is a common effect of polyhydroxy nitrobenzenes. Although the phase I clinical studies of <b>31</b> showed improvements in L-DOPA pharmacokinetics, it eventually was replaced by <b>32</b>, which was judged to be a more efficacious clinical candidate. However, <b>31</b> subsequently advanced into phase I clinical trials for the treatment of gastrointestinal lesions, but the development subsequently was discontinued in phase II due to a lack of efficacy.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">5.2 Entacapone</h3><div class="NLM_p last">Orion successfully completed phase I–III clinical trials with <b>32</b> in the late 1990s, and <b>32</b> has been approved for the adjunctive treatment of PD. In humans, Compound <b>32</b> is rapidly absorbed after oral administration, with a <i>t</i><sub>max</sub> of 1 h. Food or low gastric activity does not affect <b>32</b>’s pharmacokinetics. Clinical candidate <b>32</b> reversibly and dose-dependently inhibits erythrocyte S-COMT.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Following an oral dose of 800 mg of <b>32</b>, 82% COMT inhibition was reported. Compound <b>32</b> displays a linear pharmacokinetic profile within the dose range of 5 to 800 mg. It has also been reported that <b>32</b> is extensively metabolized, with >1% of the orally administered dose excreted in unchanged form.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Compound <b>32</b> was shown to be endowed with high selectivity in terms of peripheral COMT inhibition. Due to the limited bioavailability (<i>F</i> = 29–46%)<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> and short duration of action of <b>32</b>,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> the dosages administered to PD patients are high and repeated up to eight times daily; its clinical effectiveness in the treatment of PD has been questioned.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">5.3 Tolcapone</h3><div class="NLM_p last">In the late 1990s, the clinical candidate of Hoffman la-Roche Ltd. for PD was <b>37</b>. In a phase I study, the effect of single doses of <b>37</b> (5–800 mg) on the metabolism of L-DOPA (100 mg plus 25 mg of an AADC inhibitor) was studied. In healthy volunteers, <b>37</b> was rapidly absorbed after single oral doses ranging from 5 to 800 mg, with <i>t</i><sub>max</sub> ranges of 0.9–2 h.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The maximum inhibitory effect of <b>37</b> was achieved within 2 h. The elimination of <b>37</b> was also rapid, with a <i>t</i><sub>1/2</sub> of 2.0–2.3 h. In clinical trials, <b>37</b> showed much greater bioavailability than did <b>32</b>. Oral doses of 100–200 mg of <b>37</b> caused 80% COMT inhibition in RBCs. The COMT enzymatic activity was recovered after 13–23 h, depending on the administered dose. The inhibitory activity of <b>37</b> was found to be higher and more prolonged than that of either <b>31</b> or <b>32</b>. Inhibitor <b>37</b> increased (up to 200 mg) the AUC of L-DOPA in a dose-dependent manner without markedly changing its <i>C</i><sub>max</sub> or <i>t</i><sub>max</sub> values. In contrast, the AUC of 3-OMD was shown to be significantly decreased in a dose-dependent fashion. Doses higher than 200 mg of <b>37</b> had no beneficial effect on L-DOPA pharmacokinetics because L-DOPA absorption was inhibited by <b>37</b>, most likely due to competition for intestinal carriers. In PD patients, the effect of single doses of <b>37</b> increased the duration of the ON time (symptoms of PD are controlled) by 70%. Due to the toxicity concerns discussed in section <a class="ref internalNav" href="#sec4_2_1_2" aria-label="4.2.1.2">4.2.1.2</a>, <b>37</b> can only be used in patients afflicted with PD who are unresponsive to other treatments and only with regular monitoring of liver function, which is expensive and uncomfortable for patients.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">5.4 Nebicapone</h3><div class="NLM_p last">When oral single doses of <b>39</b> were administered to humans, the maximum plasma concentrations (<i>C</i><sub>max</sub> = 2.7–5.9 mg/mL) were reached within 0.5–2 h, depending on the given dose (50–200 mg), followed by rapid elimination (<i>t</i><sub>1/2</sub> = 2.0–2.4 h).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Clinical candidate <b>39</b> was shown to display a linear pharmacokinetic profile over the dose range of 50 to 200 mg. In a single dose study with <b>39</b> administered together with L-DOPA and a peripherally selective AADC inhibitor, the AUC of L-DOPA increased by 39–80%, while the AUC of 3-OMD markedly decreased (by 38–62%) depending on the given dose of <b>39</b> (50, 100, 200, and 400 mg).<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Inhibition of human RBCs by <b>39</b> was shown to occur in the range of 57–84%. Compound <b>39</b> demonstrated a similar inhibitory profile to that of <b>37</b>. Oral doses of 100 and 200 mg of <b>39</b> caused 69% and 81% COMT inhibition, respectively. The peripheral COMT inhibition by <b>39</b> was maintained up to 18 h postadministration. An oral dose of 75 mg of <b>39</b> and 200 mg of <b>32</b> exhibited very similar levels of COMT inhibition, but the inhibitory effect of <b>39</b> lasted longer than did that of <b>32</b>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The metabolic and toxicological profile of <b>39</b> reflects quite well the profile of <b>37</b>. Unfortunately, the clinical development of was discontinued due to safety concerns.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34">5.5 Opicapone</h3><div class="NLM_p last">In 2010, BIAL – Portela & C<sup>a</sup>, S.A., disclosed that <b>50c</b> was a clinical candidate for the adjunctive treatment of PD. In a study that evaluated the tolerability, pharmacokinetics (including the effect of food), and pharmacodynamics (effect on COMT activity) following single oral doses of <b>50c</b> (10 to 1200 mg) in young healthy male volunteers, <b>50c</b> was well-tolerated and presented dose-proportional kinetics. Clinical candidate <b>50c</b> demonstrated marked and sustained inhibition of erythrocyte S-COMT activity. Based on the observation that the half-life of COMT inhibition was independent of the dose and that it reflected an underlying kinetic process that was consistent with the <i>k</i><sub>off</sub> value of the COMT–inhibitor <b>50c</b> complex, it was proposed that the sustained COMT inhibition, which continued even after the clearance of the circulating drug, was due to the long residence time of the reversible complex formed between COMT and <b>50c</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In another study to assess the tolerability, pharmacokinetics, and inhibitory effect on erythrocyte S-COMT activity following repeated doses of <b>50c</b>, the drug was tested in a randomized, placebo-controlled, double-blind study that enrolled healthy male subjects who received either a once daily placebo or <b>50c</b> at a dose of 5, 10, 20, or 30 mg for 8 days.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Compound <b>50c</b> was well tolerated, and its systemic exposure increased in an approximately dose-proportional manner, with an apparent terminal half-life of 1.0–1.4 h. Sulfation was the main metabolic pathway, and the <b>50c</b> metabolites recovered in urine accounted for less than 3% of the amount of <b>50c</b> administered, suggesting that bile was likely the main route of excretion. The maximum S-COMT inhibition (<i>E</i><sub>max</sub>) ranged from 69.9% to 98.0% following the last dose of <b>50c</b>. The induced S-COMT inhibition showed a half-life in excess of 100 h, which was dose-independent and much longer than the plasma drug exposure. Such a half-life reflects a putative underlying rate constant that is comparable to the estimated dissociation rate constant of the COMT–<b>50c</b> complex.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> The S-COMT inhibitory effect by <b>50c</b> described in these studies was much stronger than that reported for <b>37</b> and <b>32</b> in healthy subjects. <i>E</i><sub>max</sub> was reported as 72% and 80% for 100 mg and 200 mg <b>37</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> respectively, and 65% for 200 mg <b>32</b>.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Whereas the S-COMT activity returned to the baseline approximately 18 h after <b>37</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and 8 h after <b>32</b><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> administration, the inhibitory effect of <b>50c</b> on S-COMT activity lasted longer: 24 h after the last dose of <b>50c</b> (which is the expected dosing interval for <b>50c</b> in clinical use), the S-COMT activity was still depressed by 42.8%, 52.4%, 56.8%, and 64.9% in the 5, 10, 20, and 30 mg <b>50c</b> groups, respectively. Another recent study compared the L-DOPA pharmacokinetic profile throughout a day driven by the COMT inhibition following either repeated doses of <b>50c</b> or concomitant administration with <b>32</b>.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> This was a randomized, double-blind, gender-balanced, parallel-group study in 4 groups of 20 healthy subjects each. Four subjects in each group received placebo during the entire study. Sixteen (16) subjects in one group received placebo once-daily for 11 days and on day 12, 200 mg concomitantly with each L-DOPA/carbidopa dose (three times separated by a 5 h interval). Sixteen (16) subjects in each of the remaining three groups received, respectively, 25, 50, and 75 mg <b>50c</b> once-daily for 11 days and, on day 12, placebo concomitantly with each L-DOPA/carbidopa dose. L-DOPA <i>C</i><sub>min</sub> for each L-DOPA/carbidopa dose and for the mean of all L-DOPA/carbidopa doses increased substantially with all active treatments (<b>32</b> and <b>50c</b>) compared with the control group (placebo) with values ranging from 1.7-fold (200 mg <b>32</b>) to 3.3-fold (75 mg <b>50c</b>). No statistical difference was found for L-DOPA peak of systemic exposure (as assessed by <i>C</i><sub>max</sub>) between all active treatments and placebo. A significant increase in the L-DOPA extent of systemic exposure (as assessed by AUC) occurred with all <b>50c</b> treatments in relation to placebo. No statistical difference was found for L-DOPA AUC when <b>32</b> was compared with placebo. Point estimates (PE) of the geometric mean ratios (GMR) <b>32</b>/placebo was 102.97% and the 90% CI was 76.16–139.21%. Compared with <b>32</b>, both 50 and 75 mg <b>50c</b> presented a statistical difference for the L-DOPA AUC increase (PE <b>50c</b>/<b>32</b> [90% CI] = 148.23% [105.88–207.50%]) with 50 mg <b>50c</b> and 173.74% [124.11–243.22%] with 75 mg <b>50c</b>). All active treatments significantly inhibited both peak (as assessed by <i>E</i><sub>max</sub>) and extent (as assessed by AUEC) of the COMT activity in relation to placebo. Compared with <b>32</b>, all <b>50c</b> treatments significantly decreased the extent (AUEC) of the COMT activity due to a long-lasting and sustained effect. It was concluded that <b>50c</b> compared with <b>32</b> provides a superior response upon the bioavailability of L-DOPA associated with more pronounced, long-lasting, and sustained COMT inhibition. Overall, the results clearly suggest that <b>50c</b> has a unique pharmacodynamic profile adequate for a once-daily regimen, which in the treatment of PD patients could represent an advantage over <b>32</b> and <b>37</b>, which have a short S-COMT inhibitory effect and require multiple daily doses. Compound <b>50c</b> is currently under phase III clinical trials to demonstrate the efficacy and safety of <b>50c</b> once-daily treatment for patients with PD and end-of-dose motor fluctuations in comparison to a placebo<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> or a placebo and <b>32</b>.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">6 Conclusions and Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The historical development of COMT inhibitors and the corresponding patent landscape has been reviewed. Various structurally diverse COMT inhibitors have been reported and optimized to produce potent and selective inhibitors. The majority of disclosed inhibitors share catechol, pyrogallol, or nitrocatechol pharmacophores. The first-generation competitive inhibitors showed relatively weak in vitro COMT inhibitory activity and exhibited weak in vivo efficacy and poor target selectivity, which precluded their further clinical use. The development of clinically relevant COMT inhibitors, such as <b>31</b> (Orion), <b>32</b> (Orion), <b>37</b> (Hoffman-la Roche), and <b>39</b> (BIAL) was based on a nitrocatechol scaffold (second-generation inhibitors), which is one of the most potent pharmacophores for the COMT enzyme. The presence of a nitro group at the <i>ortho</i>-position relative to the hydroxyl group of the catechol nucleus markedly alters the physicochemical properties of the molecule. Generally, nitrocatechol structured compounds are poor substrates for the COMT enzyme and known as tight-binding inhibitors, but their binding to the COMT enzyme is fully reversible. Moreover, they are highly selective inhibitors of COMT versus the other enzymes involved in catecholamine metabolism. From an efficacy point of view, it is important to incorporate a second EWG group into the molecule in addition to the nitro group to further enhance in vitro activity. Medicinal chemistry problems, such as extensive metabolism through glucuronidation of the phenolic hydroxyls (e.g., benzothiophene <b>69</b>), limited oral bioavailability (e.g., <b>32</b>), and liver toxicity (e.g., <b>37</b>) sometimes have been associated with the presence of the nitocatechol ring. In the last ten years, several modifications have been made to nitrocatechol COMT inhibitors, which were intended to improve their pharmacokinetic profile. Replacement of the nitro group with two other EWGs (e.g., cyano) resulted in highly potent trisubstituted COMT inhibitors in vitro, but some exhibited shorter in vivo half-lives than their disubstituted nitrocatechol analogues. Other approaches include prodrugs and codrugs of known COMT inhibitors (e.g., <b>32</b>), as well as novel aromatic nitrocatechols and novel heterocyclic nitrocatechols (e.g., <b>50c</b>). The design of new COMT inhibitors has been facilitated by a number of available X-ray structures of COMT in complex with various inhibitors. The catalytic site of COMT is very tight and located at the outer surface of the protein. Therefore, the side chain of the inhibitor has a limited role in the interaction with COMT, but conversely it can be used for optimization of the pharmacokinetic profile of the inhibitor.</div><div class="NLM_p">Over the last 50 years, COMT has become an attractive target for the treatment of various peripheral and CNS disorders. The sole clinical application of COMT inhibitors thus far is their coadministration with an AADC inhibitor plus L-DOPA (a biological precursor of dopamine) for the symptomatic treatment of PD. The first orally bioavailable COMT inhibitors, such as <b>37</b> from Hoffman-la Roche and <b>32</b> from Orion, were found to alter the in vivo metabolism of L-DOPA (i.e., they prolonged its half-life) in different animal species and initially showed high promise in clinical studies. However, their daily clinical use has revealed several disadvantages, such as short in vivo half-lives and low oral bioavailability (<b>32</b>), as well as selectivity and liver toxicity problems (<b>37</b>). After the withdrawal of <b>37</b> from the market, <b>32</b> has become the sole COMT inhibitor available in the clinic for use as an adjunct to the L-DOPA treatment of PD patients. Although other nitrocatechol-based inhibitors, such as <b>39</b>, <b>42</b>, and <b>58</b> exhibit improved pharmacokinetic properties (i.e., selectivity and duration of action) over <b>32</b> and <b>37</b>, none of them have advanced to clinical trials. Structurally related nitrocatechol COMT inhibitors have been developed by Kissei Pharmaceuticals. The information included in the patent applications about these compounds is limited, but from a structural point of view, the disclosed compounds may show metabolic instability (e.g., <i>ortho</i>-nitrated derivatives), poor aqueous solubility, and high lipophilicity. Heterocyclic COMT inhibitors appear to be the most attractive scaffolds from the nitrocatechol group. In contrast with phenyl-substituted nitrocatechols (e.g., <b>37</b>), the large structural variations in heterocyclic rings provide increased opportunities to tune the physicochemical properties of the molecule, resulting in inhibitors with enhanced pharmacokinetic profiles that maintain excellent pharmacodynamic interactions with COMT. Several classes of condensed and nonfused heterocyclic COMT inhibitors have been designed and claimed in the patent literature. One of the main challenges with such structures is to mitigate the potential metabolism of the heterocyclic ring by appropriate substitution and to balance both the lipophilicity and aqueous solubility of the molecule in order to improve the negative impact of the nitrocatechol nucleus on intestinal absorption. The most advanced COMT inhibitor from the heterocyclic class is <b>50c</b>, which is being evaluated in phase III clinical trials as an adjunct to L-DOPA therapy in patients with PD. Inhibitor <b>50c</b> has shown high efficacy (i.e., very long acting) and an excellent safety profile in clinical studies and is expected to be an alternative to other COMT inhibitors (e.g., <b>32</b> or <b>37</b>) in the adjunctive L-DOPA therapy of PD. In our opinion, bisubstrate molecules are not promising clinical candidates as COMT inhibitors. They exhibit excessive molecular weights and are very polar, which may limit their oral absorption. In principle, the codrug approach could be an alternative to the simple consecutive administration of L-DOPA and a COMT inhibitor. However, due to potential pharmacokinetic interactions, L-DOPA and COMT inhibitors are not necessarily administered at the same time, which may limit the clinical usefulness of codrugs.</div><div class="NLM_p last">Finally, COMT inhibitors for other possible therapeutic applications (listed in the introduction of this perspective) have yet to reach the clinical phase. Recently published structures by Merck (hydroxy-pyridones and hydroxyl-pyrimidones) have been claimed to be useful in the treatment of psychotic disorders such as schizophrenia; however, the disclosed pharmacological data are not sufficient to evaluate their potential clinical efficacy.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm500572b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">László E. Kiss</span> - <span class="hlFld-Affiliation affiliation">Department
of Research & Development, BIAL −
Portela & C, S.A., À Avenida da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e38f8290998f8ccd888a9090a3818a828fcd808c8e"><span class="__cf_email__" data-cfemail="157974666f797a3b7e7c666655777c74793b767a78">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrício Soares-da-Silva</span> - <span class="hlFld-Affiliation affiliation">Department
of Research & Development, BIAL −
Portela & C, S.A., À Avenida da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology & Therapeutics, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal</span>; 
    <span class="hlFld-Affiliation affiliation">MedInUP
− Center for Drug Discovery and Innovative Medicines, University of Porto, 4200-319 Porto, Portugal</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="21" class="article__inlineFigure"><h2 class="fig-label">László E. Kiss</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=BIO-d2154e4847-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>László E. Kiss</b> received his M.Sc. in 1994 and his Ph.D. in organic chemistry from Eötvös Loránd University, Budapest, Hungary, with Professor József Rábai. From 1998 to 2002, he worked as a combinatorial chemist and Project Leader at Comgenex Inc. in Budapest, Hungary. In 2002, he joined BIAL – Portela & C<sup>a</sup>, S.A., S. Mamede do Coronado, Portugal, as a medicinal chemist and became the leader of the Medicinal Chemistry Group of BIAL in 2011, working on several lead generation and optimization programs. His research interests focus on cardiovascular and CNS disorders.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Patrício Soares-da-Silva</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=BIO-d2154e4855-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Patrı́cio Soares-da-Silva</b> received his medical degree in 1981 and his Ph.D. in Medicine (Physiology and Pharmacology) in 1988 at the University of Porto (Porto, Portugal). Since 1996, he has been a full professor of Clinical Pharmacology & Therapeutics at the Faculty of Medicine of the University of Porto (Portugal) and heads the Department of Research and Development at BIAL – Portela & C<sup>a</sup>, S.A. (S. Mamede do Coronado, Portugal). His main research interests concern pharmacology, toxicology, and clinical pharmacology of new molecular entities for cardiovascular and CNS disorders.</p></figure></div><div class="ack" id="ACK-d2154e4612-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Zsuzsa Sárkány is thanked for the generation of Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> Abbreviations used</h2><tr><td class="NLM_term">COMT</td><td class="NLM_def"><p class="first last">catechol <i>O</i>-methyltransferase</p></td></tr><tr><td class="NLM_term">S-COMT</td><td class="NLM_def"><p class="first last">soluble form of COMT</p></td></tr><tr><td class="NLM_term">MB-COMT</td><td class="NLM_def"><p class="first last">membrane bound form of COMT</p></td></tr><tr><td class="NLM_term">DβH</td><td class="NLM_def"><p class="first last">dopamine β-hydroxylase</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">ADD</td><td class="NLM_def"><p class="first last">attention deficit disorders</p></td></tr><tr><td class="NLM_term">ADHD</td><td class="NLM_def"><p class="first last">attention deficit hyperactivity disorder</p></td></tr><tr><td class="NLM_term">RLS</td><td class="NLM_def"><p class="first last">restless leg syndrome</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GFR</td><td class="NLM_def"><p class="first last">glomerular filtration rate</p></td></tr><tr><td class="NLM_term">AER</td><td class="NLM_def"><p class="first last">albumin excretion rate</p></td></tr><tr><td class="NLM_term">L-DOPA or levodopa</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3,4-dihydroxy phenylalanine</p></td></tr><tr><td class="NLM_term">3-OMD</td><td class="NLM_def"><p class="first last">3-<i>O</i>-methyl-L-DOPA</p></td></tr><tr><td class="NLM_term">DOMA</td><td class="NLM_def"><p class="first last">3,4-dihydroxymandelic acid</p></td></tr><tr><td class="NLM_term">DOPAC</td><td class="NLM_def"><p class="first last">3,4-dihydroxyphenylacetic acid</p></td></tr><tr><td class="NLM_term">3-MT</td><td class="NLM_def"><p class="first last">3-methoxytyramine</p></td></tr><tr><td class="NLM_term">HVA</td><td class="NLM_def"><p class="first last">homovanillic acid</p></td></tr><tr><td class="NLM_term">3,5-DNC</td><td class="NLM_def"><p class="first last">3,5-dinitrocatechol</p></td></tr><tr><td class="NLM_term">SAM or AdoMet</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-methionine</p></td></tr><tr><td class="NLM_term">AdHcy or SAH</td><td class="NLM_def"><p class="first last"><i>S</i>-adenosyl-<span class="smallcaps smallerCapital">l</span>-homocysteine</p></td></tr><tr><td class="NLM_term">AADC</td><td class="NLM_def"><p class="first last">amino acid decarboxylase</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cell</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">log <i>P</i></td><td class="NLM_def"><p class="first last">partition coefficient</p></td></tr><tr><td class="NLM_term">UGDPA</td><td class="NLM_def"><p class="first last">uridine-5′-diphosphglucuronic acid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">EWG</td><td class="NLM_def"><p class="first last">electron-withdrawing group</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma concentration–time curve</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">point estimates</p></td></tr><tr><td class="NLM_term">GMR</td><td class="NLM_def"><p class="first last">geometric mean ratios</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 179 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. N. F.</span><span> </span><span class="NLM_article-title">3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1957&pages=422-423&author=M.+D.+Armstrongauthor=A.+McMillanauthor=K.+N.+F.+Shaw&title=3-Methoxy-4-hydroxy-D-mandelic+acid%2C+a+urinary+metabolite+of+norepinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DK.%2BN.%2BF.%26atitle%3D3-Methoxy-4-hydroxy-D-mandelic%2520acid%252C%2520a%2520urinary%2520metabolite%2520of%2520norepinephrine%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1957%26volume%3D25%26spage%3D422%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomchick, R.</span><span> </span><span class="NLM_article-title">Enzymatic <i>O</i>-methylation of epinephrine and other catechols</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=13575440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaG1MXht1SltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=702-705&author=J.+Axelrodauthor=R.+Tomchick&title=Enzymatic+O-methylation+of+epinephrine+and+other+catechols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic O-methylation of adrenaline and other catechols</span></div><div class="casAuthors">Axelrod, Julius; Tomchick, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">702-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. ibid. 697-701.  An enzyme (catechol O-methyl transferase) is described that transfers the Me group of S-adenosylmethionine to the 3-OH group of adrenaline and other catechols.  The enzyme requires bivalent cations and is inhibited by HS-binding reagents.  It occurs in various organs of mammals, including man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9qbqIHQs-bVg90H21EOLACvtfcHk0lj_FSjJort43Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXht1SltQ%253D%253D&md5=81021efa9533bf91bb1d4103aeaba995</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DTomchick%26aufirst%3DR.%26atitle%3DEnzymatic%2520O-methylation%2520of%2520epinephrine%2520and%2520other%2520catechols%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D702%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkop, B.</span><span> </span><span class="NLM_article-title"><i>O</i>-Methylation of catecholamines <i>in vivo</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=697-701&author=J.+Axelrodauthor=S.+Senohauthor=B.+Witkop&title=O-Methylation+of+catecholamines+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DSenoh%26aufirst%3DS.%26aulast%3DWitkop%26aufirst%3DB.%26atitle%3DO-Methylation%2520of%2520catecholamines%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D697%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bacq, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dresse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renson, J.</span><span> </span><span class="NLM_article-title">Inhibition of O-methyltransferase by catechol and sensitization to epinephrine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1959&pages=453-454&author=Z.+M.+Bacqauthor=L.+Gosselinauthor=A.+Dresseauthor=J.+Renson&title=Inhibition+of+O-methyltransferase+by+catechol+and+sensitization+to+epinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBacq%26aufirst%3DZ.%2BM.%26aulast%3DGosselin%26aufirst%3DL.%26aulast%3DDresse%26aufirst%3DA.%26aulast%3DRenson%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520O-methyltransferase%2520by%2520catechol%2520and%2520sensitization%2520to%2520epinephrine%26jtitle%3DScience%26date%3D1959%26volume%3D130%26spage%3D453%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Calne, D. B.</span><span> </span><span class="NLM_article-title">Treatment of Parkinson’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1056%2FNEJM199309303291408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8366903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK3szns1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1993&pages=1021-1027&author=D.+B.+Calne&title=Treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Parkinson's disease</span></div><div class="casAuthors">Calne D B</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1021-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzoAKl_8Tjn1vAgqb2vdc5fW6udTcc2ebe5598LcCSOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szns1Sgsg%253D%253D&md5=4e20a3db2b5d8b28689c22fb8fbdee2a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199309303291408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199309303291408%26sid%3Dliteratum%253Aachs%26aulast%3DCalne%26aufirst%3DD.%2BB.%26atitle%3DTreatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1993%26volume%3D329%26spage%3D1021%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentikainen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rita, H.</span><span> </span><span class="NLM_article-title">Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-Dopa in healthy volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=436-447&author=S.+Kaakkolaauthor=A.+Gordinauthor=M.+Jarvinenauthor=T.+Wikbergauthor=E.+Schultzauthor=E.+Nissinenauthor=P.+J.+Pentikainenauthor=H.+Rita&title=Effect+of+a+novel+catechol-O-methyltransferase+inhibitor%2C+nitecapone%2C+on+the+metabolism+of+L-Dopa+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DJarvinen%26aufirst%3DM.%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DPentikainen%26aufirst%3DP.%2BJ.%26aulast%3DRita%26aufirst%3DH.%26atitle%3DEffect%2520of%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%252C%2520nitecapone%252C%2520on%2520the%2520metabolism%2520of%2520L-Dopa%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1990%26volume%3D13%26spage%3D436%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Keranen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span> </span><span class="NLM_article-title">Inhibition of soluble catechol <i>O</i>-methyltranferse and single dose pharmacokinetics after oral and intraveneus administration of entacapone</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=151-157&author=T.+Keranenauthor=A.+Gordinauthor=+Karlsonauthor=T.+Wikberg&title=Inhibition+of+soluble+catechol+O-methyltranferse+and+single+dose+pharmacokinetics+after+oral+and+intraveneus+administration+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DT.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DKarlson%26aulast%3DWikberg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520soluble%2520catechol%2520O-methyltranferse%2520and%2520single%2520dose%2520pharmacokinetics%2520after%2520oral%2520and%2520intraveneus%2520administration%2520of%2520entacapone%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Brummelen, P.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetics and pharmacodynamics of the novel catechol-<i>O</i>-methyltransferase inhibitor tolcapone during first administration to humans</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0009-9236%2895%2990035-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7768073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVGqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=508-517&author=J.+Dingemanseauthor=K.+M.+Jorgaauthor=M.+Schmittauthor=R.+Gieschkeauthor=B.+Fottelerauthor=G.+Z%C3%BCrcherauthor=M.+Da+Pradaauthor=P.+van+Brummelen&title=Integrated+pharmacokinetics+and+pharmacodynamics+of+the+novel+catechol-O-methyltransferase+inhibitor+tolcapone+during+first+administration+to+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans</span></div><div class="casAuthors">Dingemanse, Jasper; Jorga, Karin M.; Schmitt, Monique; Gieschke, Ronald; Fotteler, Baerbel; Zuercher, Gerhard; Da Prada, Mose; van Brummelen, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">508-17</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">The tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of the novel catechol-O-methyltransferase (COMT) inhibitor tolcapone were assessed in healthy volunteers.  In this double-blind, placebo-controlled, ascending-single-dose study, doses of 5 to 800 mg tolcapone were administered orally to eight sequential groups of six young healthy male volunteers.  Adverse events, vital signs, and clin. lab. variables were recorded.  Pharmacokinetic parameters of tolcapone and its 3-O-methylmetabolite were detd.  Pharmacodynamics were assessed by detn. of COMT activity in erythrocytes.  Tolcapone was well tolerated at all dose levels and did not exert a detectable influence on vital sign measurements.  The drug was rapidly absorbed and showed dose-proportional pharmacokinetics.  Its mean elimination half-life was 2.0 ± 0.8 h (n = 42).  Plasma levels of the 3-O-methylmetabolite of tolcapone were not proportional to dose, and its formation was delayed at higher doses.  Its elimination half-life was 32 ± 7 h (n = 29).  Tolcapone caused a rapid and reversible inhibition of COMT activity in erythrocytes.  At doses of 200 mg and higher, COMT activity was inhibited by more than 80%.  The pharmacokinetic-pharmacodynamic relationship could be described by an inhibitory Emax model and suggested that metabolites of tolcapone did not substantially contribute to its inhibitory activity.  In conclusion, the novel COMT inhibitor tolcapone was well tolerated at oral doses of 5 to 800 mg.  Tolcapone concn.-dependently inhibited COMT activity in erythrocytes and exhibited dose-proportional kinetics.  Further investigations into its applicability in the treatment of Parkinson's disease are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeK3yLrlVyM7Vg90H21EOLACvtfcHk0ljud_2E8Q4dCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVGqs74%253D&md5=d049b04e9796340b48920dbe2ddf5e8c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990035-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990035-7%26sid%3Dliteratum%253Aachs%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DGieschke%26aufirst%3DR.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26aulast%3Dvan%2BBrummelen%26aufirst%3DP.%26atitle%3DIntegrated%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520during%2520first%2520administration%2520to%2520humans%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D508%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Januario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgadinho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ticmeanu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitu, C.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novac, M.</span><span> </span><span class="NLM_article-title">A double-blind, randomised, placebo- and entacapone-controlled study to investigate the effect of nebicapone (BIA 3–202) on the levodopa pharmacokinetics, COMT activity and motor response in Parkinson disease patients</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 15</span><span class="NLM_x">) </span> <span class="NLM_fpage">S644</span><span class="NLM_x">–</span> <span class="NLM_lpage">S645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=S644-S645&issue=Suppl.+15&author=J.+Ferreiraauthor=M.+M.+Rosaauthor=M.+Coelhoauthor=L.+Cunhaauthor=C.+Januarioauthor=C.+Machadoauthor=A.+Morgadinhoauthor=M.+Ticmeanuauthor=C.-E.+Mituauthor=M.+Novac&title=A+double-blind%2C+randomised%2C+placebo-+and+entacapone-controlled+study+to+investigate+the+effect+of+nebicapone+%28BIA+3%E2%80%93202%29+on+the+levodopa+pharmacokinetics%2C+COMT+activity+and+motor+response+in+Parkinson+disease+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DM.%2BM.%26aulast%3DCoelho%26aufirst%3DM.%26aulast%3DCunha%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DC.%26aulast%3DMachado%26aufirst%3DC.%26aulast%3DMorgadinho%26aufirst%3DA.%26aulast%3DTicmeanu%26aufirst%3DM.%26aulast%3DMitu%26aufirst%3DC.-E.%26aulast%3DNovac%26aufirst%3DM.%26atitle%3DA%2520double-blind%252C%2520randomised%252C%2520placebo-%2520and%2520entacapone-controlled%2520study%2520to%2520investigate%2520the%2520effect%2520of%2520nebicapone%2520%2528BIA%25203%25E2%2580%2593202%2529%2520on%2520the%2520levodopa%2520pharmacokinetics%252C%2520COMT%2520activity%2520and%2520motor%2520response%2520in%2520Parkinson%2520disease%2520patients%26jtitle%3DMov.%2520Disord.%26date%3D2006%26volume%3D21%26issue%3DSuppl.%252015%26spage%3DS644%26epage%3DS645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuno Palma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-o-methyltransferase inhibitor, in healthy subjects: Prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2Fs40262-012-0024-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=23248072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=139-151&author=L.+Almeidaauthor=J.+F.+Rochaauthor=A.+Falc%C3%A3oauthor=P.+Nuno+Palmaauthor=A.+I.+Loureiroauthor=R.+Pintoauthor=M.+J.+Bonifacioauthor=L.+C.+Wrightauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=Pharmacokinetics%2C+pharmacodynamics+and+tolerability+of+opicapone%2C+a+novel+catechol-o-methyltransferase+inhibitor%2C+in+healthy+subjects%3A+Prediction+of+slow+enzyme-inhibitor+complex+dissociation+of+a+short-living+and+very+long-acting+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects</span></div><div class="casAuthors">Almeida, Luis; Rocha, Jose Francisco; Falcao, Amilcar; Nuno Palma, P.; Loureiro, Ana I.; Pinto, Roberto; Bonifacio, Maria Joao; Wright, Lyndon C.; Nunes, Teresa; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-151</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Opicapone is a novel catechol-O-methyltransferase (COMT) inhibitor.  The purpose of this study was to evaluate the tolerability, pharmacokinetics (including the effect of food) and pharmacodynamics (effect on COMT activity) following single oral doses of opicapone in young healthy male volunteers.  Methods Single rising oral doses of opicapone (10, 25, 50, 100, 200, 400, 800 and 1,200 mg) were administered to eight groups of eight subjects per group (two subjects randomized to placebo and six subjects to opicapone), under a double-blind, randomized, placebo-controlled design.  In an addnl. group of 12 subjects, a 50 mg single dose of opicapone was administered on two occasions, once having fasted overnight and once with a high-fat high-calorie meal.  Results Opicapone was well tolerated at all doses tested.  The extent of systemic exposure (area under the plasma concn.-time curve and max. plasma concn.) to opicapone and metabolites increased in an approx. dose-proportional manner and showed a decrease following concomitant ingestion of a high-fat high-calorie meal.  The apparent terminal elimination half-life of opicapone was 0.8-3.2 h.  Sulphation appeared to be the main metabolic pathway for opicapone, and both opicapone and the main sulfated metabolite are likely excreted by the biliary route.  Maximum COMT inhibition by opicapone was dose dependent, ranged from 36.1 % (10 mg) to 100 % (200 mg and above), and reached statistical significance at all doses tested.  The long duration of COMT inhibition by opicapone, however, tended to be independent from the dose taken.  The obsd. half-life of opicapone-induced COMT inhibition in human erythrocytes was 61.6 h (std. deviation [SD] = 37.6 h), which reflects an underlying dissociative process with a kinetic rate const. of 3.1 × 10-6 s-1 (SD = 1.9 × 10-6 s-1).  Such a process compares well to the estd. dissocn. rate const. (koff) of the COMT-opicapone mol. complex (koff = 1.9 × 10-6 s-1).  Conclusions Opicapone was well-tolerated and presented dose-proportional kinetics.  Opicapone demonstrated marked and sustained inhibition of erythrocyte sol. COMT activity.  Based on the observation that the half-life of COMT inhibition is independent of the dose and that it reflects an underlying kinetic process that is consistent with the koff value of the COMT-opicapone complex, we propose that the sustained COMT inhibition, far beyond the observable point of clearance of circulating drug, is due to the long residence time of the reversible complex formed between COMT and opicapone.  Globally, these promising results provide a basis for further clin. development of opicapone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6Fv8W5B9c7Vg90H21EOLACvtfcHk0lhLSB0mNqTTyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtrfJ&md5=98c92fb5920e6c3004dd6f3d2848439a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs40262-012-0024-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-012-0024-7%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DNuno%2BPalma%26aufirst%3DP.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%2520and%2520tolerability%2520of%2520opicapone%252C%2520a%2520novel%2520catechol-o-methyltransferase%2520inhibitor%252C%2520in%2520healthy%2520subjects%253A%2520Prediction%2520of%2520slow%2520enzyme-inhibitor%2520complex%2520dissociation%2520of%2520a%2520short-living%2520and%2520very%2520long-acting%2520inhibitor%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26spage%3D139%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Axelrod, J.</span><span> </span><span class="NLM_article-title">Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1966&pages=95-113&author=J.+Axelrod&title=Methylation+reactions+in+the+formation+and+metabolism+of+catecholamines+and+other+biogenic+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26atitle%3DMethylation%2520reactions%2520in%2520the%2520formation%2520and%2520metabolism%2520of%2520catecholamines%2520and%2520other%2520biogenic%2520amines%26jtitle%3DPharmacol.%2520Rev.%26date%3D1966%26volume%3D18%26spage%3D95%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Crevelimg, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Catechol <i>O</i>-methyltransferase: III. <i>m</i>- and <i>p</i>-<i>O</i>-methylation of catecholamines and their metabolites</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=691-696&author=C.+R.+Crevelimgauthor=N.+Dalgardauthor=H.+Shimizuauthor=J.+W.+Daly&title=Catechol+O-methyltransferase%3A+III.+m-+and+p-O-methylation+of+catecholamines+and+their+metabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrevelimg%26aufirst%3DC.%2BR.%26aulast%3DDalgard%26aufirst%3DN.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCatechol%2520O-methyltransferase%253A%2520III.%2520m-%2520and%2520p-O-methylation%2520of%2520catecholamines%2520and%2520their%2520metabolites%26jtitle%3DMol.%2520Pharmacol.%26date%3D1970%26volume%3D6%26spage%3D691%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystal structure of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=354-358&author=J.+Vidgrenauthor=L.+A.+Svenssonauthor=A.+Liljas&title=Crystal+structure+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DL.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520catechol-O-methyltransferase%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D354%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Masri, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">Selective <i>para- or meta-O</i>-methylation with catechol <i>O</i>-methyl transferase from rat liver</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=878-879&author=M.+S.+Masriauthor=D.+J.+Robbinsauthor=O.+H.+Emersonauthor=F.+Deeds&title=Selective+para-+or+meta-O-methylation+with+catechol+O-methyl+transferase+from+rat+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DM.%2BS.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DSelective%2520para-%2520or%2520meta-O-methylation%2520with%2520catechol%2520O-methyl%2520transferase%2520from%2520rat%2520liver%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D878%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Guldberg, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase: Pharmacological aspects and physiological role</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1975&pages=135-206&author=H.+C.+Guldbergauthor=C.+A.+Marsden&title=Catechol-O-methyltransferase%3A+Pharmacological+aspects+and+physiological+role"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuldberg%26aufirst%3DH.%2BC.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26atitle%3DCatechol-O-methyltransferase%253A%2520Pharmacological%2520aspects%2520and%2520physiological%2520role%26jtitle%3DPharmacol.%2520Rev.%26date%3D1975%26volume%3D27%26spage%3D135%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zhu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezell, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liehr, J. G.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase-catalysed rapid <i>O</i>-methylation of mutagenic flavanoids. metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=292-299&author=B.+T.+Zhuauthor=E.+L.+Ezellauthor=J.+G.+Liehr&title=Catechol-O-methyltransferase-catalysed+rapid+O-methylation+of+mutagenic+flavanoids.+metabolic+inactivation+as+a+possible+reason+for+their+lack+of+carcinogenicity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BT.%26aulast%3DEzell%26aufirst%3DE.%2BL.%26aulast%3DLiehr%26aufirst%3DJ.%2BG.%26atitle%3DCatechol-O-methyltransferase-catalysed%2520rapid%2520O-methylation%2520of%2520mutagenic%2520flavanoids.%2520metabolic%2520inactivation%2520as%2520a%2520possible%2520reason%2520for%2520their%2520lack%2520of%2520carcinogenicity%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D292%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Burba, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becking, G. C.</span><span> </span><span class="NLM_article-title">Effect of the antioxidant norhydroguaiaretic acid on the <i>in vitro</i> activity of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5348405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE3cXhvVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1969&pages=323-329&author=J.+V.+Burbaauthor=G.+C.+Becking&title=Effect+of+the+antioxidant+norhydroguaiaretic+acid+on+the+in+vitro+activity+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the antioxidant nordihydroguaiaretic acid on the in vitro activity of catechol-O-methyl transferase</span></div><div class="casAuthors">Burba, John V.; Becking, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-30</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The phenolic antioxidant, nordihydro-guaiaretic acid (NDGA), was a good substrate in vitro for rat liver, human liver, and human placenta catechol-O-methyl transferase (COMT); the Km values for rat and human liver COMT with NDGA as substrate were identical at 5 × 10-4M, while the human placental enzyme had a Km value of 2.5 × 10-4M.  NDGA at 6 × 10-6M inhibited the utilization of norepinephrine by COMT by 50%.  Both catechol rings of NDGA were O-methylated by COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP_XYl8hufPbVg90H21EOLACvtfcHk0ljYOWszi2jXew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhvVKruw%253D%253D&md5=2b4d833313cd2f0fe518471974a09a17</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurba%26aufirst%3DJ.%2BV.%26aulast%3DBecking%26aufirst%3DG.%2BC.%26atitle%3DEffect%2520of%2520the%2520antioxidant%2520norhydroguaiaretic%2520acid%2520on%2520the%2520in%2520vitro%2520activity%2520of%2520catechol-O-methyltransferase%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1969%26volume%3D180%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Porter, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titus, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totaro, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byer, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1962&pages=1067-1077&author=C.+C.+Porterauthor=L.+S.+Watsonauthor=D.+C.+Titusauthor=J.+A.+Totaroauthor=S.+S.+Byer&title=Inhibition+of+DOPA+decarboxylase+by+the+hydrazino+analog+of+alpha-methylDOPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BC.%26aulast%3DWatson%26aufirst%3DL.%2BS.%26aulast%3DTitus%26aufirst%3DD.%2BC.%26aulast%3DTotaro%26aufirst%3DJ.%2BA.%26aulast%3DByer%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520DOPA%2520decarboxylase%2520by%2520the%2520hydrazino%2520analog%2520of%2520alpha-methylDOPA%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1962%26volume%3D11%26spage%3D1067%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Burkard, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gey, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletscher, A.</span><span> </span><span class="NLM_article-title">A new inhibitor of decarboxylase of aromatic amino acids</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1962&pages=411-412&author=W.+P.+Burkardauthor=K.+F.+Geyauthor=A.+Pletscher&title=A+new+inhibitor+of+decarboxylase+of+aromatic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurkard%26aufirst%3DW.%2BP.%26aulast%3DGey%26aufirst%3DK.%2BF.%26aulast%3DPletscher%26aufirst%3DA.%26atitle%3DA%2520new%2520inhibitor%2520of%2520decarboxylase%2520of%2520aromatic%2520amino%2520acids%26jtitle%3DExperientia%26date%3D1962%26volume%3D18%26spage%3D411%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Muguet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broussolle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazot, G.</span><span> </span><span class="NLM_article-title">Apomorphine in patients with Parkinson’s disease</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0753-3322%2896%2982620-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7669939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK2MzpvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=197-209&author=D.+Muguetauthor=E.+Broussolleauthor=G.+Chazot&title=Apomorphine+in+patients+with+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Apomorphine in patients with Parkinson's disease</span></div><div class="casAuthors">Muguet D; Broussolle E; Chazot G</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">197-209</span>
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    </div><div class="casAbstract">We present a review of the recent literature and personal experience with apomorphine in patients with Parkinson's disease.  Apomorphine is a potent D1 and D2 dopaminergic agonist.  It has a rapid and short duration effect after subcutaneous administration at doses ranging from 15 to 180 micrograms/kg.  Plasma maximal concentration is reached in 8-16 minutes, with a plasma half life of 34-70 minutes.  Bioavailability is close to 100%.  Repeated injections in patients show post-stimulative hyposensitivity.  Apomorphine test appears very useful for the differential diagnosis between idiopathic Parkinson's disease and other Parkinson plus syndromes, and as a predictive test for dopaminergic responsiveness.  Appropriate doses are able to alleviate akinesia, rigidity and tremor.  Recent therapeutic trials have demonstrated the high interest of intermittent multiple subcutaneous apomorphine injections to cut the "off" motor phases in fluctuating parkinsonian patients under chronic levodopa treatment.  In some cases, continuous apomorphine subcutaneous infusion with a portable pump may be required, particularly when levodopa treatment is temporarily interrupted, as after abdominal surgery.  During long-term treatment, the apomorphine dose able to relieve akinesia remains stable.  Peripheral side effects such as nausea and hypotension may be prevented by the co-administration of domperidone, a peripheral dopaminergic antagonist.  Cutaneous fibrous nodules and psychiatric symptoms may occur, but usually at high dosages with continuous infusion.  Local allergic effects have limited the use of other routes of administration, such as intranasal, sublingual, and rectal routes.  Apomorphine is also used as a pharmacological tool for clinical research with the aim of a better understanding of the pathophysiology of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTE1sU-ZqRrMs25P7XSLhESfW6udTcc2eakHbBJ7Vx8Mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzpvFGrsw%253D%253D&md5=7feae36234d6eed7f8839ee02086eaa5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0753-3322%2896%2982620-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0753-3322%252896%252982620-5%26sid%3Dliteratum%253Aachs%26aulast%3DMuguet%26aufirst%3DD.%26aulast%3DBroussolle%26aufirst%3DE.%26aulast%3DChazot%26aufirst%3DG.%26atitle%3DApomorphine%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D1995%26volume%3D49%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sonnenblick, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeJemiel, T. H.</span><span> </span><span class="NLM_article-title">Dobutamine: A new synthetic cardioactive sympathetic amine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1056%2FNEJM197901043000105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=362214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE1MXhtFCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1979&pages=17-22&author=E.+H.+Sonnenblickauthor=W.+H.+Frishmanauthor=T.+H.+LeJemiel&title=Dobutamine%3A+A+new+synthetic+cardioactive+sympathetic+amine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dobutamine:  a new synthetic cardioactive sympathetic amine</span></div><div class="casAuthors">Sonnenblick, Edmund H.; Frishman, William H.; LeJemtel, Thierry H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-22</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review and discussion, with 38 refs., of cardiac effects of dobutamine (I)  [34368-04-2].  Myocardial contractility is increased by I with less peripheral arterial effects or tachycardia than seen with other sympathomimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp14RRDuLsv17Vg90H21EOLACvtfcHk0li6dNu_qu0Uew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhtFCmu7c%253D&md5=a3d5f3a3b887db7489ccda5e3f95a578</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJM197901043000105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197901043000105%26sid%3Dliteratum%253Aachs%26aulast%3DSonnenblick%26aufirst%3DE.%2BH.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26aulast%3DLeJemiel%26aufirst%3DT.%2BH.%26atitle%3DDobutamine%253A%2520A%2520new%2520synthetic%2520cardioactive%2520sympathetic%2520amine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1979%26volume%3D300%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Caruana, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raftery, E. B.</span><span> </span><span class="NLM_article-title">Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1365-2125.1987.tb03237.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1984&pages=721-727&author=M.+P.+Caruanaauthor=M.+Heberauthor=G.+Brigdenauthor=E.+B.+Raftery&title=Effects+of+fenoldopam%2C+a+specific+dopamine+receptor+agonist%2C+on+blood+pressure+and+left+ventricular+function+in+systemic+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1987.tb03237.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1987.tb03237.x%26sid%3Dliteratum%253Aachs%26aulast%3DCaruana%26aufirst%3DM.%2BP.%26aulast%3DHeber%26aufirst%3DM.%26aulast%3DBrigden%26aufirst%3DG.%26aulast%3DRaftery%26aufirst%3DE.%2BB.%26atitle%3DEffects%2520of%2520fenoldopam%252C%2520a%2520specific%2520dopamine%2520receptor%2520agonist%252C%2520on%2520blood%2520pressure%2520and%2520left%2520ventricular%2520function%2520in%2520systemic%2520hypertension%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1984%26volume%3D24%26spage%3D721%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Frohlich, E. D.</span><span> </span><span class="NLM_article-title">Methyldopa. Mechanisms and treatment 25 years later</span> <span class="citation_source-journal">Arch. Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1001%2Farchinte.1980.00040020954016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6247989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaL3c3hvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1980&pages=954-959&author=E.+D.+Frohlich&title=Methyldopa.+Mechanisms+and+treatment+25+years+later"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Methyldopa. Mechanisms and treatment 25 years later</span></div><div class="casAuthors">Frohlich E D</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">954-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">Methyldopa, an adrenergic-inhibiting compound, has been used for over 25 years as a safe and effective antihypertensive agent.  The postulated mechanisms for the antihypertensive action of this compound have been varied and parallel our broadening knowledge of the role of the adrenergic nervous system in controlling arterial pressure.  This review outlines the mechanisms of adrenergic control of the circulation and how the proposed mechanisms of action of methyldopa (ie, dopa decarboxylation, false neurotransmission, inhibition of renin release, and stimulation of alpha receptor sites in the brain) seem to account for the depressor action of the drug.  Physiologic effects as well as immunologic and other clinical effects are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKPcou_cxq3uR_TJajKxJDfW6udTcc2eY4k-A22UnLA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c3hvFamtg%253D%253D&md5=f04531e3f4184937bd0258963eaf15d2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1001%2Farchinte.1980.00040020954016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.1980.00040020954016%26sid%3Dliteratum%253Aachs%26aulast%3DFrohlich%26aufirst%3DE.%2BD.%26atitle%3DMethyldopa.%2520Mechanisms%2520and%2520treatment%252025%2520years%2520later%26jtitle%3DArch.%2520Int.%2520Med.%26date%3D1980%26volume%3D140%26spage%3D954%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Popa, V. T.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of adrenergic drugs</span> <span class="citation_source-journal">J. Asthma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F02770908409077417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6145698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2cXltVens78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1984&pages=183-207&author=V.+T.+Popa&title=Clinical+pharmacology+of+adrenergic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of adrenergic drugs</span></div><div class="casAuthors">Popa, Valentin T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asthma</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-207</span>CODEN:
                <span class="NLM_cas:coden">JOUADU</span>;
        ISSN:<span class="NLM_cas:issn">0277-0903</span>.
    </div><div class="casAbstract">A review with 198 refs. on the clin. pharmacol. of adrenergic agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqeQ3OfmJf-rVg90H21EOLACvtfcHk0lgFVWsIeAajlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVens78%253D&md5=bb8785938ffc2b394d5cfdfa6336c017</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3109%2F02770908409077417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02770908409077417%26sid%3Dliteratum%253Aachs%26aulast%3DPopa%26aufirst%3DV.%2BT.%26atitle%3DClinical%2520pharmacology%2520of%2520adrenergic%2520drugs%26jtitle%3DJ.%2520Asthma%26date%3D1984%26volume%3D21%26spage%3D183%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bowman, W. c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I. W.</span><span> </span><span class="NLM_article-title">Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1972.tb08115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5085231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE38XlsVOltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1972&pages=574-583&author=W.+c.+Bowmanauthor=I.+W.+Rodger&title=Actions+of+the+sympathomimetic+bronchodilator%2C+rimiterol+%28R798%29%2C+on+the+cardiovascular%2C+respiratory+and+skeletal+muscle+systems+of+the+anaesthetized+cat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory, and skeletal muscle systems of the anesthetized cat</span></div><div class="casAuthors">Bowman, W. C.; Rodger, I. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">574-83</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Rimiterol (R 798) (erythro-(3,4-dihydroxyphenyl)-2-piperidylmethanol HBr) (I) [31842-61-2] was equipotent to salbutamol [18559-94-9] and .sim. 8-fold less potent than l-isoprenaline bitartrate [59-60-9] in opposing serotonin-induced bronchoconstriction and in decreasing the tension and degree of fusion of incomplete tetanic contractions of the soleus muscle of the cat.  Both I and salbutamol were .sim. 19-fold less potent than L-isoprenaline in increasing cat heart rate.  The action of I on the soleus muscle suggests that systemic bronchodilator doses of I may, like salbutamol, produce muscle tremor as an unwanted side effect.  I and salbutamol produced less tachycardia in cats than did l-isoprenaline.  The greater safety margin between bronchial and cardiac effects of I and salbutamol indicates a therapeutic advantage over isoprenaline.  The safety margin for salbutamol was small in the cat compared to that reported for other animal species and this may indicate a less clear differentiation between β1-and β2-adrenoceptors in the cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBysEtSdLSyLVg90H21EOLACvtfcHk0lg4ycAnAvTusQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsVOltbk%253D&md5=a27d60eb603f98dd6af59a417df17fd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1972.tb08115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1972.tb08115.x%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DW.%2Bc.%26aulast%3DRodger%26aufirst%3DI.%2BW.%26atitle%3DActions%2520of%2520the%2520sympathomimetic%2520bronchodilator%252C%2520rimiterol%2520%2528R798%2529%252C%2520on%2520the%2520cardiovascular%252C%2520respiratory%2520and%2520skeletal%2520muscle%2520systems%2520of%2520the%2520anaesthetized%2520cat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1972%26volume%3D45%26spage%3D574%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Miyöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schendzielorz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Distribution of catechol-<i>O</i>-methyltransferase (COMT) proteins and enzymatic activities in wild-type and S-COMT deficient mice</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=20374420" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=1632-1643&author=T.+T.+Miy%C3%B6h%C3%A4nenauthor=N.+Schendzielorzauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Distribution+of+catechol-O-methyltransferase+%28COMT%29+proteins+and+enzymatic+activities+in+wild-type+and+S-COMT+deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DSchendzielorz%26aufirst%3DN.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DDistribution%2520of%2520catechol-O-methyltransferase%2520%2528COMT%2529%2520proteins%2520and%2520enzymatic%2520activities%2520in%2520wild-type%2520and%2520S-COMT%2520deficient%2520mice%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D113%26spage%3D1632%26epage%3D1643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ellingson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddempudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhofer, G.</span><span> </span><span class="NLM_article-title">Determination of differential activities of soluble and mebrane-bound catechol-O-methyltransferase in tissues and erythrocytes</span> <span class="citation_source-journal">J. Chromatogr. B: Biomed. Sci. Appl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1–2</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0378-4347%2899%2900125-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=1999&pages=347-353&author=T.+Ellingsonauthor=S.+Duddempudiauthor=B.+D.+Greenbergauthor=D.+Hooperauthor=G.+Eisenhofer&title=Determination+of+differential+activities+of+soluble+and+mebrane-bound+catechol-O-methyltransferase+in+tissues+and+erythrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0378-4347%2899%2900125-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4347%252899%252900125-5%26sid%3Dliteratum%253Aachs%26aulast%3DEllingson%26aufirst%3DT.%26aulast%3DDuddempudi%26aufirst%3DS.%26aulast%3DGreenberg%26aufirst%3DB.%2BD.%26aulast%3DHooper%26aufirst%3DD.%26aulast%3DEisenhofer%26aufirst%3DG.%26atitle%3DDetermination%2520of%2520differential%2520activities%2520of%2520soluble%2520and%2520mebrane-bound%2520catechol-O-methyltransferase%2520in%2520tissues%2520and%2520erythrocytes%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Biomed.%2520Sci.%2520Appl.%26date%3D1999%26volume%3D1%25E2%2580%25932%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, P. H.</span><span> </span><span class="NLM_article-title">The purification and kinetic properties of liver microsomal-catechol-O-methyltransferase</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1974&pages=1089-1100&author=R.+T.+Borchardtauthor=C.-F.+Chengauthor=P.+H.+Cooke&title=The+purification+and+kinetic+properties+of+liver+microsomal-catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DCheng%26aufirst%3DC.-F.%26aulast%3DCooke%26aufirst%3DP.%2BH.%26atitle%3DThe%2520purification%2520and%2520kinetic%2520properties%2520of%2520liver%2520microsomal-catechol-O-methyltransferase%26jtitle%3DLife%2520Sci.%26date%3D1974%26volume%3D14%26spage%3D1089%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tenhunen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalanko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukkonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span> </span><span class="NLM_article-title">Structure of the rat catechol-<i>O</i>-methyltransferase gene: Separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme</span> <span class="citation_source-journal">DNA Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=253-263&author=J.+Tenhunenauthor=M.+Salminenauthor=A.+Jalankoauthor=S.+Ukkonenauthor=I.+Ulmanen&title=Structure+of+the+rat+catechol-O-methyltransferase+gene%3A+Separate+promoters+are+used+to+produce+mRNAs+for+soluble+and+membrane-bound+forms+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenhunen%26aufirst%3DJ.%26aulast%3DSalminen%26aufirst%3DM.%26aulast%3DJalanko%26aufirst%3DA.%26aulast%3DUkkonen%26aufirst%3DS.%26aulast%3DUlmanen%26aufirst%3DI.%26atitle%3DStructure%2520of%2520the%2520rat%2520catechol-O-methyltransferase%2520gene%253A%2520Separate%2520promoters%2520are%2520used%2520to%2520produce%2520mRNAs%2520for%2520soluble%2520and%2520membrane-bound%2520forms%2520of%2520the%2520enzyme%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D1993%26volume%3D12%26spage%3D253%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Grossman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budarf, M. L.</span><span> </span><span class="NLM_article-title">Chromosomal mapping of the human catechol-<i>O</i>-methyltransferase gene to 22q11.1→q11.2</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=822-825&author=M.+H.+Grossmanauthor=B.+S.+Emanuelauthor=M.+L.+Budarf&title=Chromosomal+mapping+of+the+human+catechol-O-methyltransferase+gene+to+22q11.1%E2%86%92q11.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DM.%2BH.%26aulast%3DEmanuel%26aufirst%3DB.%2BS.%26aulast%3DBudarf%26aufirst%3DM.%2BL.%26atitle%3DChromosomal%2520mapping%2520of%2520the%2520human%2520catechol-O-methyltransferase%2520gene%2520to%252022q11.1%25E2%2586%2592q11.2%26jtitle%3DGenomics%26date%3D1992%26volume%3D12%26spage%3D822%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lotta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melén, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julkunen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">4202</span><span class="NLM_x">–</span> <span class="NLM_lpage">4210</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00013a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXks1Kisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=4202-4210&author=T.+Lottaauthor=J.+Vidgrenauthor=C.+Tilgmannauthor=I.+Ulmanenauthor=K.+Mel%C3%A9nauthor=I.+Julkunenauthor=J.+Taskinen&title=Kinetics+of+human+soluble+and+membrane-bound+catechol+O-methyltransferase%3A+A+revised+mechanism+and+description+of+the+thermolabile+variant+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme</span></div><div class="casAuthors">Lotta, Timo; Vidgren, Jukka; Tilgmann, Carola; Ulmanen, Ismo; Melen, Krister; Julkunen, Ilkka; Taskinen, Jyrki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4202-10</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human sol. (S) and membrane-bound (MB) catechol O-methyltransferase (COMT, EC 2.1.1.6) enzymes have been expressed at sufficiently high levels of Escherichia coli and in baculovirus-infected insect cells to allow kinetic characterization of the enzyme forms.  The use of tight-binding inhibitors such as entacapone enabled the estn. of actual enzyme concns. and, thereby, comparison of velocity parameters, substrate selectivity, and regioselectivity of the methylation of both enzyme forms.  Kinetics of the methylation reaction of dopamine, (-)-noradrenaline, L-dopa, and 3,4-dihydroxybenzoic acid was studied in detail.  Here, the catalytic no. (Vmax) of S-COMT was somewhat higher than that of MB-COMT for all four substrates.  The Km values varied considerably, depending on both substrate and enzyme form.  S-COMT showed about 15 times higher Km values for catecholamines than MB-COMT.  The distinctive difference between the enzyme forms was also the higher affinity of MB-COMT for the coenzyme S-adenosyl-L-methionine (AdoMet).  The av. dissocn. consts. Ks were 3.4 and 20.2 μM for MB-COMT and S-COMT, resp.  Comparison between the kinetic results and the at. structure of S-COMT is presented, and a revised mechanism for the reaction cycle is discussed.  Two recently published human COMT cDNA sequences differed in the position of S-COMT amino acid 108, the residue being either Val-108 [Lundstroem et al. (1991) DNA Cell. Biol. 10, 181-189] or Met-108 [Bertocci et al. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 1416-1420].  The catalytic activities of these two COMT variants, expressed in E. coli, were similar, but the Met-108 enzyme was more thermolabile already at physiol. temp. (37°).  The reported existence of a common polymorphism of the human COMT gene coding for a thermolabile low activity, COMTL, and a thermostable high activity, COMTH, is discussed in light of the different thermostability of the two enzyme forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfn6AZM45drLVg90H21EOLACvtfcHk0lh6a57GEDqBQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXks1Kisrc%253D&md5=f97041642b8258b067ee667021ed37c4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi00013a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00013a008%26sid%3Dliteratum%253Aachs%26aulast%3DLotta%26aufirst%3DT.%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DUlmanen%26aufirst%3DI.%26aulast%3DMel%25C3%25A9n%26aufirst%3DK.%26aulast%3DJulkunen%26aufirst%3DI.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DKinetics%2520of%2520human%2520soluble%2520and%2520membrane-bound%2520catechol%2520O-methyltransferase%253A%2520A%2520revised%2520mechanism%2520and%2520description%2520of%2520the%2520thermolabile%2520variant%2520of%2520the%2520enzyme%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D4202%26epage%3D4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Karhunen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julkunen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panula, P.</span><span> </span><span class="NLM_article-title">Distribution of catechol-<i>O</i>-methyltransferase enzyme in rat tissues</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1177%2F42.8.8027527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8027527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2cXltlSltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1994&pages=1079-1090&author=T.+Karhunenauthor=C.+Tilgmannauthor=I.+Ulmanenauthor=I.+Julkunenauthor=P.+Panula&title=Distribution+of+catechol-O-methyltransferase+enzyme+in+rat+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of catechol-O-methyltransferase enzyme in rat tissues</span></div><div class="casAuthors">Karhunen, Tuula; Tilgmann, Carola; Ulmanen, Ismo; Julkunen, Ilkka; Panula, Pertti</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1079-90</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">In the present study the authors show the distribution of catechol O-methyltransferase (COMT) in various rat tissues with a highly specific antiserum prepd. against recombinant rat COMT.  Immunopptn. and immunocytochem. controls confirmed the COMT specificity of the antibodies.  The antiserum detected both the 24 kDa sol. and the 28 kDa membrane-bound forms of the enzyme.  By immunohistochem. staining the COMT enzyme was found in most rat tissues.  Staining was most intense in the liver and in the kidney, in agreement with previous studies and the authors' immunoblotting results.  In the gastrointestinal tract, epithelial cells of the stomach, duodenum, and ileum were immunoreactive for COMT.  In the pancreas, COMT immunoreactivity was found in insulin-producing β-cells and somatostatin-producing D-cells but not in glucagon-producing α-cells of the islets of Langerhans.  In the pituitary, COMT immunoreactivity was found in cleft cells, in pituicytes of the posterior lobe, and in the anterior lobe, partly in the cells contg. LH.  In other endocrine organs, COMT immunoreactivity was found in epithelial cells of the thyroid gland and in zona glomerulosa of the adrenal cortex.  In the brain, brightest immunofluorescence was seen in ependymal cells of the cerebral ventricles and choroid plexus.  Weak to moderate immunofluorescence was found in the neuropil of several brain areas, including striatum and cortex.  Scattered small neurons in spinal sensory ganglia were also COMT immunoreactive.  Previous immunocytochem. studies, enzyme activity detns., and distribution of the COMT mRNA are in general agreement with the results presented here.  The wide distribution of COMT in different tissues suggests an important role for this protein in activation of catechol compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvw8XXI5XPILVg90H21EOLACvtfcHk0lh6a57GEDqBQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltlSltLo%253D&md5=164e17c68070ba15dd1592504f5af7fc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F42.8.8027527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F42.8.8027527%26sid%3Dliteratum%253Aachs%26aulast%3DKarhunen%26aufirst%3DT.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DUlmanen%26aufirst%3DI.%26aulast%3DJulkunen%26aufirst%3DI.%26aulast%3DPanula%26aufirst%3DP.%26atitle%3DDistribution%2520of%2520catechol-O-methyltransferase%2520enzyme%2520in%2520rat%2520tissues%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1994%26volume%3D42%26spage%3D1079%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Roth, J. A.</span><span> </span><span class="NLM_article-title">Membrane-bound catechol-O-methyltransferase: A re-evaluation of its role in the O-methylation of catecholamine neurotransmitters</span> <span class="citation_source-journal">Rev. Physiol. Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBFb0036121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1519017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1entA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1992&pages=1-29&author=J.+A.+Roth&title=Membrane-bound+catechol-O-methyltransferase%3A+A+re-evaluation+of+its+role+in+the+O-methylation+of+catecholamine+neurotransmitters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-bound catechol-O-methyltransferase:  A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters</span></div><div class="casAuthors">Roth, Jerome A.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    </div><div class="casAbstract">A review, with 82 refs.  The following topics are discussed: contribution of sol. catechol-O-methyltransferase (COMT) and membrane-bound COMT (MB-COMT) to O-methylation of catecholamines, biochem. properties of MB-COMT; MB-COMT in human brain, significance and localization of MB-COMT; genetic regulation of sol. COMT and MB-COMT; and new COMT inhibitors as anti-Parkinson's disease and anti-depressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCHh4PSD2UbVg90H21EOLACvtfcHk0lhN6q1IyP5Cug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1entA%253D%253D&md5=17842053668c4372dcedbd51782c0454</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBFb0036121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBFb0036121%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DMembrane-bound%2520catechol-O-methyltransferase%253A%2520A%2520re-evaluation%2520of%2520its%2520role%2520in%2520the%2520O-methylation%2520of%2520catecholamine%2520neurotransmitters%26jtitle%3DRev.%2520Physiol.%2520Biochem.%2520Pharmacol.%26date%3D1992%26volume%3D120%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Huotari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raasmaja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.0953-816x.2001.01856.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11849292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=246-256&author=M.+Huotariauthor=J.+A.+Gogosauthor=M.+Karayiorgouauthor=O.+Koponenauthor=M.+Forsbergauthor=A.+Raasmajaauthor=J.+Hyttinenauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Brain+catecholamine+metabolism+in+catechol-O-methyltransferase+%28COMT%29-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice</span></div><div class="casAuthors">Huotari Marko; Gogos Joseph A; Karayiorgou Maria; Koponen Olli; Forsberg Markus; Raasmaja Atso; Hyttinen Juha; Mannisto Pekka T</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-56</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) catalyses the O-methylation of compounds having a catechol structure and its main function involves the elimination of biologically active or toxic catechols and their metabolites.  By means of homologous recombination in embryonic stem cells, a strain of mice has been produced in which the gene encoding the COMT enzyme is disrupted.  We report here the levels of catecholamines and their metabolites in striatal extracellular fluid in these mice as well as in homogenates from different parts of the brain, under normal conditions and after acute levodopa administration.  In immunoblotting studies, COMT-knockout mice had no COMT protein in brain or kidney tissues but the amounts of catecholamine synthesizing and other metabolizing enzyme proteins were normal.  Under normal conditions, COMT deficiency does not appear to affect significantly brain dopamine and noradrenaline levels in spite of relevant changes in their metabolites.  This finding is consistent with previous pharmacological studies with COMT inhibitors and confirms the pivotal role of synaptic reuptake processes and monoamine oxidase-dependent metabolism in terminating the actions of catecholamines at nerve terminals.  In contrast, when COMT-deficient mice are challenged with l-dihydroxyphenylalanine, they show an extensive accumulation of 3,4-dihydroxyphenylacetic acid and dihydroxyphenylglycol and even dopamine, revealing an important role for COMT under such situations.  Notably, in some cases these changes appear to be Comt gene dosage-dependent, brain-region specific and sexually dimorphic.  Our results may have implications for improving the treatment of Parkinson's disease and for understanding the contribution of the natural variation in COMT activity to psychiatric phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQem9MhWlUjNBBrI9DTGjC0fW6udTcc2ebGnqIGznQ_1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVynug%253D%253D&md5=7993411fcf4fa9d03717489e3f29271d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01856.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01856.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuotari%26aufirst%3DM.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26aulast%3DKoponen%26aufirst%3DO.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DRaasmaja%26aufirst%3DA.%26aulast%3DHyttinen%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DBrain%2520catecholamine%2520metabolism%2520in%2520catechol-O-methyltransferase%2520%2528COMT%2529-deficient%2520mice%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Coward, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slixz, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F. Y.</span><span> </span><span class="NLM_article-title">Kinetic studies on catechol O-methyltransferase: Product inhibition and the nature of the catechol binding site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00736a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1973&pages=2291-2297&author=J.+K.+Cowardauthor=E.+P.+Slixzauthor=F.+Y.+Wu&title=Kinetic+studies+on+catechol+O-methyltransferase%3A+Product+inhibition+and+the+nature+of+the+catechol+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi00736a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00736a017%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DJ.%2BK.%26aulast%3DSlixz%26aufirst%3DE.%2BP.%26aulast%3DWu%26aufirst%3DF.%2BY.%26atitle%3DKinetic%2520studies%2520on%2520catechol%2520O-methyltransferase%253A%2520Product%2520inhibition%2520and%2520the%2520nature%2520of%2520the%2520catechol%2520binding%2520site%26jtitle%3DBiochemistry%26date%3D1973%26volume%3D12%26spage%3D2291%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Woodard, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floss, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, J. K.</span><span> </span><span class="NLM_article-title">Stereochemical course of the transmethylation catalyzed by catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">9124</span><span class="NLM_x">–</span> <span class="NLM_lpage">9127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=9124-9127&author=R.+W.+Woodardauthor=M.+D.+Tsaiauthor=H.+G.+Flossauthor=P.+A.+Crooksauthor=J.+K.+Coward&title=Stereochemical+course+of+the+transmethylation+catalyzed+by+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodard%26aufirst%3DR.%2BW.%26aulast%3DTsai%26aufirst%3DM.%2BD.%26aulast%3DFloss%26aufirst%3DH.%2BG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DCoward%26aufirst%3DJ.%2BK.%26atitle%3DStereochemical%2520course%2520of%2520the%2520transmethylation%2520catalyzed%2520by%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D9124%26epage%3D9127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruderer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase-inhibiting pyrocatechol derivatives: Synthesis and structure–activity studies</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1989&pages=952-968&author=J.+Borgulyaauthor=H.+Brudererauthor=K.+Bernauerauthor=G.+Zurcherauthor=M.+Da+Prada&title=Catechol-O-methyltransferase-inhibiting+pyrocatechol+derivatives%3A+Synthesis+and+structure%E2%80%93activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DBruderer%26aufirst%3DH.%26aulast%3DBernauer%26aufirst%3DK.%26aulast%3DZurcher%26aufirst%3DG.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DCatechol-O-methyltransferase-inhibiting%2520pyrocatechol%2520derivatives%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1989%26volume%3D72%26spage%3D952%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystallisation and preliminary X-ray investigation of a recombinant form of rat catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=233-236&author=J.+Vidgrenauthor=C.+Tilgmannauthor=K.+Lundstr%C3%B6mauthor=A.+Liljas&title=Crystallisation+and+preliminary+X-ray+investigation+of+a+recombinant+form+of+rat+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystallisation%2520and%2520preliminary%2520X-ray%2520investigation%2520of%2520a%2520recombinant%2520form%2520of%2520rat%2520catechol-O-methyltransferase%26jtitle%3DProteins%26date%3D1991%26volume%3D11%26spage%3D233%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fbcp.12169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=410-420&author=Z.+Maauthor=H.+Liuauthor=B.+Wu&title=Structure-based+drug+design+of+catechol-O-methyltransferase+inhibitors+for+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12169%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure-based%2520drug%2520design%2520of%2520catechol-O-methyltransferase%2520inhibitors%2520for%2520CNS%2520disorders%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D77%26spage%3D410%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rutherford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Trong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenkamp, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parson, W. W.</span><span> </span><span class="NLM_article-title">Crystal structures of human 108V and 108M catechol O-methyltransferase</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2008&pages=120-130&author=K.+Rutherfordauthor=I.+Le+Trongauthor=R.+E.+Stenkampauthor=W.+W.+Parson&title=Crystal+structures+of+human+108V+and+108M+catechol+O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRutherford%26aufirst%3DK.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DStenkamp%26aufirst%3DR.%2BE.%26aulast%3DParson%26aufirst%3DW.%2BW.%26atitle%3DCrystal%2520structures%2520of%2520human%2520108V%2520and%2520108M%2520catechol%2520O-methyltransferase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D380%26spage%3D120%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elorriaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase by <i>N</i>-(3,4-dihydroxyphenyl) maleimide</span> <span class="citation_source-journal">J. Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F14756369009030387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2128841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVOhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=43-50&author=F.+J.+Piedrafitaauthor=C.+Elorriagaauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nieto&title=Inhibition+of+catechol-O-methyltransferase+by+N-%283%2C4-dihydroxyphenyl%29+maleimide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide</span></div><div class="casAuthors">Piedrafita, F. J.; Elorriaga, C.; Fernandez-Alvarez, E.; Nieto, O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (EC 2.1.1.6, COMT) is inhibited rapidly and irreversibly by N-(3,4-dihydroxyphenyl) maleimide.  S-Adenosylmethionine (AdoMet) and Mg ions protect the enzyme from inactivation by this compd., but no protection is obsd. by the catechol substrate.  However, the corresponding succinimide analog shows a reversible inhibition of COMT, which is competitive with pyrocatecholphthalein and noncompetitive with AdoMet.  Amino group reagents also inhibit COMT and this inhibition is protected by AdoMet, suggesting that SH and amino groups essential for activity are located in an AdoMet-binding site on COMT.  The maleimide deriv. may be considered to be an active site directed inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOTAKp4wDbdLVg90H21EOLACvtfcHk0liBVLqnqS9ggQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVOhtL4%253D&md5=2c49534fccd483134be3349aa2331b4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3109%2F14756369009030387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756369009030387%26sid%3Dliteratum%253Aachs%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26aulast%3DElorriaga%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520by%2520N-%25283%252C4-dihydroxyphenyl%2529%2520maleimide%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D1990%26volume%3D4%26spage%3D43%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jatana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apoorva, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, Sonika</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latha, N.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-O-methyltransferase in the treatment of neurological disorders</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2174%2F1871524913666140109113341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=24450388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOnsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=166-194&author=N.+Jatanaauthor=N.+Apoorvaauthor=Sonika+Malikauthor=A.+Sharmaauthor=N.+Latha&title=Inhibitors+of+catechol-O-methyltransferase+in+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders</span></div><div class="casAuthors">Jatana, Nidhi; Apoorva, N.; Malik, Sonika; Sharma, Aditya; Latha, Narayanan</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-194</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Catechol-O-methyltransferase (COMT) is the enzyme which catalyzes the transfer of a Me group from S-adenosylmethionine to catechols and catecholamines, like the neurotransmitters dopamine, epinephrine and norepinephrine.  COMT has implications in many neurol. and psychiatric disorders like schizophrenia, Parkinson's disease (PD), bipolar disorders, etc. and therefore, it serves as an important drug target.  Since its characterization in 1957, many inhibitors were designed where the first generation inhibitors were found to be highly toxic, short acting and had poor bioavailability.  Currently, two of the second generation inhibitors, tolcapone and entacapone have been used for treatment of PD but are assocd. with various dopaminergic and gastro-intestinal side-effects.  There have been several approaches for the design of novel COMT inhibitors with a good and safe therapeutic profile.  The focus of this article is to review the current knowledge on COMT and the role of COMT inhibitors in the treatment of neurol. disorders.  The inhibitors have been classified into six different classes based on the structural framework.  A historical overview of the discovery and development of COMT inhibitors is presented with a special emphasis on new generation of inhibitors till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJPFjVGa4dHrVg90H21EOLACvtfcHk0liQcUjNk_y0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOnsLnK&md5=4eea3036094000e1183637fb4f4b1123</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F1871524913666140109113341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524913666140109113341%26sid%3Dliteratum%253Aachs%26aulast%3DJatana%26aufirst%3DN.%26aulast%3DApoorva%26aufirst%3DN.%26aulast%3DMalik%26aufirst%3DSonika%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DLatha%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520in%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D166%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span> </span><span class="NLM_article-title">New selective COMT inhibitors: useful adjuncts for Parkinson’s disease?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=54-56&author=P.+T.+M%C3%A4nnist%C3%B6author=S.+Kaakkola&title=New+selective+COMT+inhibitors%3A+useful+adjuncts+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DKaakkola%26aufirst%3DS.%26atitle%3DNew%2520selective%2520COMT%2520inhibitors%253A%2520useful%2520adjuncts%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1989%26volume%3D10%26spage%3D54%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Sharif, A. A.</span><span> </span><span class="NLM_article-title">Entacapone in restless legs syndrome</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=421&author=A.+A.+Sharif&title=Entacapone+in+restless+legs+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DA.%2BA.%26atitle%3DEntacapone%2520in%2520restless%2520legs%2520syndrome%26jtitle%3DMov.%2520Disord.%26date%3D2002%26volume%3D17%26spage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Egan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolachana, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callicott, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzanti, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. USA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">6917</span><span class="NLM_x">–</span> <span class="NLM_lpage">6922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=6917-6922&author=M.+F.+Eganauthor=T.+E.+Goldbergauthor=B.+S.+Kolachanaauthor=J.+H.+Callicottauthor=C.+M.+Mazzantiauthor=R.+E.+Straubauthor=D.+Goldmanauthor=D.+R.+Weinberger&title=Effect+of+COMT+Val108%2F158+Met+genotype+on+frontal+lobe+function+and+risk+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DGoldberg%26aufirst%3DT.%2BE.%26aulast%3DKolachana%26aufirst%3DB.%2BS.%26aulast%3DCallicott%26aufirst%3DJ.%2BH.%26aulast%3DMazzanti%26aufirst%3DC.%2BM.%26aulast%3DStraub%26aufirst%3DR.%2BE.%26aulast%3DGoldman%26aufirst%3DD.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DEffect%2520of%2520COMT%2520Val108%252F158%2520Met%2520genotype%2520on%2520frontal%2520lobe%2520function%2520and%2520risk%2520for%2520schizophrenia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520USA%26date%3D2001%26volume%3D98%26spage%3D6917%26epage%3D6922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Fava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolsky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpert, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiglieri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, G.</span><span> </span><span class="NLM_article-title">Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004714-199908000-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10440460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1aisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=329-335&author=M.+Favaauthor=J.+F.+Rosenbaumauthor=A.+R.+Kolskyauthor=J.+E.+Alpertauthor=A.+A.+Nierenbergauthor=M.+Spillmannauthor=C.+Mooreauthor=P.+Renshawauthor=T.+Bottiglieriauthor=G.+Morozauthor=G.+Magni&title=Open+study+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+in+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder</span></div><div class="casAuthors">Fava, Maurizio; Rosenbaum, Jerrold F.; Kolsky, Andrea R.; Alpert, Jonathan E.; Nierenberg, Andrew A.; Spillmann, Maya; Moore, Constance; Renshaw, Perry; Bottiglieri, Teodoro; Moroz, Georges; Magni, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor that has shown efficacy in the treatment of Parkinson's disease.  The authors undertook the first study on the efficacy of this COMT inhibitor in the treatment of major depressive disorder (MDD).  The authors also wanted to assess the effects of tolcapone on the choline and myoinositol resonances in the left caudate and dorsolateral frontal lobe through proton magnetic resonance spectroscopy and on whole blood levels of S-adenosyl-L-methionine (SAMe).  The study enrolled 21 adults (10 men and 11 women; mean age, 42.6±9.6 yr) with MDD, which was diagnosed using the Structured Clin. Interview for DSM-IV, and an initial score of≥16 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17).  Patients were then treated openly for 8 wk with tolcapone 400 mg twice daily.  Treatment efficacy was assessed with the HAM-D-17, the Clin. Global Impressions Severity (CGI-S) scale, and the Beck Depression Inventory (BDI).  Among all subjects (N = 21), there were significant (p <.0001) decreases at endpoint in HAM-D-17 scores (from 19.4±2.9 to 10.7±5.5), CGI-S scores (from 3.9±0.6 to 2.4±1.1), and BDI scores (from 21.6±8.1 to 12.3±8.6).  Eight patients (38%) dropped out before completing the 8-wk open study because of diarrhea, elevated liver function tests, increased anxiety, and non-compliance.  No significant effects were noted on choline and myoinositol resonance or on SAMe levels in whole blood before and after 2 wk of tolcapone treatment.  The preliminary results suggest that tolcapone may be a promising agent in the treatment of MDD.  Furthermore, double-blind, placebo-controlled studies are necessary to confirm this impression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn_3Adio8eT7Vg90H21EOLACvtfcHk0liQcUjNk_y0ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1aisL0%253D&md5=acc57237b57733bfaaad60957265b2ad</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1097%2F00004714-199908000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199908000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DFava%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DJ.%2BF.%26aulast%3DKolsky%26aufirst%3DA.%2BR.%26aulast%3DAlpert%26aufirst%3DJ.%2BE.%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DSpillmann%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DRenshaw%26aufirst%3DP.%26aulast%3DBottiglieri%26aufirst%3DT.%26aulast%3DMoroz%26aufirst%3DG.%26aulast%3DMagni%26aufirst%3DG.%26atitle%3DOpen%2520study%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520in%2520major%2520depressive%2520disorder%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D329%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lachman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papolos, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szumlanski, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshilboum, R. M.</span><span> </span><span class="NLM_article-title">Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00008571-199606000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8807664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK28XksFemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=243-250&author=H.+M.+Lachmanauthor=D.+F.+Papolosauthor=T.+Saitoauthor=Y.+M.+Yuauthor=C.+L.+Szumlanskiauthor=R.+M.+Weinshilboum&title=Human+catechol-O-methyltransferase+pharmacogenetics%3A+Description+of+a+functional+polymorphism+and+its+potential+application+to+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders</span></div><div class="casAuthors">Lachman, Herbert M.; Papolos, Demitri F.; Saito, Takuya; Yu, Yue-Min; Szumlanski, Carol L.; Weinshilboum, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-250</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) inactivates catecholamines and catechol drugs such as L-DOPA.  A common genetic polymorphism in humans is assocd. with a three-to-four-fold variation in COMT enzyme activity and is also assocd. with individual variation in COMT thermal instability.  We now show that this is due to G→A transition at codon 158 of the COMT gene that results in a valine to methionine substitution.  The two alleles can be identified with a PCR-based restriction fragment length polymorphism anal. using the restriction enzyme N1a III.  The identification of a genetic marker assocd. with significant alterations is enzyme activity will facilitate the anal. of a possible role for the COMT gene in neuropsychiatric conditions in which abnormalities in catecholamine neurotransmission are believed to occur, including mood disorders, schizophrenia, obsessive compulsive disorder, alc. and substance abuse, and attention deficit hyperactivity disorder.  In addn., this polymorphism may have pharmacogenetic significance in that it will help make it possible to identify patients who display altered metab. of catechol drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEjfvU45qu7rVg90H21EOLACvtfcHk0lg8y3rpab5Xcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFemsLw%253D&md5=b1a6c776f38a9b218d54a26f9efa9c7d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1097%2F00008571-199606000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-199606000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DLachman%26aufirst%3DH.%2BM.%26aulast%3DPapolos%26aufirst%3DD.%2BF.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%2BM.%26aulast%3DSzumlanski%26aufirst%3DC.%2BL.%26aulast%3DWeinshilboum%26aufirst%3DR.%2BM.%26atitle%3DHuman%2520catechol-O-methyltransferase%2520pharmacogenetics%253A%2520Description%2520of%2520a%2520functional%2520polymorphism%2520and%2520its%2520potential%2520application%2520to%2520neuropsychiatric%2520disorders%26jtitle%3DPharmacogenetics%26date%3D1996%26volume%3D6%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Berk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauer-Sant’Anna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapczinski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T.</span><span> </span><span class="NLM_article-title">Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder</span> <span class="citation_source-journal">Acta Psychiatr. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0447.2007.01058.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=41-49&author=M.+Berkauthor=S.+Doddauthor=M.+Kauer-Sant%E2%80%99Annaauthor=G.+S.+Malhiauthor=M.+Bourinauthor=F.+Kapczinskiauthor=T.+Norman&title=Dopamine+dysregulation+syndrome%3A+Implications+for+a+dopamine+hypothesis+of+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0447.2007.01058.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0447.2007.01058.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DKauer-Sant%25E2%2580%2599Anna%26aufirst%3DM.%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DBourin%26aufirst%3DM.%26aulast%3DKapczinski%26aufirst%3DF.%26aulast%3DNorman%26aufirst%3DT.%26atitle%3DDopamine%2520dysregulation%2520syndrome%253A%2520Implications%2520for%2520a%2520dopamine%2520hypothesis%2520of%2520bipolar%2520disorder%26jtitle%3DActa%2520Psychiatr.%2520Scand.%26date%3D2007%26volume%3D116%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrão, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">D<sub>1</sub>-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.1523-1755.2001.0590051683.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11318939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1683-1694&author=M.+A.+Vieira-Coelhoauthor=P.+Gomesauthor=M.+P.+Serr%C3%A3oauthor=P.+Soares-da-Silva&title=D1-like+dopamine+receptor+activation+and+natriuresis+by+nitrocatechol+COMT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors</span></div><div class="casAuthors">Vieira-Coelho, Maria Augusta; Gomes, Pedro; Serrao, Maria Paula; Soares-Da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1683-1694</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">In recent years, several nitrocatechol derivs. (tolcapone, entacapone, and nitecapone) have been developed and found to be highly selective and potent inhibitors of catechol-O-methyltransferase (COMT).  More recently, natriuretic properties were described for two of these compds. (entacapone and nitecapone), although this was not accompanied by enhanced urinary excretion of dopamine.  We hypothesized that nitrocatechol derivs. stimulate D1-like dopamine receptors.  Adult male Wistar rats were treated with a nitrocatechol COMT inhibitor (entacapone, tolcapone, or nitecapone, 30 mg/kg, orally), and the urinary excretion of dopamine and sodium was quantitated.  The interaction of nitrocatechol derivs. with D1-like receptors was evaluated by their ability to displace [3H]-Sch23390 binding from membranes of rat renal cortex and cAMP prodn. in opossum kidney (OK) cells.  Urinary excretion of sodium (μmol/h) was markedly increased by all three nitrocatechol derivs.: vehicle, 55.0 ± 5.6; entacapone, 98.4 ± 9.3; tolcapone, 97.5 ± 9.3; and nitecapone, 120.5 ± 12.6.  Pretreatment with the selective, D1 antagonist Sch 23390 (60 μg/kg) completely prevented their natriuretic effects.  Nitecapone and tolcapone were equipotent (IC of 48 and 42 μmol/L) and more potent than entacapone and dopamine (IC50s of 107 and 279 μmol/L) in displacing [3H]-Sch23390 binding.  In OK cells, all three nitrocatechol derivs. significantly increased cAMP accumulation and reduced Na+/H+ exchange and Na+ K+-ATPase activities, this being prevented by a blockade of D1-like receptors.  Stimulation of D1-like dopamine receptors and inhibition of Na+/H+ exchange and Na+, K+-ATPase activities by nitrocatechol COMT inhibitors may contribute to natriuresis produced by these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt3w4fBILa5bVg90H21EOLACvtfcHk0lg8y3rpab5Xcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ehsL4%253D&md5=77802ae3c5d0677f0ed17a9fbbe7426a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2001.0590051683.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2001.0590051683.x%26sid%3Dliteratum%253Aachs%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DGomes%26aufirst%3DP.%26aulast%3DSerr%25C3%25A3o%26aufirst%3DM.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DD1-like%2520dopamine%2520receptor%2520activation%2520and%2520natriuresis%2520by%2520nitrocatechol%2520COMT%2520inhibitors%26jtitle%3DKidney%2520Int.%26date%3D2001%26volume%3D59%26spage%3D1683%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Larsen, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. G.</span><span> </span><span class="NLM_article-title">Effects of tolcapone, a catechol-<i>O</i>-methyltransferase inhibitor, and sinemet on intestinal electrolyte and fluid transport in conscious dogs</span> <span class="citation_source-journal">Dig. Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1806</span><span class="NLM_x">–</span> <span class="NLM_lpage">1813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1023%2FA%3A1018852223902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9724173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=1806-1813&author=K.+R.+Larsenauthor=E.+Z.+Dajaniauthor=N.+E.+Dajaniauthor=M.+T.+Daytonauthor=J.+G.+Moore&title=Effects+of+tolcapone%2C+a+catechol-O-methyltransferase+inhibitor%2C+and+sinemet+on+intestinal+electrolyte+and+fluid+transport+in+conscious+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of tolcapone, a catechol-O-methyltransferase inhibitor, and Sinemet on intestinal electrolyte and fluid transport in conscious dogs</span></div><div class="casAuthors">Larsen, Kenneth R.; Dajani, Esam Z.; Dajani, Nora E.; Dayton, Merril T.; Moore, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1806-1813</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Tolcapone (T) is a novel catechol-O-methyltransferase (COMT) inhibitor recently introduced for the treatment of Parkinson's disease.  In clin. efficacy studies, T has been assocd. with a low incidence of diarrhea.  The objectives of the study were to examine whether T and its adjunctive drug Sinemet (S) could influence intestinal fluid and electrolyte transport as a possible cause for the diarrhea.  The studies were conducted in conscious dogs surgically prepd. with Thiry-Vella loops constructed from a 40-cm jejunal segment.  A physiol. buffered test soln. was perfused into the oral stoma and collected from the caudad stoma.  Secretions were collected at 15-min intervals and analyzed for vol., electrolytes, lipid phosphorus, and protein.  The acute oral administration of T (10 and 30 mg/kg doses) was well tolerated.  Concurrent acute administration of S (25 mg/kg) with T (30 mg/kg) was also well tolerated.  The acute oral administration of T induced a dose-dependent efflux of intestinal fluid and electrolytes (sodium, potassium, chloride, and bicarbonate) secretion (P < 0.05).  The oral coadministration of S (25 mg/kg) with T (30 mg/kg) accelerated the onset of the stimulation of intestinal secretion.  Despite the significant stimulation of intestinal secretion, none of the dogs developed diarrhea, indicating the importance of intestinal compensatory mechanisms.  Neither T nor T&S affected calcium, lipid, or protein efflux rates, suggesting that the stimulated secretion was not a consequence of intestinal mucosal injury.  The chronic (seven-day) administration of T and T&S was assocd. with reduced intestinal secretory responses when compared with the acute administration of the same drugs; S enhanced the T-induced tolerance development.  The basis for such tolerance is unknown.  In conclusion, the stimulatory systemic actions of tolcapone on intestinal secretion may, under certain conditions, contribute to the induction of diarrhea in susceptible patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryU13DRqZsGbVg90H21EOLACvtfcHk0lhB5GaPAa8P3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVyqsbg%253D&md5=74b066d9fb51e644cb8881c2bc3fc4a9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018852223902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018852223902%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DK.%2BR.%26aulast%3DDajani%26aufirst%3DE.%2BZ.%26aulast%3DDajani%26aufirst%3DN.%2BE.%26aulast%3DDayton%26aufirst%3DM.%2BT.%26aulast%3DMoore%26aufirst%3DJ.%2BG.%26atitle%3DEffects%2520of%2520tolcapone%252C%2520a%2520catechol-O-methyltransferase%2520inhibitor%252C%2520and%2520sinemet%2520on%2520intestinal%2520electrolyte%2520and%2520fluid%2520transport%2520in%2520conscious%2520dogs%26jtitle%3DDig.%2520Dis.%2520Sci.%26date%3D1998%26volume%3D43%26spage%3D1806%26epage%3D1813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Talan, J.</span><span> </span><span class="NLM_article-title">Attention deficit disorder associated with dopamine deficits in brain</span> <span class="citation_source-journal">Neurol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=19236723" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=10&author=J.+Talan&title=Attention+deficit+disorder+associated+with+dopamine+deficits+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalan%26aufirst%3DJ.%26atitle%3DAttention%2520deficit%2520disorder%2520associated%2520with%2520dopamine%2520deficits%2520in%2520brain%26jtitle%3DNeurol.%2520Today%26date%3D2009%26volume%3D9%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">DiMaio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joober, R.</span><span> </span><span class="NLM_article-title">Dopamine genes and attention-deficit hyperactivity disorder: A review</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12587848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fns1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=27-38&author=S.+DiMaioauthor=N.+Grizenkoauthor=R.+Joober&title=Dopamine+genes+and+attention-deficit+hyperactivity+disorder%3A+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine genes and attention-deficit hyperactivity disorder: a review</span></div><div class="casAuthors">DiMaio Salvatore; Grizenko Nathalie; Joober Ridha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-38</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To review the results of genetic studies investigating dopamine-related genes in attention-deficit hyperactivity disorder (ADHD).  DATA SOURCES:  Papers (association/linkage, meta-analyses and animal model studies) were identified through searches of the PubMed database and systematically reviewed.  DATA SYNTHESIS:  Consistent results from molecular genetic studies are pointing strongly to the possible link between 2 specific genes, the dopamine transporter (SLC3A6) and the dopamine receptor 4 (DRD4), and ADHD.  CONCLUSIONS:  The implication of SLC6A3 and DRD4 genes in ADHD appears to be one of the most replicated in psychiatric genetics and strongly suggests the involvement of the brain dopamine systems in the pathogenesis of ADHD.  However, more work is required to further these findings by genotype-to-phenotype correlations and identify the functional allelic variants/mutations that are responsible for these associations.  The role of other dopamine genes, which may have smaller effects than SLC6A3 and DRD4, needs also to be determined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIfPAxtqjoYhOk4JA3soTqfW6udTcc2ebzvKCMu-BRE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fns1Glsw%253D%253D&md5=485289692e83bcea52e47490f6186575</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMaio%26aufirst%3DS.%26aulast%3DGrizenko%26aufirst%3DN.%26aulast%3DJoober%26aufirst%3DR.%26atitle%3DDopamine%2520genes%2520and%2520attention-deficit%2520hyperactivity%2520disorder%253A%2520A%2520review%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2003%26volume%3D28%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Orth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in Parkinson’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0197-0186%2801%2900124-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11850110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFyktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=533-541&author=M.+Orthauthor=A.+H.+Schapira&title=Mitochondrial+involvement+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial involvement in Parkinson's disease</span></div><div class="casAuthors">Orth, M.; Schapira, A. H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-541</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review on the role of mitochondria in the pathogenesis of Parkinson's disease (PD) is discussed.  Oxidative phosphorylation system (OXPHOS) function is compromised in PD and complex I inhibition was used to produce rodent models of PD.  The prodn. of free radicals within mitochondria and from DA metab. could be enhanced by a pre-existing mitochondrial defect and in turn may produce OXPHOS dysfunction and mtDNA abnormalities.  The discovery of mutations underlying familial PD syndromes provides new models to understand the mechanisms of selective dopaminergic cell death and the involvement of mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRwYMKYqNfnbVg90H21EOLACvtfcHk0lhB5GaPAa8P3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFyktb8%253D&md5=42e3c4ed4aa962ffe1613571ac411316</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2801%2900124-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252801%252900124-3%26sid%3Dliteratum%253Aachs%26aulast%3DOrth%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26atitle%3DMitochondrial%2520involvement%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2002%26volume%3D40%26spage%3D533%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase and catecholamine metabolism</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7931266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1994&pages=57-67&author=I.+J.+Kopin&title=Monoamine+oxidase+and+catecholamine+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase and catecholamine metabolism</span></div><div class="casAuthors">Kopin, I. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission, Supplement</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">JNTSD4</span>;
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">A review, with 68 refs., of the role of MAO in catecholamine metab. which discusses: biochem. assessment of catecholamine metab.; physiol. assessment of the role of MAO and COMT; clin. effects of MAO inhibitors; MAO subtypes; and deprenyl treatment in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokypN_UKb7F7Vg90H21EOLACvtfcHk0lgQ8nTpm-uMuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFamu7w%253D&md5=f7b72f440235b6e8584db83132655597</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DMonoamine%2520oxidase%2520and%2520catecholamine%2520metabolism%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D1994%26volume%3D41%26spage%3D57%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Birkmayer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornykiewicz, O.</span><span> </span><span class="NLM_article-title">Der L-3,4-dioxyphenylalanin (L-DOPA)-effekt bei der Parkinson-akinese</span> <span class="citation_source-journal">Wien. Klin. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=13869404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaF38%252FhtVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1961&pages=787-788&author=W.+Birkmayerauthor=O.+Hornykiewicz&title=Der+L-3%2C4-dioxyphenylalanin+%28L-DOPA%29-effekt+bei+der+Parkinson-akinese"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia</span></div><div class="casAuthors">BIRKMAYER W; HORNYKIEWICZ O</div><div class="citationInfo"><span class="NLM_cas:title">Wiener klinische Wochenschrift</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">787-8</span>
        ISSN:<span class="NLM_cas:issn">0043-5325</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwpe8412F9xK2q3xNe7a7QfW6udTcc2ebcw87AaUo_BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF38%252FhtVKrsA%253D%253D&md5=1b9753c7fbfa3e24f006005b1d5bad66</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26aulast%3DHornykiewicz%26aufirst%3DO.%26atitle%3DDer%2520L-3%252C4-dioxyphenylalanin%2520%2528L-DOPA%2529-effekt%2520bei%2520der%2520Parkinson-akinese%26jtitle%3DWien.%2520Klin.%2520Wochenschr.%26date%3D1961%26volume%3D73%26spage%3D787%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Rinne, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molsa, P.</span><span> </span><span class="NLM_article-title">Levodopa with benserazide or carbidopa in Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1979&pages=1584-1589&author=U.+K.+Rinneauthor=P.+Molsa&title=Levodopa+with+benserazide+or+carbidopa+in+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DU.%2BK.%26aulast%3DMolsa%26aufirst%3DP.%26atitle%3DLevodopa%2520with%2520benserazide%2520or%2520carbidopa%2520in%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D1979%26volume%3D29%26spage%3D1584%26epage%3D1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellman, J. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of levodopa</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=35-39&author=J.+G.+Nuttauthor=J.+H.+Fellman&title=Pharmacokinetics+of+levodopa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DFellman%26aufirst%3DJ.%2BH.%26atitle%3DPharmacokinetics%2520of%2520levodopa%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1984%26volume%3D7%26spage%3D35%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kuruma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletscher, A.</span><span> </span><span class="NLM_article-title">The metabolism of L-3-<i>O</i>-methyldopa, a precursor dopa in man</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2Fcpt1971124678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5567811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE3M3ot1Wlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1971&pages=678-682&author=I.+Kurumaauthor=G.+Bartholiniauthor=R.+Tissotauthor=A.+Pletscher&title=The+metabolism+of+L-3-O-methyldopa%2C+a+precursor+dopa+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of L-3-O-methyldopa, a precursor of dopa in man</span></div><div class="casAuthors">Kuruma I; Bartholini G; Tissot R; Pletscher A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">678-82</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2qDicW6Xp0c-crCu0nI_sfW6udTcc2ebcw87AaUo_BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M3ot1Wlsw%253D%253D&md5=9c378263440c52982a1d49b1e6e8ddc3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcpt1971124678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1971124678%26sid%3Dliteratum%253Aachs%26aulast%3DKuruma%26aufirst%3DI.%26aulast%3DBartholini%26aufirst%3DG.%26aulast%3DTissot%26aufirst%3DR.%26aulast%3DPletscher%26aufirst%3DA.%26atitle%3DThe%2520metabolism%2520of%2520L-3-O-methyldopa%252C%2520a%2520precursor%2520dopa%2520in%2520man%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1971%26volume%3D12%26spage%3D678%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckner, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berggren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gancher, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerstad, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span> </span><span class="NLM_article-title">Effect of peripheral catechol-<i>O</i>-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=913-919&author=J.+G.+Nuttauthor=W.+R.+Woodwardauthor=R.+M.+Becknerauthor=C.+K.+Stoneauthor=K.+Berggrenauthor=J.+H.+Carterauthor=S.+T.+Gancherauthor=J.+P.+Hammerstadauthor=A.+Gordin&title=Effect+of+peripheral+catechol-O-methyltransferase+inhibition+on+the+pharmacokinetics+and+pharmacodynamics+of+levodopa+in+parkinsonian+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DWoodward%26aufirst%3DW.%2BR.%26aulast%3DBeckner%26aufirst%3DR.%2BM.%26aulast%3DStone%26aufirst%3DC.%2BK.%26aulast%3DBerggren%26aufirst%3DK.%26aulast%3DCarter%26aufirst%3DJ.%2BH.%26aulast%3DGancher%26aufirst%3DS.%2BT.%26aulast%3DHammerstad%26aufirst%3DJ.%2BP.%26aulast%3DGordin%26aufirst%3DA.%26atitle%3DEffect%2520of%2520peripheral%2520catechol-O-methyltransferase%2520inhibition%2520on%2520the%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520levodopa%2520in%2520parkinsonian%2520patients%26jtitle%3DNeurology%26date%3D1994%26volume%3D44%26spage%3D913%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Green, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyoung, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R.</span><span> </span><span class="NLM_article-title">A gene-brain-cognition pathway: Prefrontal activity mediates the effect of COMT on cognitive control and IQ</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fcercor%2Fbhs035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=22368081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BC38vksVWmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=552-559&author=A.+E.+Greenauthor=D.+J.+Kraemerauthor=C.+G.+Deyoungauthor=J.+A.+Fossellaauthor=J.+R.+Gray&title=A+gene-brain-cognition+pathway%3A+Prefrontal+activity+mediates+the+effect+of+COMT+on+cognitive+control+and+IQ"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A gene-brain-cognition pathway: prefrontal activity mediates the effect of COMT on cognitive control and IQ</span></div><div class="casAuthors">Green Adam E; Kraemer David J M; Deyoung Colin G; Fossella John A; Gray Jeremy R</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">552-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A core thesis of cognitive neurogenetic research is that genetic effects on cognitive ability are mediated by specific neural functions, however, demonstrating neural mediation has proved elusive.  Pairwise relationships between genetic variation and brain function have yielded heterogeneous findings to date.  This heterogeneity indicates that a multiple mediator modeling approach may be useful to account for complex relationships involving function at multiple brain regions.  This is relevant not only for characterizing healthy cognition but for modeling the complex neural pathways by which disease-related genetic effects are transmitted to disordered cognitive phenotypes in psychiatric illness.  Here, in 160 genotyped functional magnetic resonance imaging participants, we used a multiple mediator model to test a gene-brain-cognition pathway by which activity in 4 prefrontal brain regions mediates the effects of catechol-O-methyltransferase (COMT) gene on cognitive control and IQ.  Results provide evidence for gene-brain-cognition mediation and help delineate a pathway by which gene expression contributes to intelligence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmpbR3jFKAWJNiNltV31zlfW6udTcc2ebZ_uX2igZFoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vksVWmtg%253D%253D&md5=8f7f4e7f32d20a2d15ee2aa852caa4d2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2Fbhs035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252Fbhs035%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BE.%26aulast%3DKraemer%26aufirst%3DD.%2BJ.%26aulast%3DDeyoung%26aufirst%3DC.%2BG.%26aulast%3DFossella%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DJ.%2BR.%26atitle%3DA%2520gene-brain-cognition%2520pathway%253A%2520Prefrontal%2520activity%2520mediates%2520the%2520effect%2520of%2520COMT%2520on%2520cognitive%2520control%2520and%2520IQ%26jtitle%3DCereb.%2520Cortex%26date%3D2013%26volume%3D23%26spage%3D552%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Apud, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2165%2F00023210-200721070-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17579498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFCis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=535-557&author=J.+A.+Apudauthor=D.+R.+Weinberger&title=Treatment+of+cognitive+deficits+associated+with+schizophrenia%3A+potential+role+of+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cognitive deficits associated with schizophrenia. Potential role of catechol-O-methyltransferase inhibitors</span></div><div class="casAuthors">Apud, Jose A.; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">535-557</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last two decades, understanding of the dynamics of dopamine function in the prefrontal cortex and its role in prefrontal cortex physiol. has opened up new avenues for therapeutic interventions in conditions in which prefrontal cortex function is compromised.  Neuropsychol. and imaging studies of prefrontal information processing have confirmed specific cognitive and neurophysiol. abnormalities in individuals with schizophrenia.  Because such findings are also obsd. in the healthy siblings of patients with schizophrenia, they may represent intermediate phenotypes related to schizophrenia susceptibility genes.  Catechol-O-methyltransferase (COMT) represents an important candidate as a susceptibility gene for cognitive dysfunction in schizophrenia because of the unique role this enzyme plays in regulating prefrontal dopaminergic function.  A functional COMT polymorphism (Val158Met) predicts performance in tasks of prefrontal executive function and the neurophysiol. response measured with electroencephalog. and functional magnetic resonance imaging in tasks assessing working memory.  In fact, individuals with the Val/Val genotype, which encodes for the high-activity enzyme resulting in lower dopamine concns. in the prefrontal cortex, perform less well and are less efficient physiol. than Met/Met individuals.  These findings raise the possibility of new pharmacol. interventions for the treatment of prefrontal cortex dysfunction and of predicting outcome based on COMT genotype.  One strategy consists of the use of CNS-penetrant COMT inhibitors such as tolcapone.  A second strategy is to increase extracellular dopamine concns. in the frontal cortex by blocking the noradrenaline (norepinephrine) reuptake system, a secondary mechanism responsible for the disposal of dopamine from synaptic clefts in the prefrontal cortex.  A third possibility involves the use of modafinil, a drug with an unclear mechanism of action but with pos. effects on working memory in rodents.  The potential of these drugs to improve executive cognitive function by selectively increasing dopamine load in the frontal cortex but not in subcortical territories, and the possibility that response to them may be modified by a COMT polymorphism, provides a novel genotype-based targeted pharmacol. approach without abuse potential for the treatment of cognitive disorder in schizophrenia and in other conditions involving prefrontal cortex dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZmnS6TUnyZ7Vg90H21EOLACvtfcHk0lhHFZBAnXxuzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFCis7s%253D&md5=380a19dbe5725aee9c41c264bee848ac</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2165%2F00023210-200721070-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200721070-00002%26sid%3Dliteratum%253Aachs%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520of%2520cognitive%2520deficits%2520associated%2520with%2520schizophrenia%253A%2520potential%2520role%2520of%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D535%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Talkowski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgieva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdari, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimgaonkar, V. L.</span><span> </span><span class="NLM_article-title">A network of dopaminergic gene variations implicated as risk factors for schizophrenia</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fhmg%2Fddm347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=18045777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=747-758&author=M.+E.+Talkowskiauthor=G.+Kirovauthor=M.+Bamneauthor=L.+Georgievaauthor=G.+Torresauthor=H.+Mansourauthor=K.+V.+Chowdariauthor=V.+Milanovaauthor=J.+Woodauthor=L.+McClainauthor=K.+Prasadauthor=B.+Shirtsauthor=J.+Zhangauthor=M.+C.+O%E2%80%99Donovanauthor=M.+J.+Owenauthor=B.+Devlinauthor=V.+L.+Nimgaonkar&title=A+network+of+dopaminergic+gene+variations+implicated+as+risk+factors+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A network of dopaminergic gene variations implicated as risk factors for schizophrenia</span></div><div class="casAuthors">Talkowski, Michael E.; Kirov, George; Bamne, Mikhil; Georgieva, Lyudmila; Torres, Gonzalo; Mansour, Hader; Chowdari, Kodavali V.; Milanova, Vihra; Wood, Joel; McClain, Lora; Prasad, Konasale; Shirts, Brian; Zhang, Jianping; O'Donovan, Michael C.; Owen, Michael J.; Devlin, Bernie; Nimgaonkar, Vishwajit L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-758</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ).  In stage I, we screened 18 dopamine-related genes in two independent US Caucasian samples: 150 trios and 328 cases/501 controls.  The most promising assocns. were detected with SLC6A3 (alias DAT), DRD3, COMT and SLC18A2 (alias VMAT2).  In stage II, we comprehensively evaluated these four genes by genotyping 68 SNPs in all 478 cases and 501 controls from stage I. Fifteen (23.1%) significant assocns. were found (p ≤ 0.05).  We sought epistasis between pairs of SNPs providing evidence of a main effect and obsd. 17 significant interactions (169 tests); 41.2% of significant interactions involved rs3756450 (5' near promoter) or rs464049 (intron 4) at SLC6A3.  In stage III, we confirmed our findings by genotyping 65 SNPs among 659 Bulgarian trios.  Both SLC6A3 variants implicated in the US interactions were overtransmitted in this cohort (rs3756450, p = 0.035; rs464049, p = 0.011).  Joint analyses from stages II and III identified assocns. at all four genes (pjoint < 0.05).  We tested 29 putative interactions from stage II and detected replication between seven locus pairs (p ≤ 0.05).  Simulations suggested our stage II and stage III interaction results were unlikely to have occurred by chance (p = 0.008 and 0.001, resp.).  In stage IV we evaluated rs464049 and rs3756450 for functional effects and found significant allele-specific differences at rs3756450 using electrophoretic mobility shift assays and dual-luciferase promoter assays.  Our data suggest that a network of dopaminergic polymorphisms increase risk for SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0YS6gKmgbQLVg90H21EOLACvtfcHk0ljxpIE3nIzO8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVemsrw%253D&md5=fee4e39fc949fab802dc77f0f6c6646b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm347%26sid%3Dliteratum%253Aachs%26aulast%3DTalkowski%26aufirst%3DM.%2BE.%26aulast%3DKirov%26aufirst%3DG.%26aulast%3DBamne%26aufirst%3DM.%26aulast%3DGeorgieva%26aufirst%3DL.%26aulast%3DTorres%26aufirst%3DG.%26aulast%3DMansour%26aufirst%3DH.%26aulast%3DChowdari%26aufirst%3DK.%2BV.%26aulast%3DMilanova%26aufirst%3DV.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DMcClain%26aufirst%3DL.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DShirts%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BC.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DDevlin%26aufirst%3DB.%26aulast%3DNimgaonkar%26aufirst%3DV.%2BL.%26atitle%3DA%2520network%2520of%2520dopaminergic%2520gene%2520variations%2520implicated%2520as%2520risk%2520factors%2520for%2520schizophrenia%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26spage%3D747%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Williams, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. C.</span><span> </span><span class="NLM_article-title">Is COMT a susceptibility gene for schizophrenia?</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fschbul%2Fsbm019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17412710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD2s3pslSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=635-641&author=H.+J.+Williamsauthor=M.+J.+Owenauthor=M.+C.+O%E2%80%99Donovan&title=Is+COMT+a+susceptibility+gene+for+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Is COMT a susceptibility gene for schizophrenia?</span></div><div class="casAuthors">Williams Hywel J; Owen Michael J; O'Donovan Michael C</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-41</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">Catechol-O-methyl transferase (COMT) is a catabolic enzyme involved in the degradation of a number of bioactive molecules; of principal interest to psychiatry, these include dopamine.  The enzyme is encoded by the COMT gene.  COMT is located (along with 47 other genes) in a fragment of chromosome 22q11 which when deleted results in a complex syndrome, the psychiatric manifestations of which include schizophrenia and other psychoses.  These 2 observations have placed COMT near the top of a rather long list of plausible candidate genes for schizophrenia.  The ability to test the hypothesis that COMT might be a susceptibility gene for schizophrenia has been simplified in principle by the existence of a valine-to-methionine (Val/Met) polymorphism which results respectively in high and low activity forms of the enzyme.  Given the unequivocal effect of this polymorphism on the function of COMT, and the evidence for a critical role for dopamine in the pathophysiology and treatment of psychosis, there are strong prior expectations that Val/Met influences susceptibility to schizophrenia as well as other psychiatric phenotypes.  Indeed the Val/Met polymorphism has become the most widely studied polymorphism in psychiatry.  In this review, we consider the evidence for and against the involvement of COMT in schizophrenia.  The current data allow us to virtually exclude a simple relationship between schizophrenia and the Val/Met variant previously thought to dominate COMT function.  However, recent data suggest a more complex pattern of genetic regulation of COMT function beyond that attributable to the Val/Met locus.  Moreover, it is also clear that there is a complex nonlinear relationship between dopamine availability and brain function.  These 2 factors, allied to phenotypic complexity within schizophrenia, make it difficult to draw strong conclusions regarding COMT in schizophrenia.  Nevertheless, emerging research that takes greater account of all these levels of complexity is beginning to provide tantalizing, but far from definitive, support for the view that COMT influences susceptibility to at least some forms of psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuOwJc-OjaynwOGIfWJ7-GfW6udTcc2eYbGkkxwB6NDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3pslSquw%253D%253D&md5=938a03107eec95dd327bbc2bb224b8f2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbm019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbm019%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DH.%2BJ.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BC.%26atitle%3DIs%2520COMT%2520a%2520susceptibility%2520gene%2520for%2520schizophrenia%253F%26jtitle%3DSchizophr.%2520Bull.%26date%3D2007%26volume%3D33%26spage%3D635%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Caramona, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1985.tb08903.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=3931730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2MXlvFSnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1985&pages=351-356&author=M.+M.+Caramonaauthor=P.+Soares-da-Silva&title=The+effects+of+chemical+sympathectomy+on+dopamine%2C+noradrenaline+and+adrenaline+content+in+some+peripheral+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues</span></div><div class="casAuthors">Caramona, M. M.; Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-6</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Dopamine  [51-61-6], noradrenaline (NA)  [51-41-2], and adrenaline (Ad)  [51-43-4] depletion by 6-hydroxydopamine (6-OHDA)  [1199-18-4] and pargyline  [555-57-7] plus 6-OHDA was investigated in the cat left ventricle, mesenteric and renal arteries, renal cortex, renal medulla, and adrenal medulla.  Catecholamine concns. in plasma were also analyzed in these 2 exptl. conditions.  6-OHDA alone or in combination with pargyline induced parallel decreases of NA and dopamine contents in the left ventricle.  In the main trunk and proximal branches of the mesenteric artery and renal artery 6-OHDA selectively reduced NA without a parallel decrease in dopamine content.  Previous treatment with pargyline abolished this selectivity.  In the kidney of control animals, dopamine content was greater than could be attributed to its presence only in noradrenergic neurons.  In the renal cortex 6-OHDA reduced dopamine and NA contents, and in the renal medulla only NA levels were decreased by this drug.  Pargyline plus 6-OHDA did not deplete the NA content either in the renal cortex or in the renal medulla, and only reduced the dopamine content in the renal cortex.  NA concns. in plasma were increased by pargyline plus 6-OHDA and Ad remained unaffected.  In the adrenal medulla only NA was reduced by 6-OHDA or pargyline plus 6-OHDA.  A NA-independent dopamine pool is suggested for both segments of the mesenteric artery and renal artery but not in the left ventricle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2VIUJTtqxHLVg90H21EOLACvtfcHk0lgF4UtlJY62bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvFSnsL8%253D&md5=3fec52806c4d15280a9d76bff0d00dec</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1985.tb08903.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1985.tb08903.x%26sid%3Dliteratum%253Aachs%26aulast%3DCaramona%26aufirst%3DM.%2BM.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520effects%2520of%2520chemical%2520sympathectomy%2520on%2520dopamine%252C%2520noradrenaline%2520and%2520adrenaline%2520content%2520in%2520some%2520peripheral%2520tissues%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D86%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1988.tb16567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2905904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL1cXlsVeisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1988&pages=218-224&author=P.+Soares-da-Silva&title=Evidence+for+dopaminergic+co-transmission+in+dog+mesenteric+arterial+vessels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for dopaminergic cotransmission in dog mesenteric arterial vessels</span></div><div class="casAuthors">Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The overflow of dopamine and noradrenaline (NA) from the main trunk of the dog mesenteric artery and its proximal branches during prolonged depolarization (120 min) by K+ (52 mM) was quantified by high performance liq. chromatog. with electrochem. detection.  K+-induced depolarization resulted in release of both dopamine and NA.  The amt. of NA released from both blood vessels declined progressively throughout the expt.  In the main trunk the same pattern of release was obsd. for dopamine, whereas in the proximal branches the overflow of dopamine increased throughout the expt.  The addn. of phentolamine (0.2 μM) to the perifusion fluid increased the overflow of both amines.  In the presence of sulpiride (1 μM) the overflow of dopamine and NA was increased in the proximal branches, but not in the main trunk.  The addn. of phentolamine to sulpiride caused a further increase in amine overflow in proximal branches, but not in the main trunk.  The addn. of α-methyl-p-tyrosine (50 μM) to the perifusion fluid caused a decrease in the amts. of dopamine and NA released from both prepns.  In α-methyl-p-tyrosine-treated prepns., phentolamine increased amine overflow to the same extent as in expts. without tyrosine hydroxylase inhibition.  The increasing effect of sulpiride on the overflow of dopamine and NA from the proximal branches was completely abolished after α-methyl-p-tyrosine.  Thus, in the proximal branches of the dog mesenteric artery, dopamine β-hydroxylase represents a rate limiting step in the synthesis of NA.  Dopamine, through activation of prejunctional dopamine receptors, acts like a prejunctional co-transmitter in the control of transmitter release; however, only newly-synthesized dopamine appears to be responsible for this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwW8b9zkgLNbVg90H21EOLACvtfcHk0lgF4UtlJY62bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsVeisLw%253D&md5=cceab9bf74878b6788ba0b32bc526ff3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb16567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb16567.x%26sid%3Dliteratum%253Aachs%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DEvidence%2520for%2520dopaminergic%2520co-transmission%2520in%2520dog%2520mesenteric%2520arterial%2520vessels%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D95%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrão, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Renal and intestinal autocrine monoaminergic systems: Dopamine versus 5-hydroxytryptamine</span> <span class="citation_source-journal">Clin. Exp. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F10641969709080803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9028634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=43-58&author=M.+A.+Vieira-Coelhoauthor=P.+Gomesauthor=M.+P.+Serr%C3%A3oauthor=P.+Soares-da-Silva&title=Renal+and+intestinal+autocrine+monoaminergic+systems%3A+Dopamine+versus+5-hydroxytryptamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Renal and intestinal autocrine monoaminergic systems: dopamine versus 5-hydroxytryptamine</span></div><div class="casAuthors">Vieira-Coelho, M. A.; Gomes, P.; Serrao, M. P.; Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Hypertension</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">43-58</span>CODEN:
                <span class="NLM_cas:coden">CEHYER</span>;
        ISSN:<span class="NLM_cas:issn">1064-1963</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A review, with 22 refs., of the basic mechanisms involved in the formation of dopamine and serotonin in renal and intestinal epithelial cells and of the antagonistic nature of dopaminergic and serotoninergic tonus at the kidney and intestinal level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJis3lx_IZ7bVg90H21EOLACvtfcHk0lgF4UtlJY62bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlGisb4%253D&md5=84a4de46c48a0cddf7d77b70c99fa311</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F10641969709080803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969709080803%26sid%3Dliteratum%253Aachs%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DGomes%26aufirst%3DP.%26aulast%3DSerr%25C3%25A3o%26aufirst%3DM.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DRenal%2520and%2520intestinal%2520autocrine%2520monoaminergic%2520systems%253A%2520Dopamine%2520versus%25205-hydroxytryptamine%26jtitle%3DClin.%2520Exp.%2520Hypertens.%26date%3D1997%26volume%3D19%26spage%3D43%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Jose, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, R. A.</span><span> </span><span class="NLM_article-title">Dopamine and G protein-coupled receptor kinase 4 in the kidney: Role in blood pressure regulation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1802</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=1259-1267&author=P.+A.+Joseauthor=P.+Soares-da-Silvaauthor=G.+M.+Eisnerauthor=R.+A.+Felder&title=Dopamine+and+G+protein-coupled+receptor+kinase+4+in+the+kidney%3A+Role+in+blood+pressure+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJose%26aufirst%3DP.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DEisner%26aufirst%3DG.%2BM.%26aulast%3DFelder%26aufirst%3DR.%2BA.%26atitle%3DDopamine%2520and%2520G%2520protein-coupled%2520receptor%2520kinase%25204%2520in%2520the%2520kidney%253A%2520Role%2520in%2520blood%2520pressure%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1802%26spage%3D1259%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Helkamaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finckenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huotari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span> </span><span class="NLM_article-title">Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2365</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004872-200312000-00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14654758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2365-2374&author=T.+Helkamaaauthor=P.+T.+M%C3%A4nnist%C3%B6author=P.+Rauhalaauthor=Z.+J.+Chengauthor=P.+Finckenbergauthor=M.+Huotariauthor=J.+A.+Gogosauthor=M.+Karayiorgouauthor=E.+M.+Mervaala&title=Resistance+to+salt-induced+hypertension+in+catechol-O-methyltransferase-gene-disrupted+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice</span></div><div class="casAuthors">Helkamaa, Teemu; Maennistoe, Pekka T.; Rauhala, Pekka; Cheng, Zhong Jian; Finckenberg, Piet; Huotari, Marko; Gogos, Joseph A.; Karayiorgou, Maria; Mervaala, Eero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2365-2374</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Previous studies have indicated that catechol-O-methyltransferase (COMT) can modulate renal dopaminergic tone.  OBJECTIVE: To test the hypothesis that COMT blockade protects from salt-induced hypertension.  METHODS: COMT gene-disrupted (-/-) mice and wild-type controls received a high-sodium diet (NaCl 6%) for 3 wk.  Blood pressure and heart rate were recorded by radiotelemetry.  Tissue and urine samples were assessed by light microscopy and high-performance liq. chromatog.  The effects of nitecapone treatment were also examd.  RESULTS: Systolic blood pressure and heart rate during normal sodium diet were similar in COMT (-/-) and wild-type mice.  The high-sodium diet increased night-time systolic and diastolic blood pressures in wild-type mice, whereas blood pressure in COMT (-/-) mice remained unaltered.  In wild-type mice, the sodium-induced increase in blood pressure was completely normalized by treatment with the COMT inhibitor, nitecapone.  At baseline, 24-h urinary excretion of levodopa (L-DOPA), dopamine and noradrenaline was increased by 145, 85 and 74%, resp., in COMT (-/-) mice compared with wild-type controls.  In COMT (-/-) and wild-type mice, a high-sodium diet increased urinary L-DOPA excretion by 405 and 660% (reflected as 102 and 212% increases in dopamine excretion), resp.  The abs. amts. of urinary L-DOPA and dopamine remained 60 and 20% greater in COMT (-/-) mice.  The high-sodium diet did not influence renal cortical COMT activity.  CONCLUSION: The authors' findings suggest that COMT deficiency in mice increases the availability of L-DOPA, leading to enhanced dopaminergic tone, which may be assocd. with resistance to salt-induced hypertension.  The findings of the present study also underline the importance of COMT in the regulation of blood pressure, sodium excretion and renal dopaminergic tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrobR-UlWZXabVg90H21EOLACvtfcHk0ljsVhTA8_dbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLk%253D&md5=b4a11cec7a2e3c5d5677d0bd857d9027</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1097%2F00004872-200312000-00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200312000-00026%26sid%3Dliteratum%253Aachs%26aulast%3DHelkamaa%26aufirst%3DT.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DZ.%2BJ.%26aulast%3DFinckenberg%26aufirst%3DP.%26aulast%3DHuotari%26aufirst%3DM.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26atitle%3DResistance%2520to%2520salt-induced%2520hypertension%2520in%2520catechol-O-methyltransferase-gene-disrupted%2520mice%26jtitle%3DJ.%2520Hypertens.%26date%3D2003%26volume%3D21%26spage%3D2365%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Helkamaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finckenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louhelainen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merasto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapatto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reenila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span> </span><span class="NLM_article-title">Entacapone protects from angiotensin II-induced inflammation and renal injury</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2353</span><span class="NLM_x">–</span> <span class="NLM_lpage">2363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004872-200312000-00025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14654757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2353-2363&author=T.+Helkamaaauthor=P.+Finckenbergauthor=M.+Louhelainenauthor=S.+Merastoauthor=P.+Rauhalaauthor=R.+Lapattoauthor=Z.+J.+Chengauthor=I.+Reenilaauthor=P.+T.+M%C3%A4nnist%C3%B6author=D.+N.+M%C3%BCllerauthor=F.+C.+Luftauthor=E.+M.+Mervaala&title=Entacapone+protects+from+angiotensin+II-induced+inflammation+and+renal+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone protects from angiotensin II-induced inflammation and renal injury</span></div><div class="casAuthors">Helkamaa, Teemu; Finckenberg, Piet; Louhelainen, Marjut; Merasto, Saara; Rauhala, Pekka; Lapatto, Risto; Cheng, Zhong Jian; Reenilae, Ilkka; Maennistoe, Pekka; Mueller, Dominik N.; Luft, Friedrich C.; Mervaala, Eero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2353-2363</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Angiotensin II (Ang II)-induced renal damage is assocd. with perivascular inflammation and increased oxidative stress.  We tested the hypothesis whether entacapone, a catechol-O-methyltransferase (COMT) inhibitor exerting antioxidative and anti-inflammatory properties, protects against the Ang II-induced inflammatory response and end-organ damage.  Samples from double-transgenic rats harboring human renin and human angiotensinogen genes (dTGR) and normotensive Sprague-Dawley rats (SD) were assessed by light microscopy, immunohistochem., reverse transcriptase-polymerase chain reaction (RT-PCR), and high pressure liq. chromatog.  The effects of entacapone treatment for 3 wk were examd. in dTGR and SD.  Entacapone completely prevented cardiovascular mortality and decreased albuminuria by 85% in dTGR.  Entacapone ameliorated Ang II-induced vascular and glomerular damage, leukocyte infiltration, and intercellular adhesion mol.-1 (ICAM-1) overexpression in the kidneys.  Serum 8-isoprostane concn., as well as renal nitrotyrosine and 8-hydroxydeoxyguanosine expressions, all markers of oxidative stress, were markedly increased in dTGR and normalized by entacapone.  Entacapone also decreased p22phox mRNA expression in the kidney.  COMT expression was increased by 500% locally in the renal vascular wall in dTGR; however, COMT activity in the whole kidney remained unchanged.  Urinary dopamine excretion, a marker of renal dopaminergic tone, was decreased by 50% in untreated dTGR.  Even though entacapone decreased renal COMT activity by 40%, the renal dopaminergic tone remained unchanged in entacapone-treated dTGR.  Our findings suggest that entacapone provides protection against Ang II-induced renal damage through antioxidative and anti-inflammatory mechanisms, rather than by COMT inhibition-induced changes in renal dopaminergic tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUb14b4AMXrbVg90H21EOLACvtfcHk0ljsVhTA8_dbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLg%253D&md5=f6dbdaf1c4e8bd03f4d574d356c68bf6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1097%2F00004872-200312000-00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200312000-00025%26sid%3Dliteratum%253Aachs%26aulast%3DHelkamaa%26aufirst%3DT.%26aulast%3DFinckenberg%26aufirst%3DP.%26aulast%3DLouhelainen%26aufirst%3DM.%26aulast%3DMerasto%26aufirst%3DS.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DLapatto%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DZ.%2BJ.%26aulast%3DReenila%26aufirst%3DI.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26atitle%3DEntacapone%2520protects%2520from%2520angiotensin%2520II-induced%2520inflammation%2520and%2520renal%2520injury%26jtitle%3DJ.%2520Hypertens.%26date%3D2003%26volume%3D21%26spage%3D2353%26epage%3D2363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Eriksson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrtic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niklason, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultén, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span> </span><span class="NLM_article-title">Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2Fj.ehj.2003.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=15033250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=386-391&author=A.+L.+Erikssonauthor=S.+Skrticauthor=A.+Niklasonauthor=L.+M.+Hult%C3%A9nauthor=O.+Wiklundauthor=T.+Hednerauthor=C.+Ohlsson&title=Association+between+the+low+activity+genotype+of+catechol-O-methyltransferase+and+myocardial+infarction+in+a+hypertensive+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population</span></div><div class="casAuthors">Eriksson, Anna-Lena; Skrtic, Stanko; Niklason, Anders; Hulten, Lillemor Mattsson; Wiklund, Olov; Hedner, Thomas; Ohlsson, Claes</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-391</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aim: Estrogens regulate several biol. processes involved in the pathogenesis of myocardial infarction.  Catechol-O-methyltransferase (COMT) is a key enzyme in the degrdn. of estrogens.  There is a functional polymorphism in the COMT gene (Val158Met), affecting the activity of the enzyme.  We investigated if the low activity genotype of COMT is assocd. with an altered risk of myocardial infarction.  Methods and Results: In a prospectively followed hypertensive cohort we identified 174 patients who suffered a myocardial infarction during the study and compared them to 348 controls from the same cohort.  The COMT polymorphism and serum levels of sex hormones were analyzed.  Patients homozygous for the low activity COMT genotype had a decreased risk of myocardial infarction compared to those with the high activity genotype, odds ratio 0.65 (95% CI 0.44-0.97, p=0.033).  The protective effect of the low activity genotype was most evident among older patients (>58 yr of age), odds ratio 0.43 (95% CI 0.23-0.79, p=0.006).  Serum levels of estradiol were increased (p=0.006) in males with the low activity genotype.  Conclusions: Our findings suggest that the low activity COMT genotype is protective against myocardial infarction.  One may speculate that the altered estrogen status could be involved in this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7szuXK-GNnbVg90H21EOLACvtfcHk0limaH2O0neKOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKnsrs%253D&md5=be7900b261a7c08078e337f0ec3cac26</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ehj.2003.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ehj.2003.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BL.%26aulast%3DSkrtic%26aufirst%3DS.%26aulast%3DNiklason%26aufirst%3DA.%26aulast%3DHult%25C3%25A9n%26aufirst%3DL.%2BM.%26aulast%3DWiklund%26aufirst%3DO.%26aulast%3DHedner%26aufirst%3DT.%26aulast%3DOhlsson%26aufirst%3DC.%26atitle%3DAssociation%2520between%2520the%2520low%2520activity%2520genotype%2520of%2520catechol-O-methyltransferase%2520and%2520myocardial%2520infarction%2520in%2520a%2520hypertensive%2520population%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2004%26volume%3D25%26spage%3D386%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Hagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stovner, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skorpen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, J. A.</span><span> </span><span class="NLM_article-title">High systolic blood pressure is associated with Val/Val genotype in the catechol-<i>O</i>-methyltransferase gene. The Nord-Trondelag Health Study (HUNT)</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2Fj.amjhyper.2006.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17198907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=21-26&author=K.+Hagenauthor=E.+Pettersenauthor=L.+J.+Stovnerauthor=F.+Skorpenauthor=J.+Holmenauthor=J.+A.+Zwart&title=High+systolic+blood+pressure+is+associated+with+Val%2FVal+genotype+in+the+catechol-O-methyltransferase+gene.+The+Nord-Trondelag+Health+Study+%28HUNT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">High Systolic Blood Pressure Is Associated With Val/Val Genotype in the Catechol-O-Methyltransferase Gene</span></div><div class="casAuthors">Hagen, Knut; Pettersen, Elin; Stovner, Lars Jacob; Skorpen, Frank; Holmen, Jostein; Zwart, John-Anker</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-26</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: The catechol-O-methyltransferase (COMT) gene contains a functional polymorphism, Val158Met.  A few studies on animals have shown a relationship between the COMT gene and BP, but whether this exists in human beings is unclear.  The aim of this study was to evaluate the relationship between codon 158 COMT gene polymorphism and BP in a population-based cohort.  Methods: In the 1995-97 Nord-Trondelag Health Study (HUNT), the assocn. between Val/Met polymorphism at the COMT gene and BP was evaluated in a group of 2966 nondiabetic individuals.  Results: Among the 2591 individuals without current use of antihypertensive drugs, systolic BP ≥140 mm Hg was more likely among persons with Val/Val genotype compared with the other genotypes (44.8% v 39.1%, P = .02).  In the multivariate anal. the prevalence odds ratio for having the Val/Val genotype was 1.63 (95% CI = 1.18 to 2.24) among individuals with systolic BP ≥160 mm Hg compared with those with systolic BP <140 mm Hg.  Val/Val genotype was also more likely (OR = 1.30, 95% CI = 1.04 to 1.63) among individuals with hypertension (as defined by use of antihypertensive medication, systolic BP ≥140 mm Hg, or diastolic BP ≥90 mm Hg) than among those with normal BP.  Conclusions: Based on the study findings, the Val/Val genotype appears to be assocd. with a higher prevalence of increased systolic BP compared with the Met/Met or Met/Val genotypes at the COMTgene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4TF7VRTb2rVg90H21EOLACvtfcHk0limaH2O0neKOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFGjsQ%253D%253D&md5=e28245420564ae8fa51e8fb569317b62</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2006.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2006.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DK.%26aulast%3DPettersen%26aufirst%3DE.%26aulast%3DStovner%26aufirst%3DL.%2BJ.%26aulast%3DSkorpen%26aufirst%3DF.%26aulast%3DHolmen%26aufirst%3DJ.%26aulast%3DZwart%26aufirst%3DJ.%2BA.%26atitle%3DHigh%2520systolic%2520blood%2520pressure%2520is%2520associated%2520with%2520Val%252FVal%2520genotype%2520in%2520the%2520catechol-O-methyltransferase%2520gene.%2520The%2520Nord-Trondelag%2520Health%2520Study%2520%2528HUNT%2529%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2007%26volume%3D20%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Htun, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimbo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span> </span><span class="NLM_article-title">Association of the catechol-O-methyl transferase gene Val158Met polymorphism with blood pressure and prevalence of hypertension: interaction with dietary energy intake</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1038%2Fajh.2011.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21776034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1022-1026&author=N.+C.+Htunauthor=K.+Miyakiauthor=Y.+Songauthor=S.+Ikedaauthor=T.+Shimboauthor=M.+Muramatsu&title=Association+of+the+catechol-O-methyl+transferase+gene+Val158Met+polymorphism+with+blood+pressure+and+prevalence+of+hypertension%3A+interaction+with+dietary+energy+intake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Association of the Catechol-O-Methyl Transferase Gene Val158Met Polymorphism With Blood Pressure and Prevalence of Hypertension: Interaction With Dietary Energy Intake</span></div><div class="casAuthors">Htun, Nay Chi; Miyaki, Koichi; Song, Yixuan; Ikeda, Shinobu; Shimbo, Takuro; Muramatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1022-1026</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background Previous studies of a functional variant of the catechol-O-Me transferase (COMT) gene, Val158Met, have provided inconsistent results with regard to blood pressure or hypertension.  We examd. the effect of this variant, the considering environmental factors of daily salt and energy intakes.  Methods A total of 735 Japanese men (mean age, 47 years) were recruited from two sep. occupational cohorts from Kanagawa and Kyoto prefectures.  Participants were genotyped for the presence of COMT Val158Met (rs4680, G/A).  Daily salt and energy intakes were evaluated by the food frequency questionnaire (FFQ).  Results Met/Met carriers had higher adjusted systolic blood pressure (SBP) (+4.79 mm Hg, P < 0.001) and diastolic blood pressure (DBP) (+2.33 mm Hg, P = 0.001) than Met/Val or Val/Val carriers.  There was a significant assocn. between being a Met/Met carrier and having a higher prevalence of hypertension (odds ratio = 2.448, 95% confidence interval = 1.426-4.205, P = 0.001).  When salt and energy intakes were dichotomized, the effect of Val158Met on hypertension was obsd. only in the high-energy intake group, and was equiv. between low- and high-salt groups.  Conclusion The Met allele of COMT Val158Met is assocd. with higher blood pressure and higher prevalence of hypertension in Japanese men, and energy intake may interact with this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY3VrATIhDDrVg90H21EOLACvtfcHk0ljAwvMuvcJ3DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegt7rF&md5=2a22ae7361d6b48ea7b6a0c8f2dfb0b5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fajh.2011.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajh.2011.93%26sid%3Dliteratum%253Aachs%26aulast%3DHtun%26aufirst%3DN.%2BC.%26aulast%3DMiyaki%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DShimbo%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520the%2520catechol-O-methyl%2520transferase%2520gene%2520Val158Met%2520polymorphism%2520with%2520blood%2520pressure%2520and%2520prevalence%2520of%2520hypertension%253A%2520interaction%2520with%2520dietary%2520energy%2520intake%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2011%26volume%3D24%26spage%3D1022%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Friese, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid-Schonbein, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, D. T.</span><span> </span><span class="NLM_article-title">Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension</span> <span class="citation_source-journal">Blood Press.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F08037051.2011.566012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21428728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlyks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=222-231&author=R.+S.+Frieseauthor=G.+W.+Schmid-Schonbeinauthor=D.+T.+O%E2%80%99Connor&title=Systematic+polymorphism+discovery+after+genome-wide+identification+of+potential+susceptibility+loci+in+a+hereditary+rodent+model+of+human+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension</span></div><div class="casAuthors">Friese, Ryan S.; Schmid-Schoeoenbein, Geert W.; O'Connor, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Pressure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">BLPREG</span>;
        ISSN:<span class="NLM_cas:issn">0803-7051</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Genetic strategies such as linkage anal. and quant. trait locus (QTL) mapping have identified a multi-tude of loci implicated in the pathogenesis of hypertension in the spontaneously hypertensive rat (SHR).  While several candidate genetic regions have been identified in the SHR and its control, the Wistar-Kyoto rat (WKY), systematic follow-up of candidate identification with polymorphism discovery has not been widespread.  In the current report, we develop a data-mining strategy to identify candidate genes for hypertension in the SHR, and then sequence each gene in the SHR and WKY strains.  We integrate blood pressure QTL data, microarray data and data-mining methods.  First, we detd. the set of genes differentially expressed in SHR and WKY adrenal glands.  Next, the chromosomal position of all differentially expressed genes was compared with peak marker position of all reported SHR blood pressure QTLs.  We also identified the set of differentially expressed genes with the most extreme fold-change.  Finally, the QTL positional candidates and the genes with extreme differential expression were proposed as candidate genes if they had biol. plausible roles in hypertensive pathol.  We identified seven candidate genes that merit resequencing (catechol-O-methyltransferase [Comt], chromogranin A [Chga], dopamine beta-hydroxylase [Dbh], electron transferring flavoprotein dehydrogenase [Etfdh], endothelin receptor type B [Ednrb], neuropeptide Y [Npy] and phenylethanolamine-N-methyltransferase [Pnmt]), and then discovered polymorphism in four of these seven candidate genes.  Chga is proposed as the strongest candidate for addnl. functional investigation.  Our method for candidate gene identification is portable and can be applied to microarray data from any tissue, in any disease model with a QTL database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo11DcQP31SHrVg90H21EOLACvtfcHk0ljAwvMuvcJ3DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlyks7o%253D&md5=f14a375ea099d66fb11c76ef3b20ce05</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3109%2F08037051.2011.566012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08037051.2011.566012%26sid%3Dliteratum%253Aachs%26aulast%3DFriese%26aufirst%3DR.%2BS.%26aulast%3DSchmid-Schonbein%26aufirst%3DG.%2BW.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%2BT.%26atitle%3DSystematic%2520polymorphism%2520discovery%2520after%2520genome-wide%2520identification%2520of%2520potential%2520susceptibility%2520loci%2520in%2520a%2520hereditary%2520rodent%2520model%2520of%2520human%2520hypertension%26jtitle%3DBlood%2520Press.%26date%3D2011%26volume%3D20%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Flemström, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safsten, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedstedt, G.</span><span> </span><span class="NLM_article-title">Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1993&pages=825-833&author=G.+Flemstr%C3%B6mauthor=B.+Safstenauthor=G.+Jedstedt&title=Stimulation+of+mucosal+alkaline+secretion+in+rat+duodenum+by+dopamine+and+dopaminergic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlemstr%25C3%25B6m%26aufirst%3DG.%26aulast%3DSafsten%26aufirst%3DB.%26aulast%3DJedstedt%26aufirst%3DG.%26atitle%3DStimulation%2520of%2520mucosal%2520alkaline%2520secretion%2520in%2520rat%2520duodenum%2520by%2520dopamine%2520and%2520dopaminergic%2520compounds%26jtitle%3DGastroenterology%26date%3D1993%26volume%3D104%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Li, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. X.</span><span> </span><span class="NLM_article-title">Entacapone promotes cAMP-dependent colonic Cl(−) secretion in rats</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">e277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1365-2982.2011.01715.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21501335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=657-e277&author=L.+S.+Liauthor=L.+F.+Zhengauthor=J.+D.+Xuauthor=T.+Jiauthor=H.+Guoauthor=X.+F.+Liauthor=Y.+Liauthor=Y.+Zhangauthor=J.+X.+Zhu&title=Entacapone+promotes+cAMP-dependent+colonic+Cl%28%E2%88%92%29+secretion+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone promotes cAMP-dependent colonic C1- secretion in rats</span></div><div class="casAuthors">Li, L.-S.; Zheng, L.-F.; Xu, J.-D.; Ji, T.; Guo, H.; Li, X.-F.; Li, Y.; Zhang, Y.; Zhu, J.-X.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">657-665</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Entacapone is a promising drug used widely for the treatment of Parkinson's disease (PD) as a catechol-O-Me transferase (COMT) inhibitor.  However, entacapone has gastrointestinal side effects.  The aim of this study was to investigate the effects of entacapone on the epithelial ion transport in rat distal colon, and explore the underlying mechanism.  The study was performed on freshly isolated colonic mucosa-only, submucosa-only and mucosa-submucosa prepns. in rat.  The short circuit current (ISC) was measured to det. electrogenic ion transport, and a scanning ion-selective electrode technique (SIET) was used to directly measure Cl- flux across the epithelium.  The content of intracellular cAMP was measured with RIA.  Entacapone increased mucosal ISC in the rat distal colon.  ISC was inhibited significantly by apical addn. of diphenylamine-2,2'-dicarboxylic acid (DPC), a blocker of the Cl- channel, basolateral application of bumetanide, an inhibitor of Na+-K+-2Cl- co-transporter (NKCC), removal of Cl- from the bathing soln., and pretreatment with MDL 12330A, an inhibitor of adenylate cyclase.  Inhibiting endogenous prostaglandin (PG) synthesis with indomethacin, and eliminating submucosal enteric neural activity with tetrodotoxin (TTX)-inhibited entacapone-evoked ISC increases.  Similar results were also obtained when Cl- flux was measured with SIET.  Entacapone significantly increased intracellular cAMP content, which was greatly inhibited by either indomethacin or TTX in the tissues contg. submucosal plexus, and by only indomethacin in the mucosa-only prepns.  Entacapone stimulates cAMP-dependent Cl- secretion in the rat colon, and this process is regulated by endogenous PG and the submucosal enteric nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe7U-leAKt2rVg90H21EOLACvtfcHk0lhjuweOqOK27g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWntLnE&md5=23ca263ab8f0965a58661b8fd7336775</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2982.2011.01715.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2982.2011.01715.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DZheng%26aufirst%3DL.%2BF.%26aulast%3DXu%26aufirst%3DJ.%2BD.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%2BF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%2BX.%26atitle%3DEntacapone%2520promotes%2520cAMP-dependent%2520colonic%2520Cl%2528%25E2%2588%2592%2529%2520secretion%2520in%2520rats%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2011%26volume%3D23%26spage%3D657%26epage%3De277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Tahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arisawa, T.</span><span> </span><span class="NLM_article-title">COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in <i>H. pylori</i> infected older subjects</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=19579610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD1MvmslCntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=411-415&author=T.+Taharaauthor=T.+Shibataauthor=M.+Nakamuraauthor=D.+Yoshiokaauthor=M.+Okuboauthor=N.+Maruyamaauthor=T.+Kamanoauthor=Y.+Kamiyaauthor=H.+Fujitaauthor=M.+Nagasakaauthor=M.+Iwataauthor=K.+Takahamaauthor=M.+Watanabeauthor=H.+Yamashitaauthor=H.+Nakanoauthor=I.+Hirataauthor=T.+Arisawa&title=COMT+gene+Val158Met+polymorphism+influences+the+severity+of+intestinal+metaplasia+in+H.+pylori+infected+older+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in H. pylori infected older subjects</span></div><div class="casAuthors">Tahara Tomomitsu; Shibata Tomoyuki; Nakamura Masakatsu; Yoshioka Daisuke; Okubo Masaaki; Maruyama Naoko; Kamano Toshiaki; Kamiya Yoshio; Fujita Hiroshi; Nagasaka Mitsuo; Iwata Masami; Takahama Kazuya; Watanabe Makoto; Yamashita Hiromi; Nakano Hiroshi; Hirata Ichiro; Arisawa Tomiyasu</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">90</span>),
    <span class="NLM_cas:pages">411-5</span>
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  A complex interaction of host genetic and environmental factors may be relevant in the development of Helocobacter pylori (H. pylori) related gastroduodenal diseases.  Catechol-O-methyltransferase (COMT) is expressed catalyzes the methylation of various endobiotic and xenobiotic substances and thus might protect DNA from oxidative damage.  We aimed to clarify the effect of COMT functional polymorphism on the severity of histological gastritis in a Japanese population.  METHODOLOGY:  203 subjects were included in this study.  Restriction fragment length polymorphism analysis was performed for polymorphisms at codon 158 in the COMT gene.  Gastritis scores of antral gastric mucosa were assessed according to the updated Sydney system.  RESULTS:  COMT genotype distribution in the study subjects was 158Val/Val (51.2%), 84Val/Met (41.4%), and 15Met/Met (7.4%).  It was within the Hardy-Weinberg equilibrium (p = 0.73).  In over all subjects, the degree of intestinal metaplasia tended to be lower among 158Met/Met when compared to Val/Val (Val/Val vs.  Met/Met; 0.59 +/- 0.93 vs. 0.13 +/- 0.52, p = 0.052).  Among H. pylori infected subjects, the degree of intestinal metaplasia was significantly lower among 158Met carriers in 50 years or older age (Val/Val vs.  Met carriers; 1.20 +/- 1.06 vs. 0.75 +/- 1.08, p = 0.0436).  No significant association was found between COMT genotypes and the degree of gastritis in different gender  CONCLUSION:  Our data suggest that COMT gene 158Met polymorphism is associate with a reduced risk of developing more severe intestinal metaplasia in H. pylori infected older subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJk4gHGS1_CyM8MEzWGjS9fW6udTcc2eZi2g2swaRNFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvmslCntA%253D%253D&md5=f8ce07c73e5f8a761b452e859a4a255e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahara%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DN.%26aulast%3DKamano%26aufirst%3DT.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DNagasaka%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DTakahama%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHirata%26aufirst%3DI.%26aulast%3DArisawa%26aufirst%3DT.%26atitle%3DCOMT%2520gene%2520Val158Met%2520polymorphism%2520influences%2520the%2520severity%2520of%2520intestinal%2520metaplasia%2520in%2520H.%2520pylori%2520infected%2520older%2520subjects%26jtitle%3DHepatogastroenterology%26date%3D2009%26volume%3D56%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Palma, P. N.; Kiss, L. E.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyl-transferase inhibitors: Present problems and relevance of the new ones</span>. In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1039%2F9781849737357-00083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=83-109&author=P.+N.+Palma&author=L.+E.+Kiss&author=P.+Soares-da-Silvaauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00083%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26atitle%3DCatechol-O-methyl-transferase%2520inhibitors%253A%2520Present%2520problems%2520and%2520relevance%2520of%2520the%2520new%2520ones%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRSC%2520Publishing%26date%3D2013%26spage%3D83%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Learmonth, D. A.; Kiss, L. E.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Chemistry of COMT Inhibitors</span>. In  <span class="citation_source-book">Basic Aspects of Catechol-O-methyltransferase and the Clinical Applications of Its Inhibitors</span>; <span class="NLM_contrib-group">Nissinen, E.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FB978-0-12-381326-8.00006-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=119-162&author=D.+A.+Learmonth&author=L.+E.+Kiss&author=P.+Soares-da-Silvaauthor=E.+Nissinen&title=Basic+Aspects+of+Catechol-O-methyltransferase+and+the+Clinical+Applications+of+Its+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381326-8.00006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-381326-8.00006-5%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26atitle%3DChemistry%2520of%2520COMT%2520Inhibitors%26btitle%3DBasic%2520Aspects%2520of%2520Catechol-O-methyltransferase%2520and%2520the%2520Clinical%2520Applications%2520of%2520Its%2520Inhibitors%26aulast%3DNissinen%26aufirst%3DE.%26pub%3DElsevier%26date%3D2010%26spage%3D119%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Masri, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">O-Methylation in vitro of dihydroxy- and trihydroxy-phenolic compounds by liver slices</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1962&pages=495-505&author=M.+S.+Masriauthor=A.+N.+Boothauthor=F.+Deeds&title=O-Methylation+in+vitro+of+dihydroxy-+and+trihydroxy-phenolic+compounds+by+liver+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DM.%2BS.%26aulast%3DBooth%26aufirst%3DA.%2BN.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DO-Methylation%2520in%2520vitro%2520of%2520dihydroxy-%2520and%2520trihydroxy-phenolic%2520compounds%2520by%2520liver%2520slices%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1962%26volume%3D65%26spage%3D495%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Gugler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, H. J.</span><span> </span><span class="NLM_article-title">Inhibition of liver catechol-O-methyltransferase by flavanoids</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF00501194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=4268471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE3sXhtVOmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1973&pages=223-233&author=R.+Guglerauthor=H.+J.+Dengler&title=Inhibition+of+liver+catechol-O-methyltransferase+by+flavanoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human liver catechol O-methyltransferase by flavonoids</span></div><div class="casAuthors">Gugler, R.; Dengler, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">All of 19 tested flavonoids having flavone, flavonol, flavanone, flavanol, flavanonol, and chalcone structures inhibited liver catechol O-methyltransferase in vitro to various degrees, the glycosides being weaker inhibitors than the corresponding genins.  The most effective inhibitors were those with a catechol configuration, esp. quercetin and fisetin.  The inhibition by quercetin and rutin was competitive, that by isorhamnetin of the mixed type.  The Km of the enzyme for norepinephrine was 3.3 × 10-4M, and the inhibitor consts. for quercetin and rutin were 5.3 × 10-6 and 10.8 × 10-6M, resp.  The inhibition was more pronounced at lower pH values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7G8vIuYIMVLVg90H21EOLACvtfcHk0lhP5NcGdLS_EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtVOmsLc%253D&md5=45c2808075fb6a02e9b344d923d61343</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2FBF00501194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00501194%26sid%3Dliteratum%253Aachs%26aulast%3DGugler%26aufirst%3DR.%26aulast%3DDengler%26aufirst%3DH.%2BJ.%26atitle%3DInhibition%2520of%2520liver%2520catechol-O-methyltransferase%2520by%2520flavanoids%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1973%26volume%3D276%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Giles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. W.</span><span> </span><span class="NLM_article-title">The catechol-O-methyltransferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3,4-dihydroxy-2-methylpropiophenone)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5625691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaF2sXltFGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=1967&pages=189-194&author=R.+E.+Gilesauthor=J.+W.+Miller&title=The+catechol-O-methyltransferase+activity+and+endogenous+catecholamine+content+of+various+tissues+in+the+rat+and+the+effect+of+administration+of+U-0521+%283%2C4-dihydroxy-2-methylpropiophenone%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol O-methyl transferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3',4'-dihydroxy-2-methyl propiophenone)</span></div><div class="casAuthors">Giles, Ralph E.; Miller, Jack W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-94</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The regulatory influence of COMT (catechol O-methyl transferase) on the catechol amine content of various tissues was investigated.  The COMT activity of the heart, brain, uterus, and liver was inhibited by administration of U-0521.  This agent increased the epinephrine but not the norepinephrine content of the uterus within a period of 1 hr.  The norepinephrine concn. in the brain was also elevated, but no significant changes occurred in the catechol amine content of the heart.  The increases in catechol amines were probably due to the localized inhibition of COMT in the tissues where these changes occurred.  The COMT activity of the uterus was greater during estrus than during diestrus and it increased after estrogen administration to ovariectomized rats.  The cyclic variation of the catechol amine content in the uterus could not be explained on the basis of these changes in COMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhASzJnVbk7bVg90H21EOLACvtfcHk0lhP5NcGdLS_EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXltFGlsbc%253D&md5=eadd2690f2e0a51e405ae75962f69843</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiles%26aufirst%3DR.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520catechol-O-methyltransferase%2520activity%2520and%2520endogenous%2520catecholamine%2520content%2520of%2520various%2520tissues%2520in%2520the%2520rat%2520and%2520the%2520effect%2520of%2520administration%2520of%2520U-0521%2520%25283%252C4-dihydroxy-2-methylpropiophenone%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1967%26volume%3D158%26spage%3D189%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Ross, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haljasmaa, O.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase inhibitors. In vivo inhibition in mice</span> <span class="citation_source-journal">Acta. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1964.tb01786.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14209613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaF2MXhtVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1964&pages=215-225&author=S.+B.+Rossauthor=O.+Haljasmaa&title=Catechol-O-methyltransferase+inhibitors.+In+vivo+inhibition+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition in mice</span></div><div class="casAuthors">Ross, S. B.; Haljasmaa, O.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-25</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">Inhibitors of the enzyme activity in peripheral organs and brains in mice were investigated.  Tropolones had the highest inhibition potency in peripheral organs but were less effective in brain.  Pyrogallol, iso-Pr ester of gallate, and 2,3,4-trihydroxyacetophenone were the most effective compds. inhibiting the enzyme in the brain.  Many of the compds. interfered with other adrenergic mechanisms such as stimulation or blockade of adrenergic β-receptor blocking capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWGP5lxv1f7Vg90H21EOLACvtfcHk0ljnBDYpRbz5YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXhtVagsA%253D%253D&md5=a4ffb4be646e9ffb4660db5b3dd9ab60</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1964.tb01786.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1964.tb01786.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DS.%2BB.%26aulast%3DHaljasmaa%26aufirst%3DO.%26atitle%3DCatechol-O-methyltransferase%2520inhibitors.%2520In%2520vivo%2520inhibition%2520in%2520mice%26jtitle%3DActa.%2520Pharmacol.%2520Toxicol.%26date%3D1964%26volume%3D21%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Angel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K. J.</span><span> </span><span class="NLM_article-title">Convulsant action of polyphenols</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1968&pages=84-85&author=A.+Angelauthor=K.+J.+Rogers&title=Convulsant+action+of+polyphenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngel%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DK.%2BJ.%26atitle%3DConvulsant%2520action%2520of%2520polyphenols%26jtitle%3DNature%26date%3D1968%26volume%3D217%26spage%3D84%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Reches, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase and Parkinson’s disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6695593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2cXhtFCrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1984&pages=171&author=A.+Rechesauthor=S.+Fahn&title=Catechol-O-methyltransferase+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase and Parkinson's disease</span></div><div class="casAuthors">Reches, Avinoam; Fahn, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">Parkinson-Specific Mot. Ment. Disord.:  Role Pallidum</span>),
    <span class="NLM_cas:pages">171-9</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">U-0521 (I)  [5466-89-7], a potent inhibitor of catechol-O-methyltransferase (COMT)  [9012-25-3], when given i.p. (200 mg/kg) to rats blocked the accumulation of 3-O-methyldopa  [300-48-1] in plasma and enhanced L-DOPA  [59-92-7] metab. in the striatum.  I was not active, however, when given orally to rats or to a patient with Parkinson's disease.  The use of L-DOPA plus a COMT-inhibitor which is active when taken orally, may be useful in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd00xaqkHu9rVg90H21EOLACvtfcHk0ljnBDYpRbz5YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtFCrtro%253D&md5=c161876690f7eb118db3b09e3fae78cf</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReches%26aufirst%3DA.%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DCatechol-O-methyltransferase%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1984%26volume%3D40%26spage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullnig, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wylie, D.</span><span> </span><span class="NLM_article-title">The enzymic methylation of pyrogallol</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1960&pages=53-154&author=S.+Archerauthor=A.+Arnoldauthor=R.+K.+Kullnigauthor=D.+Wylie&title=The+enzymic+methylation+of+pyrogallol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DA.%26aulast%3DKullnig%26aufirst%3DR.%2BK.%26aulast%3DWylie%26aufirst%3DD.%26atitle%3DThe%2520enzymic%2520methylation%2520of%2520pyrogallol%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1960%26volume%3D87%26spage%3D53%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRoche, M.-J.</span><span> </span><span class="NLM_article-title">Inhibitor of O-methylation of epinephrine and norepinephrine in vitro and in vivo</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1959&pages=800&author=J.+Axelrodauthor=M.-J.+LaRoche&title=Inhibitor+of+O-methylation+of+epinephrine+and+norepinephrine+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DLaRoche%26aufirst%3DM.-J.%26atitle%3DInhibitor%2520of%2520O-methylation%2520of%2520epinephrine%2520and%2520norepinephrine%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DScience%26date%3D1959%26volume%3D130%26spage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Booth, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">The metabolic fate of gallic acid and related compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1959&pages=3014-3016&author=A.+N.+Boothauthor=M.+Masriauthor=D.+J.+Robbinsauthor=O.+H.+Emersonauthor=F.+T.+Jonesauthor=F.+Deeds&title=The+metabolic+fate+of+gallic+acid+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DA.%2BN.%26aulast%3DMasri%26aufirst%3DM.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26aulast%3DJones%26aufirst%3DF.%2BT.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DThe%2520metabolic%2520fate%2520of%2520gallic%2520acid%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1959%26volume%3D234%26spage%3D3014%26epage%3D3016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Ericson, A. D.</span><span> </span><span class="NLM_article-title">Potentiation of the L-dopa effect in man by the use of catechol-<i>O</i>-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0022-510X%2871%2990088-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1971&pages=193-197&author=A.+D.+Ericson&title=Potentiation+of+the+L-dopa+effect+in+man+by+the+use+of+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0022-510X%2871%2990088-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-510X%252871%252990088-8%26sid%3Dliteratum%253Aachs%26aulast%3DEricson%26aufirst%3DA.%2BD.%26atitle%3DPotentiation%2520of%2520the%2520L-dopa%2520effect%2520in%2520man%2520by%2520the%2520use%2520of%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D1971%26volume%3D24%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Simpson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, V.</span><span> </span><span class="NLM_article-title">An investigation of the clinical effect of GPA-1714, a catechol-O-methyl transferase inhibitor</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgslWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1972&pages=417-421&author=G.+M.+Simpsonauthor=V.+Varga&title=An+investigation+of+the+clinical+effect+of+GPA-1714%2C+a+catechol-O-methyl+transferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of the clinical effect of GPA-1714, a catechol-O-methyl transferase inhibitor</span></div><div class="casAuthors">Simpson G M; Varga V</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical pharmacology and new drugs</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">417-21</span>
        ISSN:<span class="NLM_cas:issn">0021-9754</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbUW91mHQ8a6qcneEtCi92fW6udTcc2eZQ7Z1xfxX1rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgslWqtA%253D%253D&md5=5ba992765dd89098c218bd1168146658</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DG.%2BM.%26aulast%3DVarga%26aufirst%3DV.%26atitle%3DAn%2520investigation%2520of%2520the%2520clinical%2520effect%2520of%2520GPA-1714%252C%2520a%2520catechol-O-methyl%2520transferase%2520inhibitor%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D1972%26volume%3D12%26spage%3D417%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Bäckström, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honkanen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippuri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairisalo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pystynen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindén, I.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohto, P.</span><span> </span><span class="NLM_article-title">Synthesis of some novel potent and selective catechol <i>O</i>-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00124a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=841-846&author=R.+B%C3%A4ckstr%C3%B6mauthor=E.+Honkanenauthor=A.+Pippuriauthor=P.+Kairisaloauthor=J.+Pystynenauthor=K.+Heinolaauthor=E.+Nissinenauthor=I.-B.+Lind%C3%A9nauthor=P.+T.+M%C3%A4nnist%C3%B6author=S.+Kaakkolaauthor=P.+Pohto&title=Synthesis+of+some+novel+potent+and+selective+catechol+O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00124a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00124a017%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26aulast%3DHonkanen%26aufirst%3DE.%26aulast%3DPippuri%26aufirst%3DA.%26aulast%3DKairisalo%26aufirst%3DP.%26aulast%3DPystynen%26aufirst%3DJ.%26aulast%3DHeinola%26aufirst%3DK.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLind%25C3%25A9n%26aufirst%3DI.-B.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DPohto%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520some%2520novel%2520potent%2520and%2520selective%2520catechol%2520O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Bäckström, R. J.; Heinola, K. E.; Honkanen, E. J.; Kaakkola, S. K.; Kairisalo, P. J.; Linden, I.-B. Y.; Männistö, P. T.; Nissinen, E. A. O.; Pohto, P.; Pippuri, A. K.; Pystynen, J. J.</span><span> </span><span class="NLM_article-title">Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same</span>. U.S. Patent US4963590,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=K.+E.+Heinola&author=E.+J.+Honkanen&author=S.+K.+Kaakkola&author=P.+J.+Kairisalo&author=I.-B.+Y.+Linden&author=P.+T.+M%C3%A4nnist%C3%B6&author=E.+A.+O.+Nissinen&author=P.+Pohto&author=A.+K.+Pippuri&author=J.+J.+Pystynen&title=Pharmacologically+active+compounds%2C+methods+for+the+preparation+thereof+and+compositions+containing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%2BJ.%26atitle%3DPharmacologically%2520active%2520compounds%252C%2520methods%2520for%2520the%2520preparation%2520thereof%2520and%2520compositions%2520containing%2520the%2520same%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0014-2999%2888%2990614-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=3181288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL1cXmtVCkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1988&pages=263-269&author=E.+Nissinenauthor=I.+B.+Lindenauthor=E.+Schultzauthor=S.+Kaakkolaauthor=P.+M%C3%A4nnist%C3%B6&title=Inhibition+of+catechol-O-methyltransferase+activity+by+two+novel+disubstituted+catechols+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat</span></div><div class="casAuthors">Nissinen, Erkki; Linden, Inge Britt; Schultz, Eija; Kaakkola, Seppo; Mannisto, Pekka T.; Pohto, Pentti</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">263-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) has an important role in the extraneuronal inactivation of catecholamine neurotransmitters and drugs with a catechol structure.  Two novel COMT inhibitors, OR-462 and OR-486, were highly effective (50% inhibitory concns. (IC50) = 18 and 12 nM, resp.) and selective in inhibiting COMT activity in vitro.  Tyrosine hydroxylase was not inhibited until micromolar concns. of these compds. were used: the IC50 values for OR-462 and OR-486 were 10 and 14 μM, resp.  The IC50 values for dopamine β-hydroxylase, dopa decarboxylase and monoamine oxidase forms A and B were >50 μM.  In studies ex vivo in rats, oral OR-462 inhibited mainly the COMT activity in the duodenum, while OR-486 inhibited COMT activity in the liver and red cells as well.  Oral OR-462 did not penetrate into the brain in doses of ≤30 mg/kg, while the same doses of OR-486 had some effect on striatal COMT activity.  When tested in combination with levodopa-carbidopa, orally administered OR-462 and OR-486 were more effective in reducing the formation of 3-O-methyldopa from levodopa than was the levodopa-carbidopa treatment alone.  Thus, OR-462 and OR-486 are effective and long-lasting inhibitors of COMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz879OV4z61LVg90H21EOLACvtfcHk0lj6RIZwZvALaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtVCkt74%253D&md5=c1a228d9538369802233db62c470bc94</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990614-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990614-0%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520activity%2520by%2520two%2520novel%2520disubstituted%2520catechols%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D153%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span> </span><span class="NLM_article-title">Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3953</span><span class="NLM_x">–</span> <span class="NLM_lpage">3956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0006-2952%2889%2990673-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2597177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3cXjt1Gmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=3953-3956&author=E.+Schultzauthor=E.+Nissinen&title=Inhibition+of+rat+liver+and+duodenum+soluble+catechol-O-methyltransferase+by+a+tight-binding+inhibitor+OR-462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462</span></div><div class="casAuthors">Schultz, Eija; Nissinen, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3953-6</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The inhibition kinetics of rat liver and duodenum sol. catechol O-methyltransferase (COMT) with the disubstituted catechol, OR-462, was studied.  After preincubation of the enzyme and inhibitor in the presence of Mg2+ and S-adenosylmethionine, an inhibition ∼30-fold greater than that without preincubation was obsd.  Reversible tight-binding inhibition was demonstrated with Ki values of 0.7 and 1.0 nM for the liver and duodenum enzymes, resp.  The Km values of 53.4 and 56.9 μM for 3,4-dihydroxybenzoic acid and 23.0 and 17.5 μM for S-adenosylmethionine were calcd. for liver and duodenum enzyme, resp.  A catalytic no. of 24 min-1 for liver sol. COMT was calcd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSurcO5KL2r7Vg90H21EOLACvtfcHk0ljWhbmk71GQ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjt1Gmug%253D%253D&md5=c1f0690d8f0607f8bde3d96a18502ec2</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2889%2990673-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252889%252990673-4%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DNissinen%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520rat%2520liver%2520and%2520duodenum%2520soluble%2520catechol-O-methyltransferase%2520by%2520a%2520tight-binding%2520inhibitor%2520OR-462%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D3953%26epage%3D3956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Männistö, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuomainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuomainen, R. K.</span><span> </span><span class="NLM_article-title">Different in vivo properties of three new inhibitors of catechol-O-methyltransferase in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1992.tb09020.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1628144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XitVOltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1992&pages=569-574&author=P.+M%C3%A4nnist%C3%B6author=T.+Tuomainenauthor=R.+K.+Tuomainen&title=Different+in+vivo+properties+of+three+new+inhibitors+of+catechol-O-methyltransferase+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat</span></div><div class="casAuthors">Mannisto, Pekka T.; Tuomainen, Paivi; Tuominen, Raimo K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-74</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The authors compared three new catechol O-methyltransferase (COMT) inhibitors (OR-611, Ro 40-7592 and CGP 28014; 10 and 30 mg kg-1, i.p.) in male rats given levodopa (L-DOPA, 50 mg kg-1, i.p.) and carbidopa ((-)-L-α-Me dopa, 50 mg kg-1, i.p.).  In some studies pretreatment with pargyline (80 mg kg-1, i.p.) was used to block the function of monoamine oxidase (MAO).  Decreases of hypothalamic and striatal 3-O-methyl-dopa (3-OMD) levels were used as measures of the inhibition of peripheral COMT.  The inhibition of brain COMT activity was estd. by decreases of hypothalamic and striatal homovanillic acid (HVA) and 3-methoxytyramine (3-MT; after pargyline) levels.  The three COMT inhibitors studied had different individual characteristics.  OR-611 was primarily a peripherally acting COMT inhibitor, decreasing 3-OMD levels in the striatum (to 31-52%) and in the hypothalamus (to 16-27%) both in the control and pargyline-treated animals at 1 and 3 h.  It did not have any effect on brain HVA and 3-MT.  Ro 40-7592 was a broad spectrum COMT inhibitor decreasing striatal and hypothalamic 3-OMD (always to <30%), HVA (to <50%) and 3-MT levels (to <23%) significantly both at 1 and 3 h.  It was more potent than OR-611.  CGP 28014 functioned as a weak COMT inhibitor in the periphery inhibiting 3-OMD formation only at 3 h.  In contrast, it was fairly potent in decreasing the brain HVA and 3-MT levels at 1 h (to 37-22% and 42-35% in the striatum, and to 57-33% and 64-35% in the hypothalamus, resp.) but not at 3 h.  Since CGP 28014, unlike OR-611 and Ro 40-7592, did not generally increase the brain DOPA, dopamine or DOPAC levels, it was not a typical COMT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGDBh5WX2SbVg90H21EOLACvtfcHk0ljWhbmk71GQ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitVOltbw%253D&md5=907c08efd59e6cbed4c221aba7bca69f</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb09020.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb09020.x%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%26aulast%3DTuomainen%26aufirst%3DT.%26aulast%3DTuomainen%26aufirst%3DR.%2BK.%26atitle%3DDifferent%2520in%2520vivo%2520properties%2520of%2520three%2520new%2520inhibitors%2520of%2520catechol-O-methyltransferase%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D105%26spage%3D569%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Cedarbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reches, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, M.</span><span> </span><span class="NLM_article-title">Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeys</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=544-552&author=J.+Cedarbaumauthor=G.+Legerauthor=A.+Rechesauthor=M.+Guttman&title=Effect+of+nitecapone+%28OR-462%29+on+the+pharmacokinetics+of+levodopa+and+3-O-methyldopa+formation+in+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCedarbaum%26aufirst%3DJ.%26aulast%3DLeger%26aufirst%3DG.%26aulast%3DReches%26aufirst%3DA.%26aulast%3DGuttman%26aufirst%3DM.%26atitle%3DEffect%2520of%2520nitecapone%2520%2528OR-462%2529%2520on%2520the%2520pharmacokinetics%2520of%2520levodopa%2520and%25203-O-methyldopa%2520formation%2520in%2520cynomolgus%2520monkeys%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1990%26volume%3D13%26spage%3D544%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohto, P.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF00173538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1407012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1992&pages=262-266&author=E.+Nissinenauthor=I.+B.+Lindenauthor=E.+Schultzauthor=P.+Pohto&title=Biochemical+and+pharmacological+properties+of+a+peripherally+acting+catechol-O-methyltransferase+inhibitor+entacapone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone</span></div><div class="casAuthors">Nissinen, Erkki; Linden, Inge Britt; Schultz, Eija; Pohto, Pentti</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Entacapone, OR-611, was found to be a potent peripherally acting inhibitor of catechol-O-methyl-transferase (COMT).  IC50 values of 10 nmol/L and 160 nmol/L were obtained for rat duodenum and liver-sol. COMT, resp.  There were not effects on other catecholamine metabolizing enzymes.  Entacapone showed reversible, tight-binding type of inhibition of sol. rat liver COMT with a Ki-value of 14 nmol/L and it also caused 50% inhibition of rat duodenal, erythrocyte, liver and striatal COMT activity 1 h after oral dosing with 1.1, 5.4, 6.7 and 24.2 mg/kg, resp.  However, penetration of entacapone into the brain was poor, since the formation of homovanillic acid (HVA), the O-Me metabolite of dopamine in the striatum, was not reduced, even after the highest dose of 30 mg/kg.  In rat blood serum, the concn. of 3-O-methyldopa (3OMD), the O-methylated product of L-dopa, was reduced in a dose-dependent manner, and the concn. of L-dopa was increased after the administration of entacapone (3-30 mg/kg p.o.) together with L-dopa + carbidopa.  These changes were reflected, in the striatum, by a significant rise in the dopamine concn. and a redn. in the 3OMD concn.  Consequently, when entacapone was added to the treatment with L-dopa + carbidopa, the dose of L-dopa could be lowered from 50 to 15 mg/kg in order to produce the same striatal dopamine concns. as with 50 + 50 mg/kg of L-dopa + carbidopa alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2UnG4ReArrVg90H21EOLACvtfcHk0ljWhbmk71GQ7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGnt7w%253D&md5=6590cfbde047e5c9b4ec19ebdb3b8532</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2FBF00173538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00173538%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DPohto%26aufirst%3DP.%26atitle%3DBiochemical%2520and%2520pharmacological%2520properties%2520of%2520a%2520peripherally%2520acting%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1992%26volume%3D346%26spage%3D262%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Keranen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korpela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentikainen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span> </span><span class="NLM_article-title">Inhibition of soluble catechol-<i>O</i>-methyltransferase and single dose pharmacokinetics after oral and intraveneous administration of entacapone</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=151-157&author=T.+Keranenauthor=A.+Gordinauthor=M.+Karlssonauthor=K.+Korpelaauthor=P.+J.+Pentikainenauthor=H.+Ritaauthor=E.+Schultzauthor=L.+Seppalaauthor=T.+Wikberg&title=Inhibition+of+soluble+catechol-O-methyltransferase+and+single+dose+pharmacokinetics+after+oral+and+intraveneous+administration+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DT.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DKorpela%26aufirst%3DK.%26aulast%3DPentikainen%26aufirst%3DP.%2BJ.%26aulast%3DRita%26aufirst%3DH.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DSeppala%26aufirst%3DL.%26aulast%3DWikberg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520soluble%2520catechol-O-methyltransferase%2520and%2520single%2520dose%2520pharmacokinetics%2520after%2520oral%2520and%2520intraveneous%2520administration%2520of%2520entacapone%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doulakas, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span> </span><span class="NLM_article-title">The lipophilicity behaviour of three catechol-O-methyltransferase (COMT) inhibitors and simple analogues</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=144-152&author=L.+Novaroliauthor=G.+B.+Doulakasauthor=M.+Reistauthor=B.+Rolandoauthor=R.+Frutteroauthor=A.+Gascoauthor=P.-A.+Carrupt&title=The+lipophilicity+behaviour+of+three+catechol-O-methyltransferase+%28COMT%29+inhibitors+and+simple+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDoulakas%26aufirst%3DG.%2BB.%26aulast%3DReist%26aufirst%3DM.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26atitle%3DThe%2520lipophilicity%2520behaviour%2520of%2520three%2520catechol-O-methyltransferase%2520%2528COMT%2529%2520inhibitors%2520and%2520simple%2520analogues%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=238-244&author=J.+Savolainenauthor=M.+Forsbergauthor=H.+Taipaleauthor=P.+T.+Mannist%C3%B6author=K.+J%C3%A4rvinenauthor=J.+Gyntherauthor=P.+Jarhoauthor=T.+J%C3%A4rvinen&title=Effects+of+aqueous+solubility+and+dissolution+characteristics+on+oral+bioavailability+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DK.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DJarho%26aufirst%3DP.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DEffects%2520of%2520aqueous%2520solubility%2520and%2520dissolution%2520characteristics%2520on%2520oral%2520bioavailability%2520of%2520entacapone%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2000%26volume%3D49%26spage%3D238%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottoila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=81-92&author=T.+Wikbergauthor=A.+Vuorelaauthor=P.+Ottoilaauthor=J.+Taskinen&title=Identification+of+major+metabolites+of+the+catechol-O-methyltransferase+inhibitor+entacapone+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DOttoila%26aufirst%3DP.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520major%2520metabolites%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%2520in%2520rats%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Bäckström, R. J.; Kalevi, E.; Heinola, K. E.; Honkanen, E. J.; Kaakkola, S. K.; Kairisalo, P. J.; Linden, I.-B. Y.; Männistö, P. T.; Nissinen, E. A. O.; Pohto, P.; Pippuri, A. K.; Pystynen, J. J.</span><span> </span><span class="NLM_article-title">Pharmacologically active catechol derivatives</span>. U.S. Patent US5446194,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=E.+Kalevi&author=K.+E.+Heinola&author=E.+J.+Honkanen&author=S.+K.+Kaakkola&author=P.+J.+Kairisalo&author=I.-B.+Y.+Linden&author=P.+T.+M%C3%A4nnist%C3%B6&author=E.+A.+O.+Nissinen&author=P.+Pohto&author=A.+K.+Pippuri&author=J.+J.+Pystynen&title=Pharmacologically+active+catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%2BJ.%26atitle%3DPharmacologically%2520active%2520catechol%2520derivatives%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Aho, P.; Pohto, P.; Linden, I.-B. Y.; Bäckström, R. J.; Honkanen, E.; Nissinen, E.</span><span> </span><span class="NLM_article-title">New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters</span>. European Patent EP0323162,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=P.+Aho&author=P.+Pohto&author=I.-B.+Y.+Linden&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=E.+Honkanen&author=E.+Nissinen&title=New+use+of+catechol-o-methyl+transferase+%28comt%29+inhibitors+and+their+physiologically+acceptable+salts+and+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAho%26aufirst%3DP.%26atitle%3DNew%2520use%2520of%2520catechol-o-methyl%2520transferase%2520%2528comt%2529%2520inhibitors%2520and%2520their%2520physiologically%2520acceptable%2520salts%2520and%2520esters%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Linden, I.-B. Y.; Ranta, S. H.; Heinonen, E. O.; Kaakkola, S. K.; Nissinen, E. A. O.; Pohlo, P.</span><span> </span><span class="NLM_article-title">Use of catechol-o·methyl transferase (COMT) inhibitors as anti-cancer agents</span>. U.K. Patent GB2220569,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=I.-B.+Y.+Linden&author=S.+H.+Ranta&author=E.+O.+Heinonen&author=S.+K.+Kaakkola&author=E.+A.+O.+Nissinen&author=P.+Pohlo&title=Use+of+catechol-o%C2%B7methyl+transferase+%28COMT%29+inhibitors+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DI.-B.%2BY.%26atitle%3DUse%2520of%2520catechol-o%25C2%25B7methyl%2520transferase%2520%2528COMT%2529%2520inhibitors%2520as%2520anti-cancer%2520agents%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Aperia, A. C.; Linden, I.-B. Y.</span><span> </span><span class="NLM_article-title">Use of COMT Inhibitors for the manufacture of a medicament for the prevention of Diabetic Vascular Dysfunctions</span>. International Patent WO199827973,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+C.+Aperia&author=I.-B.+Y.+Linden&title=Use+of+COMT+Inhibitors+for+the+manufacture+of+a+medicament+for+the+prevention+of+Diabetic+Vascular+Dysfunctions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAperia%26aufirst%3DA.%2BC.%26atitle%3DUse%2520of%2520COMT%2520Inhibitors%2520for%2520the%2520manufacture%2520of%2520a%2520medicament%2520for%2520the%2520prevention%2520of%2520Diabetic%2520Vascular%2520Dysfunctions%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Aho, P.; Linden, I.-B. Y.</span><span> </span><span class="NLM_article-title">Use of COMT inhibitors as analgesics</span>. International Patent WO200168083,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=P.+Aho&author=I.-B.+Y.+Linden&title=Use+of+COMT+inhibitors+as+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAho%26aufirst%3DP.%26atitle%3DUse%2520of%2520COMT%2520inhibitors%2520as%2520analgesics%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Ellimen, J.; Karvinen, J.; Vahteristo, M.</span><span> </span><span class="NLM_article-title">Treatment of restless leg syndrome</span>. International Patent WO2006051154,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Ellimen&author=J.+Karvinen&author=M.+Vahteristo&title=Treatment+of+restless+leg+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllimen%26aufirst%3DJ.%26atitle%3DTreatment%2520of%2520restless%2520leg%2520syndrome%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Nissinen, H.; Vahteristo, M.; Kuoppamaki, M.; Ellmen, J.; Leionen, M.</span><span> </span><span class="NLM_article-title">Treatment of symptoms of motor dysfunction</span>. International Patent WO2007034024,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Nissinen&author=M.+Vahteristo&author=M.+Kuoppamaki&author=J.+Ellmen&author=M.+Leionen&title=Treatment+of+symptoms+of+motor+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520symptoms%2520of%2520motor%2520dysfunction%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Eremadzadeh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S. K.</span><span> </span><span class="NLM_article-title">Computerized rotometer apparatus for recording circling behaviour</span> <span class="citation_source-journal">Methods Find. Exp. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2501597" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1989&pages=399-407&author=E.+Eremadzadehauthor=L.+Koskinenauthor=S.+K.+Kaakkola&title=Computerized+rotometer+apparatus+for+recording+circling+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEremadzadeh%26aufirst%3DE.%26aulast%3DKoskinen%26aufirst%3DL.%26aulast%3DKaakkola%26aufirst%3DS.%2BK.%26atitle%3DComputerized%2520rotometer%2520apparatus%2520for%2520recording%2520circling%2520behaviour%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D1989%26volume%3D11%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Bernauer, K.; Borgulya, J.; Bruderer, H.; Da Prada, M.; Zürcher, G.</span><span> </span><span class="NLM_article-title">Catechol derivatives</span>. U.S. Patent US5236952,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=K.+Bernauer&author=J.+Borgulya&author=H.+Bruderer&author=M.+Da+Prada&author=G.+Z%C3%BCrcher&title=Catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernauer%26aufirst%3DK.%26atitle%3DCatechol%2520derivatives%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherschlicht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlappi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span> </span><span class="NLM_article-title">Ro 40-7592. Catechol-<i>O</i>-methyltransferase (COMT) inhibitor</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=719-721&author=J.+Borgulyaauthor=M.+Da+Pradaauthor=J.+Dingemanseauthor=R.+Scherschlichtauthor=B.+Schlappiauthor=G.+Z%C3%BCrcher&title=Ro+40-7592.+Catechol-O-methyltransferase+%28COMT%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DScherschlicht%26aufirst%3DR.%26aulast%3DSchlappi%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26atitle%3DRo%252040-7592.%2520Catechol-O-methyltransferase%2520%2528COMT%2529%2520inhibitor%26jtitle%3DDrugs%2520Future%26date%3D1991%26volume%3D16%26spage%3D719%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtman, R. J.</span><span> </span><span class="NLM_article-title">Effects of COMT inhibitors on striatal dopamine metabolism a microdialysis study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0006-8993%2892%2991003-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1381981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=1992&pages=241-249&author=S.+Kaakkolaauthor=R.+J.+Wurtman&title=Effects+of+COMT+inhibitors+on+striatal+dopamine+metabolism+a+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of COMT inhibitors on striatal dopamine metabolism:  a microdialysis study</span></div><div class="casAuthors">Kaakkola, S.; Wurtman, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-9</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">In vivo microdialysis was used to examine the effect of 2 catechol-O-methyltransferase (COMT) inhibitors, Ro 40-7592 and OR-611, on extracellular levels of dopamine, DOPAC, HVA, and 5-HIAA in rat striatum.  The interactions of the COMT inhibitors with nomifensine, clorgyline, and deprenyl were also studied.  Ro 40-7592 (3-30 mg/kg, i.p.) decreased dose-dependently the efflux of HVA, increased that of DOPAC, and tended to increase that of dopamine.  Higher doses of OR-611 (30-100 mg/kg i.p.) also decreased the dialyzate level of HVA, increased that of DOPAC, and tended to increase that of dopamine.  Ro 40-7592 was about 10-fold as potent as OR-611.  Neither of the COMT inhibitors changed dialyzate levels of 5-HIAA.  An OR-611 dose of 10 mg/kg i.p. had no effect, in contrast to Ro-7592, on any of the parameters studied; this dose was thus used to differentiate between the effects of central and peripheral COMT inhibition.  Both nomifensine (15 mg/kg, i.p.) and clorgyline (4 mg/kg, i.p.) alone elevated extracellular dopamine levels, and lowered those of DOPAC and HVA, though there were quant. and temporal differences between the drugs.  L-Deprenyl (1 mg/kg, i.p.) alone had no effect on any of the compds. measured.  Ro 40-7592 (10 mg/kg, i.p.) potentiated the effect of nomifensine on dopamine efflux, and it tended to increase clorgyline-induced dopamine efflux.  DOPAC levels in dialyzates were increased by combinations of Ro 40-7592 and nomifensine or clorgyline, whereas HVA levels remained about as low as they were after Ro 40-7592 alone.  Ro 40-7592 had no interaction with L-deprenyl.  OR-611 (10 mg/kg, i.p.) did not modify the effects on dopamine metab. of nomifensine, clorgyline, or L-deprenyl.  Thus, Ro 40-7592 is a potent centrally active COMT inhibitor, whereas OR-611 is principally a peripherally active inhibitor.  Use of drugs which inhibit brain COMT can considerable modify dopamine metab.  COMT inhibitors may be of clin. significance in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0DCkRazKLLVg90H21EOLACvtfcHk0lhaBJRplPX7lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGgtL4%253D&md5=191b4e677e3c68efcea6381e7efabc60</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2892%2991003-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252892%252991003-W%26sid%3Dliteratum%253Aachs%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26atitle%3DEffects%2520of%2520COMT%2520inhibitors%2520on%2520striatal%2520dopamine%2520metabolism%2520a%2520microdialysis%2520study%26jtitle%3DBrain%2520Res.%26date%3D1992%26volume%3D587%26spage%3D241%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Potent COMT inhibition by Ro40-7592 in the periphery and in the brain: preclinical and clinical findings</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8420203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1SgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=641-647&author=G.+Z%C3%BCrcherauthor=J.+Dingemanseauthor=M.+Da+Prada&title=Potent+COMT+inhibition+by+Ro40-7592+in+the+periphery+and+in+the+brain%3A+preclinical+and+clinical+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings</span></div><div class="casAuthors">Zuercher, Gerhard; Dingemanse, Jasper; Da Prada, Mose</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">641-7</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">The amino acid 3,4-dihydroxyphenyl-L-alanine (levodopa, DOPA) administered in combination with inhibitors of extracerebral arom. L-amino acid decarboxylase (AADC; i.e., benserazide in Madopar and carbidopa in Sinemet) are still the std. treatments for the therapy of Parkinson's disease (PD).  The administration of DOPA together with AADC inhibitors, which poorly penetrate into the brain, results in a blockade of the decarboxylation of DOPA in the periphery, i.e., gastrointestinal tract, kidney, and brain capillaries.  As a consequence, a dramatic redn. of the conversion of DOPA into dopamine (DA) occurs in extra-cerebral tissues and thereby several side effects produced by the formation of DA in the periphery (nausea, vomiting, and orthostatic hypotension) are eliminated.  Moreover, the inhibition of the AADC restricted to the extracerebral tissues results in an improved access of DOPA into the brain, where the amino acid can easily be converted into DA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbc5ZFqKg9IbVg90H21EOLACvtfcHk0lhT-I9cCvA5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1SgsbY%253D&md5=a3610c5dcbd75a015e47f792c6722ba2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DPotent%2520COMT%2520inhibition%2520by%2520Ro40-7592%2520in%2520the%2520periphery%2520and%2520in%2520the%2520brain%253A%2520preclinical%2520and%2520clinical%2520findings%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D641%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonetti, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da parada, M.</span><span> </span><span class="NLM_article-title">Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol O-methyltransferase: a pharmacological study in rats</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2239490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1990&pages=497-503&author=G.+Z%C3%BCrcherauthor=H.+H.+Kellerauthor=R.+Kettlerauthor=J.+Borgulyaauthor=E.+P.+Bonettiauthor=R.+Eigenmannauthor=M.+Da+parada&title=Ro+40-7592%2C+a+novel%2C+very+potent%2C+and+orally+active+inhibitor+of+catechol+O-methyltransferase%3A+a+pharmacological+study+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DKeller%26aufirst%3DH.%2BH.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DBonetti%26aufirst%3DE.%2BP.%26aulast%3DEigenmann%26aufirst%3DR.%26aulast%3DDa%2Bparada%26aufirst%3DM.%26atitle%3DRo%252040-7592%252C%2520a%2520novel%252C%2520very%2520potent%252C%2520and%2520orally%2520active%2520inhibitor%2520of%2520catechol%2520O-methyltransferase%253A%2520a%2520pharmacological%2520study%2520in%2520rats%26jtitle%3DAdv.%2520Neurol.%26date%3D1990%26volume%3D53%26spage%3D497%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span> </span><span class="NLM_article-title">Tolcapone: A potential new antidepressant detected in a novel animal model of depression</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=344-350&author=J.+L.+Moreauauthor=J.+Borgulyaauthor=F.+Jenckauthor=J.+R.+Martin&title=Tolcapone%3A+A+potential+new+antidepressant+detected+in+a+novel+animal+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26atitle%3DTolcapone%253A%2520A%2520potential%2520new%2520antidepressant%2520detected%2520in%2520a%2520novel%2520animal%2520model%2520of%2520depression%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1994%26volume%3D5%26spage%3D344%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, E.</span><span> </span><span class="NLM_article-title">Beneficial effects of co-administration of catechol O-methyltransferase inhibitors and L-dihydroxypheylalanine in rat models of depression</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0014-2999%2894%2900776-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7768276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK2M3osFyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=229-233&author=P.+T.+M%C3%A4nnist%C3%B6author=A.+Langauthor=P.+Rauhalaauthor=E.+Vasar&title=Beneficial+effects+of+co-administration+of+catechol+O-methyltransferase+inhibitors+and+L-dihydroxypheylalanine+in+rat+models+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression</span></div><div class="casAuthors">Mannisto P T; Lang A; Rauhala P; Vasar E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">229-33</span>
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The administration of catechol-O-methyltransferase inhibitors alone changed neither the behavior of the rats in two animal models of depression, the forced swimming test (entacapone and tolcapone) or in the learned helplessness paradigm (tolcapone), nor the locomotor activity.  L-Dihydroxyphenylalanine (L-DOPA) and carbidopa treatment as such decreased motility but did not improve the behavior in the antidepressant tests.  Co-administration of catechol-O-methyltransferase inhibitors and L-DOPA/carbidopa increased the performance of rats in both tests without increasing locomotor activity.  Catechol-O-methyltransferase inhibitors could be beneficial as adjunct drugs of L-DOPA not only in Parkinson's disease but also in the coincident depressive illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRefyru2M4boe2qxNLjzXe8fW6udTcc2eY3jjeLS92Gtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3osFyktQ%253D%253D&md5=9472278a0074e4f8a6771fabba57a9ef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2900776-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252900776-4%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DLang%26aufirst%3DA.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DVasar%26aufirst%3DE.%26atitle%3DBeneficial%2520effects%2520of%2520co-administration%2520of%2520catechol%2520O-methyltransferase%2520inhibitors%2520and%2520L-dihydroxypheylalanine%2520in%2520rat%2520models%2520of%2520depression%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D274%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Maj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogóz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skuza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowinska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superata, J.</span><span> </span><span class="NLM_article-title">Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinsons disease</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF02260898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1977408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Kku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=101-112&author=J.+Majauthor=Z.+Rog%C3%B3zauthor=G.+Skuzaauthor=H.+Sowinskaauthor=J.+Superata&title=Behavioural+and+neurochemical+effects+of+Ro+40-7592%2C+a+new+COMT+inhibitor+with+a+potential+therapeutic+activity+in+Parkinsons+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease</span></div><div class="casAuthors">Maj, J.; Rogoz, Z.; Skuza, G.; Sowinska, H.; Superata, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission:  Parkinson's Disease and Dementia Section</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-12</span>CODEN:
                <span class="NLM_cas:coden">JNPSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Behavioral and neurochem. effects of Ro 40-7592 (I), a new catechol-O-methyltransferase (COMI) inhibitor, were studied in rats and mice.  I increased the effect of L-DOPA (plus benserazide) on locomotor activity, reserpine-induced hypothermia, and catalepsy induced by pimozide, haloperidol and fluphenazine.  Locomotor hyperactivity induced by amphetamine or nomifensine, as well as stereotypy induced by amphetamine (but not apomorphine), were also increased by I.  The drug stimulated exploratory activity in the open field test.  It decreased the levels of HFA and 3-MT, increased the level of DOPAC but did not change the levels of dopamine in the striatum, nucleus accumbens and frontal cortex.  These results indicate that I may improve therapy with L-DOPA (plus decarboxylase inhibitor) of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGa4QWw3HnLVg90H21EOLACvtfcHk0lid8hweRBbQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Kku7o%253D&md5=718bd38b92436031ac4982ae554d96c3</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2FBF02260898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02260898%26sid%3Dliteratum%253Aachs%26aulast%3DMaj%26aufirst%3DJ.%26aulast%3DRog%25C3%25B3z%26aufirst%3DZ.%26aulast%3DSkuza%26aufirst%3DG.%26aulast%3DSowinska%26aufirst%3DH.%26aulast%3DSuperata%26aufirst%3DJ.%26atitle%3DBehavioural%2520and%2520neurochemical%2520effects%2520of%2520Ro%252040-7592%252C%2520a%2520new%2520COMT%2520inhibitor%2520with%2520a%2520potential%2520therapeutic%2520activity%2520in%2520Parkinsons%2520disease%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1990%26volume%3D2%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Törnwall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span> </span><span class="NLM_article-title">Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission</span> <span class="citation_source-journal">Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1991.tb00412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1658768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3MXltVGnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1991&pages=64-70&author=M.+T%C3%B6rnwallauthor=P.+T.+Mannist%C3%B6&title=Acute+toxicity+of+three+new+selective+COMT+inhibitors+in+mice+with+special+emphasis+on+interactions+with+drugs+increasing+catecholaminergic+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission</span></div><div class="casAuthors">Tornwall, M.; Mannisto, P. T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">3-Nitropyrocatechols are very potent and selective inhibitors of catechol O-methyltransferase (COMT).  LD50 of 3 of these compds. were assessed after i.p. administration with a special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.  LD50 of the inhibitors varied from 137 mg/kg (Ro 41-0960) (I) to 507 mg/kg (OR 462) (II) and 544 mg/kg (OR 611) (III).  The LD50 of Ro 41-0960 was significantly lower than II and III.  At toxic dose levels all inhibitors caused convulsions and hypomotility.  II and III had statistically significant mortality increasing interaction with 20 mg/kg of nomifensine and the former also with 10 mg of amphetamine.  Owing to their high therapeutic indexes, these compds. can be considered useful new tools in pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVfCG6R6Co7Vg90H21EOLACvtfcHk0lid8hweRBbQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltVGnur4%253D&md5=b7b9f61a49070072239e5b4cb8f3dcf3</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1991.tb00412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1991.tb00412.x%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25B6rnwall%26aufirst%3DM.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DAcute%2520toxicity%2520of%2520three%2520new%2520selective%2520COMT%2520inhibitors%2520in%2520mice%2520with%2520special%2520emphasis%2520on%2520interactions%2520with%2520drugs%2520increasing%2520catecholaminergic%2520neurotransmission%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1991%26volume%3D69%26spage%3D64%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Tolcapone and hepatotoxic effects</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1001%2Farchneur.57.2.263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10681087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD3c7ktlehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=263-267&author=C.+W.+Olanow&title=Tolcapone+and+hepatotoxic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Tolcapone and hepatotoxic effects. Tasmar Advisory Panel</span></div><div class="casAuthors">Olanow C W</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-7</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">Four patients with Parkinson disease have recently been described in whom severe hepatic dysfunction developed in association with tolcapone therapy.  These reports led to the introduction of a "black box" warning and more intensive monitoring requirements in the United States.  A review of these cases and all clinical trials indicates that liver dysfunction did not develop in any patient who had received monitoring of liver function according to the original prescribing information.  Virtually all instances of liver enzyme abnormality and clinical liver dysfunction occurred within 6 months of initiating treatment.  To assess the current role of tolcapone therapy in Parkinson disease, a panel of neurologists and hepatologists was convened.  Consensus was reached with respect to the following: (1) Tolcapone is an effective agent in the treatment of patients with fluctuating Parkinson disease. (2) The risk of developing irreversible liver injury is negligible with appropriate monitoring. (3) It may be possible to reduce the frequency of monitoring after 6 months of treatment. (4) The requirement that tolcapone be withdrawn if liver enzymes are elevated above the upper limit of normal on a single occasion is unnecessarily restrictive.  It was concluded that tolcapone, when used as an adjunct to levodopa, is an effective anti-parkinsonian agent and that less frequent monitoring after 6 months, with an action limit of 2 to 3 times the upper limit of normal, is sufficient to ensure safety in patients who are deriving benefit from the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSvLil8Il-hnRxY89Cm6SyfW6udTcc2ebB1Z48to0M1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7ktlehsA%253D%253D&md5=bf1f26ab7b6132952888840225f92417</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1001%2Farchneur.57.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.57.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DTolcapone%2520and%2520hepatotoxic%2520effects%26jtitle%3DArch.%2520Neurol.%26date%3D2000%26volume%3D57%26spage%3D263%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Assal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spahr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadengue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubbici-Brandt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhard, P. R.</span><span> </span><span class="NLM_article-title">Tolcapone and fulminant hepaptitis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=958&author=F.+Assalauthor=L.+Spahrauthor=A.+Hadengueauthor=L.+Rubbici-Brandtauthor=P.+R.+Burkhard&title=Tolcapone+and+fulminant+hepaptitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssal%26aufirst%3DF.%26aulast%3DSpahr%26aufirst%3DL.%26aulast%3DHadengue%26aufirst%3DA.%26aulast%3DRubbici-Brandt%26aufirst%3DL.%26aulast%3DBurkhard%26aufirst%3DP.%2BR.%26atitle%3DTolcapone%2520and%2520fulminant%2520hepaptitis%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heizmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, R.</span><span> </span><span class="NLM_article-title">Metabolism and excretion of tolcapone, a novel inhibitor of catechol O-methyltransferase</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.1365-2125.1999.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10583021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=513-520&author=K.+M.+Jorgaauthor=B.+Fottelerauthor=P.+Heizmannauthor=R.+Gasser&title=Metabolism+and+excretion+of+tolcapone%2C+a+novel+inhibitor+of+catechol+O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase</span></div><div class="casAuthors">Jorga, Karin; Fotteler, Barbel; Heizmann, Peter; Gasser, Rodolfo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The rate of excretion and routes of metab. of tolcapone, a novel inhibitor of catechol-O-methyltransferase (COMT) were studied.  Six healthy male volunteers were given 200 mg [14C]-tolcapone (approx. 50 μCi) orally.  To assess excretion balance and to identify metabolites, urine and feces were collected before administration and until radioactivity fell below 75 d min-1 ml-1 (urine) and 100 d min-1 mg-1 (feces).  Blood samples were collected frequently before and after administration to det. plasma radioactivity, to identify tolcapone metabolites and to measure plasma tolcapone and its methylated deriv. 3-O-methyltolcapone (3-OMT).  The mean proportion of the dose excreted in urine was 57.3% and in feces 40.5%.  Excretion was almost complete (more than 95%) in all participants after 9 days.  The major early metabolite present in plasma was the 3-O-β,D-glucuronide conjugate, which was detectable within 2 h after dosing.  The major late metabolite in plasma was 3-OMT.  The 3-O-β,D-glucuronide was also the most abundant metabolite in urine and feces, accounting for 27% and 33%, resp., of the total radioactivity excreted by these routes and for 26% of the original dose.  Redn. of the nitro moiety yields an amine deriv., detected in both urine and feces, with subsequent modifications, such as acetylation of the amine group and conjugation with glucuronic acid or sulfate, or both.  Oxidative reactions due to cytochrome P 450 enzymes are of small significance, as is 3-O-methylation by COMT.  Tolcapone is almost completely metabolized and excreted in urine and feces (only 0.5% of tolcapone was excreted unchanged); glucuronidation is the most important route of metab.  The relatively long duration of excretion is caused by the long half-life of 3-OMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomxbJ3foHx37Vg90H21EOLACvtfcHk0ljoKCL9LtO50g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D&md5=53200da79657f3560fc6de831654cd86</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1999.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1999.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DHeizmann%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DR.%26atitle%3DMetabolism%2520and%2520excretion%2520of%2520tolcapone%252C%2520a%2520novel%2520inhibitor%2520of%2520catechol%2520O-methyltransferase%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1999%26volume%3D48%26spage%3D513%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Smith, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heady, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trugman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harman, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. L.</span><span> </span><span class="NLM_article-title">In vitro metabolism of tolcapone to reactive intermediates relevance to tolcapone liver toxicity</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx025569n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=123-128&author=K.+S.+Smithauthor=P.+L.+Smithauthor=T.+N.+Headyauthor=J.+M.+Trugmanauthor=W.+D.+Harmanauthor=T.+L.+McDonald&title=In+vitro+metabolism+of+tolcapone+to+reactive+intermediates+relevance+to+tolcapone+liver+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Ftx025569n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx025569n%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DK.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DHeady%26aufirst%3DT.%2BN.%26aulast%3DTrugman%26aufirst%3DJ.%2BM.%26aulast%3DHarman%26aufirst%3DW.%2BD.%26aulast%3DMcDonald%26aufirst%3DT.%2BL.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520tolcapone%2520to%2520reactive%2520intermediates%2520relevance%2520to%2520tolcapone%2520liver%2520toxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D123%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Haasio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentilla, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span> </span><span class="NLM_article-title">Effects of entacapone and tolcapone on mitochondrial membrane potential</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0014-2999%2802%2902383-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12393055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=21-26&author=K.+Haasioauthor=A.+Koponenauthor=K.+E.+Pentillaauthor=E.+Nissinen&title=Effects+of+entacapone+and+tolcapone+on+mitochondrial+membrane+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of entacapone and tolcapone on mitochondrial membrane potential</span></div><div class="casAuthors">Haasio, Kristiina; Koponen, Anita; Penttila, Kai E.; Nissinen, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Catechol-O-Me transferase (COMT) inhibitors, entacapone and tolcapone, are used as an adjunctive treatment to L-dopa in Parkinson's disease.  Based on their catechol structure, both inhibitors are potential uncoupling agents, but only tolcapone shows this effect in vitro at clin. relevant concns.  This study was designed to evaluate the direct uncoupling effects of the two COMT inhibitors in vitro and in vivo.  In isolated rat liver mitochondria, entacapone had no effect on the membrane potential at therapeutical concns., but both tolcapone and the ref. compd. 2,4-dinitrophenol disrupted the potential at low μM concns.  Since protein binding is speculated to decrease the uncoupling effects in vivo, the COMT inhibitory effect of entacapone and tolcapone as a surrogate for the overall activity of these inhibitors was evaluated in vitro with or without serum.  The COMT inhibitory activity of entacapone was reduced to half, while tolcapone had only about 1/10 of its activity left in the presence of serum.  Further, uncoupling is known to induce an increase in the body temp. in vivo, and these effects were evaluated in the rat by a possible hyperthermic response to the treatment with entacapone or tolcapone in combination with L-dopa (10 mg/kg) and carbidopa (20 mg/kg).  This combination with entacapone (400 mg/kg) had no effect on the rectal body temp.  In contrast, tolcapone (50 mg/kg) caused an elevation in the body temp. together with L-dopa and carbidopa (P<0.01).  Both in vitro and in vivo results indicate that entacapone does not impair energy metab. related to uncoupling of oxidative phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRip7eAsgAabVg90H21EOLACvtfcHk0liNhEvH1z4Ckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCht7Y%253D&md5=8a649045794a303d435cf67fef4fdcb9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902383-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902383-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaasio%26aufirst%3DK.%26aulast%3DKoponen%26aufirst%3DA.%26aulast%3DPentilla%26aufirst%3DK.%2BE.%26aulast%3DNissinen%26aufirst%3DE.%26atitle%3DEffects%2520of%2520entacapone%2520and%2520tolcapone%2520on%2520mitochondrial%2520membrane%2520potential%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaheinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentilla, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaivola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span> </span><span class="NLM_article-title">Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson’s disease, does not impair mitochondrial energy production</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0014-2999%2897%2901431-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9537825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2sXotVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1997&pages=287-294&author=E.+Nissinenauthor=P.+Kaheinenauthor=K.+E.+Pentillaauthor=K.+Kaivolaauthor=I.+B.+Linden&title=Entacapone%2C+a+novel+catechol-O-methyltransferase+inhibitor+for+Parkinson%E2%80%99s+disease%2C+does+not+impair+mitochondrial+energy+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production</span></div><div class="casAuthors">Nissinen, Erkki; Kaheinen, Petri; Penttila, Kai E.; Kaivola, Juha; Linden, Inge-Britt</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Entacapone, a novel mainly peripherally acting catechol-O-methyltransferase inhibitor used in the treatment of Parkinson's disease, was evaluated for its possible uncoupling activity in cell culture, in rat liver mitochondria, and in isolated guinea-pig heart.  Entacapone did not stimulate respiration in the L1210 murine T cell lymphoma cell line at the concns. studied (5-40 μM).  Furthermore, entacapone neither increased mitochondrial respiration nor impaired cardiac function at pharmacol. relevant concns. (<10 μM).  In fact, the threshold concn. for increased mitochondrial oxygen consumption was 20 μM and half-maximal stimulation of respiration was not detected until 58 μM.  Surprisingly, tolcapone, another catechol-O-methyltransferase inhibitor, which acts both peripherally and centrally, stimulated respiration in L1210 cells at the lowest concn. studied (5 μM).  In addn., 1 μM tolcapone increased mitochondrial respiration, indicating that it caused uncoupling at a much lower concn. than that of 2,4-dinitrophenol, a well-known uncoupler of oxidative phosphorylation.  Tolcapone also impaired the mech. function and oxygen consumption of the isolated guinea-pig heart at 1 μM. These results show that peripherally acting entacapone, unlike the brain-penetrating tolcapone, is a safe catechol-O-methyltransferase inhibitor for the treatment of Parkinson's disease, since it does not interfere with mitochondrial energy metab. at pharmacol. effective concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVpzZyM4Ek7Vg90H21EOLACvtfcHk0liNhEvH1z4Ckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVyjsbY%253D&md5=441064c55e00ba634bc3b3657e55ade8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901431-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901431-3%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DKaheinen%26aufirst%3DP.%26aulast%3DPentilla%26aufirst%3DK.%2BE.%26aulast%3DKaivola%26aufirst%3DK.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26atitle%3DEntacapone%252C%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520for%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520does%2520not%2520impair%2520mitochondrial%2520energy%2520production%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D340%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Korlipara, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span> </span><span class="NLM_article-title">Differencies in toxicity of catechol O-methyltransferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=562-569&author=L.+P.+Korliparaauthor=J.+M.+Cooperauthor=A.+H.+Schapira&title=Differencies+in+toxicity+of+catechol+O-methyltransferase+inhibitors%2C+tolcapone+and+entacapone+to+cultured+human+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorlipara%26aufirst%3DL.%2BP.%26aulast%3DCooper%26aufirst%3DJ.%2BM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26atitle%3DDifferencies%2520in%2520toxicity%2520of%2520catechol%2520O-methyltransferase%2520inhibitors%252C%2520tolcapone%2520and%2520entacapone%2520to%2520cultured%2520human%2520neuroblastoma%2520cells%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D56%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Benes, J.; Soares-da-Silva, P.; Learmonth, D.</span><span> </span><span class="NLM_article-title">Substituted 2-Phenyl-l-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical composition containing them</span>. International Patent WO200037423,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=J.+Benes&author=P.+Soares-da-Silva&author=D.+Learmonth&title=Substituted+2-Phenyl-l-%283%2C4-dihydroxy-5-nitrophenyl%29-1-ethanones%2C+their+use+in+the+treatment+of+some+central+and+peripheral+nervous+system+disorders+and+pharmaceutical+composition+containing+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DJ.%26atitle%3DSubstituted%25202-Phenyl-l-%25283%252C4-dihydroxy-5-nitrophenyl%2529-1-ethanones%252C%2520their%2520use%2520in%2520the%2520treatment%2520of%2520some%2520central%2520and%2520peripheral%2520nervous%2520system%2520disorders%2520and%2520pharmaceutical%2520composition%2520containing%2520them%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109964" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=685-695&author=D.+A.+Learmonthauthor=M.+A.+Vieira-Coelhoauthor=J.+Benesauthor=P.+C.+Alvesauthor=N.+Borgesauthor=A.+P.+Freitasauthor=P.+Soares-da-Silva&title=Synthesis+of+1-%283%2C4-dihydroxy-5-nitrophenyl%29-2-phenyl-ethanone+and+derivatives+as+potent+and+long-acting+peripheral+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm0109964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109964%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DBenes%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DP.%2BC.%26aulast%3DBorges%26aufirst%3DN.%26aulast%3DFreitas%26aufirst%3DA.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%2520of%25201-%25283%252C4-dihydroxy-5-nitrophenyl%2529-2-phenyl-ethanone%2520and%2520derivatives%2520as%2520potent%2520and%2520long-acting%2520peripheral%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D685%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=250-258&author=P.+N.+Palmaauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=L.+C.+Wrightauthor=D.+A.+Learmonthauthor=P.+Soares-da-Silva&title=Molecular+modeling+and+metabolic+studies+of+the+interaction+of+catechol-O-methyltransferase+and+a+new+nitrocatechol+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DMolecular%2520modeling%2520and%2520metabolic%2520studies%2520of%2520the%2520interaction%2520of%2520catechol-O-methyltransferase%2520and%2520a%2520new%2520nitrocatechol%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D250%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Learmonth, D.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them</span>. International Patent WO200198251,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+Learmonth&author=P.+Soares-da-Silva&title=Substituted+nitrated+catechols%2C+their+use+in+the+treatment+of+some+central+and+peripheral+nervous+system+disorders+and+pharmaceutical+compositions+containing+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%26atitle%3DSubstituted%2520nitrated%2520catechols%252C%2520their%2520use%2520in%2520the%2520treatment%2520of%2520some%2520central%2520and%2520peripheral%2520nervous%2520system%2520disorders%2520and%2520pharmaceutical%2520compositions%2520containing%2520them%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6207</span><span class="NLM_x">–</span> <span class="NLM_lpage">6217</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040848o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6207-6217&author=D.+A.+Learmonthauthor=P.+N.+Palmaauthor=M.+A.+Vieira-Coelhoauthor=P.+Soares-da-Silva&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+studies+of+a+novel%2C+peripherally+selective+inhibitor+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm040848o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040848o%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520studies%2520of%2520a%2520novel%252C%2520peripherally%2520selective%2520inhibitor%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6207%26epage%3D6217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-Da-Silva, P.</span><span> </span><span class="NLM_article-title">Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=795-805&author=M.+J.+Bonif%C3%A1cioauthor=M.+Archerauthor=M.+L.+Rodriguesauthor=P.+M.+Matiasauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-Da-Silva&title=Kinetics+and+crystal+structure+of+catechol-O-methyltransferase+complex+with+co-substrate+and+a+novel+inhibitor+with+potential+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DMatias%26aufirst%3DP.%2BM.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-Da-Silva%26aufirst%3DP.%26atitle%3DKinetics%2520and%2520crystal%2520structure%2520of%2520catechol-O-methyltransferase%2520complex%2520with%2520co-substrate%2520and%2520a%2520novel%2520inhibitor%2520with%2520potential%2520therapeutic%2520application%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D795%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Kiss, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span> </span><span class="NLM_article-title">Discovery of a long-acting, peripherally selective inhibitor of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3396</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1001524" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3396-3411&author=L.+E.+Kissauthor=H.+S.+Ferreiraauthor=L.+Torr%C3%A3oauthor=M.+J.+Bonif%C3%A1cioauthor=P.+N.+Palmaauthor=P.+Soares-da-Silvaauthor=D.+A.+Learmonth&title=Discovery+of+a+long-acting%2C+peripherally+selective+inhibitor+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm1001524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1001524%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DL.%2BE.%26aulast%3DFerreira%26aufirst%3DH.%2BS.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520long-acting%252C%2520peripherally%2520selective%2520inhibitor%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3396%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Computation of the binding affinities of catechol-<i>O</i>-methyltransferase inhibitors: Multisubstate relative free energy calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=970-986&author=P.+N.+Palmaauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=P.+Soares-da-Silva&title=Computation+of+the+binding+affinities+of+catechol-O-methyltransferase+inhibitors%3A+Multisubstate+relative+free+energy+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DComputation%2520of%2520the%2520binding%2520affinities%2520of%2520catechol-O-methyltransferase%2520inhibitors%253A%2520Multisubstate%2520relative%2520free%2520energy%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2012%26volume%3D33%26spage%3D970%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Opicapone: Characterization of a novel peripheral long-acting catechol-<i>O</i>-methyltransferase inhibitior</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">S2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S125&issue=S2&author=M.+J.+Bonif%C3%A1cioauthor=L.+Torr%C3%A3oauthor=A.+I.+Loureiroauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Opicapone%3A+Characterization+of+a+novel+peripheral+long-acting+catechol-O-methyltransferase+inhibitior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DOpicapone%253A%2520Characterization%2520of%2520a%2520novel%2520peripheral%2520long-acting%2520catechol-O-methyltransferase%2520inhibitior%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DS2%26spage%3DS125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Brain and peripheral levodopa pharmacokinetics in the cynomolgus monkey following administration of opicapone, a novel catechol-<i>O</i>-methyltransferase inhibitor</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">S2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S125&issue=S2&author=M.+J.+Bonif%C3%A1cioauthor=J.+S.+Sutcliffeauthor=L.+Torr%C3%A3oauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Brain+and+peripheral+levodopa+pharmacokinetics+in+the+cynomolgus+monkey+following+administration+of+opicapone%2C+a+novel+catechol-O-methyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DBrain%2520and%2520peripheral%2520levodopa%2520pharmacokinetics%2520in%2520the%2520cynomolgus%2520monkey%2520following%2520administration%2520of%2520opicapone%252C%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DS2%26spage%3DS125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Takehiro, I.; Toshihiro, N.; Hitoshi, I.; Nobuyuki, T.; Hideyuki, M.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and uses of those</span>. International Patent WO2007063789,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=I.+Takehiro&author=N.+Toshihiro&author=I.+Hitoshi&author=T.+Nobuyuki&author=M.+Hideyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+uses+of+those"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520uses%2520of%2520those%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: Synthesis and biological activity as catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4584</span><span class="NLM_x">–</span> <span class="NLM_lpage">4588</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4584-4588&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Dihydroxynitrobenzaldehydes+and+hydroxymethoxynitrobenzaldehydes%3A+Synthesis+and+biological+activity+as+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a011%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DDihydroxynitrobenzaldehydes%2520and%2520hydroxymethoxynitrobenzaldehydes%253A%2520Synthesis%2520and%2520biological%2520activity%2520as%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4584%26epage%3D4588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=1973-1981&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Inhibition+of+catechol-O-methyltransferase+by+1-vinyl+derivatives+of+nitrocatechols+and+nitroguaiacols.+Kinetics+of+the+irreversible+inhibition+by+3-%283-hydroxy-4-methoxy-5-nitro+benzylidene%29-2%2C4-pentanedione"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520by%25201-vinyl%2520derivatives%2520of%2520nitrocatechols%2520and%2520nitroguaiacols.%2520Kinetics%2520of%2520the%2520irreversible%2520inhibition%2520by%25203-%25283-hydroxy-4-methoxy-5-nitro%2520benzylidene%2529-2%252C4-pentanedione%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D1973%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible tight-binding inhibition of pig liver catechol-<i>O</i>-methyltransferase by [2-(3,4-dihydroxy-2-nitrophenyl) vinyl]phenyl ketone</span> <span class="citation_source-journal">Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F14756369409020195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7539072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXis1Cjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=123-131&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Kinetics+of+the+reversible+tight-binding+inhibition+of+pig+liver+catechol-O-methyltransferase+by+%5B2-%283%2C4-dihydroxy-2-nitrophenyl%29+vinyl%5Dphenyl+ketone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenyl ketone</span></div><div class="casAuthors">Perez, Rosa A.; Fernandez-Alvarez, Eldiberto; Nieto, Ofelia; Piedrafita, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-31</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">The inactivation of partially purified pig liver catechol-O-methyltransferase (COMT) by [2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenylketone has been studied.  The results demonstrated that COMAT is inhibited in a reversible tight-binding fashion with an apparent Ki of 0.2 μM.  IC50 values were detd. at different concns. of both substrates of the enzymic reaction, pyrocatechol and S-adenosyl-L-methionine (AdoMet).  The plot of IC50 vs. pyrocatechol concn. gave a straight line, suggesting competitive inhibition.  However the nitrocatechol deriv. showed an uncompetitive inhibition pattern when measured as a function of AdoMet concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2bJxWnRCH7Vg90H21EOLACvtfcHk0lgrWXDqkBI43w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXis1Cjt7s%253D&md5=a20073cab8993056859d7c5d7fa6a610</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.3109%2F14756369409020195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756369409020195%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520tight-binding%2520inhibition%2520of%2520pig%2520liver%2520catechol-O-methyltransferase%2520by%2520%255B2-%25283%252C4-dihydroxy-2-nitrophenyl%2529%2520vinyl%255Dphenyl%2520ketone%26jtitle%3DEnzyme%2520Inhib.%26date%3D1994%26volume%3D8%26spage%3D123%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Rivas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ceballos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontenla, J. A.</span><span> </span><span class="NLM_article-title">In vivo effects of new inhibitors of catechol-O-methyltransferase</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1038%2Fsj.bjp.0702474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10323601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXislGku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=1667-1673&author=E.+Rivasauthor=M.+L.+de+Ceballosauthor=O.+Nietoauthor=J.+A.+Fontenla&title=In+vivo+effects+of+new+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of new inhibitors of catechol-O-methyl transferase</span></div><div class="casAuthors">Rivas, Emilia; De Ceballos, Maria L.; Nieto, Ofelia; Fontenla, Jose Angel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1667-1673</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The effects of two new synthetic compds. showing in vitro catechol-O-Me transferase (COMT) inhibitor properties were studied in vivo and compared with the effects of nitecapone and Ro-41-0960.  QO IA (3-(3-hydroxy-4-methoxy-5-nitrobenzylidene)-2,4-pentanedione), QO IIR ([2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenyl ketone), nitecapone and Ro-41-0960 (30 mg kg-1, i.p.) were given to reserpinized rats 1 h before the administration of L-DOPA/carbidopa (LD/CD, 50: 50 mg kg-1, i.p.).  Locomotor activity was assessed 1 h later.  All the COMT inhibitors (COMTI), with the exception of QO IA, markedly potentiated LD/CD reversal of reserpine-induced akinesia.  Similar results were obtained when the COMTI were coadministered with LD/CD.  The effect of compd. QO IIR was dose-dependent (7.5-30 mg kg-1, i.p.).  The COMTI (30 mg kg-1, i.p.) potentiated LD/CD reversal of both catalepsy and hypothermia of reserpinized mice.  QO IIR, nitecapone and Ro-41-0960 (30 mg kg-1, i.p.) reduced striatal 3-methyl-DOPA (3-OMD) levels and increased dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) levels.  Compd. QO IA was devoid of any effect on striatal amine levels.  In contrast to the other inhibitors, Ro-41-0961 reduced HVA levels as well.  The effect of QO IIR on striatal amine levels was dose-dependent (7.5-60 mg kg-1, i.p.).  These results suggest that the new compd. QO IIR is an effective peripherally acting COMT inhibitor in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhPwwT8u4ILVg90H21EOLACvtfcHk0lggMnBE-BKsmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGku7s%253D&md5=5f23c89adf3d9f53280fa873c245d250</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702474%26sid%3Dliteratum%253Aachs%26aulast%3DRivas%26aufirst%3DE.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DFontenla%26aufirst%3DJ.%2BA.%26atitle%3DIn%2520vivo%2520effects%2520of%2520new%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D1667%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel series of “ortho-nitrated” inhibitors of catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8070</span><span class="NLM_x">–</span> <span class="NLM_lpage">8078</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0580454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=8070-8078&author=D.+A.+Learmonthauthor=M.+J.+Bonif%C3%A1cioauthor=P.+Soares-da-Silva&title=Synthesis+and+biological+evaluation+of+a+novel+series+of+%E2%80%9Cortho-nitrated%E2%80%9D+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm0580454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0580454%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520%25E2%2580%259Cortho-nitrated%25E2%2580%259D%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D8070%26epage%3D8078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span> </span><span class="NLM_article-title">Crystallization and preliminary X-ray diffraction studies of a catechol-<i>O</i>-methyltransferase/inhibitor complex</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">F61</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=F61&publication_year=2005&pages=118-120&author=M.+L.+Rodriguesauthor=M.+J.+Bonif%C3%A1cioauthor=P.+Soares-da-Silvaauthor=M.+A.+Carrondoauthor=M.+Archer&title=Crystallization+and+preliminary+X-ray+diffraction+studies+of+a+catechol-O-methyltransferase%2Finhibitor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DArcher%26aufirst%3DM.%26atitle%3DCrystallization%2520and%2520preliminary%2520X-ray%2520diffraction%2520studies%2520of%2520a%2520catechol-O-methyltransferase%252Finhibitor%2520complex%26jtitle%3DActa%2520Crystallogr.%26date%3D2005%26volume%3DF61%26spage%3D118%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase. Interactions with the active site and regioselectivity of <i>O</i>-methylation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=143-153&author=P.+N.+Palmaauthor=M.+L.+Rodriguesauthor=M.+Archerauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-da-Silva&title=Comparative+study+of+ortho-+and+meta-nitrated+inhibitors+of+catechol-O-methyltransferase.+Interactions+with+the+active+site+and+regioselectivity+of+O-methylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DComparative%2520study%2520of%2520ortho-%2520and%2520meta-nitrated%2520inhibitors%2520of%2520catechol-O-methyltransferase.%2520Interactions%2520with%2520the%2520active%2520site%2520and%2520regioselectivity%2520of%2520O-methylation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Pystynen, J.; Luiro, A.; Lotta, T.; Ovaska, M.; Vidgren, J.</span><span> </span><span class="NLM_article-title">New catechol derivatives</span>. International Patent WO199637456,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=J.+Pystynen&author=A.+Luiro&author=T.+Lotta&author=M.+Ovaska&author=J.+Vidgren&title=New+catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPystynen%26aufirst%3DJ.%26atitle%3DNew%2520catechol%2520derivatives%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Ahlmark, M.; Din Belle, D.; Kauppala, M.; Luiro, A.; Pajunen, T.; Pystynen, J.; Tiainen, E.; Vaismaa, M.</span><span> </span><span class="NLM_article-title">Catechol O-methyltransferase activity inhibiting compounds</span>. International Patent WO2013175053,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Ahlmark&author=D.+Din+Belle&author=M.+Kauppala&author=A.+Luiro&author=T.+Pajunen&author=J.+Pystynen&author=E.+Tiainen&author=M.+Vaismaa&title=Catechol+O-methyltransferase+activity+inhibiting+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhlmark%26aufirst%3DM.%26atitle%3DCatechol%2520O-methyltransferase%2520activity%2520inhibiting%2520compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Takehiro, I.; Inoue, H.; Kobayashi, S.; Yoshida, M.; Shiohara, H.; Ueno, Y.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and use of the catechol derivative and use of the pharmaceutical composition</span>. International Patent WO2009081891,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Takehiro&author=H.+Inoue&author=S.+Kobayashi&author=M.+Yoshida&author=H.+Shiohara&author=Y.+Ueno&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+use+of+the+catechol+derivative+and+use+of+the+pharmaceutical+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520use%2520of%2520the%2520catechol%2520derivative%2520and%2520use%2520of%2520the%2520pharmaceutical%2520composition%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Hiroaki, S.; Satoko, K.; Hitoshi, I.; Masako, Y.; Yasunori, U.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and uses of those</span>. International Patent WO2009081892,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Hiroaki&author=K.+Satoko&author=I.+Hitoshi&author=Y.+Masako&author=U.+Yasunori&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+uses+of+those"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiroaki%26aufirst%3DS.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520uses%2520of%2520those%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Takehiro, I.; Satoko, K.; Hitoshi, I.; Yasunori, U.; Masako, Y.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and use of the catechol derivative and use of the pharmaceutical composition</span>. International Patent WO2010001821,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=I.+Takehiro&author=K.+Satoko&author=I.+Hitoshi&author=U.+Yasunori&author=Y.+Masako&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+use+of+the+catechol+derivative+and+use+of+the+pharmaceutical+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520use%2520of%2520the%2520catechol%2520derivative%2520and%2520use%2520of%2520the%2520pharmaceutical%2520composition%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Pystynen, J.; Ovaska, M.; Vidgren, J.; Lotta, T.; Yliperttula-ikonen, M.</span><span> </span><span class="NLM_article-title">Coumarin derivatives with COMT inhibiting activity</span>. International Patent WO200202548,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+Pystynen&author=M.+Ovaska&author=J.+Vidgren&author=T.+Lotta&author=M.+Yliperttula-ikonen&title=Coumarin+derivatives+with+COMT+inhibiting+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPystynen%26aufirst%3DJ.%26atitle%3DCoumarin%2520derivatives%2520with%2520COMT%2520inhibiting%2520activity%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Bäckström, R.; Pystynen, J.; Lotta, T.; Ovaska, M.; Taskinen, J.</span><span> </span><span class="NLM_article-title">Derivatives of naphthalene with COMT inhibiting activity</span>. International Patent WO200222551,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+B%C3%A4ckstr%C3%B6m&author=J.+Pystynen&author=T.+Lotta&author=M.+Ovaska&author=J.+Taskinen&title=Derivatives+of+naphthalene+with+COMT+inhibiting+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26atitle%3DDerivatives%2520of%2520naphthalene%2520with%2520COMT%2520inhibiting%2520activity%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Ahlmark, M.; Bäckström, R.; Luiro, A.; Pystynen, J.; Tiainen, E.</span><span> </span><span class="NLM_article-title">New pharmaceutical compounds</span>. International Patent WO2007010085,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Ahlmark&author=R.+B%C3%A4ckstr%C3%B6m&author=A.+Luiro&author=J.+Pystynen&author=E.+Tiainen&title=New+pharmaceutical+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhlmark%26aufirst%3DM.%26atitle%3DNew%2520pharmaceutical%2520compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pystynen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sairanen, M.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-<i>O</i>-methyltransferase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2614</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2614-2616&author=J.+Rautioauthor=J.+Lepp%C3%A4nenauthor=M.+Lehtonenauthor=K.+Laineauthor=M.+Koskinenauthor=J.+Pystynenauthor=J.+Savolainenauthor=M.+Sairanen&title=Design%2C+synthesis+and+in+vitro%2Fin+vivo+evaluation+of+orally+bioavailable+prodrugs+of+a+catechol-O-methyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DKoskinen%26aufirst%3DM.%26aulast%3DPystynen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DSairanen%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520evaluation%2520of%2520orally%2520bioavailable%2520prodrugs%2520of%2520a%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2614%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Belleau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burba, J.</span><span> </span><span class="NLM_article-title">Tropolones: A unique class of potent non-competitive inhibitors of S-adenosylmethionine-catechol methyltransferase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1961&pages=195-196&author=B.+Belleauauthor=J.+Burba&title=Tropolones%3A+A+unique+class+of+potent+non-competitive+inhibitors+of+S-adenosylmethionine-catechol+methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB.%26aulast%3DBurba%26aufirst%3DJ.%26atitle%3DTropolones%253A%2520A%2520unique%2520class%2520of%2520potent%2520non-competitive%2520inhibitors%2520of%2520S-adenosylmethionine-catechol%2520methyltransferase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1961%26volume%3D54%26spage%3D195%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Broch, O. J.</span><span> </span><span class="NLM_article-title">The in vivo effect of tropolone on noradrenaline metabolism and catechol-O-methyltransferase activity in the striatum of the rat</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1973.tb01543.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=4801086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE2c%252FntFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1973&pages=417-428&author=O.+J.+Broch&title=The+in+vivo+effect+of+tropolone+on+noradrenaline+metabolism+and+catechol-O-methyltransferase+activity+in+the+striatum+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The in vivo effect of tropolone on noradrenaline metabolism and catechol-O-methyl transferase activity in tissues of the rat</span></div><div class="casAuthors">Broch O J Jr</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica et toxicologica</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-28</span>
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfqbUGvdtxZUNHe_gFldTbfW6udTcc2eao3S1tqfOiBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c%252FntFamsQ%253D%253D&md5=ff3d27d81628e8825787b70b41ffe604</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1973.tb01543.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1973.tb01543.x%26sid%3Dliteratum%253Aachs%26aulast%3DBroch%26aufirst%3DO.%2BJ.%26atitle%3DThe%2520in%2520vivo%2520effect%2520of%2520tropolone%2520on%2520noradrenaline%2520metabolism%2520and%2520catechol-O-methyltransferase%2520activity%2520in%2520the%2520striatum%2520of%2520the%2520rat%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1973%26volume%3D33%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Borchardt, R. T.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase. 4. In vitro inhibition by 3-hydroxy-4-pyrones, 3-hydroxy-2-pyridones and 3-hydroxy-4-pyridones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00263a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=581-583&author=R.+T.+Borchardt&title=Catechol-O-methyltransferase.+4.+In+vitro+inhibition+by+3-hydroxy-4-pyrones%2C+3-hydroxy-2-pyridones+and+3-hydroxy-4-pyridones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm00263a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00263a047%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DCatechol-O-methyltransferase.%25204.%2520In%2520vitro%2520inhibition%2520by%25203-hydroxy-4-pyrones%252C%25203-hydroxy-2-pyridones%2520and%25203-hydroxy-4-pyridones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D581%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Wolkenberg, S.; Barrow, J. C.; Poslusney, S. T.; Harrison, S. T.; Trotter, B. W.; Mulhearn, J.; Nanda, K. K.; Manley, P. J.; Zhao, Z.; Scubert, J. W.; Kett, N.; Zartman, A.</span><span> </span><span class="NLM_article-title">Inhibitors of Catechol-O-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109254,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=J.+C.+Barrow&author=S.+T.+Poslusney&author=S.+T.+Harrison&author=B.+W.+Trotter&author=J.+Mulhearn&author=K.+K.+Nanda&author=P.+J.+Manley&author=Z.+Zhao&author=J.+W.+Scubert&author=N.+Kett&author=A.+Zartman&title=Inhibitors+of+Catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520Catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Wolkenberg, S.; Barrow, J. C.; Harrison, S. T.; Trotter, B. W.; Nanda, K. K.; Manley, P. J.; Zhao, Z.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-<i>O</i>-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109261,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=J.+C.+Barrow&author=S.+T.+Harrison&author=B.+W.+Trotter&author=K.+K.+Nanda&author=P.+J.+Manley&author=Z.+Zhao&title=Inhibitors+of+catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Wolkenberg, S.; Harrison, S. T.; Barrow, J. C.; Zhao, Z.; Kett, N.; Zartman, A.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-O-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109267,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=S.+T.+Harrison&author=J.+C.+Barrow&author=Z.+Zhao&author=N.+Kett&author=A.+Zartman&title=Inhibitors+of+catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Brevitt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. W.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of two progressive series of bifunctional polyhdroxybenzamide catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9605187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2035-2039&author=S.+E.+Brevittauthor=E.+W.+Tan&title=Synthesis+and+in+vitro+evaluation+of+two+progressive+series+of+bifunctional+polyhdroxybenzamide+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm9605187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9605187%26sid%3Dliteratum%253Aachs%26aulast%3DBrevitt%26aufirst%3DS.%2BE.%26aulast%3DTan%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520two%2520progressive%2520series%2520of%2520bifunctional%2520polyhdroxybenzamide%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2035%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Bailey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. W.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5740</span><span class="NLM_x">–</span> <span class="NLM_lpage">5749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=5740-5749&author=K.+Baileyauthor=E.+W.+Tan&title=Synthesis+and+evaluation+of+bifunctional+nitrocatechol+inhibitors+of+pig+liver+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bifunctional%2520nitrocatechol%2520inhibitors%2520of%2520pig%2520liver%2520catechol-O-methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D5740%26epage%3D5749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT)</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2F%28SICI%291521-3765%2820000317%296%3A6%3C971%3A%3AAID-CHEM971%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10785817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=971-982&author=B.+Masjostauthor=P.+Ballmerauthor=E.+Borroniauthor=G.+Z%C3%BCrcherauthor=F.+K.+Winklerauthor=R.+Jakob-Roetneauthor=F.+Diederich&title=Structure-based+design%2C+synthesis%2C+and+in+vitro+evaluation+of+bisubstrate+inhibitors+for+catechol+O-methyltransferase+%28COMT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and in vitro evaluation of bi-substrate inhibitors for catechol O-methyltransferase (COMT)</span></div><div class="casAuthors">Masjost, Birgit; Ballmer, Patrick; Borroni, Edilio; Zurcher, Gerhard; Winkler, Fritz K.; Jakob-Roetne, Roland; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">971-982</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The enzyme catechol O-methyltransferase (COMT) catalyzes the Me group transfer from the cofactor S-adenosylmethionine (SAM) to the hydroxy group of catechol substrates.  Potential bisubstrate inhibitors of COMT were developed by structure-based design and synthesized.  The compds. were tested for in vitro inhibitory activity against COMT obtained from rat liver, and the inhibition kinetics were examd. with regard to the binding sites of cofactor and substrate.  One of the designed mols. was found to be a bisubstrate inhibitor of COMT with an IC50 = 2 μM.  It exhibits competitive kinetics for the SAM and non-competitive kinetics for the catechol binding site.  Useful structure-activity relationships were established which provide important guidelines for the design of future generations of bisubstrate inhibitors of COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3n0QtsrURUbVg90H21EOLACvtfcHk0lijzamoDoFXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFCjt7s%253D&md5=42e749bce69de74dbb6e6382f3e56534</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2820000317%296%3A6%3C971%3A%3AAID-CHEM971%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252820000317%25296%253A6%253C971%253A%253AAID-CHEM971%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DBallmer%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520bisubstrate%2520inhibitors%2520for%2520catechol%2520O-methyltransferase%2520%2528COMT%2529%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2000%26volume%3D6%26spage%3D971%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of a bisubstrate inhibitor bound to the enzyme catechol-<i>O</i>-methyltransferase: A dramatic effect of inhibitor preorganization on binding affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=4040-4042&author=C.+Lernerauthor=A.+Rufauthor=V.+Gramlichauthor=B.+Masjostauthor=G.+Z%C3%BCrcherauthor=R.+Jakob-Roetneauthor=E.+Borroniauthor=F.+Diederich&title=X-ray+crystal+structure+of+a+bisubstrate+inhibitor+bound+to+the+enzyme+catechol-O-methyltransferase%3A+A+dramatic+effect+of+inhibitor+preorganization+on+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520a%2520bisubstrate%2520inhibitor%2520bound%2520to%2520the%2520enzyme%2520catechol-O-methyltransferase%253A%2520A%2520dramatic%2520effect%2520of%2520inhibitor%2520preorganization%2520on%2520binding%2520affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D4040%26epage%3D4042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors for the enzyme catechol-<i>O</i>-methyltransferase (COMT): Influence of inhibitor preorganisation and linker length between two substrate moieties on binding affinity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=42-49&author=C.+Lernerauthor=B.+Masjostauthor=A.+Rufauthor=V.+Gramlichauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+inhibitors+for+the+enzyme+catechol-O-methyltransferase+%28COMT%29%3A+Influence+of+inhibitor+preorganisation+and+linker+length+between+two+substrate+moieties+on+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520inhibitors%2520for%2520the%2520enzyme%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Influence%2520of%2520inhibitor%2520preorganisation%2520and%2520linker%2520length%2520between%2520two%2520substrate%2520moieties%2520on%2520binding%2520affinity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D42%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors of the enzyme catechol-O-methyltransferase (COMT): Efficient inhibition despite the lack of a nitro group</span> <span class="citation_source-journal">Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1270-1274&author=R.+Pauliniauthor=C.+Lernerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+inhibitors+of+the+enzyme+catechol-O-methyltransferase+%28COMT%29%3A+Efficient+inhibition+despite+the+lack+of+a+nitro+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520inhibitors%2520of%2520the%2520enzyme%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Efficient%2520inhibition%2520despite%2520the%2520lack%2520of%2520a%2520nitro%2520group%26jtitle%3DChem.%2520Biochem.%26date%3D2004%26volume%3D5%26spage%3D1270%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Diedrich, F.; Jakob-Roetne, R.; Lerner, C.; Paulini, R.</span><span> </span><span class="NLM_article-title">COMT inhibitors</span>. International Patent WO2005058228,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Diedrich&author=R.+Jakob-Roetne&author=C.+Lerner&author=R.+Paulini&title=COMT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiedrich%26aufirst%3DF.%26atitle%3DCOMT%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allemann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase in complex with substituted 3′-deoxyribose bisubstrate inhibitors</span> <span class="citation_source-journal">Acta Crystallogr. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1107%2FS0907444912001138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=22349227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=253-260&author=M.+Ellermannauthor=C.+Lernerauthor=G.+Burgyauthor=A.+Ehlerauthor=C.+Bissantzauthor=R.+Jakob-Roetneauthor=R.+Pauliniauthor=O.+Allemannauthor=H.+Tissotauthor=D.+Grunsteinauthor=M.+Stihleauthor=F.+Diederichauthor=M.+G.+Rudolph&title=Catechol-O-methyltransferase+in+complex+with+substituted+3%E2%80%B2-deoxyribose+bisubstrate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Lerner, Christian; Burgy, Guillaume; Ehler, Andreas; Bissantz, Caterina; Jakob-Roetne, Roland; Paulini, Ralph; Allemann, Oliver; Tissot, Heloise; Gruenstein, Dan; Stihle, Martine; Diederich, Francois; Rudolph, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">High-resoln. structures of catechol-O-methyltransferase with ribose-modified inhibitors and Mg2+ identify the side chain of Glu90 as crucial for hydrogen bonding to the ribose hydroxyl groups.  Glu90 subtly aligns with the 2'-hydroxyl, but not the 3'-hydroxyl, group to increase binding affinity, explaining the obsd. activities of bisubstrate inhibitors with a 3'-desoxyribose moiety.  The biol. activity of catechol neurotransmitters such as dopamine in the synapse is modulated by transporters and enzymes.  Catechol-O-methyltransferase (COMT; EC 2.1.1.6) inactivates neurotransmitters by catalyzing the transfer of a Me group from S-adenosylmethionine to catechols in the presence of Mg2+.  This pathway also inactivates L-DOPA, the std. therapeutic for Parkinson's disease.  Depletion of catechol neurotransmitters in the prefrontal cortex has been linked to schizophrenia.  The inhibition of COMT therefore promises improvements in the treatment of these diseases.  The concept of bisubstrate inhibitors for COMT has been described previously.  Here, ribose-modified bisubstrate inhibitors were studied.  Three high-resoln. crystal structures of COMT in complex with novel ribose-modified bisubstrate inhibitors confirmed the predicted binding mode but displayed subtle alterations at the ribose-binding site.  The high affinity of the inhibitors can be convincingly rationalized from the structures, which document the possibility of removing and/or replacing the ribose 3'-hydroxyl group and provide a framework for further inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocHxOEL-zuzLVg90H21EOLACvtfcHk0lhuUDKVlxTyJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D&md5=2b1b40fde37e8eae240dd4a1c2c58c4f</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001138%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DAllemann%26aufirst%3DO.%26aulast%3DTissot%26aufirst%3DH.%26aulast%3DGrunstein%26aufirst%3DD.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26atitle%3DCatechol-O-methyltransferase%2520in%2520complex%2520with%2520substituted%25203%25E2%2580%25B2-deoxyribose%2520bisubstrate%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D253%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Molecular recognition at the active site of catechol-O-methyltransferase (COMT): Adenine replacements in bisubstrate inhibitors</span> <span class="citation_source-journal">Chemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2Fchem.201003648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21538606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6369-6381&author=M.+Ellermannauthor=R.+Pauliniauthor=R.+Jakob-Roetneauthor=C.+Lernerauthor=E.+Borroniauthor=D.+Rothauthor=A.+Ehlerauthor=W.+B.+Schweizerauthor=D.+Schlatterauthor=M.+G.+Rudolphauthor=F.+Diederich&title=Molecular+recognition+at+the+active+site+of+catechol-O-methyltransferase+%28COMT%29%3A+Adenine+replacements+in+bisubstrate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Paulini, Ralph; Jakob-Roetne, Roland; Lerner, Christian; Borroni, Edilio; Roth, Doris; Ehler, Andreas; Schweizer, W. Bernd; Schlatter, Daniel; Rudolph, Markus G.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6369-6381, S6369/1-S6369/95</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">L-Dopa, the std. therapeutic for Parkinson's disease, is inactivated by the enzyme catechol-O-methyltransferase (COMT).  COMT catalyzes the transfer of an activated Me group from S-adenosylmethionine (SAM) to its catechol substrates, such as L-dopa, in the presence of magnesium ions.  The mol. recognition properties of the SAM-binding site of COMT have been investigated only sparsely.  Here, we explore this site by structural alterations of the adenine moiety of bisubstrate inhibitors.  The mol. recognition of adenine is of special interest due to the great abundance and importance of this nucleobase in biol. systems.  Novel bisubstrate inhibitors with adenine replacements were developed by structure-based design and synthesized using a nucleosidation protocol introduced by Vorbrueggen and co-workers.  Key interactions of the adenine moiety with COMT were measured with a radiochem. assay.  Several bisubstrate inhibitors, most notably the adenine replacements thiopyridine, purine, N-methyladenine, and 6-methylpurine, displayed nanomolar IC50 values (median inhibitory concn.) for COMT down to 6 nM.  A series of six cocrystal structures of the bisubstrate inhibitors in ternary complexes with COMT and Mg2+ confirm our predicted binding mode of the adenine replacements.  The cocrystal structure of an inhibitor bearing no nucleobase can be regarded as an intermediate along the reaction coordinate of bisubstrate inhibitor binding to COMT.  Our studies show that solvation varies with the type of adenine replacement, whereas among the adenine derivs., the nitrogen atom at position 1 is essential for high affinity, while the exocyclic amino group is most efficiently substituted by a Me group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo1pH4WO4rXLVg90H21EOLACvtfcHk0lhuUDKVlxTyJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D&md5=2e3849c0801ab409dd4e41b9a5957a8b</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003648%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DMolecular%2520recognition%2520at%2520the%2520active%2520site%2520of%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Adenine%2520replacements%2520in%2520bisubstrate%2520inhibitors%26jtitle%3DChemistry%26date%3D2011%26volume%3D17%26spage%3D6369%26epage%3D6381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Lanier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosbeary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikatendu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hixon, M. S.</span><span> </span><span class="NLM_article-title">A fragment-based approach to identifying S-adenosyl-L-methionine -competitive inhibitors of catechol-<i>O</i>-methyl transferase (COMT)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500475k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5459-5463&author=M.+Lanierauthor=G.+Ambrusauthor=D.+C.+Coleauthor=R.+Davenportauthor=J.+Elleryauthor=R.+Fosbearyauthor=A.+J.+Jenningsauthor=A.+Kadotaniauthor=Y.+Kamadaauthor=R.+Kamranauthor=S.-I.+Matsumotoauthor=A.+Mizukamiauthor=S.+Okuboauthor=K.+Okadaauthor=K.+Saikatenduauthor=L.+Walshauthor=H.+Wuauthor=M.+S.+Hixon&title=A+fragment-based+approach+to+identifying+S-adenosyl-L-methionine+-competitive+inhibitors+of+catechol-O-methyl+transferase+%28COMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm500475k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500475k%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DAmbrus%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DEllery%26aufirst%3DJ.%26aulast%3DFosbeary%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.-I.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DSaikatendu%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DA%2520fragment-based%2520approach%2520to%2520identifying%2520S-adenosyl-L-methionine%2520-competitive%2520inhibitors%2520of%2520catechol-O-methyl%2520transferase%2520%2528COMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5459%26epage%3D5463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vepsäläinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis of a water-soluble prodrug of entacapone</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0960-894X%2800%2900384-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10987428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1967-1969&author=J.+Lepp%C3%A4nenauthor=J.+Huuskonenauthor=J.+Savolainenauthor=T.+Nevalainenauthor=H.+Taipaleauthor=J.+Veps%C3%A4l%C3%A4inenauthor=J.+Gyntherauthor=T.+J%C3%A4rvinen&title=Synthesis+of+a+water-soluble+prodrug+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a water-soluble prodrug of entacapone</span></div><div class="casAuthors">Leppanen, Jukka; Huuskonen, Juhani; Savolainen, Jouko; Nevalainen, Tapio; Taipale, Hannu; Vepsalainen, Jouko; Gynther, Jukka; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1967-1969</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Entacapone reacted with phosphorous oxychloride in dry pyridine yielding a phosphate ester.  The phosphate promoiety increased aq. soly. of the parent drug by more than 1700- and 20-fold at pH 1.2 and 7.4, resp.  The phosphate ester provides adequate stability (t1/2=2227 h; pH 7.4) towards chem. hydrolysis, and allowed for release of the parent drug via enzymic hydrolysis in liver homogenate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeadkHp-iAr7Vg90H21EOLACvtfcHk0lgH0kPfwyx-Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsro%253D&md5=69c20cc5a6d807b2574becee373af46b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900384-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900384-X%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DVeps%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520a%2520water-soluble%2520prodrug%2520of%2520entacapone%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1967%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1489</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1211%2F0022357011778025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11732751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Sgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=1489-1498&author=J.+Lepp%C3%A4nenauthor=J.+Savolainenauthor=T.+Nevalainenauthor=M.+Forsbergauthor=J.+Huuskonenauthor=H.+Taipaleauthor=J.+Gyntherauthor=P.+T.+Mannist%C3%B6author=T.+J%C3%A4rvinen&title=Synthesis+and+in-vitro%2Fin-vivo+evaluation+of+orally+administered+entacapone+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs</span></div><div class="casAuthors">Leppanen, Jukka; Savolainen, Jouko; Nevalainen, Tapio; Forsberg, Markus; Huuskonen, Juhani; Taipale, Hannu; Gynther, Jukka; Mannisto, Pekka T.; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1489-1498</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Entacapone is a new inhibitor of catechol-O-methyltransferase (COMT) that is used as an adjunct to L-dopa therapy in the treatment of Parkinson's disease.  The bioavailability of orally administered entacapone is, however, relatively low (29-46%).  In this study we have prepd. more lipophilic acyl and acyloxyacyl esters, an acyloxy alkyl ether and an alkyloxycarbonyl ester of entacapone, and we have evaluated them as potential prodrugs to enhance the oral bioavailability of entacapone.  All the derivs. fulfilled prodrug criteria and released entacapone in human serum in-vitro.  The oral bioavailability of monopivaloyl (I) and dipivaloyl (II) esters of entacapone were investigated further in rats.  The lipophilicity of II was high (log Papp 4.0 at pH 7.4) but its oral bioavailability was low (F = 0.6%), most probably due to its low aq. soly.  The monopivaloyl ester I had a higher lipophilicity (log Papp 0.80) than entacapone (log Papp 0.18) at pH 7.4 while maintaining an aq. soly. equal to entacapone.  However, oral bioavailability was not increased when compared with the parent drug entacapone (F = 7.0% and 10.4%, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9kFE8zCmxcrVg90H21EOLACvtfcHk0lj2w_6Q4mZQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Sgsr0%253D&md5=896ef764cd519975146b5c57127a510d</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1211%2F0022357011778025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011778025%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in-vitro%252Fin-vivo%2520evaluation%2520of%2520orally%2520administered%2520entacapone%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D1489%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl and N,N-dialkyl-carbamate esters of entacapone</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2000&pages=205-206&author=J.+Savolainenauthor=J.+Lepp%C3%A4nenauthor=M.+Forsbergauthor=H.+Taipaleauthor=T.+Nevalainenauthor=J.+Huuskonenauthor=J.+Gyntherauthor=P.+T.+Mannist%C3%B6author=T.+J%C3%A4rvinen&title=Synthesis+and+in+vitro%2Fin+vivo+evaluation+of+novel+oral+N-alkyl+and+N%2CN-dialkyl-carbamate+esters+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520evaluation%2520of%2520novel%2520oral%2520N-alkyl%2520and%2520N%252CN-dialkyl-carbamate%2520esters%2520of%2520entacapone%26jtitle%3DLife%2520Sci.%26date%3D2000%26volume%3D67%26spage%3D205%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel L-Dopa-entacapone codrug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010980d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1379-1382&author=J.+Lepp%C3%A4nenauthor=J.+Huuskonenauthor=T.+Nevalainenauthor=J.+Gyntherauthor=H.+Taipaleauthor=T.+J%C3%A4rvinen&title=Design+and+synthesis+of+a+novel+L-Dopa-entacapone+codrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm010980d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010980d%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520L-Dopa-entacapone%2520codrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1379%26epage%3D1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarpila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäckström, R.</span><span> </span><span class="NLM_article-title">Inhibition of soluble COMT activity in healty volunteers by OR-462, a potential drug for Parkinson’s disease</span> <span class="citation_source-journal">Neurol. India</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1989&pages=286&issue=suppl&author=A.+Gordinauthor=S.+Tarpilaauthor=S.+Kaakkolaauthor=E.+Nissinenauthor=E.+Schultzauthor=R.+B%C3%A4ckstr%C3%B6m&title=Inhibition+of+soluble+COMT+activity+in+healty+volunteers+by+OR-462%2C+a+potential+drug+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DTarpila%26aufirst%3DS.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520soluble%2520COMT%2520activity%2520in%2520healty%2520volunteers%2520by%2520OR-462%252C%2520a%2520potential%2520drug%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurol.%2520India%26date%3D1989%26volume%3D37%26issue%3Dsuppl%26spage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Borges, N.</span><span> </span><span class="NLM_article-title">Tolcapone in Parkinson’s disease: Liver toxicity and clinical efficacy</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1517%2F14740338.4.1.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=15709899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=69-73&author=N.+Borges&title=Tolcapone+in+Parkinson%E2%80%99s+disease%3A+Liver+toxicity+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Tolcapone in Parkinson's disease: liver toxicity and clinical efficacy</span></div><div class="casAuthors">Borges, Nuno</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-73</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease patients treated with a combination of levodopa and an arom. L-amino acid decarboxylase inhibitor usually develop motor complications after some years.  To minimise this problem, selective catechol-O-methyltransferase (COMT) inhibitors were developed in order to improve the poor pharmacokinetic profile of levodopa.  Tolcapone and entacapone are the two marketed drugs in this class, and both increase the half-life of levodopa and improve clin. parameters, such as the increase in the duration of 'on' and decrease of 'off' time.  Soon after its release, tolcapone was suspended in the EU due to its implication in the deaths of three Parkinsonian patients.  The cause of death in these patients was fulminant hepatitis.  The mechanism by which tolcapone induces liver damage has been studied.  Results show that this drug induces uncoupling of oxidative phosphorylation in mitochondria, thus significantly reducing the cell's capacity to generate ATP.  This toxic effect was demonstrated both in vitro and in vivo in several models but the concns. required to induce it are significantly higher than those needed to inhibit COMT.  Inter-individual differences in the capacity to metabolise tolcapone may yield higher plasma levels and may explain its toxic effects in a small sample of patients.  Recently, the suspension on tolcapone was lifted, based on new clin. data and ongoing monitoring of its use in other countries.  The European Agency for the Evaluation of Medicinal Products concluded that, in some situations, tolcapone has a clin. efficacy that is superior to entacapone and that an adequate level of safety could be achieved with appropriate liver function monitoring and other measures.  It is concluded that tolcapone can be safely used in Parkinsonian patients who do not respond or cannot, for other reasons, be prescribed with other COMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocg8m3WMSA0LVg90H21EOLACvtfcHk0lj2w_6Q4mZQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yrsbY%253D&md5=d3ffbf4427aa75a41fe36370a9a750e2</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1517%2F14740338.4.1.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.4.1.69%26sid%3Dliteratum%253Aachs%26aulast%3DBorges%26aufirst%3DN.%26atitle%3DTolcapone%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520Liver%2520toxicity%2520and%2520clinical%2520efficacy%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2005%26volume%3D4%26spage%3D69%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of BIA3-202, a novel COMT inhibitor, during first administration to humans</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2165%2F00126839-200304040-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12848585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=207-217&author=L.+Almeidaauthor=P.+Soares-da-Silva&title=Pharmacokinetics+and+pharmacodynamics+of+BIA3-202%2C+a+novel+COMT+inhibitor%2C+during+first+administration+to+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of BIA 3-202, a novel COMT inhibitor, during first administration to humans</span></div><div class="casAuthors">Almeida, Luis; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in R&D</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">DRDDFD</span>;
        ISSN:<span class="NLM_cas:issn">1174-5886</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">Objective: To det. the tolerability, pharmacodynamics and pharmacokinetics of single oral doses of BIA 3-202, a novel catechol-O-methyltransferase (COMT) inhibitor, in healthy male volunteers.  Methods: Single increasing oral doses of BIA 3-202 (10, 30, 50, 100, 200, 400 and 800mg) were administered under fasting conditions to seven sequential groups of nine subjects, under a double-blind, randomized, placebo-controlled design.  In an addnl. group of eight subjects (group 8), a single dose of BIA 3-202 400mg was administered on two occasions, once under fasting conditions and once with a high-fat meal, under an open-label, two-way crossover design.  Results: BIA 3-202 was well tolerated at all doses tested.  Most adverse events were mild in severity and their incidence was similar between BIA 3-202 and placebo.  Maximum plasma concns. (Cmax) of BIA 3-202 were attained at 0.5-2.5h (tmax) and thereafter declined with an apparent terminal half-life (t1/2) of 1.5-5h.  Over the, dose range of 10-800mg, there was an approx. dose-proportional increase in the area under the plasma concn.-time curve (AUC) values of BIA 3-202: for a dose level increase in the ratio 3.0:1.7:2.0:2.0:2.0:2.0, AUC increased in the ratio 3.1:1.7:1.9:2.2:2.1:1.7.  Plasma concns. of the O-methylated deriv., BIA 3-270, increased markedly less than predicted from a proportional relationship: for a dose level increase in the ratio 1:80, AUC0-t increased in the ratio 1:5.  In most subjects, the tmax of BIA 3-270 was attained at the last sampling time and, therefore, t1/2 could not be estd.  Urine assays showed that less than 1% of the total dose administered was excreted in urine as BIA 3-202.  Urine concns. of BIA 3-270 were below the limit of quantification.  In group 8, the rate and extent of systemic availability (tmax, AUC and Cmax) of BIA 3-202 and BIA 3-270 after a high-fat meal were similar, to those under fasting conditions.  Inhibition of COMT activity in erythrocytes reached max. levels at 2-2.5h post dose, with sustained inhibition up to approx. 4-6 h, returning to baseline by about 16 h.  Conclusion: BIA 3-202 was well tolerated at single 10-800mg oral doses and presented dose-proportional kinetics.  It effectively inhibited COMT activity and the presence of food did not affect its pharmacokinetics or COMT inhibitory activity.  The results provide a basis for further clin. studies with BIA 3-202.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYK3Wkddgk1rVg90H21EOLACvtfcHk0lhLWYEPaa6HDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFygsLc%253D&md5=fee139ce13401d6e955807a6d92bed4a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2165%2F00126839-200304040-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00126839-200304040-00001%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520BIA3-202%252C%2520a%2520novel%2520COMT%2520inhibitor%252C%2520during%2520first%2520administration%2520to%2520humans%26jtitle%3DDrugs%2520R%2526D%26date%3D2003%26volume%3D4%26spage%3D207%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Silveira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz-Da-Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=603-609&author=P.+Silveiraauthor=M.+Vaz-Da-Silvaauthor=L.+Almeidaauthor=J.+Maiaauthor=A.+Falc%C3%A3oauthor=A.+Loureiroauthor=L.+Torr%C3%A3oauthor=R.+Machadoauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Pharmacokinetic-pharmacodynamic+interaction+between+BIA+3-202%2C+a+novel+COMT+inhibitor%2C+and+levodopa%2Fbenserazide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilveira%26aufirst%3DP.%26aulast%3DVaz-Da-Silva%26aufirst%3DM.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DMaia%26aufirst%3DJ.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DLoureiro%26aufirst%3DA.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DMachado%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetic-pharmacodynamic%2520interaction%2520between%2520BIA%25203-202%252C%2520a%2520novel%2520COMT%2520inhibitor%252C%2520and%2520levodopa%252Fbenserazide%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol%26date%3D2003%26volume%3D59%26spage%3D603%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Opicapone: A short lived and very long acting novel catechol-<i>O</i>-methyltransferase inhibitor following multiple-dose administration in healthy subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fbcp.12081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=23336248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=763-775&author=J.+F.+Rochaauthor=L.+Almeidaauthor=A.+Falcaoauthor=P.+N.+Palmaauthor=A.+I.+Loureiroauthor=R.+Pintoauthor=M.+J.+Bonifacioauthor=L.+C.+Wrightauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=Opicapone%3A+A+short+lived+and+very+long+acting+novel+catechol-O-methyltransferase+inhibitor+following+multiple-dose+administration+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects</span></div><div class="casAuthors">Rocha, Jose Francisco; Almeida, Luis; Falcao, Amilcar; Palma, P. Nuno; Loureiro, Ana I.; Pinto, Roberto; Bonifacio, Maria Joao; Wright, Lyndon C.; Nunes, Teresa; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">763-775</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : The aim of this study was to assess the tolerability, pharmacokinetics and inhibitory effect on erythrocyte sol. catechol-O-methyltransferase (S-COMT) activity following repeated doses of opicapone.  Methods : This randomized, placebo-controlled, double-blind study enrolled healthy male subjects who received either once daily placebo or opicapone 5, 10, 20 or 30 mg for 8 days.  Results : Opicapone was well tolerated.  Its systemic exposure increased in an approx. dose-proportional manner with an apparent terminal half-life of 1.0 to 1.4 h.  Sulphation was the main metabolic pathway.  Opicapone metabolites recovered in urine accounted for less than 3% of the amt. of opicapone administered suggesting that bile is likely the main route of excretion.  Maximum S-COMT inhibition (Emax) ranged from 69.9% to 98.0% following the last dose of opicapone.  The opicapone-induced S-COMT inhibition showed a half-life in excess of 100 h, which was dose-independent and much longer than plasma drug exposure.  Such a half-life translates into a putative underlying rate const. that is comparable with the estd. dissocn. rate const. of the COMT-opicapone complex.  Conclusion : Despite its short elimination half-life, opicapone markedly and sustainably inhibited erythrocyte S-COMT activity making it suitable for a once daily regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLkdVAbBdZHrVg90H21EOLACvtfcHk0lhLWYEPaa6HDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr7F&md5=a65d6b1c3442a858b607b1cfc2d8efb0</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12081%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DFalcao%26aufirst%3DA.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DOpicapone%253A%2520A%2520short%2520lived%2520and%2520very%2520long%2520acting%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520following%2520multiple-dose%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D76%26spage%3D763%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz-da-Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=1059-1071&author=J.+F.+Rochaauthor=A.+Falc%C3%A3oauthor=A.+Santosauthor=R.+Pintoauthor=N.+Lopesauthor=T.+Nunesauthor=L.+C.+Wrightauthor=M.+Vaz-da-Silvaauthor=P.+Soares-da-Silva&title=Effect+of+opicapone+and+entacapone+upon+levodopa+pharmacokinetics+during+three+daily+levodopa+administrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DLopes%26aufirst%3DN.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DVaz-da-Silva%26aufirst%3DM.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DEffect%2520of%2520opicapone%2520and%2520entacapone%2520upon%2520levodopa%2520pharmacokinetics%2520during%2520three%2520daily%2520levodopa%2520administrations%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D70%26spage%3D1059%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The design of a double-blind, placebo-controlled, multi-national phase-III trial in patients with Parkinson’s disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=S127&author=A.+Leesauthor=R.+Costaauthor=C.+Oliveiraauthor=N.+Lopesauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=The+design+of+a+double-blind%2C+placebo-controlled%2C+multi-national+phase-III+trial+in+patients+with+Parkinson%E2%80%99s+disease+and+end-of-dose+motor+fluctuations%3A+Opicapone+superiority+vs.+placebo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%26aulast%3DCosta%26aufirst%3DR.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DLopes%26aufirst%3DN.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520design%2520of%2520a%2520double-blind%252C%2520placebo-controlled%252C%2520multi-national%2520phase-III%2520trial%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520end-of-dose%2520motor%2520fluctuations%253A%2520Opicapone%2520superiority%2520vs.%2520placebo%26jtitle%3DMov.%2520Disord.%26date%3D2012%26volume%3D27%26spage%3DS127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Ferreira, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The design of a double-blind, placebo- and active-controlled, multi-national phase-III trial in patients with Parkinson’s disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo and non-inferiority vs. entacapone</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=S118&author=J.+J.+Ferreiraauthor=J.+F.+Rochaauthor=A.+Santosauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=The+design+of+a+double-blind%2C+placebo-+and+active-controlled%2C+multi-national+phase-III+trial+in+patients+with+Parkinson%E2%80%99s+disease+and+end-of-dose+motor+fluctuations%3A+Opicapone+superiority+vs.+placebo+and+non-inferiority+vs.+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%2BJ.%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520design%2520of%2520a%2520double-blind%252C%2520placebo-%2520and%2520active-controlled%252C%2520multi-national%2520phase-III%2520trial%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520end-of-dose%2520motor%2520fluctuations%253A%2520Opicapone%2520superiority%2520vs.%2520placebo%2520and%2520non-inferiority%2520vs.%2520entacapone%26jtitle%3DMov.%2520Disord.%26date%3D2012%26volume%3D27%26spage%3DS118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 57 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xi Chen, <span class="NLM_string-name hlFld-ContribAuthor">Steven D. Schwartz</span>. </span><span class="cited-content_cbyCitation_article-title">Examining the Origin of Catalytic Power of Catechol O-Methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (11)
                                     , 9870-9879. <a href="https://doi.org/10.1021/acscatal.9b02657" title="DOI URL">https://doi.org/10.1021/acscatal.9b02657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b02657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b02657%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DExamining%252Bthe%252BOrigin%252Bof%252BCatalytic%252BPower%252Bof%252BCatechol%252BO-Methyltransferase%26aulast%3DChen%26aufirst%3DXi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24062019%26date%3D10092019%26date%3D03102019%26date%3D17092019%26volume%3D9%26issue%3D11%26spage%3D9870%26epage%3D9879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sylwia Czarnota, Linus O. Johannissen, Nicola J. Baxter, Felix Rummel, Alex L. Wilson, Matthew J. Cliff, Colin W. Levy, Nigel S. Scrutton, Jonathan P. Waltho, <span class="NLM_string-name hlFld-ContribAuthor">Sam Hay</span>. </span><span class="cited-content_cbyCitation_article-title">Equatorial Active Site Compaction and Electrostatic Reorganization in Catechol-O-methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (5)
                                     , 4394-4401. <a href="https://doi.org/10.1021/acscatal.9b00174" title="DOI URL">https://doi.org/10.1021/acscatal.9b00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b00174%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DEquatorial%252BActive%252BSite%252BCompaction%252Band%252BElectrostatic%252BReorganization%252Bin%252BCatechol-O-methyltransferase%26aulast%3DCzarnota%26aufirst%3DSylwia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14012019%26date%3D26032019%26date%3D17042019%26date%3D09042019%26volume%3D9%26issue%3D5%26spage%3D4394%26epage%3D4401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Allie
Y. Chen, Rebecca N. Adamek, Benjamin L. Dick, Cy V. Credille, Christine N. Morrison, <span class="NLM_string-name hlFld-ContribAuthor">Seth M. Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metalloenzymes for Therapeutic Intervention. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1323-1455. <a href="https://doi.org/10.1021/acs.chemrev.8b00201" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00201%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTargeting%252BMetalloenzymes%252Bfor%252BTherapeutic%252BIntervention%26aulast%3DChen%26aufirst%3DAllie%2BY.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D29032018%26date%3D07092018%26volume%3D119%26issue%3D2%26spage%3D1323%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David
Adrian Saez, Kirill Zinovjev, Iñaki Tuñón, <span class="NLM_string-name hlFld-ContribAuthor">Esteban Vöhringer-Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Reaction Mechanism in Native and Mutant Catechol-O-methyltransferase from the Adaptive String Method and Mean Reaction Force Analysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2018,</strong> <em>122 </em>
                                    (38)
                                     , 8861-8871. <a href="https://doi.org/10.1021/acs.jpcb.8b07339" title="DOI URL">https://doi.org/10.1021/acs.jpcb.8b07339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.8b07339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.8b07339%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DCatalytic%252BReaction%252BMechanism%252Bin%252BNative%252Band%252BMutant%252BCatechol-O-methyltransferase%252Bfrom%252Bthe%252BAdaptive%252BString%252BMethod%252Band%252BMean%252BReaction%252BForce%252BAnalysis%26aulast%3DSaez%26aufirst%3DDavid%2BAdrian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30072018%26date%3D28082018%26date%3D12092018%26date%3D30082018%26volume%3D122%26issue%3D38%26spage%3D8861%26epage%3D8871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew
C. Flick, Hong X. Ding, Carolyn A. Leverett, Sarah J. Fink, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to New Drugs Approved During 2016. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (16)
                                     , 7004-7031. <a href="https://doi.org/10.1021/acs.jmedchem.8b00260" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00260%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252BNew%252BDrugs%252BApproved%252BDuring%252B2016%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15022018%26date%3D19042018%26date%3D05042018%26volume%3D61%26issue%3D16%26spage%3D7004%26epage%3D7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Billy J.  Williams-Noonan</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Yuriev</span>, and <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>  . </span><span class="cited-content_cbyCitation_article-title">Free Energy Methods in Drug Design: Prospects of “Alchemical Perturbation” in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 638-649. <a href="https://doi.org/10.1021/acs.jmedchem.7b00681" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00681%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFree%252BEnergy%252BMethods%252Bin%252BDrug%252BDesign%25253A%252BProspects%252Bof%252B%2525E2%252580%25259CAlchemical%252BPerturbation%2525E2%252580%25259D%252Bin%252BMedicinal%252BChemistry%26aulast%3DWilliams-Noonan%26aufirst%3DBilly%2BJ.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D07052017%26date%3D04082017%26date%3D08022018%26date%3D26072017%26volume%3D61%26issue%3D3%26spage%3D638%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Lerner</span>, <span class="hlFld-ContribAuthor ">Roland  Jakob-Roetne</span>, <span class="hlFld-ContribAuthor ">Bernd  Buettelmann</span>, <span class="hlFld-ContribAuthor ">Andreas  Ehler</span>, <span class="hlFld-ContribAuthor ">Markus  Rudolph</span>, and <span class="hlFld-ContribAuthor ">Rosa María  Rodríguez Sarmiento</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10163-10175. <a href="https://doi.org/10.1021/acs.jmedchem.6b00927" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00927%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BPotent%252Band%252BDruglike%252BNonphenolic%252BInhibitors%252Bfor%252BCatechol%252BO-Methyltransferase%252BDerived%252Bfrom%252Ba%252BFragment%252BScreening%252BApproach%252BTargeting%252Bthe%252BS-Adenosyl-l-methionine%252BPocket%26aulast%3DLerner%26aufirst%3DChristian%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21062016%26date%3D14102016%26date%3D23112016%26date%3D29092016%26volume%3D59%26issue%3D22%26spage%3D10163%26epage%3D10175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Pretze</span>, <span class="hlFld-ContribAuthor ">Prama  Pallavi</span>, <span class="hlFld-ContribAuthor ">Mareike  Roscher</span>, <span class="hlFld-ContribAuthor ">Sarah  Klotz</span>, <span class="hlFld-ContribAuthor ">Julio  Caballero</span>, <span class="hlFld-ContribAuthor ">Uta  Binzen</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Greffrath</span>, <span class="hlFld-ContribAuthor ">Rolf-Detlef  Treede</span>, <span class="hlFld-ContribAuthor ">Martin C.  Harmsen</span>, <span class="hlFld-ContribAuthor ">Mathias  Hafner</span>, <span class="hlFld-ContribAuthor ">Benito  Yard</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>, and <span class="hlFld-ContribAuthor ">Björn  Wängler</span>  . </span><span class="cited-content_cbyCitation_article-title">Radiofluorinated N-Octanoyl Dopamine ([18F]F-NOD) as a Tool To Study Tissue Distribution and Elimination of NOD in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9855-9865. <a href="https://doi.org/10.1021/acs.jmedchem.6b01191" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01191%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRadiofluorinated%252BN-Octanoyl%252BDopamine%252B%252528%25255B18F%25255DF-NOD%252529%252Bas%252Ba%252BTool%252BTo%252BStudy%252BTissue%252BDistribution%252Band%252BElimination%252Bof%252BNOD%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DPretze%26aufirst%3DMarc%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D24102016%26date%3D10112016%26date%3D12102016%26volume%3D59%26issue%3D21%26spage%3D9855%26epage%3D9865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiago  Silva</span>, <span class="hlFld-ContribAuthor ">Tarek  Mohamed</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>, <span class="hlFld-ContribAuthor ">Praveen P. N.  Rao</span>, <span class="hlFld-ContribAuthor ">Loreto  Martínez-González</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Pérez</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Maria João  Valente</span>, <span class="hlFld-ContribAuthor ">Jorge  Garrido</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Paula  Serrão</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>, <span class="hlFld-ContribAuthor ">Fernando  Remião</span>, and <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Blood–Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7584-7597. <a href="https://doi.org/10.1021/acs.jmedchem.6b00666" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPermeable%252BNitrocatechol-Based%252BCatechol%252BO-Methyltransferase%252BInhibitors%252Bwith%252BReduced%252BPotential%252Bfor%252BHepatotoxicity%26aulast%3DSilva%26aufirst%3DTiago%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29042016%26date%3D05082016%26date%3D25082016%26date%3D27072016%26volume%3D59%26issue%3D16%26spage%3D7584%26epage%3D7597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  von Kleist</span>, <span class="hlFld-ContribAuthor ">Simon  Michaelis</span>, <span class="hlFld-ContribAuthor ">Kathrin  Bartho</span>, <span class="hlFld-ContribAuthor ">Olivia  Graebner</span>, <span class="hlFld-ContribAuthor ">Marén  Schlief</span>, <span class="hlFld-ContribAuthor ">Mathias  Dreger</span>, <span class="hlFld-ContribAuthor ">Anna K.  Schrey</span>, <span class="hlFld-ContribAuthor ">Michael  Sefkow</span>, <span class="hlFld-ContribAuthor ">Friedrich  Kroll</span>, <span class="hlFld-ContribAuthor ">Hubert  Koester</span>, and <span class="hlFld-ContribAuthor ">Yan  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Potential Off-target Toxicity Liabilities of Catechol-O-methyltransferase Inhibitors by Differential Competition Capture Compound Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4664-4675. <a href="https://doi.org/10.1021/acs.jmedchem.5b01970" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01970%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPotential%252BOff-target%252BToxicity%252BLiabilities%252Bof%252BCatechol-O-methyltransferase%252BInhibitors%252Bby%252BDifferential%252BCompetition%252BCapture%252BCompound%252BMass%252BSpectrometry%26aulast%3Dvon%2BKleist%26aufirst%3DLisa%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04012016%26date%3D25042016%26date%3D26052016%26date%3D13042016%26volume%3D59%26issue%3D10%26spage%3D4664%26epage%3D4675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott T.  Harrison</span>, <span class="hlFld-ContribAuthor ">Michael S.  Poslusney</span>, <span class="hlFld-ContribAuthor ">James J.  Mulhearn</span>, <span class="hlFld-ContribAuthor ">Zhijian  Zhao</span>, <span class="hlFld-ContribAuthor ">Nathan R.  Kett</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Schubert</span>, <span class="hlFld-ContribAuthor ">Jeffrey Y.  Melamed</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Allison</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Sujata  Sharma</span>, <span class="hlFld-ContribAuthor ">Robert F.  Smith</span>, <span class="hlFld-ContribAuthor ">Dawn L.  Hall</span>, <span class="hlFld-ContribAuthor ">Ronald G.  Robinson</span>, <span class="hlFld-ContribAuthor ">Nancy A.  Sachs</span>, <span class="hlFld-ContribAuthor ">Pete H.  Hutson</span>, <span class="hlFld-ContribAuthor ">Scott E.  Wolkenberg</span>, and <span class="hlFld-ContribAuthor ">James C.  Barrow</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 318-323. <a href="https://doi.org/10.1021/ml500502d" title="DOI URL">https://doi.org/10.1021/ml500502d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500502d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500502d%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BHeterocyclic%252BCatechol%252BMimics%252Bas%252BInhibitors%252Bof%252BCatechol-O-methyltransferase%252B%252528COMT%252529%26aulast%3DHarrison%26aufirst%3DScott%2BT.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D16012015%26date%3D26012015%26date%3D12032015%26volume%3D6%26issue%3D3%26spage%3D318%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Fang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu-Fan  Fan</span>, <span class="hlFld-ContribAuthor ">Hao-Nan  Yu</span>, <span class="hlFld-ContribAuthor ">Fan-bin  Hou</span>, <span class="hlFld-ContribAuthor ">Yan-Wei  Xiang</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Guang-Bo  Ge</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Jian-Guang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of flavonoids in vine tea as catechol-O-methyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2021,</strong> <em>152 </em>, 104913. <a href="https://doi.org/10.1016/j.fitote.2021.104913" title="DOI URL">https://doi.org/10.1016/j.fitote.2021.104913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2021.104913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2021.104913%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bflavonoids%252Bin%252Bvine%252Btea%252Bas%252Bcatechol-O-methyltransferase%252Binhibitors%26aulast%3DZhao%26aufirst%3DDong-Fang%26date%3D2021%26volume%3D152%26spage%3D104913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Feldman</span>, <span class="hlFld-ContribAuthor ">Jason  Margolesky</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone for the treatment of Parkinson’s disease: a review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuroscience</span><span> <strong>2021,</strong> <em>386 </em>, 1-12. <a href="https://doi.org/10.1080/00207454.2021.1929217" title="DOI URL">https://doi.org/10.1080/00207454.2021.1929217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00207454.2021.1929217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00207454.2021.1929217%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuroscience%26atitle%3DOpicapone%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%25253A%252Ba%252Breview%26aulast%3DFeldman%26aufirst%3DMatthew%26date%3D2021%26date%3D2021%26volume%3D386%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannie  de Beer</span>, <span class="hlFld-ContribAuthor ">Jacobus P.  Petzer</span>, <span class="hlFld-ContribAuthor ">Anna C. U.  Lourens</span>, <span class="hlFld-ContribAuthor ">Anél  Petzer</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (2)
                                     , 753-762. <a href="https://doi.org/10.1007/s11030-020-10053-x" title="DOI URL">https://doi.org/10.1007/s11030-020-10053-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10053-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10053-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B3-hydroxypyridin-4-ones%252Bas%252Binhibitors%252Bof%252Bcatechol-O-methyltransferase%26aulast%3Dde%2BBeer%26aufirst%3DJohannie%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D753%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xue</span>, <span class="hlFld-ContribAuthor ">Yan  Tan</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Changjiang  Xu</span>, <span class="hlFld-ContribAuthor ">Duanduan  Cong</span>, <span class="hlFld-ContribAuthor ">Liping  Zhong</span>, <span class="hlFld-ContribAuthor ">Jie  Song</span>, <span class="hlFld-ContribAuthor ">Aimin  Hui</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qi</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Liu</span>, <span class="hlFld-ContribAuthor ">Kexin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2021,</strong> <em>55 </em><a href="https://doi.org/10.1002/cpdd.922" title="DOI URL">https://doi.org/10.1002/cpdd.922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.922%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DPharmacokinetics%252Bof%252BOpicapone%252Band%252BIts%252BMetabolites%252Bin%252BHealthy%252BWhite%252Band%252BChinese%252BSubjects%26aulast%3DXue%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaro  Jalkanen</span>, <span class="hlFld-ContribAuthor ">Veera  Lassheikki</span>, <span class="hlFld-ContribAuthor ">Tommi  Torsti</span>, <span class="hlFld-ContribAuthor ">Elham  Gharib</span>, <span class="hlFld-ContribAuthor ">Marko  Lehtonen</span>, <span class="hlFld-ContribAuthor ">Risto O.  Juvonen</span>. </span><span class="cited-content_cbyCitation_article-title">Tissue and interspecies comparison of catechol-
              O
              -methyltransferase mediated catalysis of 6-
              O
              -methylation of esculetin to scopoletin and its inhibition by entacapone and tolcapone. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2021,</strong> <em>51 </em>
                                    (3)
                                     , 268-278. <a href="https://doi.org/10.1080/00498254.2020.1853850" title="DOI URL">https://doi.org/10.1080/00498254.2020.1853850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2020.1853850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2020.1853850%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DTissue%252Band%252Binterspecies%252Bcomparison%252Bof%252Bcatechol-%252BO%252B-methyltransferase%252Bmediated%252Bcatalysis%252Bof%252B6-%252BO%252B-methylation%252Bof%252Besculetin%252Bto%252Bscopoletin%252Band%252Bits%252Binhibition%252Bby%252Bentacapone%252Band%252Btolcapone%26aulast%3DJalkanen%26aufirst%3DAaro%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D3%26spage%3D268%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Cruz-Vicente</span>, <span class="hlFld-ContribAuthor ">Luís A.  Passarinha</span>, <span class="hlFld-ContribAuthor ">Samuel  Silvestre</span>, <span class="hlFld-ContribAuthor ">Eugenia  Gallardo</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (8)
                                     , 2193. <a href="https://doi.org/10.3390/molecules26082193" title="DOI URL">https://doi.org/10.3390/molecules26082193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26082193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26082193%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BDevelopments%252Bin%252BNew%252BTherapeutic%252BAgents%252Bagainst%252BAlzheimer%252Band%252BParkinson%252BDiseases%25253A%252BIn-Silico%252BApproaches%26aulast%3DCruz-Vicente%26aufirst%3DPedro%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D8%26spage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Fang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yu-Fan  Fan</span>, <span class="hlFld-ContribAuthor ">Fang-Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Fan-Bin  Hou</span>, <span class="hlFld-ContribAuthor ">Frank J.  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Shi-Yang  Li</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Yang-Liu  Xia</span>, <span class="hlFld-ContribAuthor ">Guang-Bo  Ge</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of naturally occurring potent inhibitors of catechol-
              O
              -methyltransferase from herbal medicines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (17)
                                     , 10385-10392. <a href="https://doi.org/10.1039/D0RA10425F" title="DOI URL">https://doi.org/10.1039/D0RA10425F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA10425F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA10425F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bnaturally%252Boccurring%252Bpotent%252Binhibitors%252Bof%252Bcatechol-%252BO%252B-methyltransferase%252Bfrom%252Bherbal%252Bmedicines%26aulast%3DZhao%26aufirst%3DDong-Fang%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D17%26spage%3D10385%26epage%3D10392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saman  Saedi</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Jafarzadeh Shirazi</span>, <span class="hlFld-ContribAuthor ">Ali  Niazi</span>, <span class="hlFld-ContribAuthor ">Ahmad  Tahmasebi</span>, <span class="hlFld-ContribAuthor ">Esmaeil  Ebrahimie</span>. </span><span class="cited-content_cbyCitation_article-title">Prepubertal exposure to high dose of cadmium induces hypothalamic injury through transcriptome profiling alteration and neuronal degeneration in female rats. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2021,</strong> <em>337 </em>, 109379. <a href="https://doi.org/10.1016/j.cbi.2021.109379" title="DOI URL">https://doi.org/10.1016/j.cbi.2021.109379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2021.109379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2021.109379%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DPrepubertal%252Bexposure%252Bto%252Bhigh%252Bdose%252Bof%252Bcadmium%252Binduces%252Bhypothalamic%252Binjury%252Bthrough%252Btranscriptome%252Bprofiling%252Balteration%252Band%252Bneuronal%252Bdegeneration%252Bin%252Bfemale%252Brats%26aulast%3DSaedi%26aufirst%3DSaman%26date%3D2021%26volume%3D337%26spage%3D109379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Gomes</span>, <span class="hlFld-ContribAuthor ">C.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">A.M.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">J.A.  Queiroz</span>, <span class="hlFld-ContribAuthor ">A.  Sousa</span>, <span class="hlFld-ContribAuthor ">L.A.  Passarinha</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of gellan natural polymer microspheres in recombinant catechol-O-methyltransferase direct capture from a Komagataella pastoris lysate. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>172 </em>, 186-196. <a href="https://doi.org/10.1016/j.ijbiomac.2020.12.225" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.12.225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.12.225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.12.225%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DApplications%252Bof%252Bgellan%252Bnatural%252Bpolymer%252Bmicrospheres%252Bin%252Brecombinant%252Bcatechol-O-methyltransferase%252Bdirect%252Bcapture%252Bfrom%252Ba%252BKomagataella%252Bpastoris%252Blysate%26aulast%3DGomes%26aufirst%3DD.%26date%3D2021%26volume%3D172%26spage%3D186%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheyi  Liu</span>, <span class="hlFld-ContribAuthor ">Wenxiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Binwen  Sun</span>, <span class="hlFld-ContribAuthor ">Yaolu  Ma</span>, <span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Yuanjiang  Pan</span>, <span class="hlFld-ContribAuthor ">Fangjun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Probing conformational hotspots for the recognition and intervention of protein complexes by lysine reactivity profiling. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 1451-1457. <a href="https://doi.org/10.1039/D0SC05330A" title="DOI URL">https://doi.org/10.1039/D0SC05330A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC05330A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC05330A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DProbing%252Bconformational%252Bhotspots%252Bfor%252Bthe%252Brecognition%252Band%252Bintervention%252Bof%252Bprotein%252Bcomplexes%252Bby%252Blysine%252Breactivity%252Bprofiling%26aulast%3DLiu%26aufirst%3DZheyi%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D1451%26epage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Heinz  Reichmann</span>, <span class="hlFld-ContribAuthor ">Andrew  Lees</span>, <span class="hlFld-ContribAuthor ">José-Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Diogo  Magalhães</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study. </span><span class="cited-content_cbyCitation_journal-name">Translational Neurodegeneration</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40035-020-00187-1" title="DOI URL">https://doi.org/10.1186/s40035-020-00187-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40035-020-00187-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40035-020-00187-1%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Neurodegeneration%26atitle%3DEffectiveness%252Band%252Bsafety%252Bof%252Bopicapone%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bpatients%252Bwith%252Bmotor%252Bfluctuations%25253A%252Bthe%252BOPTIPARK%252Bopen-label%252Bstudy%26aulast%3DReichmann%26aufirst%3DHeinz%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  López-Ríos</span>, <span class="hlFld-ContribAuthor ">Julia C  Wiebe</span>, <span class="hlFld-ContribAuthor ">Tanausú  Vega-Morales</span>, <span class="hlFld-ContribAuthor ">Nigel  Gericke</span>. </span><span class="cited-content_cbyCitation_article-title">Central nervous system activities of extract Mangifera indica L.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2020,</strong> <em>260 </em>, 112996. <a href="https://doi.org/10.1016/j.jep.2020.112996" title="DOI URL">https://doi.org/10.1016/j.jep.2020.112996</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2020.112996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2020.112996%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DCentral%252Bnervous%252Bsystem%252Bactivities%252Bof%252Bextract%252BMangifera%252Bindica%252BL.%26aulast%3DL%25C3%25B3pez-R%25C3%25ADos%26aufirst%3DLaura%26date%3D2020%26volume%3D260%26spage%3D112996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miren  Ettcheto</span>, <span class="hlFld-ContribAuthor ">Oriol  Busquets</span>, <span class="hlFld-ContribAuthor ">Elena  Sánchez-Lopez</span>, <span class="hlFld-ContribAuthor ">Amanda  Cano</span>, <span class="hlFld-ContribAuthor ">Patricia R.  Manzine</span>, <span class="hlFld-ContribAuthor ">Ester  Verdaguer</span>, <span class="hlFld-ContribAuthor ">Jordi  Olloquequi</span>, <span class="hlFld-ContribAuthor ">Carme  Auladell</span>, <span class="hlFld-ContribAuthor ">Jaume  Folch</span>, <span class="hlFld-ContribAuthor ">Antoni  Camins</span>. </span><span class="cited-content_cbyCitation_article-title">The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (9)
                                     , 993-1003. <a href="https://doi.org/10.1080/17460441.2020.1767580" title="DOI URL">https://doi.org/10.1080/17460441.2020.1767580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1767580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1767580%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bpreclinical%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bopicapone%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DEttcheto%26aufirst%3DMiren%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D9%26spage%3D993%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. A.  Zherebtsov</span>, <span class="hlFld-ContribAuthor ">M. V.  Arsenyev</span>, <span class="hlFld-ContribAuthor ">S. A.  Chesnokov</span>, <span class="hlFld-ContribAuthor ">V. K.  Cherkasov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1-Substituted
5,5,8,8-Tetramethyl5,6,7,8-tetrahydronaphthalene-2,3-diols and
5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2,3-dione. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (3)
                                     , 534-537. <a href="https://doi.org/10.1134/S1070428020030264" title="DOI URL">https://doi.org/10.1134/S1070428020030264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020030264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020030264%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1-Substituted%252B5%25252C5%25252C8%25252C8-Tetramethyl5%25252C6%25252C7%25252C8-tetrahydronaphthalene-2%25252C3-diols%252Band%252B5%25252C5%25252C8%25252C8-Tetramethyl-5%25252C6%25252C7%25252C8-tetrahydronaphthalene-2%25252C3-dione%26aulast%3DZherebtsov%26aufirst%3DM.%2BA.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D3%26spage%3D534%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Entacapone/Tolcapone/Opicapone for Treating Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-18. <a href="https://doi.org/10.1007/978-3-319-56015-1_230-1" title="DOI URL">https://doi.org/10.1007/978-3-319-56015-1_230-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-56015-1_230-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-56015-1_230-1%26sid%3Dliteratum%253Aachs%26atitle%3DEntacapone%25252FTolcapone%25252FOpicapone%252Bfor%252BTreating%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DM%25C3%25BCller%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D18%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNeuroPsychopharmacotherapy%26aulast%3DRiederer%26aufirst%3DPeter%26date%3D2020%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">M. Shahar  Yar</span>, <span class="hlFld-ContribAuthor ">Gourav  Grover</span>, <span class="hlFld-ContribAuthor ">Rajarshi  Nath</span>. </span><span class="cited-content_cbyCitation_article-title">Neurological and psychiatric management using COMT inhibitors: A review. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103418. <a href="https://doi.org/10.1016/j.bioorg.2019.103418" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103418%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNeurological%252Band%252Bpsychiatric%252Bmanagement%252Busing%252BCOMT%252Binhibitors%25253A%252BA%252Breview%26aulast%3DAkhtar%26aufirst%3DMd%2BJawaid%26date%3D2020%26volume%3D94%26spage%3D103418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Faktor</span>, <span class="hlFld-ContribAuthor ">Lucia  Knopfova</span>, <span class="hlFld-ContribAuthor ">Petr  Lapcik</span>, <span class="hlFld-ContribAuthor ">Lucia  Janacova</span>, <span class="hlFld-ContribAuthor ">Vendula  Paralova</span>, <span class="hlFld-ContribAuthor ">Pavla  Bouchalova</span>, <span class="hlFld-ContribAuthor ">Petr  Muller</span>, <span class="hlFld-ContribAuthor ">Petr  Benes</span>, <span class="hlFld-ContribAuthor ">Pavel  Bouchal</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomics Identification and Validation of Desmocollin‐1 and Catechol‐O‐Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis. </span><span class="cited-content_cbyCitation_journal-name">PROTEOMICS</span><span> <strong>2019,</strong> <em>19 </em>
                                    (21-22)
                                     , 1900073. <a href="https://doi.org/10.1002/pmic.201900073" title="DOI URL">https://doi.org/10.1002/pmic.201900073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pmic.201900073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpmic.201900073%26sid%3Dliteratum%253Aachs%26jtitle%3DPROTEOMICS%26atitle%3DProteomics%252BIdentification%252Band%252BValidation%252Bof%252BDesmocollin%2525E2%252580%2525901%252Band%252BCatechol%2525E2%252580%252590O%2525E2%252580%252590Methyltransferase%252Bas%252BProteins%252BAssociated%252Bwith%252BBreast%252BCancer%252BCell%252BMigration%252Band%252BMetastasis%26aulast%3DFaktor%26aufirst%3DJakub%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D21-22%26spage%3D1900073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Lees</span>, <span class="hlFld-ContribAuthor ">Joaquim J.  Ferreira</span>, <span class="hlFld-ContribAuthor ">José-Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Olivier  Rascol</span>, <span class="hlFld-ContribAuthor ">Werner  Poewe</span>, <span class="hlFld-ContribAuthor ">Helena  Gama</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Safety Profile of Opicapone in the Management of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Parkinson's Disease</span><span> <strong>2019,</strong> <em>9 </em>
                                    (4)
                                     , 733-740. <a href="https://doi.org/10.3233/JPD-191593" title="DOI URL">https://doi.org/10.3233/JPD-191593</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JPD-191593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJPD-191593%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Parkinson%2527s%2520Disease%26atitle%3DSafety%252BProfile%252Bof%252BOpicapone%252Bin%252Bthe%252BManagement%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DLees%26aufirst%3DAndrew%26date%3D2019%26volume%3D9%26issue%3D4%26spage%3D733%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabet  Cuyàs</span>, <span class="hlFld-ContribAuthor ">Sara  Verdura</span>, <span class="hlFld-ContribAuthor ">Jesús  Lozano-Sánchez</span>, <span class="hlFld-ContribAuthor ">Ignacio  Viciano</span>, <span class="hlFld-ContribAuthor ">Laura  Llorach-Parés</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Joaquim  Bosch-Barrera</span>, <span class="hlFld-ContribAuthor ">Joan  Brunet</span>, <span class="hlFld-ContribAuthor ">Antonio  Segura-Carretero</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>, <span class="hlFld-ContribAuthor ">José Antonio  Encinar</span>, <span class="hlFld-ContribAuthor ">Javier A.  Menendez</span>. </span><span class="cited-content_cbyCitation_article-title">The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Food and Chemical Toxicology</span><span> <strong>2019,</strong> <em>128 </em>, 35-45. <a href="https://doi.org/10.1016/j.fct.2019.03.049" title="DOI URL">https://doi.org/10.1016/j.fct.2019.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fct.2019.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fct.2019.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Chemical%2520Toxicology%26atitle%3DThe%252Bextra%252Bvirgin%252Bolive%252Boil%252Bphenolic%252Boleacein%252Bis%252Ba%252Bdual%252Bsubstrate-inhibitor%252Bof%252Bcatechol-O-methyltransferase%26aulast%3DCuy%25C3%25A0s%26aufirst%3DElisabet%26date%3D2019%26volume%3D128%26spage%3D35%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia Dimitri  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria Paula  Serrão</span>, <span class="hlFld-ContribAuthor ">Tiago  Silva</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>847 </em>, 53-60. <a href="https://doi.org/10.1016/j.ejphar.2019.01.027" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.01.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.01.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DPharmacodynamic%252Bevaluation%252Bof%252Bnovel%252BCatechol-O-methyltransferase%252Binhibitors%26aulast%3DPinheiro%26aufirst%3DSofia%2BDimitri%26date%3D2019%26volume%3D847%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuria Elizabeth  Rocha-Guzmán</span>, <span class="hlFld-ContribAuthor ">Rubén Francisco  González-Laredo</span>, <span class="hlFld-ContribAuthor ">Blanca Denis  Vázquez-Cabral</span>, <span class="hlFld-ContribAuthor ">Martha Rocío  Moreno-Jiménez</span>, <span class="hlFld-ContribAuthor ">José Alberto  Gallegos-Infante</span>, <span class="hlFld-ContribAuthor ">Claudia Ivette  Gamboa-Gómez</span>, <span class="hlFld-ContribAuthor ">Ana Gabriela  Flores-Rueda</span>. </span><span class="cited-content_cbyCitation_article-title">Oak Leaves as a New Potential Source for Functional Beverages: Their Antioxidant Capacity and Monomer Flavonoid Composition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 381-411. <a href="https://doi.org/10.1016/B978-0-12-816397-9.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-816397-9.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816397-9.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816397-9.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DOak%252BLeaves%252Bas%252Ba%252BNew%252BPotential%252BSource%252Bfor%252BFunctional%252BBeverages%25253A%252BTheir%252BAntioxidant%252BCapacity%252Band%252BMonomer%252BFlavonoid%252BComposition%26aulast%3DRocha-Guzm%25C3%25A1n%26aufirst%3DNuria%2BElizabeth%26date%3D2019%26spage%3D381%26epage%3D411%26pub%3DElsevier%26atitle%3DFunctional%252Band%252BMedicinal%252BBeverages%26date%3D2019%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jürgen  Krauß</span>, <span class="hlFld-ContribAuthor ">Franz  Bracher</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic Enhancers (Boosters)—Escort for Drugs against Degrading Enzymes and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Scientia Pharmaceutica</span><span> <strong>2018,</strong> <em>86 </em>
                                    (4)
                                     , 43. <a href="https://doi.org/10.3390/scipharm86040043" title="DOI URL">https://doi.org/10.3390/scipharm86040043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/scipharm86040043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fscipharm86040043%26sid%3Dliteratum%253Aachs%26jtitle%3DScientia%2520Pharmaceutica%26atitle%3DPharmacokinetic%252BEnhancers%252B%252528Boosters%252529%2525E2%252580%252594Escort%252Bfor%252BDrugs%252Bagainst%252BDegrading%252BEnzymes%252Band%252BBeyond%26aulast%3DKrau%25C3%259F%26aufirst%3DJ%25C3%25BCrgen%26date%3D2018%26date%3D2018%26volume%3D86%26issue%3D4%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chirag N.  Patel</span>, <span class="hlFld-ContribAuthor ">John J.  Georrge</span>, <span class="hlFld-ContribAuthor ">Krunal M.  Modi</span>, <span class="hlFld-ContribAuthor ">Moksha B.  Narechania</span>, <span class="hlFld-ContribAuthor ">Daxesh P.  Patel</span>, <span class="hlFld-ContribAuthor ">Frank J.  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Himanshu A.  Pandya</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (15)
                                     , 3938-3957. <a href="https://doi.org/10.1080/07391102.2017.1404931" title="DOI URL">https://doi.org/10.1080/07391102.2017.1404931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1404931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1404931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DPharmacophore-based%252Bvirtual%252Bscreening%252Bof%252Bcatechol-o-methyltransferase%252B%252528COMT%252529%252Binhibitors%252Bto%252Bcombat%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DPatel%26aufirst%3DChirag%2BN.%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D15%26spage%3D3938%26epage%3D3957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margherita  Fabbri</span>, <span class="hlFld-ContribAuthor ">Joaquim J.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Andrew  Lees</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Stocchi</span>, <span class="hlFld-ContribAuthor ">Werner  Poewe</span>, <span class="hlFld-ContribAuthor ">Eduardo  Tolosa</span>, <span class="hlFld-ContribAuthor ">Olivier  Rascol</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine. </span><span class="cited-content_cbyCitation_journal-name">Movement Disorders</span><span> <strong>2018,</strong> <em>33 </em>
                                    (10)
                                     , 1528-1539. <a href="https://doi.org/10.1002/mds.27475" title="DOI URL">https://doi.org/10.1002/mds.27475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mds.27475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmds.27475%26sid%3Dliteratum%253Aachs%26jtitle%3DMovement%2520Disorders%26atitle%3DOpicapone%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%25253A%252BA%252Breview%252Bof%252Ba%252Bnew%252Blicensed%252Bmedicine%26aulast%3DFabbri%26aufirst%3DMargherita%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D10%26spage%3D1528%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karnell L.  Grimes</span>, <span class="hlFld-ContribAuthor ">Connor M.  Stuart</span>, <span class="hlFld-ContribAuthor ">Justin J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Baljinder  Kaur</span>, <span class="hlFld-ContribAuthor ">Emilio J.  Cantu</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Forester</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing the Cancer Cell Growth Inhibitory Effects of Table Grape Anthocyanins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Science</span><span> <strong>2018,</strong> <em>83 </em>
                                    (9)
                                     , 2369-2374. <a href="https://doi.org/10.1111/1750-3841.14294" title="DOI URL">https://doi.org/10.1111/1750-3841.14294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1750-3841.14294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1750-3841.14294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Science%26atitle%3DEnhancing%252Bthe%252BCancer%252BCell%252BGrowth%252BInhibitory%252BEffects%252Bof%252BTable%252BGrape%252BAnthocyanins%26aulast%3DGrimes%26aufirst%3DKarnell%2BL.%26date%3D2018%26date%3D2018%26volume%3D83%26issue%3D9%26spage%3D2369%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babiker  El-Haj</span>, <span class="hlFld-ContribAuthor ">Samrein  Ahmed</span>, <span class="hlFld-ContribAuthor ">Mousa  Garawi</span>, <span class="hlFld-ContribAuthor ">Heyam  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 2119. <a href="https://doi.org/10.3390/molecules23092119" title="DOI URL">https://doi.org/10.3390/molecules23092119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23092119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23092119%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DLinking%252BAromatic%252BHydroxy%252BMetabolic%252BFunctionalization%252Bof%252BDrug%252BMolecules%252Bto%252BStructure%252Band%252BPharmacologic%252BActivity%26aulast%3DEl-Haj%26aufirst%3DBabiker%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">László E.  Kiss</span>, <span class="hlFld-ContribAuthor ">Maria João  Bonifácio</span>, <span class="hlFld-ContribAuthor ">José Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Patrício Soares-  da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone, a Novel Catechol-
              O
              -Methyltranferase Inhibitor (COMT) to Manage the Symptoms of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 319-340. <a href="https://doi.org/10.1002/9783527808694.ch11" title="DOI URL">https://doi.org/10.1002/9783527808694.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808694.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808694.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DOpicapone%25252C%252Ba%252BNovel%252BCatechol-%252BO%252B-Methyltranferase%252BInhibitor%252B%252528COMT%252529%252Bto%252BManage%252Bthe%252BSymptoms%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DKiss%26aufirst%3DL%25C3%25A1szl%25C3%25B3%2BE.%26date%3D2018%26date%3D2018%26spage%3D319%26epage%3D340%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2018%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Biaryls. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 83-154. <a href="https://doi.org/10.1002/9781118686263.ch4" title="DOI URL">https://doi.org/10.1002/9781118686263.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DBiaryls%26date%3D2018%26date%3D2018%26spage%3D83%26epage%3D154%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangliu  Xia</span>, <span class="hlFld-ContribAuthor ">Huilin  Pang</span>, <span class="hlFld-ContribAuthor ">Tongyi  Dou</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Guangbo  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">Interspecies comparison in the COMT-mediated methylation of 3-BTD. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (29)
                                     , 16278-16284. <a href="https://doi.org/10.1039/C8RA01938J" title="DOI URL">https://doi.org/10.1039/C8RA01938J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01938J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01938J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInterspecies%252Bcomparison%252Bin%252Bthe%252BCOMT-mediated%252Bmethylation%252Bof%252B3-BTD%26aulast%3DXia%26aufirst%3DYangliu%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D29%26spage%3D16278%26epage%3D16284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana  Bicker</span>, <span class="hlFld-ContribAuthor ">Ana  Fortuna</span>, <span class="hlFld-ContribAuthor ">Gilberto  Alves</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>, <span class="hlFld-ContribAuthor ">Amílcar  Falcão</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-
              O
              -Methyltransferase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2017,</strong> <em>45 </em>
                                    (12)
                                     , 1282-1291. <a href="https://doi.org/10.1124/dmd.117.077883" title="DOI URL">https://doi.org/10.1124/dmd.117.077883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.117.077883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.117.077883%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DElucidation%252Bof%252Bthe%252BImpact%252Bof%252BP-glycoprotein%252Band%252BBreast%252BCancer%252BResistance%252BProtein%252Bon%252Bthe%252BBrain%252BDistribution%252Bof%252BCatechol-%252BO%252B-Methyltransferase%252BInhibitors%26aulast%3DBicker%26aufirst%3DJoana%26date%3D2017%26date%3D2017%26volume%3D45%26issue%3D12%26spage%3D1282%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaibhav A.  Dixit</span>, <span class="hlFld-ContribAuthor ">L. Arun  Lal</span>, <span class="hlFld-ContribAuthor ">Simran R.  Agrawal</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the prediction of non‐
              CYP450
              ‐mediated drug metabolism. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2017,</strong> <em>7 </em>
                                    (6)
                                     <a href="https://doi.org/10.1002/wcms.1323" title="DOI URL">https://doi.org/10.1002/wcms.1323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1323%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bprediction%252Bof%252Bnon%2525E2%252580%252590%252BCYP450%252B%2525E2%252580%252590mediated%252Bdrug%252Bmetabolism%26aulast%3DDixit%26aufirst%3DVaibhav%2BA.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Gilberto  Alves</span>, <span class="hlFld-ContribAuthor ">Ana  Fortuna</span>, <span class="hlFld-ContribAuthor ">Maria João  Bonifácio</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>, <span class="hlFld-ContribAuthor ">Amílcar  Falcão</span>. </span><span class="cited-content_cbyCitation_article-title">A single- and multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of opicapone, a novel COMT inhibitor, in rat. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>125 </em>, 146-155. <a href="https://doi.org/10.1016/j.neuropharm.2017.07.019" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.07.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.07.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DA%252Bsingle-%252Band%252Bmultiple-dose%252Bstudy%252Bto%252Binvestigate%252Bthe%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Bopicapone%25252C%252Ba%252Bnovel%252BCOMT%252Binhibitor%25252C%252Bin%252Brat%26aulast%3DGon%25C3%25A7alves%26aufirst%3DDaniela%26date%3D2017%26volume%3D125%26spage%3D146%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Lees</span>, <span class="hlFld-ContribAuthor ">Joaquim  Ferreira</span>, <span class="hlFld-ContribAuthor ">Olivier  Rascol</span>, <span class="hlFld-ContribAuthor ">Heinz  Reichmann</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Stocchi</span>, <span class="hlFld-ContribAuthor ">Eduardo  Tolosa</span>, <span class="hlFld-ContribAuthor ">Werner  Poewe</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2017,</strong> <em>17 </em>
                                    (7)
                                     , 649-659. <a href="https://doi.org/10.1080/14737175.2017.1336086" title="DOI URL">https://doi.org/10.1080/14737175.2017.1336086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2017.1336086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2017.1336086%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DOpicapone%252Bfor%252Bthe%252Bmanagement%252Bof%252Bend-of-dose%252Bmotor%252Bfluctuations%252Bin%252Bpatients%252Bwith%252BParkinson%2525E2%252580%252599s%252Bdisease%252Btreated%252Bwith%252BL-DOPA%26aulast%3DLees%26aufirst%3DAndrew%2BJ.%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D7%26spage%3D649%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L  Cunningham</span>, <span class="hlFld-ContribAuthor ">Zizhen  Wu</span>, <span class="hlFld-ContribAuthor ">Aria  Jafari</span>, <span class="hlFld-ContribAuthor ">Bo  Zhao</span>, <span class="hlFld-ContribAuthor ">Kat  Schrode</span>, <span class="hlFld-ContribAuthor ">Sarah  Harkins-Perry</span>, <span class="hlFld-ContribAuthor ">Amanda  Lauer</span>, <span class="hlFld-ContribAuthor ">Ulrich  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">The murine catecholamine methyltransferase mTOMT is essential for mechanotransduction by cochlear hair cells. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2017,</strong> <em>6 </em><a href="https://doi.org/10.7554/eLife.24318" title="DOI URL">https://doi.org/10.7554/eLife.24318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.24318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.24318%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DThe%252Bmurine%252Bcatecholamine%252Bmethyltransferase%252BmTOMT%252Bis%252Bessential%252Bfor%252Bmechanotransduction%252Bby%252Bcochlear%252Bhair%252Bcells%26aulast%3DCunningham%26aufirst%3DChristopher%2BL%26date%3D2017%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylwia  Czarnota</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Baxter</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Cliff</span>, <span class="hlFld-ContribAuthor ">Jonathan P.  Waltho</span>, <span class="hlFld-ContribAuthor ">Nigel S.  Scrutton</span>, <span class="hlFld-ContribAuthor ">Sam  Hay</span>. </span><span class="cited-content_cbyCitation_article-title">1H, 15N, 13C backbone resonance assignments of human soluble catechol O-methyltransferase in complex with S-adenosyl-l-methionine and 3,5-dinitrocatechol. </span><span class="cited-content_cbyCitation_journal-name">Biomolecular NMR Assignments</span><span> <strong>2017,</strong> <em>11 </em>
                                    (1)
                                     , 57-61. <a href="https://doi.org/10.1007/s12104-016-9720-9" title="DOI URL">https://doi.org/10.1007/s12104-016-9720-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12104-016-9720-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12104-016-9720-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecular%2520NMR%2520Assignments%26atitle%3D1H%25252C%252B15N%25252C%252B13C%252Bbackbone%252Bresonance%252Bassignments%252Bof%252Bhuman%252Bsoluble%252Bcatechol%252BO-methyltransferase%252Bin%252Bcomplex%252Bwith%252BS-adenosyl-l-methionine%252Band%252B3%25252C5-dinitrocatechol%26aulast%3DCzarnota%26aufirst%3DSylwia%26date%3D2017%26date%3D2016%26volume%3D11%26issue%3D1%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filipe B  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Joaquim J  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone for the treatment of Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2017,</strong> <em>18 </em>
                                    (4)
                                     , 445-453. <a href="https://doi.org/10.1080/14656566.2017.1294683" title="DOI URL">https://doi.org/10.1080/14656566.2017.1294683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2017.1294683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2017.1294683%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DOpicapone%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DRodrigues%26aufirst%3DFilipe%2BB%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D4%26spage%3D445%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José-Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Éric  Sicard</span>, <span class="hlFld-ContribAuthor ">Nicolas  Fauchoux</span>, <span class="hlFld-ContribAuthor ">Amílcar  Falcão</span>, <span class="hlFld-ContribAuthor ">Ana  Santos</span>, <span class="hlFld-ContribAuthor ">Ana I.  Loureiro</span>, <span class="hlFld-ContribAuthor ">Roberto  Pinto</span>, <span class="hlFld-ContribAuthor ">Maria João  Bonifácio</span>, <span class="hlFld-ContribAuthor ">Teresa  Nunes</span>, <span class="hlFld-ContribAuthor ">Luís  Almeida</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2017,</strong> <em>83 </em>
                                    (3)
                                     , 540-553. <a href="https://doi.org/10.1111/bcp.13156" title="DOI URL">https://doi.org/10.1111/bcp.13156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.13156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.13156%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DEffect%252Bof%252Bopicapone%252Bmultiple-dose%252Bregimens%252Bon%252Blevodopa%252Bpharmacokinetics%26aulast%3DRocha%26aufirst%3DJos%25C3%25A9-Francisco%26date%3D2017%26date%3D2016%26volume%3D83%26issue%3D3%26spage%3D540%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margherita  Fabbri</span>, <span class="hlFld-ContribAuthor ">Mario M  Rosa</span>, <span class="hlFld-ContribAuthor ">Joaquim J  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical pharmacology review of opicapone for the treatment of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurodegenerative Disease Management</span><span> <strong>2016,</strong> <em>6 </em>
                                    (5)
                                     , 349-362. <a href="https://doi.org/10.2217/nmt-2016-0022" title="DOI URL">https://doi.org/10.2217/nmt-2016-0022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/nmt-2016-0022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fnmt-2016-0022%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurodegenerative%2520Disease%2520Management%26atitle%3DClinical%252Bpharmacology%252Breview%252Bof%252Bopicapone%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DFabbri%26aufirst%3DMargherita%26date%3D2016%26volume%3D6%26issue%3D5%26spage%3D349%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing-Kai  Qian</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Yang-Liu  Xia</span>, <span class="hlFld-ContribAuthor ">Tong-Yi  Dou</span>, <span class="hlFld-ContribAuthor ">Qiang  Jin</span>, <span class="hlFld-ContribAuthor ">Dan-Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Da-Cheng  Hao</span>, <span class="hlFld-ContribAuthor ">Xiao-Lin  Bi</span>, <span class="hlFld-ContribAuthor ">Guang-Bo  Ge</span>, <span class="hlFld-ContribAuthor ">Ling  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A highly selective fluorescent probe for sensing activities of catechol- O -methyltransferase in complex biological samples. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2016,</strong> <em>231 </em>, 615-623. <a href="https://doi.org/10.1016/j.snb.2016.03.074" title="DOI URL">https://doi.org/10.1016/j.snb.2016.03.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2016.03.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2016.03.074%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DA%252Bhighly%252Bselective%252Bfluorescent%252Bprobe%252Bfor%252Bsensing%252Bactivities%252Bof%252Bcatechol-%252BO%252B-methyltransferase%252Bin%252Bcomplex%252Bbiological%252Bsamples%26aulast%3DQian%26aufirst%3DXing-Kai%26date%3D2016%26volume%3D231%26spage%3D615%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhijian  Zhao</span>, <span class="hlFld-ContribAuthor ">Scott T.  Harrison</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Schubert</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Stacey  Polsky-Fisher</span>, <span class="hlFld-ContribAuthor ">Nanyan Rena  Zhang</span>, <span class="hlFld-ContribAuthor ">Debra  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Gibson</span>, <span class="hlFld-ContribAuthor ">Ronald G.  Robinson</span>, <span class="hlFld-ContribAuthor ">Nancy A.  Sachs</span>, <span class="hlFld-ContribAuthor ">Monika  Kandebo</span>, <span class="hlFld-ContribAuthor ">Lihang  Yao</span>, <span class="hlFld-ContribAuthor ">Sean M.  Smith</span>, <span class="hlFld-ContribAuthor ">Pete H.  Hutson</span>, <span class="hlFld-ContribAuthor ">Scott E.  Wolkenberg</span>, <span class="hlFld-ContribAuthor ">James C.  Barrow</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optimization of  N -heterocyclic pyridinones as catechol- O -methyltransferase (COMT) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2952-2956. <a href="https://doi.org/10.1016/j.bmcl.2016.03.095" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.095%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Boptimization%252Bof%252BN%252B-heterocyclic%252Bpyridinones%252Bas%252Bcatechol-%252BO%252B-methyltransferase%252B%252528COMT%252529%252Binhibitors%26aulast%3DZhao%26aufirst%3DZhijian%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2952%26epage%3D2956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José-Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Joaquim J.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Amílcar  Falcão</span>, <span class="hlFld-ContribAuthor ">Ana  Santos</span>, <span class="hlFld-ContribAuthor ">Roberto  Pinto</span>, <span class="hlFld-ContribAuthor ">Teresa  Nunes</span>, <span class="hlFld-ContribAuthor ">Luis  Almeida</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-
              O
              -Methyltransferase Activity and Motor Response in Patients With Parkinson Disease. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2016,</strong> <em>5 </em>
                                    (3)
                                     , 232-240. <a href="https://doi.org/10.1002/cpdd.217" title="DOI URL">https://doi.org/10.1002/cpdd.217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.217%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DEffect%252Bof%252B3%252BSingle-Dose%252BRegimens%252Bof%252BOpicapone%252Bon%252BLevodopa%252BPharmacokinetics%25252C%252BCatechol-%252BO%252B-Methyltransferase%252BActivity%252Band%252BMotor%252BResponse%252Bin%252BPatients%252BWith%252BParkinson%252BDisease%26aulast%3DRocha%26aufirst%3DJos%25C3%25A9-Francisco%26date%3D2016%26date%3D2015%26volume%3D5%26issue%3D3%26spage%3D232%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amílcar  Falcão</span>, <span class="hlFld-ContribAuthor ">José Francisco  Rocha</span>, <span class="hlFld-ContribAuthor ">Ana  Santos</span>, <span class="hlFld-ContribAuthor ">Teresa  Nunes</span>, <span class="hlFld-ContribAuthor ">Patrício  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2016,</strong> <em>5 </em>
                                    (2)
                                     , 150-161. <a href="https://doi.org/10.1002/cpdd.213" title="DOI URL">https://doi.org/10.1002/cpdd.213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.213%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DOpicapone%252Bpharmacokinetics%252Band%252Bpharmacodynamics%252Bcomparison%252Bbetween%252Bhealthy%252BJapanese%252Band%252Bmatched%252Bwhite%252Bsubjects%26aulast%3DFalc%25C3%25A3o%26aufirst%3DAm%25C3%25ADlcar%26date%3D2016%26date%3D2015%26volume%3D5%26issue%3D2%26spage%3D150%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Hsiao</span>, <span class="hlFld-ContribAuthor ">Hicham  Zegzouti</span>, <span class="hlFld-ContribAuthor ">Said A  Goueli</span>. </span><span class="cited-content_cbyCitation_article-title">Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases. </span><span class="cited-content_cbyCitation_journal-name">Epigenomics</span><span> <strong>2016,</strong> <em>8 </em>
                                    (3)
                                     , 321-339. <a href="https://doi.org/10.2217/epi.15.113" title="DOI URL">https://doi.org/10.2217/epi.15.113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/epi.15.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fepi.15.113%26sid%3Dliteratum%253Aachs%26jtitle%3DEpigenomics%26atitle%3DMethyltransferase-Glo%25253A%252Ba%252Buniversal%25252C%252Bbioluminescent%252Band%252Bhomogenous%252Bassay%252Bfor%252Bmonitoring%252Ball%252Bclasses%252Bof%252Bmethyltransferases%26aulast%3DHsiao%26aufirst%3DKevin%26date%3D2016%26volume%3D8%26issue%3D3%26spage%3D321%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. J.  Ferreira</span>, <span class="hlFld-ContribAuthor ">J.-F.  Rocha</span>, <span class="hlFld-ContribAuthor ">A.  Falcão</span>, <span class="hlFld-ContribAuthor ">A.  Santos</span>, <span class="hlFld-ContribAuthor ">R.  Pinto</span>, <span class="hlFld-ContribAuthor ">T.  Nunes</span>, <span class="hlFld-ContribAuthor ">P.  Soares-da-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of opicapone on levodopa pharmacokinetics, catechol-
              O
              -methyltransferase activity and motor fluctuations in patients with Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Neurology</span><span> <strong>2015,</strong> <em>22 </em>
                                    (5)
                                     , 815-e56. <a href="https://doi.org/10.1111/ene.12666" title="DOI URL">https://doi.org/10.1111/ene.12666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ene.12666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fene.12666%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Neurology%26atitle%3DEffect%252Bof%252Bopicapone%252Bon%252Blevodopa%252Bpharmacokinetics%25252C%252Bcatechol-%252BO%252B-methyltransferase%252Bactivity%252Band%252Bmotor%252Bfluctuations%252Bin%2525C2%2525A0patients%252Bwith%252BParkinson%252527s%252Bdisease%26aulast%3DFerreira%26aufirst%3DJ.%2BJ.%26date%3D2015%26date%3D2015%26volume%3D22%26issue%3D5%26spage%3D815%26epage%3De56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elke  Persch</span>, <span class="hlFld-ContribAuthor ">Oliver  Dumele</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Molekulare Erkennung in chemischen und biologischen Systemen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (11)
                                     , 3341-3382. <a href="https://doi.org/10.1002/ange.201408487" title="DOI URL">https://doi.org/10.1002/ange.201408487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408487%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMolekulare%252BErkennung%252Bin%252Bchemischen%252Bund%252Bbiologischen%252BSystemen%26aulast%3DPersch%26aufirst%3DElke%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D11%26spage%3D3341%26epage%3D3382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elke  Persch</span>, <span class="hlFld-ContribAuthor ">Oliver  Dumele</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Recognition in Chemical and Biological Systems. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (11)
                                     , 3290-3327. <a href="https://doi.org/10.1002/anie.201408487" title="DOI URL">https://doi.org/10.1002/anie.201408487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408487%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMolecular%252BRecognition%252Bin%252BChemical%252Band%252BBiological%252BSystems%26aulast%3DPersch%26aufirst%3DElke%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D11%26spage%3D3290%26epage%3D3327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COMT catalyzed methylation of simple catechol and pyrogallol substrates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Drug substrates of COMT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat S-COMT in complex with the methyl donor AdoMet, the Mg<sup>2+</sup> ion and ligand <b>19</b>: (A) schematic representation of the three-dimensional structure of the protein; (B) enlarged view of the catalytic site. Figures drawn using program PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Molecular surface of COMT shown in green with the methyl donor AdoMet and ligand <b>19</b> represented in sticks. The Mg<sup>2+</sup> ion is depicted in magenta. Figure drawn using program PyMOL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Metabolism and active transport of L-DOPA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representative structures of early catechol-based competitive COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative structures of early pyrogallol-based competitive COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative examples of vinylic <i>meta</i>-nitrated COMT inhibitors and IC<sub>50</sub> values in rat brain homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative examples of acetylated and carbamoylated <i>meta</i>-nitro COMT inhibitors and their IC<sub>50</sub> values in rat liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Representative examples of heterocyclyl <i>meta</i>-nitro COMT inhibitors and their IC<sub>50</sub> values in rat liver homogenates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. COMT inhibitors developed by Kissei Pharmaceuticals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative examples of <i>ortho</i>-nitrated COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative examples of trisubstituted catechol structures of COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Fused nitrocatechol structures of COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Tropolone-based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Pyrimidone, pyridone, quinoline, and pyrone based inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Representative examples of bifunctional COMT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Bisubstrate inhibitors of the COMT enzyme and structure of AdoMet competitive fragment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Prodrugs of COMT inhibitors <b>32</b> and <b>69</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/medium/jm-2014-00572b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structure of codrug of <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-21/jm500572b/20141107/images/large/jm-2014-00572b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500572b&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 179 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Armstrong, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, K. N. F.</span><span> </span><span class="NLM_article-title">3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1957&pages=422-423&author=M.+D.+Armstrongauthor=A.+McMillanauthor=K.+N.+F.+Shaw&title=3-Methoxy-4-hydroxy-D-mandelic+acid%2C+a+urinary+metabolite+of+norepinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DM.%2BD.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DK.%2BN.%2BF.%26atitle%3D3-Methoxy-4-hydroxy-D-mandelic%2520acid%252C%2520a%2520urinary%2520metabolite%2520of%2520norepinephrine%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1957%26volume%3D25%26spage%3D422%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomchick, R.</span><span> </span><span class="NLM_article-title">Enzymatic <i>O</i>-methylation of epinephrine and other catechols</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=13575440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaG1MXht1SltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=702-705&author=J.+Axelrodauthor=R.+Tomchick&title=Enzymatic+O-methylation+of+epinephrine+and+other+catechols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic O-methylation of adrenaline and other catechols</span></div><div class="casAuthors">Axelrod, Julius; Tomchick, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">702-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">cf. ibid. 697-701.  An enzyme (catechol O-methyl transferase) is described that transfers the Me group of S-adenosylmethionine to the 3-OH group of adrenaline and other catechols.  The enzyme requires bivalent cations and is inhibited by HS-binding reagents.  It occurs in various organs of mammals, including man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9qbqIHQs-bVg90H21EOLACvtfcHk0lg-dCL2obfHig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXht1SltQ%253D%253D&md5=81021efa9533bf91bb1d4103aeaba995</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DTomchick%26aufirst%3DR.%26atitle%3DEnzymatic%2520O-methylation%2520of%2520epinephrine%2520and%2520other%2520catechols%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D702%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkop, B.</span><span> </span><span class="NLM_article-title"><i>O</i>-Methylation of catecholamines <i>in vivo</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=1958&pages=697-701&author=J.+Axelrodauthor=S.+Senohauthor=B.+Witkop&title=O-Methylation+of+catecholamines+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DSenoh%26aufirst%3DS.%26aulast%3DWitkop%26aufirst%3DB.%26atitle%3DO-Methylation%2520of%2520catecholamines%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1958%26volume%3D233%26spage%3D697%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bacq, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dresse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renson, J.</span><span> </span><span class="NLM_article-title">Inhibition of O-methyltransferase by catechol and sensitization to epinephrine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1959&pages=453-454&author=Z.+M.+Bacqauthor=L.+Gosselinauthor=A.+Dresseauthor=J.+Renson&title=Inhibition+of+O-methyltransferase+by+catechol+and+sensitization+to+epinephrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBacq%26aufirst%3DZ.%2BM.%26aulast%3DGosselin%26aufirst%3DL.%26aulast%3DDresse%26aufirst%3DA.%26aulast%3DRenson%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520O-methyltransferase%2520by%2520catechol%2520and%2520sensitization%2520to%2520epinephrine%26jtitle%3DScience%26date%3D1959%26volume%3D130%26spage%3D453%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Calne, D. B.</span><span> </span><span class="NLM_article-title">Treatment of Parkinson’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1056%2FNEJM199309303291408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8366903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK3szns1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1993&pages=1021-1027&author=D.+B.+Calne&title=Treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Parkinson's disease</span></div><div class="casAuthors">Calne D B</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1021-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzoAKl_8Tjn1vAgqb2vdc5fW6udTcc2eYA4Fa7XtP1RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szns1Sgsg%253D%253D&md5=4e20a3db2b5d8b28689c22fb8fbdee2a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM199309303291408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199309303291408%26sid%3Dliteratum%253Aachs%26aulast%3DCalne%26aufirst%3DD.%2BB.%26atitle%3DTreatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1993%26volume%3D329%26spage%3D1021%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentikainen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rita, H.</span><span> </span><span class="NLM_article-title">Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-Dopa in healthy volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=436-447&author=S.+Kaakkolaauthor=A.+Gordinauthor=M.+Jarvinenauthor=T.+Wikbergauthor=E.+Schultzauthor=E.+Nissinenauthor=P.+J.+Pentikainenauthor=H.+Rita&title=Effect+of+a+novel+catechol-O-methyltransferase+inhibitor%2C+nitecapone%2C+on+the+metabolism+of+L-Dopa+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DJarvinen%26aufirst%3DM.%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DPentikainen%26aufirst%3DP.%2BJ.%26aulast%3DRita%26aufirst%3DH.%26atitle%3DEffect%2520of%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%252C%2520nitecapone%252C%2520on%2520the%2520metabolism%2520of%2520L-Dopa%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1990%26volume%3D13%26spage%3D436%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Keranen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span> </span><span class="NLM_article-title">Inhibition of soluble catechol <i>O</i>-methyltranferse and single dose pharmacokinetics after oral and intraveneus administration of entacapone</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=151-157&author=T.+Keranenauthor=A.+Gordinauthor=+Karlsonauthor=T.+Wikberg&title=Inhibition+of+soluble+catechol+O-methyltranferse+and+single+dose+pharmacokinetics+after+oral+and+intraveneus+administration+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DT.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DKarlson%26aulast%3DWikberg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520soluble%2520catechol%2520O-methyltranferse%2520and%2520single%2520dose%2520pharmacokinetics%2520after%2520oral%2520and%2520intraveneus%2520administration%2520of%2520entacapone%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Brummelen, P.</span><span> </span><span class="NLM_article-title">Integrated pharmacokinetics and pharmacodynamics of the novel catechol-<i>O</i>-methyltransferase inhibitor tolcapone during first administration to humans</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0009-9236%2895%2990035-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7768073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXmsVGqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=508-517&author=J.+Dingemanseauthor=K.+M.+Jorgaauthor=M.+Schmittauthor=R.+Gieschkeauthor=B.+Fottelerauthor=G.+Z%C3%BCrcherauthor=M.+Da+Pradaauthor=P.+van+Brummelen&title=Integrated+pharmacokinetics+and+pharmacodynamics+of+the+novel+catechol-O-methyltransferase+inhibitor+tolcapone+during+first+administration+to+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans</span></div><div class="casAuthors">Dingemanse, Jasper; Jorga, Karin M.; Schmitt, Monique; Gieschke, Ronald; Fotteler, Baerbel; Zuercher, Gerhard; Da Prada, Mose; van Brummelen, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">508-17</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">The tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of the novel catechol-O-methyltransferase (COMT) inhibitor tolcapone were assessed in healthy volunteers.  In this double-blind, placebo-controlled, ascending-single-dose study, doses of 5 to 800 mg tolcapone were administered orally to eight sequential groups of six young healthy male volunteers.  Adverse events, vital signs, and clin. lab. variables were recorded.  Pharmacokinetic parameters of tolcapone and its 3-O-methylmetabolite were detd.  Pharmacodynamics were assessed by detn. of COMT activity in erythrocytes.  Tolcapone was well tolerated at all dose levels and did not exert a detectable influence on vital sign measurements.  The drug was rapidly absorbed and showed dose-proportional pharmacokinetics.  Its mean elimination half-life was 2.0 ± 0.8 h (n = 42).  Plasma levels of the 3-O-methylmetabolite of tolcapone were not proportional to dose, and its formation was delayed at higher doses.  Its elimination half-life was 32 ± 7 h (n = 29).  Tolcapone caused a rapid and reversible inhibition of COMT activity in erythrocytes.  At doses of 200 mg and higher, COMT activity was inhibited by more than 80%.  The pharmacokinetic-pharmacodynamic relationship could be described by an inhibitory Emax model and suggested that metabolites of tolcapone did not substantially contribute to its inhibitory activity.  In conclusion, the novel COMT inhibitor tolcapone was well tolerated at oral doses of 5 to 800 mg.  Tolcapone concn.-dependently inhibited COMT activity in erythrocytes and exhibited dose-proportional kinetics.  Further investigations into its applicability in the treatment of Parkinson's disease are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeK3yLrlVyM7Vg90H21EOLACvtfcHk0lhFLPbaWQlJug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsVGqs74%253D&md5=d049b04e9796340b48920dbe2ddf5e8c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0009-9236%2895%2990035-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-9236%252895%252990035-7%26sid%3Dliteratum%253Aachs%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DGieschke%26aufirst%3DR.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26aulast%3Dvan%2BBrummelen%26aufirst%3DP.%26atitle%3DIntegrated%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520during%2520first%2520administration%2520to%2520humans%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1995%26volume%3D57%26spage%3D508%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ferreira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Januario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgadinho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ticmeanu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitu, C.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novac, M.</span><span> </span><span class="NLM_article-title">A double-blind, randomised, placebo- and entacapone-controlled study to investigate the effect of nebicapone (BIA 3–202) on the levodopa pharmacokinetics, COMT activity and motor response in Parkinson disease patients</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 15</span><span class="NLM_x">) </span> <span class="NLM_fpage">S644</span><span class="NLM_x">–</span> <span class="NLM_lpage">S645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=S644-S645&issue=Suppl.+15&author=J.+Ferreiraauthor=M.+M.+Rosaauthor=M.+Coelhoauthor=L.+Cunhaauthor=C.+Januarioauthor=C.+Machadoauthor=A.+Morgadinhoauthor=M.+Ticmeanuauthor=C.-E.+Mituauthor=M.+Novac&title=A+double-blind%2C+randomised%2C+placebo-+and+entacapone-controlled+study+to+investigate+the+effect+of+nebicapone+%28BIA+3%E2%80%93202%29+on+the+levodopa+pharmacokinetics%2C+COMT+activity+and+motor+response+in+Parkinson+disease+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DM.%2BM.%26aulast%3DCoelho%26aufirst%3DM.%26aulast%3DCunha%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DC.%26aulast%3DMachado%26aufirst%3DC.%26aulast%3DMorgadinho%26aufirst%3DA.%26aulast%3DTicmeanu%26aufirst%3DM.%26aulast%3DMitu%26aufirst%3DC.-E.%26aulast%3DNovac%26aufirst%3DM.%26atitle%3DA%2520double-blind%252C%2520randomised%252C%2520placebo-%2520and%2520entacapone-controlled%2520study%2520to%2520investigate%2520the%2520effect%2520of%2520nebicapone%2520%2528BIA%25203%25E2%2580%2593202%2529%2520on%2520the%2520levodopa%2520pharmacokinetics%252C%2520COMT%2520activity%2520and%2520motor%2520response%2520in%2520Parkinson%2520disease%2520patients%26jtitle%3DMov.%2520Disord.%26date%3D2006%26volume%3D21%26issue%3DSuppl.%252015%26spage%3DS644%26epage%3DS645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuno Palma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-o-methyltransferase inhibitor, in healthy subjects: Prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2Fs40262-012-0024-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=23248072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=139-151&author=L.+Almeidaauthor=J.+F.+Rochaauthor=A.+Falc%C3%A3oauthor=P.+Nuno+Palmaauthor=A.+I.+Loureiroauthor=R.+Pintoauthor=M.+J.+Bonifacioauthor=L.+C.+Wrightauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=Pharmacokinetics%2C+pharmacodynamics+and+tolerability+of+opicapone%2C+a+novel+catechol-o-methyltransferase+inhibitor%2C+in+healthy+subjects%3A+Prediction+of+slow+enzyme-inhibitor+complex+dissociation+of+a+short-living+and+very+long-acting+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects</span></div><div class="casAuthors">Almeida, Luis; Rocha, Jose Francisco; Falcao, Amilcar; Nuno Palma, P.; Loureiro, Ana I.; Pinto, Roberto; Bonifacio, Maria Joao; Wright, Lyndon C.; Nunes, Teresa; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-151</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Opicapone is a novel catechol-O-methyltransferase (COMT) inhibitor.  The purpose of this study was to evaluate the tolerability, pharmacokinetics (including the effect of food) and pharmacodynamics (effect on COMT activity) following single oral doses of opicapone in young healthy male volunteers.  Methods Single rising oral doses of opicapone (10, 25, 50, 100, 200, 400, 800 and 1,200 mg) were administered to eight groups of eight subjects per group (two subjects randomized to placebo and six subjects to opicapone), under a double-blind, randomized, placebo-controlled design.  In an addnl. group of 12 subjects, a 50 mg single dose of opicapone was administered on two occasions, once having fasted overnight and once with a high-fat high-calorie meal.  Results Opicapone was well tolerated at all doses tested.  The extent of systemic exposure (area under the plasma concn.-time curve and max. plasma concn.) to opicapone and metabolites increased in an approx. dose-proportional manner and showed a decrease following concomitant ingestion of a high-fat high-calorie meal.  The apparent terminal elimination half-life of opicapone was 0.8-3.2 h.  Sulphation appeared to be the main metabolic pathway for opicapone, and both opicapone and the main sulfated metabolite are likely excreted by the biliary route.  Maximum COMT inhibition by opicapone was dose dependent, ranged from 36.1 % (10 mg) to 100 % (200 mg and above), and reached statistical significance at all doses tested.  The long duration of COMT inhibition by opicapone, however, tended to be independent from the dose taken.  The obsd. half-life of opicapone-induced COMT inhibition in human erythrocytes was 61.6 h (std. deviation [SD] = 37.6 h), which reflects an underlying dissociative process with a kinetic rate const. of 3.1 × 10-6 s-1 (SD = 1.9 × 10-6 s-1).  Such a process compares well to the estd. dissocn. rate const. (koff) of the COMT-opicapone mol. complex (koff = 1.9 × 10-6 s-1).  Conclusions Opicapone was well-tolerated and presented dose-proportional kinetics.  Opicapone demonstrated marked and sustained inhibition of erythrocyte sol. COMT activity.  Based on the observation that the half-life of COMT inhibition is independent of the dose and that it reflects an underlying kinetic process that is consistent with the koff value of the COMT-opicapone complex, we propose that the sustained COMT inhibition, far beyond the observable point of clearance of circulating drug, is due to the long residence time of the reversible complex formed between COMT and opicapone.  Globally, these promising results provide a basis for further clin. development of opicapone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6Fv8W5B9c7Vg90H21EOLACvtfcHk0lhFLPbaWQlJug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVSmtrfJ&md5=98c92fb5920e6c3004dd6f3d2848439a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs40262-012-0024-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-012-0024-7%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DNuno%2BPalma%26aufirst%3DP.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetics%252C%2520pharmacodynamics%2520and%2520tolerability%2520of%2520opicapone%252C%2520a%2520novel%2520catechol-o-methyltransferase%2520inhibitor%252C%2520in%2520healthy%2520subjects%253A%2520Prediction%2520of%2520slow%2520enzyme-inhibitor%2520complex%2520dissociation%2520of%2520a%2520short-living%2520and%2520very%2520long-acting%2520inhibitor%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26spage%3D139%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Axelrod, J.</span><span> </span><span class="NLM_article-title">Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1966&pages=95-113&author=J.+Axelrod&title=Methylation+reactions+in+the+formation+and+metabolism+of+catecholamines+and+other+biogenic+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26atitle%3DMethylation%2520reactions%2520in%2520the%2520formation%2520and%2520metabolism%2520of%2520catecholamines%2520and%2520other%2520biogenic%2520amines%26jtitle%3DPharmacol.%2520Rev.%26date%3D1966%26volume%3D18%26spage%3D95%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Crevelimg, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Catechol <i>O</i>-methyltransferase: III. <i>m</i>- and <i>p</i>-<i>O</i>-methylation of catecholamines and their metabolites</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=691-696&author=C.+R.+Crevelimgauthor=N.+Dalgardauthor=H.+Shimizuauthor=J.+W.+Daly&title=Catechol+O-methyltransferase%3A+III.+m-+and+p-O-methylation+of+catecholamines+and+their+metabolites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrevelimg%26aufirst%3DC.%2BR.%26aulast%3DDalgard%26aufirst%3DN.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DCatechol%2520O-methyltransferase%253A%2520III.%2520m-%2520and%2520p-O-methylation%2520of%2520catecholamines%2520and%2520their%2520metabolites%26jtitle%3DMol.%2520Pharmacol.%26date%3D1970%26volume%3D6%26spage%3D691%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystal structure of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=354-358&author=J.+Vidgrenauthor=L.+A.+Svenssonauthor=A.+Liljas&title=Crystal+structure+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DL.%2BA.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520catechol-O-methyltransferase%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D354%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Masri, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">Selective <i>para- or meta-O</i>-methylation with catechol <i>O</i>-methyl transferase from rat liver</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=878-879&author=M.+S.+Masriauthor=D.+J.+Robbinsauthor=O.+H.+Emersonauthor=F.+Deeds&title=Selective+para-+or+meta-O-methylation+with+catechol+O-methyl+transferase+from+rat+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DM.%2BS.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DSelective%2520para-%2520or%2520meta-O-methylation%2520with%2520catechol%2520O-methyl%2520transferase%2520from%2520rat%2520liver%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D878%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Guldberg, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase: Pharmacological aspects and physiological role</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1975&pages=135-206&author=H.+C.+Guldbergauthor=C.+A.+Marsden&title=Catechol-O-methyltransferase%3A+Pharmacological+aspects+and+physiological+role"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuldberg%26aufirst%3DH.%2BC.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26atitle%3DCatechol-O-methyltransferase%253A%2520Pharmacological%2520aspects%2520and%2520physiological%2520role%26jtitle%3DPharmacol.%2520Rev.%26date%3D1975%26volume%3D27%26spage%3D135%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zhu, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezell, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liehr, J. G.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase-catalysed rapid <i>O</i>-methylation of mutagenic flavanoids. metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=292-299&author=B.+T.+Zhuauthor=E.+L.+Ezellauthor=J.+G.+Liehr&title=Catechol-O-methyltransferase-catalysed+rapid+O-methylation+of+mutagenic+flavanoids.+metabolic+inactivation+as+a+possible+reason+for+their+lack+of+carcinogenicity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BT.%26aulast%3DEzell%26aufirst%3DE.%2BL.%26aulast%3DLiehr%26aufirst%3DJ.%2BG.%26atitle%3DCatechol-O-methyltransferase-catalysed%2520rapid%2520O-methylation%2520of%2520mutagenic%2520flavanoids.%2520metabolic%2520inactivation%2520as%2520a%2520possible%2520reason%2520for%2520their%2520lack%2520of%2520carcinogenicity%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D292%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Burba, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becking, G. C.</span><span> </span><span class="NLM_article-title">Effect of the antioxidant norhydroguaiaretic acid on the <i>in vitro</i> activity of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5348405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE3cXhvVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=1969&pages=323-329&author=J.+V.+Burbaauthor=G.+C.+Becking&title=Effect+of+the+antioxidant+norhydroguaiaretic+acid+on+the+in+vitro+activity+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the antioxidant nordihydroguaiaretic acid on the in vitro activity of catechol-O-methyl transferase</span></div><div class="casAuthors">Burba, John V.; Becking, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-30</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The phenolic antioxidant, nordihydro-guaiaretic acid (NDGA), was a good substrate in vitro for rat liver, human liver, and human placenta catechol-O-methyl transferase (COMT); the Km values for rat and human liver COMT with NDGA as substrate were identical at 5 × 10-4M, while the human placental enzyme had a Km value of 2.5 × 10-4M.  NDGA at 6 × 10-6M inhibited the utilization of norepinephrine by COMT by 50%.  Both catechol rings of NDGA were O-methylated by COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP_XYl8hufPbVg90H21EOLACvtfcHk0lj0ypfXy4dmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXhvVKruw%253D%253D&md5=2b4d833313cd2f0fe518471974a09a17</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurba%26aufirst%3DJ.%2BV.%26aulast%3DBecking%26aufirst%3DG.%2BC.%26atitle%3DEffect%2520of%2520the%2520antioxidant%2520norhydroguaiaretic%2520acid%2520on%2520the%2520in%2520vitro%2520activity%2520of%2520catechol-O-methyltransferase%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1969%26volume%3D180%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Porter, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titus, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totaro, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byer, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1962&pages=1067-1077&author=C.+C.+Porterauthor=L.+S.+Watsonauthor=D.+C.+Titusauthor=J.+A.+Totaroauthor=S.+S.+Byer&title=Inhibition+of+DOPA+decarboxylase+by+the+hydrazino+analog+of+alpha-methylDOPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DC.%2BC.%26aulast%3DWatson%26aufirst%3DL.%2BS.%26aulast%3DTitus%26aufirst%3DD.%2BC.%26aulast%3DTotaro%26aufirst%3DJ.%2BA.%26aulast%3DByer%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520DOPA%2520decarboxylase%2520by%2520the%2520hydrazino%2520analog%2520of%2520alpha-methylDOPA%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1962%26volume%3D11%26spage%3D1067%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Burkard, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gey, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletscher, A.</span><span> </span><span class="NLM_article-title">A new inhibitor of decarboxylase of aromatic amino acids</span> <span class="citation_source-journal">Experientia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1962&pages=411-412&author=W.+P.+Burkardauthor=K.+F.+Geyauthor=A.+Pletscher&title=A+new+inhibitor+of+decarboxylase+of+aromatic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurkard%26aufirst%3DW.%2BP.%26aulast%3DGey%26aufirst%3DK.%2BF.%26aulast%3DPletscher%26aufirst%3DA.%26atitle%3DA%2520new%2520inhibitor%2520of%2520decarboxylase%2520of%2520aromatic%2520amino%2520acids%26jtitle%3DExperientia%26date%3D1962%26volume%3D18%26spage%3D411%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Muguet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broussolle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chazot, G.</span><span> </span><span class="NLM_article-title">Apomorphine in patients with Parkinson’s disease</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0753-3322%2896%2982620-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7669939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK2MzpvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=197-209&author=D.+Muguetauthor=E.+Broussolleauthor=G.+Chazot&title=Apomorphine+in+patients+with+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Apomorphine in patients with Parkinson's disease</span></div><div class="casAuthors">Muguet D; Broussolle E; Chazot G</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">197-209</span>
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    </div><div class="casAbstract">We present a review of the recent literature and personal experience with apomorphine in patients with Parkinson's disease.  Apomorphine is a potent D1 and D2 dopaminergic agonist.  It has a rapid and short duration effect after subcutaneous administration at doses ranging from 15 to 180 micrograms/kg.  Plasma maximal concentration is reached in 8-16 minutes, with a plasma half life of 34-70 minutes.  Bioavailability is close to 100%.  Repeated injections in patients show post-stimulative hyposensitivity.  Apomorphine test appears very useful for the differential diagnosis between idiopathic Parkinson's disease and other Parkinson plus syndromes, and as a predictive test for dopaminergic responsiveness.  Appropriate doses are able to alleviate akinesia, rigidity and tremor.  Recent therapeutic trials have demonstrated the high interest of intermittent multiple subcutaneous apomorphine injections to cut the "off" motor phases in fluctuating parkinsonian patients under chronic levodopa treatment.  In some cases, continuous apomorphine subcutaneous infusion with a portable pump may be required, particularly when levodopa treatment is temporarily interrupted, as after abdominal surgery.  During long-term treatment, the apomorphine dose able to relieve akinesia remains stable.  Peripheral side effects such as nausea and hypotension may be prevented by the co-administration of domperidone, a peripheral dopaminergic antagonist.  Cutaneous fibrous nodules and psychiatric symptoms may occur, but usually at high dosages with continuous infusion.  Local allergic effects have limited the use of other routes of administration, such as intranasal, sublingual, and rectal routes.  Apomorphine is also used as a pharmacological tool for clinical research with the aim of a better understanding of the pathophysiology of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTE1sU-ZqRrMs25P7XSLhESfW6udTcc2eZautzVV9JXs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2MzpvFGrsw%253D%253D&md5=7feae36234d6eed7f8839ee02086eaa5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0753-3322%2896%2982620-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0753-3322%252896%252982620-5%26sid%3Dliteratum%253Aachs%26aulast%3DMuguet%26aufirst%3DD.%26aulast%3DBroussolle%26aufirst%3DE.%26aulast%3DChazot%26aufirst%3DG.%26atitle%3DApomorphine%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D1995%26volume%3D49%26spage%3D197%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sonnenblick, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frishman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeJemiel, T. H.</span><span> </span><span class="NLM_article-title">Dobutamine: A new synthetic cardioactive sympathetic amine</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1056%2FNEJM197901043000105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=362214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE1MXhtFCmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1979&pages=17-22&author=E.+H.+Sonnenblickauthor=W.+H.+Frishmanauthor=T.+H.+LeJemiel&title=Dobutamine%3A+A+new+synthetic+cardioactive+sympathetic+amine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dobutamine:  a new synthetic cardioactive sympathetic amine</span></div><div class="casAuthors">Sonnenblick, Edmund H.; Frishman, William H.; LeJemtel, Thierry H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-22</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">A review and discussion, with 38 refs., of cardiac effects of dobutamine (I)  [34368-04-2].  Myocardial contractility is increased by I with less peripheral arterial effects or tachycardia than seen with other sympathomimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp14RRDuLsv17Vg90H21EOLACvtfcHk0lih209smpWP3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXhtFCmu7c%253D&md5=a3d5f3a3b887db7489ccda5e3f95a578</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJM197901043000105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197901043000105%26sid%3Dliteratum%253Aachs%26aulast%3DSonnenblick%26aufirst%3DE.%2BH.%26aulast%3DFrishman%26aufirst%3DW.%2BH.%26aulast%3DLeJemiel%26aufirst%3DT.%2BH.%26atitle%3DDobutamine%253A%2520A%2520new%2520synthetic%2520cardioactive%2520sympathetic%2520amine%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1979%26volume%3D300%26spage%3D17%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Caruana, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigden, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raftery, E. B.</span><span> </span><span class="NLM_article-title">Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1365-2125.1987.tb03237.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1984&pages=721-727&author=M.+P.+Caruanaauthor=M.+Heberauthor=G.+Brigdenauthor=E.+B.+Raftery&title=Effects+of+fenoldopam%2C+a+specific+dopamine+receptor+agonist%2C+on+blood+pressure+and+left+ventricular+function+in+systemic+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1987.tb03237.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1987.tb03237.x%26sid%3Dliteratum%253Aachs%26aulast%3DCaruana%26aufirst%3DM.%2BP.%26aulast%3DHeber%26aufirst%3DM.%26aulast%3DBrigden%26aufirst%3DG.%26aulast%3DRaftery%26aufirst%3DE.%2BB.%26atitle%3DEffects%2520of%2520fenoldopam%252C%2520a%2520specific%2520dopamine%2520receptor%2520agonist%252C%2520on%2520blood%2520pressure%2520and%2520left%2520ventricular%2520function%2520in%2520systemic%2520hypertension%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1984%26volume%3D24%26spage%3D721%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Frohlich, E. D.</span><span> </span><span class="NLM_article-title">Methyldopa. Mechanisms and treatment 25 years later</span> <span class="citation_source-journal">Arch. Int. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1001%2Farchinte.1980.00040020954016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6247989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaL3c3hvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1980&pages=954-959&author=E.+D.+Frohlich&title=Methyldopa.+Mechanisms+and+treatment+25+years+later"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Methyldopa. Mechanisms and treatment 25 years later</span></div><div class="casAuthors">Frohlich E D</div><div class="citationInfo"><span class="NLM_cas:title">Archives of internal medicine</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">954-9</span>
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    </div><div class="casAbstract">Methyldopa, an adrenergic-inhibiting compound, has been used for over 25 years as a safe and effective antihypertensive agent.  The postulated mechanisms for the antihypertensive action of this compound have been varied and parallel our broadening knowledge of the role of the adrenergic nervous system in controlling arterial pressure.  This review outlines the mechanisms of adrenergic control of the circulation and how the proposed mechanisms of action of methyldopa (ie, dopa decarboxylation, false neurotransmission, inhibition of renin release, and stimulation of alpha receptor sites in the brain) seem to account for the depressor action of the drug.  Physiologic effects as well as immunologic and other clinical effects are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKPcou_cxq3uR_TJajKxJDfW6udTcc2eYCccEQLh-om7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c3hvFamtg%253D%253D&md5=f04531e3f4184937bd0258963eaf15d2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1001%2Farchinte.1980.00040020954016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.1980.00040020954016%26sid%3Dliteratum%253Aachs%26aulast%3DFrohlich%26aufirst%3DE.%2BD.%26atitle%3DMethyldopa.%2520Mechanisms%2520and%2520treatment%252025%2520years%2520later%26jtitle%3DArch.%2520Int.%2520Med.%26date%3D1980%26volume%3D140%26spage%3D954%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Popa, V. T.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of adrenergic drugs</span> <span class="citation_source-journal">J. Asthma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F02770908409077417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6145698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2cXltVens78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1984&pages=183-207&author=V.+T.+Popa&title=Clinical+pharmacology+of+adrenergic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of adrenergic drugs</span></div><div class="casAuthors">Popa, Valentin T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asthma</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-207</span>CODEN:
                <span class="NLM_cas:coden">JOUADU</span>;
        ISSN:<span class="NLM_cas:issn">0277-0903</span>.
    </div><div class="casAbstract">A review with 198 refs. on the clin. pharmacol. of adrenergic agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqeQ3OfmJf-rVg90H21EOLACvtfcHk0lgezLSJAZxgxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVens78%253D&md5=bb8785938ffc2b394d5cfdfa6336c017</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3109%2F02770908409077417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02770908409077417%26sid%3Dliteratum%253Aachs%26aulast%3DPopa%26aufirst%3DV.%2BT.%26atitle%3DClinical%2520pharmacology%2520of%2520adrenergic%2520drugs%26jtitle%3DJ.%2520Asthma%26date%3D1984%26volume%3D21%26spage%3D183%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bowman, W. c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I. W.</span><span> </span><span class="NLM_article-title">Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1972.tb08115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5085231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE38XlsVOltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1972&pages=574-583&author=W.+c.+Bowmanauthor=I.+W.+Rodger&title=Actions+of+the+sympathomimetic+bronchodilator%2C+rimiterol+%28R798%29%2C+on+the+cardiovascular%2C+respiratory+and+skeletal+muscle+systems+of+the+anaesthetized+cat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory, and skeletal muscle systems of the anesthetized cat</span></div><div class="casAuthors">Bowman, W. C.; Rodger, I. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">574-83</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Rimiterol (R 798) (erythro-(3,4-dihydroxyphenyl)-2-piperidylmethanol HBr) (I) [31842-61-2] was equipotent to salbutamol [18559-94-9] and .sim. 8-fold less potent than l-isoprenaline bitartrate [59-60-9] in opposing serotonin-induced bronchoconstriction and in decreasing the tension and degree of fusion of incomplete tetanic contractions of the soleus muscle of the cat.  Both I and salbutamol were .sim. 19-fold less potent than L-isoprenaline in increasing cat heart rate.  The action of I on the soleus muscle suggests that systemic bronchodilator doses of I may, like salbutamol, produce muscle tremor as an unwanted side effect.  I and salbutamol produced less tachycardia in cats than did l-isoprenaline.  The greater safety margin between bronchial and cardiac effects of I and salbutamol indicates a therapeutic advantage over isoprenaline.  The safety margin for salbutamol was small in the cat compared to that reported for other animal species and this may indicate a less clear differentiation between β1-and β2-adrenoceptors in the cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBysEtSdLSyLVg90H21EOLACvtfcHk0lg9ujgxMXIftQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsVOltbk%253D&md5=a27d60eb603f98dd6af59a417df17fd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1972.tb08115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1972.tb08115.x%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%26aufirst%3DW.%2Bc.%26aulast%3DRodger%26aufirst%3DI.%2BW.%26atitle%3DActions%2520of%2520the%2520sympathomimetic%2520bronchodilator%252C%2520rimiterol%2520%2528R798%2529%252C%2520on%2520the%2520cardiovascular%252C%2520respiratory%2520and%2520skeletal%2520muscle%2520systems%2520of%2520the%2520anaesthetized%2520cat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1972%26volume%3D45%26spage%3D574%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Miyöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schendzielorz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Distribution of catechol-<i>O</i>-methyltransferase (COMT) proteins and enzymatic activities in wild-type and S-COMT deficient mice</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1632</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=20374420" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2010&pages=1632-1643&author=T.+T.+Miy%C3%B6h%C3%A4nenauthor=N.+Schendzielorzauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Distribution+of+catechol-O-methyltransferase+%28COMT%29+proteins+and+enzymatic+activities+in+wild-type+and+S-COMT+deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DSchendzielorz%26aufirst%3DN.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DDistribution%2520of%2520catechol-O-methyltransferase%2520%2528COMT%2529%2520proteins%2520and%2520enzymatic%2520activities%2520in%2520wild-type%2520and%2520S-COMT%2520deficient%2520mice%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D113%26spage%3D1632%26epage%3D1643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ellingson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddempudi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhofer, G.</span><span> </span><span class="NLM_article-title">Determination of differential activities of soluble and mebrane-bound catechol-O-methyltransferase in tissues and erythrocytes</span> <span class="citation_source-journal">J. Chromatogr. B: Biomed. Sci. Appl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1–2</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0378-4347%2899%2900125-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=1999&pages=347-353&author=T.+Ellingsonauthor=S.+Duddempudiauthor=B.+D.+Greenbergauthor=D.+Hooperauthor=G.+Eisenhofer&title=Determination+of+differential+activities+of+soluble+and+mebrane-bound+catechol-O-methyltransferase+in+tissues+and+erythrocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0378-4347%2899%2900125-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4347%252899%252900125-5%26sid%3Dliteratum%253Aachs%26aulast%3DEllingson%26aufirst%3DT.%26aulast%3DDuddempudi%26aufirst%3DS.%26aulast%3DGreenberg%26aufirst%3DB.%2BD.%26aulast%3DHooper%26aufirst%3DD.%26aulast%3DEisenhofer%26aufirst%3DG.%26atitle%3DDetermination%2520of%2520differential%2520activities%2520of%2520soluble%2520and%2520mebrane-bound%2520catechol-O-methyltransferase%2520in%2520tissues%2520and%2520erythrocytes%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Biomed.%2520Sci.%2520Appl.%26date%3D1999%26volume%3D1%25E2%2580%25932%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Borchardt, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, P. H.</span><span> </span><span class="NLM_article-title">The purification and kinetic properties of liver microsomal-catechol-O-methyltransferase</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1974&pages=1089-1100&author=R.+T.+Borchardtauthor=C.-F.+Chengauthor=P.+H.+Cooke&title=The+purification+and+kinetic+properties+of+liver+microsomal-catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26aulast%3DCheng%26aufirst%3DC.-F.%26aulast%3DCooke%26aufirst%3DP.%2BH.%26atitle%3DThe%2520purification%2520and%2520kinetic%2520properties%2520of%2520liver%2520microsomal-catechol-O-methyltransferase%26jtitle%3DLife%2520Sci.%26date%3D1974%26volume%3D14%26spage%3D1089%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tenhunen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salminen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalanko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukkonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span> </span><span class="NLM_article-title">Structure of the rat catechol-<i>O</i>-methyltransferase gene: Separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme</span> <span class="citation_source-journal">DNA Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=253-263&author=J.+Tenhunenauthor=M.+Salminenauthor=A.+Jalankoauthor=S.+Ukkonenauthor=I.+Ulmanen&title=Structure+of+the+rat+catechol-O-methyltransferase+gene%3A+Separate+promoters+are+used+to+produce+mRNAs+for+soluble+and+membrane-bound+forms+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTenhunen%26aufirst%3DJ.%26aulast%3DSalminen%26aufirst%3DM.%26aulast%3DJalanko%26aufirst%3DA.%26aulast%3DUkkonen%26aufirst%3DS.%26aulast%3DUlmanen%26aufirst%3DI.%26atitle%3DStructure%2520of%2520the%2520rat%2520catechol-O-methyltransferase%2520gene%253A%2520Separate%2520promoters%2520are%2520used%2520to%2520produce%2520mRNAs%2520for%2520soluble%2520and%2520membrane-bound%2520forms%2520of%2520the%2520enzyme%26jtitle%3DDNA%2520Cell%2520Biol.%26date%3D1993%26volume%3D12%26spage%3D253%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Grossman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budarf, M. L.</span><span> </span><span class="NLM_article-title">Chromosomal mapping of the human catechol-<i>O</i>-methyltransferase gene to 22q11.1→q11.2</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">822</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=822-825&author=M.+H.+Grossmanauthor=B.+S.+Emanuelauthor=M.+L.+Budarf&title=Chromosomal+mapping+of+the+human+catechol-O-methyltransferase+gene+to+22q11.1%E2%86%92q11.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DM.%2BH.%26aulast%3DEmanuel%26aufirst%3DB.%2BS.%26aulast%3DBudarf%26aufirst%3DM.%2BL.%26atitle%3DChromosomal%2520mapping%2520of%2520the%2520human%2520catechol-O-methyltransferase%2520gene%2520to%252022q11.1%25E2%2586%2592q11.2%26jtitle%3DGenomics%26date%3D1992%26volume%3D12%26spage%3D822%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lotta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melén, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julkunen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">4202</span><span class="NLM_x">–</span> <span class="NLM_lpage">4210</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00013a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXks1Kisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=4202-4210&author=T.+Lottaauthor=J.+Vidgrenauthor=C.+Tilgmannauthor=I.+Ulmanenauthor=K.+Mel%C3%A9nauthor=I.+Julkunenauthor=J.+Taskinen&title=Kinetics+of+human+soluble+and+membrane-bound+catechol+O-methyltransferase%3A+A+revised+mechanism+and+description+of+the+thermolabile+variant+of+the+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme</span></div><div class="casAuthors">Lotta, Timo; Vidgren, Jukka; Tilgmann, Carola; Ulmanen, Ismo; Melen, Krister; Julkunen, Ilkka; Taskinen, Jyrki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4202-10</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human sol. (S) and membrane-bound (MB) catechol O-methyltransferase (COMT, EC 2.1.1.6) enzymes have been expressed at sufficiently high levels of Escherichia coli and in baculovirus-infected insect cells to allow kinetic characterization of the enzyme forms.  The use of tight-binding inhibitors such as entacapone enabled the estn. of actual enzyme concns. and, thereby, comparison of velocity parameters, substrate selectivity, and regioselectivity of the methylation of both enzyme forms.  Kinetics of the methylation reaction of dopamine, (-)-noradrenaline, L-dopa, and 3,4-dihydroxybenzoic acid was studied in detail.  Here, the catalytic no. (Vmax) of S-COMT was somewhat higher than that of MB-COMT for all four substrates.  The Km values varied considerably, depending on both substrate and enzyme form.  S-COMT showed about 15 times higher Km values for catecholamines than MB-COMT.  The distinctive difference between the enzyme forms was also the higher affinity of MB-COMT for the coenzyme S-adenosyl-L-methionine (AdoMet).  The av. dissocn. consts. Ks were 3.4 and 20.2 μM for MB-COMT and S-COMT, resp.  Comparison between the kinetic results and the at. structure of S-COMT is presented, and a revised mechanism for the reaction cycle is discussed.  Two recently published human COMT cDNA sequences differed in the position of S-COMT amino acid 108, the residue being either Val-108 [Lundstroem et al. (1991) DNA Cell. Biol. 10, 181-189] or Met-108 [Bertocci et al. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 1416-1420].  The catalytic activities of these two COMT variants, expressed in E. coli, were similar, but the Met-108 enzyme was more thermolabile already at physiol. temp. (37°).  The reported existence of a common polymorphism of the human COMT gene coding for a thermolabile low activity, COMTL, and a thermostable high activity, COMTH, is discussed in light of the different thermostability of the two enzyme forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfn6AZM45drLVg90H21EOLACvtfcHk0ljvfQRsRFclIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXks1Kisrc%253D&md5=f97041642b8258b067ee667021ed37c4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi00013a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00013a008%26sid%3Dliteratum%253Aachs%26aulast%3DLotta%26aufirst%3DT.%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DUlmanen%26aufirst%3DI.%26aulast%3DMel%25C3%25A9n%26aufirst%3DK.%26aulast%3DJulkunen%26aufirst%3DI.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DKinetics%2520of%2520human%2520soluble%2520and%2520membrane-bound%2520catechol%2520O-methyltransferase%253A%2520A%2520revised%2520mechanism%2520and%2520description%2520of%2520the%2520thermolabile%2520variant%2520of%2520the%2520enzyme%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D4202%26epage%3D4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Karhunen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulmanen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julkunen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panula, P.</span><span> </span><span class="NLM_article-title">Distribution of catechol-<i>O</i>-methyltransferase enzyme in rat tissues</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1177%2F42.8.8027527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8027527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2cXltlSltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1994&pages=1079-1090&author=T.+Karhunenauthor=C.+Tilgmannauthor=I.+Ulmanenauthor=I.+Julkunenauthor=P.+Panula&title=Distribution+of+catechol-O-methyltransferase+enzyme+in+rat+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of catechol-O-methyltransferase enzyme in rat tissues</span></div><div class="casAuthors">Karhunen, Tuula; Tilgmann, Carola; Ulmanen, Ismo; Julkunen, Ilkka; Panula, Pertti</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1079-90</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">In the present study the authors show the distribution of catechol O-methyltransferase (COMT) in various rat tissues with a highly specific antiserum prepd. against recombinant rat COMT.  Immunopptn. and immunocytochem. controls confirmed the COMT specificity of the antibodies.  The antiserum detected both the 24 kDa sol. and the 28 kDa membrane-bound forms of the enzyme.  By immunohistochem. staining the COMT enzyme was found in most rat tissues.  Staining was most intense in the liver and in the kidney, in agreement with previous studies and the authors' immunoblotting results.  In the gastrointestinal tract, epithelial cells of the stomach, duodenum, and ileum were immunoreactive for COMT.  In the pancreas, COMT immunoreactivity was found in insulin-producing β-cells and somatostatin-producing D-cells but not in glucagon-producing α-cells of the islets of Langerhans.  In the pituitary, COMT immunoreactivity was found in cleft cells, in pituicytes of the posterior lobe, and in the anterior lobe, partly in the cells contg. LH.  In other endocrine organs, COMT immunoreactivity was found in epithelial cells of the thyroid gland and in zona glomerulosa of the adrenal cortex.  In the brain, brightest immunofluorescence was seen in ependymal cells of the cerebral ventricles and choroid plexus.  Weak to moderate immunofluorescence was found in the neuropil of several brain areas, including striatum and cortex.  Scattered small neurons in spinal sensory ganglia were also COMT immunoreactive.  Previous immunocytochem. studies, enzyme activity detns., and distribution of the COMT mRNA are in general agreement with the results presented here.  The wide distribution of COMT in different tissues suggests an important role for this protein in activation of catechol compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvw8XXI5XPILVg90H21EOLACvtfcHk0ljvfQRsRFclIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltlSltLo%253D&md5=164e17c68070ba15dd1592504f5af7fc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1177%2F42.8.8027527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F42.8.8027527%26sid%3Dliteratum%253Aachs%26aulast%3DKarhunen%26aufirst%3DT.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DUlmanen%26aufirst%3DI.%26aulast%3DJulkunen%26aufirst%3DI.%26aulast%3DPanula%26aufirst%3DP.%26atitle%3DDistribution%2520of%2520catechol-O-methyltransferase%2520enzyme%2520in%2520rat%2520tissues%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1994%26volume%3D42%26spage%3D1079%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Roth, J. A.</span><span> </span><span class="NLM_article-title">Membrane-bound catechol-O-methyltransferase: A re-evaluation of its role in the O-methylation of catecholamine neurotransmitters</span> <span class="citation_source-journal">Rev. Physiol. Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBFb0036121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1519017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1entA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1992&pages=1-29&author=J.+A.+Roth&title=Membrane-bound+catechol-O-methyltransferase%3A+A+re-evaluation+of+its+role+in+the+O-methylation+of+catecholamine+neurotransmitters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-bound catechol-O-methyltransferase:  A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters</span></div><div class="casAuthors">Roth, Jerome A.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-29</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    </div><div class="casAbstract">A review, with 82 refs.  The following topics are discussed: contribution of sol. catechol-O-methyltransferase (COMT) and membrane-bound COMT (MB-COMT) to O-methylation of catecholamines, biochem. properties of MB-COMT; MB-COMT in human brain, significance and localization of MB-COMT; genetic regulation of sol. COMT and MB-COMT; and new COMT inhibitors as anti-Parkinson's disease and anti-depressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCHh4PSD2UbVg90H21EOLACvtfcHk0ljvfQRsRFclIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1entA%253D%253D&md5=17842053668c4372dcedbd51782c0454</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBFb0036121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBFb0036121%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DMembrane-bound%2520catechol-O-methyltransferase%253A%2520A%2520re-evaluation%2520of%2520its%2520role%2520in%2520the%2520O-methylation%2520of%2520catecholamine%2520neurotransmitters%26jtitle%3DRev.%2520Physiol.%2520Biochem.%2520Pharmacol.%26date%3D1992%26volume%3D120%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Huotari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raasmaja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyttinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.0953-816x.2001.01856.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11849292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=246-256&author=M.+Huotariauthor=J.+A.+Gogosauthor=M.+Karayiorgouauthor=O.+Koponenauthor=M.+Forsbergauthor=A.+Raasmajaauthor=J.+Hyttinenauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Brain+catecholamine+metabolism+in+catechol-O-methyltransferase+%28COMT%29-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice</span></div><div class="casAuthors">Huotari Marko; Gogos Joseph A; Karayiorgou Maria; Koponen Olli; Forsberg Markus; Raasmaja Atso; Hyttinen Juha; Mannisto Pekka T</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-56</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) catalyses the O-methylation of compounds having a catechol structure and its main function involves the elimination of biologically active or toxic catechols and their metabolites.  By means of homologous recombination in embryonic stem cells, a strain of mice has been produced in which the gene encoding the COMT enzyme is disrupted.  We report here the levels of catecholamines and their metabolites in striatal extracellular fluid in these mice as well as in homogenates from different parts of the brain, under normal conditions and after acute levodopa administration.  In immunoblotting studies, COMT-knockout mice had no COMT protein in brain or kidney tissues but the amounts of catecholamine synthesizing and other metabolizing enzyme proteins were normal.  Under normal conditions, COMT deficiency does not appear to affect significantly brain dopamine and noradrenaline levels in spite of relevant changes in their metabolites.  This finding is consistent with previous pharmacological studies with COMT inhibitors and confirms the pivotal role of synaptic reuptake processes and monoamine oxidase-dependent metabolism in terminating the actions of catecholamines at nerve terminals.  In contrast, when COMT-deficient mice are challenged with l-dihydroxyphenylalanine, they show an extensive accumulation of 3,4-dihydroxyphenylacetic acid and dihydroxyphenylglycol and even dopamine, revealing an important role for COMT under such situations.  Notably, in some cases these changes appear to be Comt gene dosage-dependent, brain-region specific and sexually dimorphic.  Our results may have implications for improving the treatment of Parkinson's disease and for understanding the contribution of the natural variation in COMT activity to psychiatric phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQem9MhWlUjNBBrI9DTGjC0fW6udTcc2eYitn5Zs2CL0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVynug%253D%253D&md5=7993411fcf4fa9d03717489e3f29271d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01856.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01856.x%26sid%3Dliteratum%253Aachs%26aulast%3DHuotari%26aufirst%3DM.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26aulast%3DKoponen%26aufirst%3DO.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DRaasmaja%26aufirst%3DA.%26aulast%3DHyttinen%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DBrain%2520catecholamine%2520metabolism%2520in%2520catechol-O-methyltransferase%2520%2528COMT%2529-deficient%2520mice%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Coward, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slixz, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F. Y.</span><span> </span><span class="NLM_article-title">Kinetic studies on catechol O-methyltransferase: Product inhibition and the nature of the catechol binding site</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2291</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00736a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1973&pages=2291-2297&author=J.+K.+Cowardauthor=E.+P.+Slixzauthor=F.+Y.+Wu&title=Kinetic+studies+on+catechol+O-methyltransferase%3A+Product+inhibition+and+the+nature+of+the+catechol+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi00736a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00736a017%26sid%3Dliteratum%253Aachs%26aulast%3DCoward%26aufirst%3DJ.%2BK.%26aulast%3DSlixz%26aufirst%3DE.%2BP.%26aulast%3DWu%26aufirst%3DF.%2BY.%26atitle%3DKinetic%2520studies%2520on%2520catechol%2520O-methyltransferase%253A%2520Product%2520inhibition%2520and%2520the%2520nature%2520of%2520the%2520catechol%2520binding%2520site%26jtitle%3DBiochemistry%26date%3D1973%26volume%3D12%26spage%3D2291%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Woodard, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floss, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, J. K.</span><span> </span><span class="NLM_article-title">Stereochemical course of the transmethylation catalyzed by catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">9124</span><span class="NLM_x">–</span> <span class="NLM_lpage">9127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=9124-9127&author=R.+W.+Woodardauthor=M.+D.+Tsaiauthor=H.+G.+Flossauthor=P.+A.+Crooksauthor=J.+K.+Coward&title=Stereochemical+course+of+the+transmethylation+catalyzed+by+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodard%26aufirst%3DR.%2BW.%26aulast%3DTsai%26aufirst%3DM.%2BD.%26aulast%3DFloss%26aufirst%3DH.%2BG.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DCoward%26aufirst%3DJ.%2BK.%26atitle%3DStereochemical%2520course%2520of%2520the%2520transmethylation%2520catalyzed%2520by%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D9124%26epage%3D9127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruderer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase-inhibiting pyrocatechol derivatives: Synthesis and structure–activity studies</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1989&pages=952-968&author=J.+Borgulyaauthor=H.+Brudererauthor=K.+Bernauerauthor=G.+Zurcherauthor=M.+Da+Prada&title=Catechol-O-methyltransferase-inhibiting+pyrocatechol+derivatives%3A+Synthesis+and+structure%E2%80%93activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DBruderer%26aufirst%3DH.%26aulast%3DBernauer%26aufirst%3DK.%26aulast%3DZurcher%26aufirst%3DG.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DCatechol-O-methyltransferase-inhibiting%2520pyrocatechol%2520derivatives%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1989%26volume%3D72%26spage%3D952%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vidgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilgmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljas, A.</span><span> </span><span class="NLM_article-title">Crystallisation and preliminary X-ray investigation of a recombinant form of rat catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=233-236&author=J.+Vidgrenauthor=C.+Tilgmannauthor=K.+Lundstr%C3%B6mauthor=A.+Liljas&title=Crystallisation+and+preliminary+X-ray+investigation+of+a+recombinant+form+of+rat+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVidgren%26aufirst%3DJ.%26aulast%3DTilgmann%26aufirst%3DC.%26aulast%3DLundstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DLiljas%26aufirst%3DA.%26atitle%3DCrystallisation%2520and%2520preliminary%2520X-ray%2520investigation%2520of%2520a%2520recombinant%2520form%2520of%2520rat%2520catechol-O-methyltransferase%26jtitle%3DProteins%26date%3D1991%26volume%3D11%26spage%3D233%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span> </span><span class="NLM_article-title">Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fbcp.12169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=410-420&author=Z.+Maauthor=H.+Liuauthor=B.+Wu&title=Structure-based+drug+design+of+catechol-O-methyltransferase+inhibitors+for+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12169%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure-based%2520drug%2520design%2520of%2520catechol-O-methyltransferase%2520inhibitors%2520for%2520CNS%2520disorders%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D77%26spage%3D410%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rutherford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Trong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenkamp, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parson, W. W.</span><span> </span><span class="NLM_article-title">Crystal structures of human 108V and 108M catechol O-methyltransferase</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2008&pages=120-130&author=K.+Rutherfordauthor=I.+Le+Trongauthor=R.+E.+Stenkampauthor=W.+W.+Parson&title=Crystal+structures+of+human+108V+and+108M+catechol+O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRutherford%26aufirst%3DK.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DStenkamp%26aufirst%3DR.%2BE.%26aulast%3DParson%26aufirst%3DW.%2BW.%26atitle%3DCrystal%2520structures%2520of%2520human%2520108V%2520and%2520108M%2520catechol%2520O-methyltransferase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D380%26spage%3D120%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elorriaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase by <i>N</i>-(3,4-dihydroxyphenyl) maleimide</span> <span class="citation_source-journal">J. Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F14756369009030387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2128841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVOhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1990&pages=43-50&author=F.+J.+Piedrafitaauthor=C.+Elorriagaauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nieto&title=Inhibition+of+catechol-O-methyltransferase+by+N-%283%2C4-dihydroxyphenyl%29+maleimide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide</span></div><div class="casAuthors">Piedrafita, F. J.; Elorriaga, C.; Fernandez-Alvarez, E.; Nieto, O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (EC 2.1.1.6, COMT) is inhibited rapidly and irreversibly by N-(3,4-dihydroxyphenyl) maleimide.  S-Adenosylmethionine (AdoMet) and Mg ions protect the enzyme from inactivation by this compd., but no protection is obsd. by the catechol substrate.  However, the corresponding succinimide analog shows a reversible inhibition of COMT, which is competitive with pyrocatecholphthalein and noncompetitive with AdoMet.  Amino group reagents also inhibit COMT and this inhibition is protected by AdoMet, suggesting that SH and amino groups essential for activity are located in an AdoMet-binding site on COMT.  The maleimide deriv. may be considered to be an active site directed inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOTAKp4wDbdLVg90H21EOLACvtfcHk0lgThNiA7vScEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVOhtL4%253D&md5=2c49534fccd483134be3349aa2331b4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3109%2F14756369009030387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756369009030387%26sid%3Dliteratum%253Aachs%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26aulast%3DElorriaga%26aufirst%3DC.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520by%2520N-%25283%252C4-dihydroxyphenyl%2529%2520maleimide%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D1990%26volume%3D4%26spage%3D43%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jatana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apoorva, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, Sonika</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latha, N.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-O-methyltransferase in the treatment of neurological disorders</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2174%2F1871524913666140109113341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=24450388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOnsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=166-194&author=N.+Jatanaauthor=N.+Apoorvaauthor=Sonika+Malikauthor=A.+Sharmaauthor=N.+Latha&title=Inhibitors+of+catechol-O-methyltransferase+in+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders</span></div><div class="casAuthors">Jatana, Nidhi; Apoorva, N.; Malik, Sonika; Sharma, Aditya; Latha, Narayanan</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-194</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Catechol-O-methyltransferase (COMT) is the enzyme which catalyzes the transfer of a Me group from S-adenosylmethionine to catechols and catecholamines, like the neurotransmitters dopamine, epinephrine and norepinephrine.  COMT has implications in many neurol. and psychiatric disorders like schizophrenia, Parkinson's disease (PD), bipolar disorders, etc. and therefore, it serves as an important drug target.  Since its characterization in 1957, many inhibitors were designed where the first generation inhibitors were found to be highly toxic, short acting and had poor bioavailability.  Currently, two of the second generation inhibitors, tolcapone and entacapone have been used for treatment of PD but are assocd. with various dopaminergic and gastro-intestinal side-effects.  There have been several approaches for the design of novel COMT inhibitors with a good and safe therapeutic profile.  The focus of this article is to review the current knowledge on COMT and the role of COMT inhibitors in the treatment of neurol. disorders.  The inhibitors have been classified into six different classes based on the structural framework.  A historical overview of the discovery and development of COMT inhibitors is presented with a special emphasis on new generation of inhibitors till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJPFjVGa4dHrVg90H21EOLACvtfcHk0lgThNiA7vScEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOnsLnK&md5=4eea3036094000e1183637fb4f4b1123</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F1871524913666140109113341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524913666140109113341%26sid%3Dliteratum%253Aachs%26aulast%3DJatana%26aufirst%3DN.%26aulast%3DApoorva%26aufirst%3DN.%26aulast%3DMalik%26aufirst%3DSonika%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DLatha%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520in%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D166%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span> </span><span class="NLM_article-title">New selective COMT inhibitors: useful adjuncts for Parkinson’s disease?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1989&pages=54-56&author=P.+T.+M%C3%A4nnist%C3%B6author=S.+Kaakkola&title=New+selective+COMT+inhibitors%3A+useful+adjuncts+for+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DKaakkola%26aufirst%3DS.%26atitle%3DNew%2520selective%2520COMT%2520inhibitors%253A%2520useful%2520adjuncts%2520for%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1989%26volume%3D10%26spage%3D54%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Sharif, A. A.</span><span> </span><span class="NLM_article-title">Entacapone in restless legs syndrome</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=421&author=A.+A.+Sharif&title=Entacapone+in+restless+legs+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharif%26aufirst%3DA.%2BA.%26atitle%3DEntacapone%2520in%2520restless%2520legs%2520syndrome%26jtitle%3DMov.%2520Disord.%26date%3D2002%26volume%3D17%26spage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Egan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolachana, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callicott, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzanti, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. USA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">6917</span><span class="NLM_x">–</span> <span class="NLM_lpage">6922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=6917-6922&author=M.+F.+Eganauthor=T.+E.+Goldbergauthor=B.+S.+Kolachanaauthor=J.+H.+Callicottauthor=C.+M.+Mazzantiauthor=R.+E.+Straubauthor=D.+Goldmanauthor=D.+R.+Weinberger&title=Effect+of+COMT+Val108%2F158+Met+genotype+on+frontal+lobe+function+and+risk+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DGoldberg%26aufirst%3DT.%2BE.%26aulast%3DKolachana%26aufirst%3DB.%2BS.%26aulast%3DCallicott%26aufirst%3DJ.%2BH.%26aulast%3DMazzanti%26aufirst%3DC.%2BM.%26aulast%3DStraub%26aufirst%3DR.%2BE.%26aulast%3DGoldman%26aufirst%3DD.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DEffect%2520of%2520COMT%2520Val108%252F158%2520Met%2520genotype%2520on%2520frontal%2520lobe%2520function%2520and%2520risk%2520for%2520schizophrenia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520USA%26date%3D2001%26volume%3D98%26spage%3D6917%26epage%3D6922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Fava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolsky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alpert, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottiglieri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moroz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, G.</span><span> </span><span class="NLM_article-title">Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004714-199908000-00008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10440460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1aisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=329-335&author=M.+Favaauthor=J.+F.+Rosenbaumauthor=A.+R.+Kolskyauthor=J.+E.+Alpertauthor=A.+A.+Nierenbergauthor=M.+Spillmannauthor=C.+Mooreauthor=P.+Renshawauthor=T.+Bottiglieriauthor=G.+Morozauthor=G.+Magni&title=Open+study+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+in+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder</span></div><div class="casAuthors">Fava, Maurizio; Rosenbaum, Jerrold F.; Kolsky, Andrea R.; Alpert, Jonathan E.; Nierenberg, Andrew A.; Spillmann, Maya; Moore, Constance; Renshaw, Perry; Bottiglieri, Teodoro; Moroz, Georges; Magni, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Tolcapone is a catechol-O-methyltransferase (COMT) inhibitor that has shown efficacy in the treatment of Parkinson's disease.  The authors undertook the first study on the efficacy of this COMT inhibitor in the treatment of major depressive disorder (MDD).  The authors also wanted to assess the effects of tolcapone on the choline and myoinositol resonances in the left caudate and dorsolateral frontal lobe through proton magnetic resonance spectroscopy and on whole blood levels of S-adenosyl-L-methionine (SAMe).  The study enrolled 21 adults (10 men and 11 women; mean age, 42.6±9.6 yr) with MDD, which was diagnosed using the Structured Clin. Interview for DSM-IV, and an initial score of≥16 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17).  Patients were then treated openly for 8 wk with tolcapone 400 mg twice daily.  Treatment efficacy was assessed with the HAM-D-17, the Clin. Global Impressions Severity (CGI-S) scale, and the Beck Depression Inventory (BDI).  Among all subjects (N = 21), there were significant (p <.0001) decreases at endpoint in HAM-D-17 scores (from 19.4±2.9 to 10.7±5.5), CGI-S scores (from 3.9±0.6 to 2.4±1.1), and BDI scores (from 21.6±8.1 to 12.3±8.6).  Eight patients (38%) dropped out before completing the 8-wk open study because of diarrhea, elevated liver function tests, increased anxiety, and non-compliance.  No significant effects were noted on choline and myoinositol resonance or on SAMe levels in whole blood before and after 2 wk of tolcapone treatment.  The preliminary results suggest that tolcapone may be a promising agent in the treatment of MDD.  Furthermore, double-blind, placebo-controlled studies are necessary to confirm this impression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn_3Adio8eT7Vg90H21EOLACvtfcHk0lhH8SEcNp9BiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1aisL0%253D&md5=acc57237b57733bfaaad60957265b2ad</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1097%2F00004714-199908000-00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199908000-00008%26sid%3Dliteratum%253Aachs%26aulast%3DFava%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DJ.%2BF.%26aulast%3DKolsky%26aufirst%3DA.%2BR.%26aulast%3DAlpert%26aufirst%3DJ.%2BE.%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DSpillmann%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DC.%26aulast%3DRenshaw%26aufirst%3DP.%26aulast%3DBottiglieri%26aufirst%3DT.%26aulast%3DMoroz%26aufirst%3DG.%26aulast%3DMagni%26aufirst%3DG.%26atitle%3DOpen%2520study%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520tolcapone%2520in%2520major%2520depressive%2520disorder%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D329%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lachman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papolos, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szumlanski, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshilboum, R. M.</span><span> </span><span class="NLM_article-title">Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00008571-199606000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8807664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK28XksFemsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=243-250&author=H.+M.+Lachmanauthor=D.+F.+Papolosauthor=T.+Saitoauthor=Y.+M.+Yuauthor=C.+L.+Szumlanskiauthor=R.+M.+Weinshilboum&title=Human+catechol-O-methyltransferase+pharmacogenetics%3A+Description+of+a+functional+polymorphism+and+its+potential+application+to+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders</span></div><div class="casAuthors">Lachman, Herbert M.; Papolos, Demitri F.; Saito, Takuya; Yu, Yue-Min; Szumlanski, Carol L.; Weinshilboum, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-250</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Chapman & Hall</span>)
        </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) inactivates catecholamines and catechol drugs such as L-DOPA.  A common genetic polymorphism in humans is assocd. with a three-to-four-fold variation in COMT enzyme activity and is also assocd. with individual variation in COMT thermal instability.  We now show that this is due to G→A transition at codon 158 of the COMT gene that results in a valine to methionine substitution.  The two alleles can be identified with a PCR-based restriction fragment length polymorphism anal. using the restriction enzyme N1a III.  The identification of a genetic marker assocd. with significant alterations is enzyme activity will facilitate the anal. of a possible role for the COMT gene in neuropsychiatric conditions in which abnormalities in catecholamine neurotransmission are believed to occur, including mood disorders, schizophrenia, obsessive compulsive disorder, alc. and substance abuse, and attention deficit hyperactivity disorder.  In addn., this polymorphism may have pharmacogenetic significance in that it will help make it possible to identify patients who display altered metab. of catechol drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEjfvU45qu7rVg90H21EOLACvtfcHk0lhH8SEcNp9BiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFemsLw%253D&md5=b1a6c776f38a9b218d54a26f9efa9c7d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1097%2F00008571-199606000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008571-199606000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DLachman%26aufirst%3DH.%2BM.%26aulast%3DPapolos%26aufirst%3DD.%2BF.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%2BM.%26aulast%3DSzumlanski%26aufirst%3DC.%2BL.%26aulast%3DWeinshilboum%26aufirst%3DR.%2BM.%26atitle%3DHuman%2520catechol-O-methyltransferase%2520pharmacogenetics%253A%2520Description%2520of%2520a%2520functional%2520polymorphism%2520and%2520its%2520potential%2520application%2520to%2520neuropsychiatric%2520disorders%26jtitle%3DPharmacogenetics%26date%3D1996%26volume%3D6%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Berk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauer-Sant’Anna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapczinski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T.</span><span> </span><span class="NLM_article-title">Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder</span> <span class="citation_source-journal">Acta Psychiatr. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0447.2007.01058.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=41-49&author=M.+Berkauthor=S.+Doddauthor=M.+Kauer-Sant%E2%80%99Annaauthor=G.+S.+Malhiauthor=M.+Bourinauthor=F.+Kapczinskiauthor=T.+Norman&title=Dopamine+dysregulation+syndrome%3A+Implications+for+a+dopamine+hypothesis+of+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0447.2007.01058.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0447.2007.01058.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DKauer-Sant%25E2%2580%2599Anna%26aufirst%3DM.%26aulast%3DMalhi%26aufirst%3DG.%2BS.%26aulast%3DBourin%26aufirst%3DM.%26aulast%3DKapczinski%26aufirst%3DF.%26aulast%3DNorman%26aufirst%3DT.%26atitle%3DDopamine%2520dysregulation%2520syndrome%253A%2520Implications%2520for%2520a%2520dopamine%2520hypothesis%2520of%2520bipolar%2520disorder%26jtitle%3DActa%2520Psychiatr.%2520Scand.%26date%3D2007%26volume%3D116%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrão, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">D<sub>1</sub>-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.1523-1755.2001.0590051683.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11318939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1683-1694&author=M.+A.+Vieira-Coelhoauthor=P.+Gomesauthor=M.+P.+Serr%C3%A3oauthor=P.+Soares-da-Silva&title=D1-like+dopamine+receptor+activation+and+natriuresis+by+nitrocatechol+COMT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors</span></div><div class="casAuthors">Vieira-Coelho, Maria Augusta; Gomes, Pedro; Serrao, Maria Paula; Soares-Da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1683-1694</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">In recent years, several nitrocatechol derivs. (tolcapone, entacapone, and nitecapone) have been developed and found to be highly selective and potent inhibitors of catechol-O-methyltransferase (COMT).  More recently, natriuretic properties were described for two of these compds. (entacapone and nitecapone), although this was not accompanied by enhanced urinary excretion of dopamine.  We hypothesized that nitrocatechol derivs. stimulate D1-like dopamine receptors.  Adult male Wistar rats were treated with a nitrocatechol COMT inhibitor (entacapone, tolcapone, or nitecapone, 30 mg/kg, orally), and the urinary excretion of dopamine and sodium was quantitated.  The interaction of nitrocatechol derivs. with D1-like receptors was evaluated by their ability to displace [3H]-Sch23390 binding from membranes of rat renal cortex and cAMP prodn. in opossum kidney (OK) cells.  Urinary excretion of sodium (μmol/h) was markedly increased by all three nitrocatechol derivs.: vehicle, 55.0 ± 5.6; entacapone, 98.4 ± 9.3; tolcapone, 97.5 ± 9.3; and nitecapone, 120.5 ± 12.6.  Pretreatment with the selective, D1 antagonist Sch 23390 (60 μg/kg) completely prevented their natriuretic effects.  Nitecapone and tolcapone were equipotent (IC of 48 and 42 μmol/L) and more potent than entacapone and dopamine (IC50s of 107 and 279 μmol/L) in displacing [3H]-Sch23390 binding.  In OK cells, all three nitrocatechol derivs. significantly increased cAMP accumulation and reduced Na+/H+ exchange and Na+ K+-ATPase activities, this being prevented by a blockade of D1-like receptors.  Stimulation of D1-like dopamine receptors and inhibition of Na+/H+ exchange and Na+, K+-ATPase activities by nitrocatechol COMT inhibitors may contribute to natriuresis produced by these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt3w4fBILa5bVg90H21EOLACvtfcHk0lgY6I9OZ7rEgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ehsL4%253D&md5=77802ae3c5d0677f0ed17a9fbbe7426a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2001.0590051683.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2001.0590051683.x%26sid%3Dliteratum%253Aachs%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DGomes%26aufirst%3DP.%26aulast%3DSerr%25C3%25A3o%26aufirst%3DM.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DD1-like%2520dopamine%2520receptor%2520activation%2520and%2520natriuresis%2520by%2520nitrocatechol%2520COMT%2520inhibitors%26jtitle%3DKidney%2520Int.%26date%3D2001%26volume%3D59%26spage%3D1683%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Larsen, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, E. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. G.</span><span> </span><span class="NLM_article-title">Effects of tolcapone, a catechol-<i>O</i>-methyltransferase inhibitor, and sinemet on intestinal electrolyte and fluid transport in conscious dogs</span> <span class="citation_source-journal">Dig. Dis. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1806</span><span class="NLM_x">–</span> <span class="NLM_lpage">1813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1023%2FA%3A1018852223902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9724173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVyqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=1806-1813&author=K.+R.+Larsenauthor=E.+Z.+Dajaniauthor=N.+E.+Dajaniauthor=M.+T.+Daytonauthor=J.+G.+Moore&title=Effects+of+tolcapone%2C+a+catechol-O-methyltransferase+inhibitor%2C+and+sinemet+on+intestinal+electrolyte+and+fluid+transport+in+conscious+dogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of tolcapone, a catechol-O-methyltransferase inhibitor, and Sinemet on intestinal electrolyte and fluid transport in conscious dogs</span></div><div class="casAuthors">Larsen, Kenneth R.; Dajani, Esam Z.; Dajani, Nora E.; Dayton, Merril T.; Moore, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Digestive Diseases and Sciences</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1806-1813</span>CODEN:
                <span class="NLM_cas:coden">DDSCDJ</span>;
        ISSN:<span class="NLM_cas:issn">0163-2116</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">Tolcapone (T) is a novel catechol-O-methyltransferase (COMT) inhibitor recently introduced for the treatment of Parkinson's disease.  In clin. efficacy studies, T has been assocd. with a low incidence of diarrhea.  The objectives of the study were to examine whether T and its adjunctive drug Sinemet (S) could influence intestinal fluid and electrolyte transport as a possible cause for the diarrhea.  The studies were conducted in conscious dogs surgically prepd. with Thiry-Vella loops constructed from a 40-cm jejunal segment.  A physiol. buffered test soln. was perfused into the oral stoma and collected from the caudad stoma.  Secretions were collected at 15-min intervals and analyzed for vol., electrolytes, lipid phosphorus, and protein.  The acute oral administration of T (10 and 30 mg/kg doses) was well tolerated.  Concurrent acute administration of S (25 mg/kg) with T (30 mg/kg) was also well tolerated.  The acute oral administration of T induced a dose-dependent efflux of intestinal fluid and electrolytes (sodium, potassium, chloride, and bicarbonate) secretion (P < 0.05).  The oral coadministration of S (25 mg/kg) with T (30 mg/kg) accelerated the onset of the stimulation of intestinal secretion.  Despite the significant stimulation of intestinal secretion, none of the dogs developed diarrhea, indicating the importance of intestinal compensatory mechanisms.  Neither T nor T&S affected calcium, lipid, or protein efflux rates, suggesting that the stimulated secretion was not a consequence of intestinal mucosal injury.  The chronic (seven-day) administration of T and T&S was assocd. with reduced intestinal secretory responses when compared with the acute administration of the same drugs; S enhanced the T-induced tolerance development.  The basis for such tolerance is unknown.  In conclusion, the stimulatory systemic actions of tolcapone on intestinal secretion may, under certain conditions, contribute to the induction of diarrhea in susceptible patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryU13DRqZsGbVg90H21EOLACvtfcHk0ljKbcub2CqC2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVyqsbg%253D&md5=74b066d9fb51e644cb8881c2bc3fc4a9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018852223902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018852223902%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DK.%2BR.%26aulast%3DDajani%26aufirst%3DE.%2BZ.%26aulast%3DDajani%26aufirst%3DN.%2BE.%26aulast%3DDayton%26aufirst%3DM.%2BT.%26aulast%3DMoore%26aufirst%3DJ.%2BG.%26atitle%3DEffects%2520of%2520tolcapone%252C%2520a%2520catechol-O-methyltransferase%2520inhibitor%252C%2520and%2520sinemet%2520on%2520intestinal%2520electrolyte%2520and%2520fluid%2520transport%2520in%2520conscious%2520dogs%26jtitle%3DDig.%2520Dis.%2520Sci.%26date%3D1998%26volume%3D43%26spage%3D1806%26epage%3D1813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Talan, J.</span><span> </span><span class="NLM_article-title">Attention deficit disorder associated with dopamine deficits in brain</span> <span class="citation_source-journal">Neurol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=19236723" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=10&author=J.+Talan&title=Attention+deficit+disorder+associated+with+dopamine+deficits+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalan%26aufirst%3DJ.%26atitle%3DAttention%2520deficit%2520disorder%2520associated%2520with%2520dopamine%2520deficits%2520in%2520brain%26jtitle%3DNeurol.%2520Today%26date%3D2009%26volume%3D9%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">DiMaio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joober, R.</span><span> </span><span class="NLM_article-title">Dopamine genes and attention-deficit hyperactivity disorder: A review</span> <span class="citation_source-journal">J. Psychiatry Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12587848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252Fns1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=27-38&author=S.+DiMaioauthor=N.+Grizenkoauthor=R.+Joober&title=Dopamine+genes+and+attention-deficit+hyperactivity+disorder%3A+A+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine genes and attention-deficit hyperactivity disorder: a review</span></div><div class="casAuthors">DiMaio Salvatore; Grizenko Nathalie; Joober Ridha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatry & neuroscience : JPN</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-38</span>
        ISSN:<span class="NLM_cas:issn">1180-4882</span>.
    </div><div class="casAbstract">OBJECTIVE:  To review the results of genetic studies investigating dopamine-related genes in attention-deficit hyperactivity disorder (ADHD).  DATA SOURCES:  Papers (association/linkage, meta-analyses and animal model studies) were identified through searches of the PubMed database and systematically reviewed.  DATA SYNTHESIS:  Consistent results from molecular genetic studies are pointing strongly to the possible link between 2 specific genes, the dopamine transporter (SLC3A6) and the dopamine receptor 4 (DRD4), and ADHD.  CONCLUSIONS:  The implication of SLC6A3 and DRD4 genes in ADHD appears to be one of the most replicated in psychiatric genetics and strongly suggests the involvement of the brain dopamine systems in the pathogenesis of ADHD.  However, more work is required to further these findings by genotype-to-phenotype correlations and identify the functional allelic variants/mutations that are responsible for these associations.  The role of other dopamine genes, which may have smaller effects than SLC6A3 and DRD4, needs also to be determined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIfPAxtqjoYhOk4JA3soTqfW6udTcc2eZqM7tRvuNKmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252Fns1Glsw%253D%253D&md5=485289692e83bcea52e47490f6186575</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMaio%26aufirst%3DS.%26aulast%3DGrizenko%26aufirst%3DN.%26aulast%3DJoober%26aufirst%3DR.%26atitle%3DDopamine%2520genes%2520and%2520attention-deficit%2520hyperactivity%2520disorder%253A%2520A%2520review%26jtitle%3DJ.%2520Psychiatry%2520Neurosci.%26date%3D2003%26volume%3D28%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Orth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in Parkinson’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0197-0186%2801%2900124-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11850110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFyktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=533-541&author=M.+Orthauthor=A.+H.+Schapira&title=Mitochondrial+involvement+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial involvement in Parkinson's disease</span></div><div class="casAuthors">Orth, M.; Schapira, A. H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-541</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review on the role of mitochondria in the pathogenesis of Parkinson's disease (PD) is discussed.  Oxidative phosphorylation system (OXPHOS) function is compromised in PD and complex I inhibition was used to produce rodent models of PD.  The prodn. of free radicals within mitochondria and from DA metab. could be enhanced by a pre-existing mitochondrial defect and in turn may produce OXPHOS dysfunction and mtDNA abnormalities.  The discovery of mutations underlying familial PD syndromes provides new models to understand the mechanisms of selective dopaminergic cell death and the involvement of mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRwYMKYqNfnbVg90H21EOLACvtfcHk0liG9wff5lJ9yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFyktb8%253D&md5=42e3c4ed4aa962ffe1613571ac411316</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0197-0186%2801%2900124-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-0186%252801%252900124-3%26sid%3Dliteratum%253Aachs%26aulast%3DOrth%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26atitle%3DMitochondrial%2520involvement%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2002%26volume%3D40%26spage%3D533%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase and catecholamine metabolism</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7931266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1994&pages=57-67&author=I.+J.+Kopin&title=Monoamine+oxidase+and+catecholamine+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase and catecholamine metabolism</span></div><div class="casAuthors">Kopin, I. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission, Supplement</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">JNTSD4</span>;
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">A review, with 68 refs., of the role of MAO in catecholamine metab. which discusses: biochem. assessment of catecholamine metab.; physiol. assessment of the role of MAO and COMT; clin. effects of MAO inhibitors; MAO subtypes; and deprenyl treatment in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokypN_UKb7F7Vg90H21EOLACvtfcHk0lgqcy-k3uV5lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFamu7w%253D&md5=f7b72f440235b6e8584db83132655597</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DMonoamine%2520oxidase%2520and%2520catecholamine%2520metabolism%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D1994%26volume%3D41%26spage%3D57%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Birkmayer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornykiewicz, O.</span><span> </span><span class="NLM_article-title">Der L-3,4-dioxyphenylalanin (L-DOPA)-effekt bei der Parkinson-akinese</span> <span class="citation_source-journal">Wien. Klin. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=13869404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaF38%252FhtVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1961&pages=787-788&author=W.+Birkmayerauthor=O.+Hornykiewicz&title=Der+L-3%2C4-dioxyphenylalanin+%28L-DOPA%29-effekt+bei+der+Parkinson-akinese"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia</span></div><div class="casAuthors">BIRKMAYER W; HORNYKIEWICZ O</div><div class="citationInfo"><span class="NLM_cas:title">Wiener klinische Wochenschrift</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">787-8</span>
        ISSN:<span class="NLM_cas:issn">0043-5325</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwpe8412F9xK2q3xNe7a7QfW6udTcc2eZ97Kqbo3_htLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF38%252FhtVKrsA%253D%253D&md5=1b9753c7fbfa3e24f006005b1d5bad66</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26aulast%3DHornykiewicz%26aufirst%3DO.%26atitle%3DDer%2520L-3%252C4-dioxyphenylalanin%2520%2528L-DOPA%2529-effekt%2520bei%2520der%2520Parkinson-akinese%26jtitle%3DWien.%2520Klin.%2520Wochenschr.%26date%3D1961%26volume%3D73%26spage%3D787%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Rinne, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molsa, P.</span><span> </span><span class="NLM_article-title">Levodopa with benserazide or carbidopa in Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1979&pages=1584-1589&author=U.+K.+Rinneauthor=P.+Molsa&title=Levodopa+with+benserazide+or+carbidopa+in+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DU.%2BK.%26aulast%3DMolsa%26aufirst%3DP.%26atitle%3DLevodopa%2520with%2520benserazide%2520or%2520carbidopa%2520in%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D1979%26volume%3D29%26spage%3D1584%26epage%3D1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellman, J. H.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of levodopa</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=35-39&author=J.+G.+Nuttauthor=J.+H.+Fellman&title=Pharmacokinetics+of+levodopa"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DFellman%26aufirst%3DJ.%2BH.%26atitle%3DPharmacokinetics%2520of%2520levodopa%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1984%26volume%3D7%26spage%3D35%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kuruma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletscher, A.</span><span> </span><span class="NLM_article-title">The metabolism of L-3-<i>O</i>-methyldopa, a precursor dopa in man</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2Fcpt1971124678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5567811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE3M3ot1Wlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1971&pages=678-682&author=I.+Kurumaauthor=G.+Bartholiniauthor=R.+Tissotauthor=A.+Pletscher&title=The+metabolism+of+L-3-O-methyldopa%2C+a+precursor+dopa+in+man"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of L-3-O-methyldopa, a precursor of dopa in man</span></div><div class="casAuthors">Kuruma I; Bartholini G; Tissot R; Pletscher A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">678-82</span>
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2qDicW6Xp0c-crCu0nI_sfW6udTcc2eZGt84NFhD9jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M3ot1Wlsw%253D%253D&md5=9c378263440c52982a1d49b1e6e8ddc3</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fcpt1971124678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt1971124678%26sid%3Dliteratum%253Aachs%26aulast%3DKuruma%26aufirst%3DI.%26aulast%3DBartholini%26aufirst%3DG.%26aulast%3DTissot%26aufirst%3DR.%26aulast%3DPletscher%26aufirst%3DA.%26atitle%3DThe%2520metabolism%2520of%2520L-3-O-methyldopa%252C%2520a%2520precursor%2520dopa%2520in%2520man%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D1971%26volume%3D12%26spage%3D678%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Nutt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckner, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berggren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gancher, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerstad, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span> </span><span class="NLM_article-title">Effect of peripheral catechol-<i>O</i>-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=913-919&author=J.+G.+Nuttauthor=W.+R.+Woodwardauthor=R.+M.+Becknerauthor=C.+K.+Stoneauthor=K.+Berggrenauthor=J.+H.+Carterauthor=S.+T.+Gancherauthor=J.+P.+Hammerstadauthor=A.+Gordin&title=Effect+of+peripheral+catechol-O-methyltransferase+inhibition+on+the+pharmacokinetics+and+pharmacodynamics+of+levodopa+in+parkinsonian+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DJ.%2BG.%26aulast%3DWoodward%26aufirst%3DW.%2BR.%26aulast%3DBeckner%26aufirst%3DR.%2BM.%26aulast%3DStone%26aufirst%3DC.%2BK.%26aulast%3DBerggren%26aufirst%3DK.%26aulast%3DCarter%26aufirst%3DJ.%2BH.%26aulast%3DGancher%26aufirst%3DS.%2BT.%26aulast%3DHammerstad%26aufirst%3DJ.%2BP.%26aulast%3DGordin%26aufirst%3DA.%26atitle%3DEffect%2520of%2520peripheral%2520catechol-O-methyltransferase%2520inhibition%2520on%2520the%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520levodopa%2520in%2520parkinsonian%2520patients%26jtitle%3DNeurology%26date%3D1994%26volume%3D44%26spage%3D913%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Green, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyoung, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R.</span><span> </span><span class="NLM_article-title">A gene-brain-cognition pathway: Prefrontal activity mediates the effect of COMT on cognitive control and IQ</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fcercor%2Fbhs035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=22368081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BC38vksVWmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=552-559&author=A.+E.+Greenauthor=D.+J.+Kraemerauthor=C.+G.+Deyoungauthor=J.+A.+Fossellaauthor=J.+R.+Gray&title=A+gene-brain-cognition+pathway%3A+Prefrontal+activity+mediates+the+effect+of+COMT+on+cognitive+control+and+IQ"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A gene-brain-cognition pathway: prefrontal activity mediates the effect of COMT on cognitive control and IQ</span></div><div class="casAuthors">Green Adam E; Kraemer David J M; Deyoung Colin G; Fossella John A; Gray Jeremy R</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">552-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A core thesis of cognitive neurogenetic research is that genetic effects on cognitive ability are mediated by specific neural functions, however, demonstrating neural mediation has proved elusive.  Pairwise relationships between genetic variation and brain function have yielded heterogeneous findings to date.  This heterogeneity indicates that a multiple mediator modeling approach may be useful to account for complex relationships involving function at multiple brain regions.  This is relevant not only for characterizing healthy cognition but for modeling the complex neural pathways by which disease-related genetic effects are transmitted to disordered cognitive phenotypes in psychiatric illness.  Here, in 160 genotyped functional magnetic resonance imaging participants, we used a multiple mediator model to test a gene-brain-cognition pathway by which activity in 4 prefrontal brain regions mediates the effects of catechol-O-methyltransferase (COMT) gene on cognitive control and IQ.  Results provide evidence for gene-brain-cognition mediation and help delineate a pathway by which gene expression contributes to intelligence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmpbR3jFKAWJNiNltV31zlfW6udTcc2ebeDjyyXuSE_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vksVWmtg%253D%253D&md5=8f7f4e7f32d20a2d15ee2aa852caa4d2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2Fbhs035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252Fbhs035%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BE.%26aulast%3DKraemer%26aufirst%3DD.%2BJ.%26aulast%3DDeyoung%26aufirst%3DC.%2BG.%26aulast%3DFossella%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DJ.%2BR.%26atitle%3DA%2520gene-brain-cognition%2520pathway%253A%2520Prefrontal%2520activity%2520mediates%2520the%2520effect%2520of%2520COMT%2520on%2520cognitive%2520control%2520and%2520IQ%26jtitle%3DCereb.%2520Cortex%26date%3D2013%26volume%3D23%26spage%3D552%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Apud, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">557</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2165%2F00023210-200721070-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17579498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFCis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=535-557&author=J.+A.+Apudauthor=D.+R.+Weinberger&title=Treatment+of+cognitive+deficits+associated+with+schizophrenia%3A+potential+role+of+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cognitive deficits associated with schizophrenia. Potential role of catechol-O-methyltransferase inhibitors</span></div><div class="casAuthors">Apud, Jose A.; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">535-557</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  In the last two decades, understanding of the dynamics of dopamine function in the prefrontal cortex and its role in prefrontal cortex physiol. has opened up new avenues for therapeutic interventions in conditions in which prefrontal cortex function is compromised.  Neuropsychol. and imaging studies of prefrontal information processing have confirmed specific cognitive and neurophysiol. abnormalities in individuals with schizophrenia.  Because such findings are also obsd. in the healthy siblings of patients with schizophrenia, they may represent intermediate phenotypes related to schizophrenia susceptibility genes.  Catechol-O-methyltransferase (COMT) represents an important candidate as a susceptibility gene for cognitive dysfunction in schizophrenia because of the unique role this enzyme plays in regulating prefrontal dopaminergic function.  A functional COMT polymorphism (Val158Met) predicts performance in tasks of prefrontal executive function and the neurophysiol. response measured with electroencephalog. and functional magnetic resonance imaging in tasks assessing working memory.  In fact, individuals with the Val/Val genotype, which encodes for the high-activity enzyme resulting in lower dopamine concns. in the prefrontal cortex, perform less well and are less efficient physiol. than Met/Met individuals.  These findings raise the possibility of new pharmacol. interventions for the treatment of prefrontal cortex dysfunction and of predicting outcome based on COMT genotype.  One strategy consists of the use of CNS-penetrant COMT inhibitors such as tolcapone.  A second strategy is to increase extracellular dopamine concns. in the frontal cortex by blocking the noradrenaline (norepinephrine) reuptake system, a secondary mechanism responsible for the disposal of dopamine from synaptic clefts in the prefrontal cortex.  A third possibility involves the use of modafinil, a drug with an unclear mechanism of action but with pos. effects on working memory in rodents.  The potential of these drugs to improve executive cognitive function by selectively increasing dopamine load in the frontal cortex but not in subcortical territories, and the possibility that response to them may be modified by a COMT polymorphism, provides a novel genotype-based targeted pharmacol. approach without abuse potential for the treatment of cognitive disorder in schizophrenia and in other conditions involving prefrontal cortex dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZmnS6TUnyZ7Vg90H21EOLACvtfcHk0liZgCLO3YFSnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFCis7s%253D&md5=380a19dbe5725aee9c41c264bee848ac</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2165%2F00023210-200721070-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200721070-00002%26sid%3Dliteratum%253Aachs%26aulast%3DApud%26aufirst%3DJ.%2BA.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520of%2520cognitive%2520deficits%2520associated%2520with%2520schizophrenia%253A%2520potential%2520role%2520of%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D535%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Talkowski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgieva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdari, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimgaonkar, V. L.</span><span> </span><span class="NLM_article-title">A network of dopaminergic gene variations implicated as risk factors for schizophrenia</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fhmg%2Fddm347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=18045777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=747-758&author=M.+E.+Talkowskiauthor=G.+Kirovauthor=M.+Bamneauthor=L.+Georgievaauthor=G.+Torresauthor=H.+Mansourauthor=K.+V.+Chowdariauthor=V.+Milanovaauthor=J.+Woodauthor=L.+McClainauthor=K.+Prasadauthor=B.+Shirtsauthor=J.+Zhangauthor=M.+C.+O%E2%80%99Donovanauthor=M.+J.+Owenauthor=B.+Devlinauthor=V.+L.+Nimgaonkar&title=A+network+of+dopaminergic+gene+variations+implicated+as+risk+factors+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A network of dopaminergic gene variations implicated as risk factors for schizophrenia</span></div><div class="casAuthors">Talkowski, Michael E.; Kirov, George; Bamne, Mikhil; Georgieva, Lyudmila; Torres, Gonzalo; Mansour, Hader; Chowdari, Kodavali V.; Milanova, Vihra; Wood, Joel; McClain, Lora; Prasad, Konasale; Shirts, Brian; Zhang, Jianping; O'Donovan, Michael C.; Owen, Michael J.; Devlin, Bernie; Nimgaonkar, Vishwajit L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-758</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ).  In stage I, we screened 18 dopamine-related genes in two independent US Caucasian samples: 150 trios and 328 cases/501 controls.  The most promising assocns. were detected with SLC6A3 (alias DAT), DRD3, COMT and SLC18A2 (alias VMAT2).  In stage II, we comprehensively evaluated these four genes by genotyping 68 SNPs in all 478 cases and 501 controls from stage I. Fifteen (23.1%) significant assocns. were found (p ≤ 0.05).  We sought epistasis between pairs of SNPs providing evidence of a main effect and obsd. 17 significant interactions (169 tests); 41.2% of significant interactions involved rs3756450 (5' near promoter) or rs464049 (intron 4) at SLC6A3.  In stage III, we confirmed our findings by genotyping 65 SNPs among 659 Bulgarian trios.  Both SLC6A3 variants implicated in the US interactions were overtransmitted in this cohort (rs3756450, p = 0.035; rs464049, p = 0.011).  Joint analyses from stages II and III identified assocns. at all four genes (pjoint < 0.05).  We tested 29 putative interactions from stage II and detected replication between seven locus pairs (p ≤ 0.05).  Simulations suggested our stage II and stage III interaction results were unlikely to have occurred by chance (p = 0.008 and 0.001, resp.).  In stage IV we evaluated rs464049 and rs3756450 for functional effects and found significant allele-specific differences at rs3756450 using electrophoretic mobility shift assays and dual-luciferase promoter assays.  Our data suggest that a network of dopaminergic polymorphisms increase risk for SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0YS6gKmgbQLVg90H21EOLACvtfcHk0lgVdhCBmuKrNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVemsrw%253D&md5=fee4e39fc949fab802dc77f0f6c6646b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddm347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddm347%26sid%3Dliteratum%253Aachs%26aulast%3DTalkowski%26aufirst%3DM.%2BE.%26aulast%3DKirov%26aufirst%3DG.%26aulast%3DBamne%26aufirst%3DM.%26aulast%3DGeorgieva%26aufirst%3DL.%26aulast%3DTorres%26aufirst%3DG.%26aulast%3DMansour%26aufirst%3DH.%26aulast%3DChowdari%26aufirst%3DK.%2BV.%26aulast%3DMilanova%26aufirst%3DV.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DMcClain%26aufirst%3DL.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DShirts%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BC.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DDevlin%26aufirst%3DB.%26aulast%3DNimgaonkar%26aufirst%3DV.%2BL.%26atitle%3DA%2520network%2520of%2520dopaminergic%2520gene%2520variations%2520implicated%2520as%2520risk%2520factors%2520for%2520schizophrenia%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2008%26volume%3D17%26spage%3D747%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Williams, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M. C.</span><span> </span><span class="NLM_article-title">Is COMT a susceptibility gene for schizophrenia?</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1093%2Fschbul%2Fsbm019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17412710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD2s3pslSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=635-641&author=H.+J.+Williamsauthor=M.+J.+Owenauthor=M.+C.+O%E2%80%99Donovan&title=Is+COMT+a+susceptibility+gene+for+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Is COMT a susceptibility gene for schizophrenia?</span></div><div class="casAuthors">Williams Hywel J; Owen Michael J; O'Donovan Michael C</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-41</span>
        ISSN:<span class="NLM_cas:issn">0586-7614</span>.
    </div><div class="casAbstract">Catechol-O-methyl transferase (COMT) is a catabolic enzyme involved in the degradation of a number of bioactive molecules; of principal interest to psychiatry, these include dopamine.  The enzyme is encoded by the COMT gene.  COMT is located (along with 47 other genes) in a fragment of chromosome 22q11 which when deleted results in a complex syndrome, the psychiatric manifestations of which include schizophrenia and other psychoses.  These 2 observations have placed COMT near the top of a rather long list of plausible candidate genes for schizophrenia.  The ability to test the hypothesis that COMT might be a susceptibility gene for schizophrenia has been simplified in principle by the existence of a valine-to-methionine (Val/Met) polymorphism which results respectively in high and low activity forms of the enzyme.  Given the unequivocal effect of this polymorphism on the function of COMT, and the evidence for a critical role for dopamine in the pathophysiology and treatment of psychosis, there are strong prior expectations that Val/Met influences susceptibility to schizophrenia as well as other psychiatric phenotypes.  Indeed the Val/Met polymorphism has become the most widely studied polymorphism in psychiatry.  In this review, we consider the evidence for and against the involvement of COMT in schizophrenia.  The current data allow us to virtually exclude a simple relationship between schizophrenia and the Val/Met variant previously thought to dominate COMT function.  However, recent data suggest a more complex pattern of genetic regulation of COMT function beyond that attributable to the Val/Met locus.  Moreover, it is also clear that there is a complex nonlinear relationship between dopamine availability and brain function.  These 2 factors, allied to phenotypic complexity within schizophrenia, make it difficult to draw strong conclusions regarding COMT in schizophrenia.  Nevertheless, emerging research that takes greater account of all these levels of complexity is beginning to provide tantalizing, but far from definitive, support for the view that COMT influences susceptibility to at least some forms of psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuOwJc-OjaynwOGIfWJ7-GfW6udTcc2eZ-QAksBPDOl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3pslSquw%253D%253D&md5=938a03107eec95dd327bbc2bb224b8f2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbm019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbm019%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DH.%2BJ.%26aulast%3DOwen%26aufirst%3DM.%2BJ.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%2BC.%26atitle%3DIs%2520COMT%2520a%2520susceptibility%2520gene%2520for%2520schizophrenia%253F%26jtitle%3DSchizophr.%2520Bull.%26date%3D2007%26volume%3D33%26spage%3D635%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Caramona, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1985.tb08903.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=3931730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2MXlvFSnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1985&pages=351-356&author=M.+M.+Caramonaauthor=P.+Soares-da-Silva&title=The+effects+of+chemical+sympathectomy+on+dopamine%2C+noradrenaline+and+adrenaline+content+in+some+peripheral+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues</span></div><div class="casAuthors">Caramona, M. M.; Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">351-6</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Dopamine  [51-61-6], noradrenaline (NA)  [51-41-2], and adrenaline (Ad)  [51-43-4] depletion by 6-hydroxydopamine (6-OHDA)  [1199-18-4] and pargyline  [555-57-7] plus 6-OHDA was investigated in the cat left ventricle, mesenteric and renal arteries, renal cortex, renal medulla, and adrenal medulla.  Catecholamine concns. in plasma were also analyzed in these 2 exptl. conditions.  6-OHDA alone or in combination with pargyline induced parallel decreases of NA and dopamine contents in the left ventricle.  In the main trunk and proximal branches of the mesenteric artery and renal artery 6-OHDA selectively reduced NA without a parallel decrease in dopamine content.  Previous treatment with pargyline abolished this selectivity.  In the kidney of control animals, dopamine content was greater than could be attributed to its presence only in noradrenergic neurons.  In the renal cortex 6-OHDA reduced dopamine and NA contents, and in the renal medulla only NA levels were decreased by this drug.  Pargyline plus 6-OHDA did not deplete the NA content either in the renal cortex or in the renal medulla, and only reduced the dopamine content in the renal cortex.  NA concns. in plasma were increased by pargyline plus 6-OHDA and Ad remained unaffected.  In the adrenal medulla only NA was reduced by 6-OHDA or pargyline plus 6-OHDA.  A NA-independent dopamine pool is suggested for both segments of the mesenteric artery and renal artery but not in the left ventricle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2VIUJTtqxHLVg90H21EOLACvtfcHk0lhHG7Nc3xCeWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlvFSnsL8%253D&md5=3fec52806c4d15280a9d76bff0d00dec</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1985.tb08903.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1985.tb08903.x%26sid%3Dliteratum%253Aachs%26aulast%3DCaramona%26aufirst%3DM.%2BM.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520effects%2520of%2520chemical%2520sympathectomy%2520on%2520dopamine%252C%2520noradrenaline%2520and%2520adrenaline%2520content%2520in%2520some%2520peripheral%2520tissues%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D86%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Evidence for dopaminergic co-transmission in dog mesenteric arterial vessels</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1988.tb16567.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2905904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL1cXlsVeisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1988&pages=218-224&author=P.+Soares-da-Silva&title=Evidence+for+dopaminergic+co-transmission+in+dog+mesenteric+arterial+vessels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for dopaminergic cotransmission in dog mesenteric arterial vessels</span></div><div class="casAuthors">Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-24</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The overflow of dopamine and noradrenaline (NA) from the main trunk of the dog mesenteric artery and its proximal branches during prolonged depolarization (120 min) by K+ (52 mM) was quantified by high performance liq. chromatog. with electrochem. detection.  K+-induced depolarization resulted in release of both dopamine and NA.  The amt. of NA released from both blood vessels declined progressively throughout the expt.  In the main trunk the same pattern of release was obsd. for dopamine, whereas in the proximal branches the overflow of dopamine increased throughout the expt.  The addn. of phentolamine (0.2 μM) to the perifusion fluid increased the overflow of both amines.  In the presence of sulpiride (1 μM) the overflow of dopamine and NA was increased in the proximal branches, but not in the main trunk.  The addn. of phentolamine to sulpiride caused a further increase in amine overflow in proximal branches, but not in the main trunk.  The addn. of α-methyl-p-tyrosine (50 μM) to the perifusion fluid caused a decrease in the amts. of dopamine and NA released from both prepns.  In α-methyl-p-tyrosine-treated prepns., phentolamine increased amine overflow to the same extent as in expts. without tyrosine hydroxylase inhibition.  The increasing effect of sulpiride on the overflow of dopamine and NA from the proximal branches was completely abolished after α-methyl-p-tyrosine.  Thus, in the proximal branches of the dog mesenteric artery, dopamine β-hydroxylase represents a rate limiting step in the synthesis of NA.  Dopamine, through activation of prejunctional dopamine receptors, acts like a prejunctional co-transmitter in the control of transmitter release; however, only newly-synthesized dopamine appears to be responsible for this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwW8b9zkgLNbVg90H21EOLACvtfcHk0lhHG7Nc3xCeWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsVeisLw%253D&md5=cceab9bf74878b6788ba0b32bc526ff3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb16567.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb16567.x%26sid%3Dliteratum%253Aachs%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DEvidence%2520for%2520dopaminergic%2520co-transmission%2520in%2520dog%2520mesenteric%2520arterial%2520vessels%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D95%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrão, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Renal and intestinal autocrine monoaminergic systems: Dopamine versus 5-hydroxytryptamine</span> <span class="citation_source-journal">Clin. Exp. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F10641969709080803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9028634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=43-58&author=M.+A.+Vieira-Coelhoauthor=P.+Gomesauthor=M.+P.+Serr%C3%A3oauthor=P.+Soares-da-Silva&title=Renal+and+intestinal+autocrine+monoaminergic+systems%3A+Dopamine+versus+5-hydroxytryptamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Renal and intestinal autocrine monoaminergic systems: dopamine versus 5-hydroxytryptamine</span></div><div class="casAuthors">Vieira-Coelho, M. A.; Gomes, P.; Serrao, M. P.; Soares-da-Silva, P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Hypertension</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1 & 2</span>),
    <span class="NLM_cas:pages">43-58</span>CODEN:
                <span class="NLM_cas:coden">CEHYER</span>;
        ISSN:<span class="NLM_cas:issn">1064-1963</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">A review, with 22 refs., of the basic mechanisms involved in the formation of dopamine and serotonin in renal and intestinal epithelial cells and of the antagonistic nature of dopaminergic and serotoninergic tonus at the kidney and intestinal level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJis3lx_IZ7bVg90H21EOLACvtfcHk0lhHG7Nc3xCeWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlGisb4%253D&md5=84a4de46c48a0cddf7d77b70c99fa311</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F10641969709080803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969709080803%26sid%3Dliteratum%253Aachs%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DGomes%26aufirst%3DP.%26aulast%3DSerr%25C3%25A3o%26aufirst%3DM.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DRenal%2520and%2520intestinal%2520autocrine%2520monoaminergic%2520systems%253A%2520Dopamine%2520versus%25205-hydroxytryptamine%26jtitle%3DClin.%2520Exp.%2520Hypertens.%26date%3D1997%26volume%3D19%26spage%3D43%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Jose, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, R. A.</span><span> </span><span class="NLM_article-title">Dopamine and G protein-coupled receptor kinase 4 in the kidney: Role in blood pressure regulation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1802</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=1259-1267&author=P.+A.+Joseauthor=P.+Soares-da-Silvaauthor=G.+M.+Eisnerauthor=R.+A.+Felder&title=Dopamine+and+G+protein-coupled+receptor+kinase+4+in+the+kidney%3A+Role+in+blood+pressure+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJose%26aufirst%3DP.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DEisner%26aufirst%3DG.%2BM.%26aulast%3DFelder%26aufirst%3DR.%2BA.%26atitle%3DDopamine%2520and%2520G%2520protein-coupled%2520receptor%2520kinase%25204%2520in%2520the%2520kidney%253A%2520Role%2520in%2520blood%2520pressure%2520regulation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1802%26spage%3D1259%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Helkamaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finckenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huotari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiorgou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span> </span><span class="NLM_article-title">Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2365</span><span class="NLM_x">–</span> <span class="NLM_lpage">2374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004872-200312000-00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14654758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2365-2374&author=T.+Helkamaaauthor=P.+T.+M%C3%A4nnist%C3%B6author=P.+Rauhalaauthor=Z.+J.+Chengauthor=P.+Finckenbergauthor=M.+Huotariauthor=J.+A.+Gogosauthor=M.+Karayiorgouauthor=E.+M.+Mervaala&title=Resistance+to+salt-induced+hypertension+in+catechol-O-methyltransferase-gene-disrupted+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice</span></div><div class="casAuthors">Helkamaa, Teemu; Maennistoe, Pekka T.; Rauhala, Pekka; Cheng, Zhong Jian; Finckenberg, Piet; Huotari, Marko; Gogos, Joseph A.; Karayiorgou, Maria; Mervaala, Eero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2365-2374</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Previous studies have indicated that catechol-O-methyltransferase (COMT) can modulate renal dopaminergic tone.  OBJECTIVE: To test the hypothesis that COMT blockade protects from salt-induced hypertension.  METHODS: COMT gene-disrupted (-/-) mice and wild-type controls received a high-sodium diet (NaCl 6%) for 3 wk.  Blood pressure and heart rate were recorded by radiotelemetry.  Tissue and urine samples were assessed by light microscopy and high-performance liq. chromatog.  The effects of nitecapone treatment were also examd.  RESULTS: Systolic blood pressure and heart rate during normal sodium diet were similar in COMT (-/-) and wild-type mice.  The high-sodium diet increased night-time systolic and diastolic blood pressures in wild-type mice, whereas blood pressure in COMT (-/-) mice remained unaltered.  In wild-type mice, the sodium-induced increase in blood pressure was completely normalized by treatment with the COMT inhibitor, nitecapone.  At baseline, 24-h urinary excretion of levodopa (L-DOPA), dopamine and noradrenaline was increased by 145, 85 and 74%, resp., in COMT (-/-) mice compared with wild-type controls.  In COMT (-/-) and wild-type mice, a high-sodium diet increased urinary L-DOPA excretion by 405 and 660% (reflected as 102 and 212% increases in dopamine excretion), resp.  The abs. amts. of urinary L-DOPA and dopamine remained 60 and 20% greater in COMT (-/-) mice.  The high-sodium diet did not influence renal cortical COMT activity.  CONCLUSION: The authors' findings suggest that COMT deficiency in mice increases the availability of L-DOPA, leading to enhanced dopaminergic tone, which may be assocd. with resistance to salt-induced hypertension.  The findings of the present study also underline the importance of COMT in the regulation of blood pressure, sodium excretion and renal dopaminergic tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrobR-UlWZXabVg90H21EOLACvtfcHk0ljx5KxTwHG9ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLk%253D&md5=b4a11cec7a2e3c5d5677d0bd857d9027</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1097%2F00004872-200312000-00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200312000-00026%26sid%3Dliteratum%253Aachs%26aulast%3DHelkamaa%26aufirst%3DT.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DZ.%2BJ.%26aulast%3DFinckenberg%26aufirst%3DP.%26aulast%3DHuotari%26aufirst%3DM.%26aulast%3DGogos%26aufirst%3DJ.%2BA.%26aulast%3DKarayiorgou%26aufirst%3DM.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26atitle%3DResistance%2520to%2520salt-induced%2520hypertension%2520in%2520catechol-O-methyltransferase-gene-disrupted%2520mice%26jtitle%3DJ.%2520Hypertens.%26date%3D2003%26volume%3D21%26spage%3D2365%26epage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Helkamaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finckenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louhelainen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merasto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapatto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reenila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span> </span><span class="NLM_article-title">Entacapone protects from angiotensin II-induced inflammation and renal injury</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2353</span><span class="NLM_x">–</span> <span class="NLM_lpage">2363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1097%2F00004872-200312000-00025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14654757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=2353-2363&author=T.+Helkamaaauthor=P.+Finckenbergauthor=M.+Louhelainenauthor=S.+Merastoauthor=P.+Rauhalaauthor=R.+Lapattoauthor=Z.+J.+Chengauthor=I.+Reenilaauthor=P.+T.+M%C3%A4nnist%C3%B6author=D.+N.+M%C3%BCllerauthor=F.+C.+Luftauthor=E.+M.+Mervaala&title=Entacapone+protects+from+angiotensin+II-induced+inflammation+and+renal+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone protects from angiotensin II-induced inflammation and renal injury</span></div><div class="casAuthors">Helkamaa, Teemu; Finckenberg, Piet; Louhelainen, Marjut; Merasto, Saara; Rauhala, Pekka; Lapatto, Risto; Cheng, Zhong Jian; Reenilae, Ilkka; Maennistoe, Pekka; Mueller, Dominik N.; Luft, Friedrich C.; Mervaala, Eero M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2353-2363</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Angiotensin II (Ang II)-induced renal damage is assocd. with perivascular inflammation and increased oxidative stress.  We tested the hypothesis whether entacapone, a catechol-O-methyltransferase (COMT) inhibitor exerting antioxidative and anti-inflammatory properties, protects against the Ang II-induced inflammatory response and end-organ damage.  Samples from double-transgenic rats harboring human renin and human angiotensinogen genes (dTGR) and normotensive Sprague-Dawley rats (SD) were assessed by light microscopy, immunohistochem., reverse transcriptase-polymerase chain reaction (RT-PCR), and high pressure liq. chromatog.  The effects of entacapone treatment for 3 wk were examd. in dTGR and SD.  Entacapone completely prevented cardiovascular mortality and decreased albuminuria by 85% in dTGR.  Entacapone ameliorated Ang II-induced vascular and glomerular damage, leukocyte infiltration, and intercellular adhesion mol.-1 (ICAM-1) overexpression in the kidneys.  Serum 8-isoprostane concn., as well as renal nitrotyrosine and 8-hydroxydeoxyguanosine expressions, all markers of oxidative stress, were markedly increased in dTGR and normalized by entacapone.  Entacapone also decreased p22phox mRNA expression in the kidney.  COMT expression was increased by 500% locally in the renal vascular wall in dTGR; however, COMT activity in the whole kidney remained unchanged.  Urinary dopamine excretion, a marker of renal dopaminergic tone, was decreased by 50% in untreated dTGR.  Even though entacapone decreased renal COMT activity by 40%, the renal dopaminergic tone remained unchanged in entacapone-treated dTGR.  Our findings suggest that entacapone provides protection against Ang II-induced renal damage through antioxidative and anti-inflammatory mechanisms, rather than by COMT inhibition-induced changes in renal dopaminergic tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUb14b4AMXrbVg90H21EOLACvtfcHk0ljx5KxTwHG9ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVGhsLg%253D&md5=f6dbdaf1c4e8bd03f4d574d356c68bf6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1097%2F00004872-200312000-00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004872-200312000-00025%26sid%3Dliteratum%253Aachs%26aulast%3DHelkamaa%26aufirst%3DT.%26aulast%3DFinckenberg%26aufirst%3DP.%26aulast%3DLouhelainen%26aufirst%3DM.%26aulast%3DMerasto%26aufirst%3DS.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DLapatto%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DZ.%2BJ.%26aulast%3DReenila%26aufirst%3DI.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26atitle%3DEntacapone%2520protects%2520from%2520angiotensin%2520II-induced%2520inflammation%2520and%2520renal%2520injury%26jtitle%3DJ.%2520Hypertens.%26date%3D2003%26volume%3D21%26spage%3D2353%26epage%3D2363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Eriksson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrtic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niklason, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultén, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlsson, C.</span><span> </span><span class="NLM_article-title">Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2Fj.ehj.2003.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=15033250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFKnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=386-391&author=A.+L.+Erikssonauthor=S.+Skrticauthor=A.+Niklasonauthor=L.+M.+Hult%C3%A9nauthor=O.+Wiklundauthor=T.+Hednerauthor=C.+Ohlsson&title=Association+between+the+low+activity+genotype+of+catechol-O-methyltransferase+and+myocardial+infarction+in+a+hypertensive+population"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population</span></div><div class="casAuthors">Eriksson, Anna-Lena; Skrtic, Stanko; Niklason, Anders; Hulten, Lillemor Mattsson; Wiklund, Olov; Hedner, Thomas; Ohlsson, Claes</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-391</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aim: Estrogens regulate several biol. processes involved in the pathogenesis of myocardial infarction.  Catechol-O-methyltransferase (COMT) is a key enzyme in the degrdn. of estrogens.  There is a functional polymorphism in the COMT gene (Val158Met), affecting the activity of the enzyme.  We investigated if the low activity genotype of COMT is assocd. with an altered risk of myocardial infarction.  Methods and Results: In a prospectively followed hypertensive cohort we identified 174 patients who suffered a myocardial infarction during the study and compared them to 348 controls from the same cohort.  The COMT polymorphism and serum levels of sex hormones were analyzed.  Patients homozygous for the low activity COMT genotype had a decreased risk of myocardial infarction compared to those with the high activity genotype, odds ratio 0.65 (95% CI 0.44-0.97, p=0.033).  The protective effect of the low activity genotype was most evident among older patients (>58 yr of age), odds ratio 0.43 (95% CI 0.23-0.79, p=0.006).  Serum levels of estradiol were increased (p=0.006) in males with the low activity genotype.  Conclusions: Our findings suggest that the low activity COMT genotype is protective against myocardial infarction.  One may speculate that the altered estrogen status could be involved in this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7szuXK-GNnbVg90H21EOLACvtfcHk0lisQdsDhBNzAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFKnsrs%253D&md5=be7900b261a7c08078e337f0ec3cac26</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ehj.2003.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ehj.2003.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BL.%26aulast%3DSkrtic%26aufirst%3DS.%26aulast%3DNiklason%26aufirst%3DA.%26aulast%3DHult%25C3%25A9n%26aufirst%3DL.%2BM.%26aulast%3DWiklund%26aufirst%3DO.%26aulast%3DHedner%26aufirst%3DT.%26aulast%3DOhlsson%26aufirst%3DC.%26atitle%3DAssociation%2520between%2520the%2520low%2520activity%2520genotype%2520of%2520catechol-O-methyltransferase%2520and%2520myocardial%2520infarction%2520in%2520a%2520hypertensive%2520population%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2004%26volume%3D25%26spage%3D386%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Hagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stovner, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skorpen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, J. A.</span><span> </span><span class="NLM_article-title">High systolic blood pressure is associated with Val/Val genotype in the catechol-<i>O</i>-methyltransferase gene. The Nord-Trondelag Health Study (HUNT)</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2Fj.amjhyper.2006.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=17198907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=21-26&author=K.+Hagenauthor=E.+Pettersenauthor=L.+J.+Stovnerauthor=F.+Skorpenauthor=J.+Holmenauthor=J.+A.+Zwart&title=High+systolic+blood+pressure+is+associated+with+Val%2FVal+genotype+in+the+catechol-O-methyltransferase+gene.+The+Nord-Trondelag+Health+Study+%28HUNT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">High Systolic Blood Pressure Is Associated With Val/Val Genotype in the Catechol-O-Methyltransferase Gene</span></div><div class="casAuthors">Hagen, Knut; Pettersen, Elin; Stovner, Lars Jacob; Skorpen, Frank; Holmen, Jostein; Zwart, John-Anker</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-26</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: The catechol-O-methyltransferase (COMT) gene contains a functional polymorphism, Val158Met.  A few studies on animals have shown a relationship between the COMT gene and BP, but whether this exists in human beings is unclear.  The aim of this study was to evaluate the relationship between codon 158 COMT gene polymorphism and BP in a population-based cohort.  Methods: In the 1995-97 Nord-Trondelag Health Study (HUNT), the assocn. between Val/Met polymorphism at the COMT gene and BP was evaluated in a group of 2966 nondiabetic individuals.  Results: Among the 2591 individuals without current use of antihypertensive drugs, systolic BP ≥140 mm Hg was more likely among persons with Val/Val genotype compared with the other genotypes (44.8% v 39.1%, P = .02).  In the multivariate anal. the prevalence odds ratio for having the Val/Val genotype was 1.63 (95% CI = 1.18 to 2.24) among individuals with systolic BP ≥160 mm Hg compared with those with systolic BP <140 mm Hg.  Val/Val genotype was also more likely (OR = 1.30, 95% CI = 1.04 to 1.63) among individuals with hypertension (as defined by use of antihypertensive medication, systolic BP ≥140 mm Hg, or diastolic BP ≥90 mm Hg) than among those with normal BP.  Conclusions: Based on the study findings, the Val/Val genotype appears to be assocd. with a higher prevalence of increased systolic BP compared with the Met/Met or Met/Val genotypes at the COMTgene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI4TF7VRTb2rVg90H21EOLACvtfcHk0lisQdsDhBNzAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFGjsQ%253D%253D&md5=e28245420564ae8fa51e8fb569317b62</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2006.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2006.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DK.%26aulast%3DPettersen%26aufirst%3DE.%26aulast%3DStovner%26aufirst%3DL.%2BJ.%26aulast%3DSkorpen%26aufirst%3DF.%26aulast%3DHolmen%26aufirst%3DJ.%26aulast%3DZwart%26aufirst%3DJ.%2BA.%26atitle%3DHigh%2520systolic%2520blood%2520pressure%2520is%2520associated%2520with%2520Val%252FVal%2520genotype%2520in%2520the%2520catechol-O-methyltransferase%2520gene.%2520The%2520Nord-Trondelag%2520Health%2520Study%2520%2528HUNT%2529%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2007%26volume%3D20%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Htun, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimbo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramatsu, M.</span><span> </span><span class="NLM_article-title">Association of the catechol-O-methyl transferase gene Val158Met polymorphism with blood pressure and prevalence of hypertension: interaction with dietary energy intake</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1038%2Fajh.2011.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21776034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVegt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1022-1026&author=N.+C.+Htunauthor=K.+Miyakiauthor=Y.+Songauthor=S.+Ikedaauthor=T.+Shimboauthor=M.+Muramatsu&title=Association+of+the+catechol-O-methyl+transferase+gene+Val158Met+polymorphism+with+blood+pressure+and+prevalence+of+hypertension%3A+interaction+with+dietary+energy+intake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Association of the Catechol-O-Methyl Transferase Gene Val158Met Polymorphism With Blood Pressure and Prevalence of Hypertension: Interaction With Dietary Energy Intake</span></div><div class="casAuthors">Htun, Nay Chi; Miyaki, Koichi; Song, Yixuan; Ikeda, Shinobu; Shimbo, Takuro; Muramatsu, Masaaki</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1022-1026</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background Previous studies of a functional variant of the catechol-O-Me transferase (COMT) gene, Val158Met, have provided inconsistent results with regard to blood pressure or hypertension.  We examd. the effect of this variant, the considering environmental factors of daily salt and energy intakes.  Methods A total of 735 Japanese men (mean age, 47 years) were recruited from two sep. occupational cohorts from Kanagawa and Kyoto prefectures.  Participants were genotyped for the presence of COMT Val158Met (rs4680, G/A).  Daily salt and energy intakes were evaluated by the food frequency questionnaire (FFQ).  Results Met/Met carriers had higher adjusted systolic blood pressure (SBP) (+4.79 mm Hg, P < 0.001) and diastolic blood pressure (DBP) (+2.33 mm Hg, P = 0.001) than Met/Val or Val/Val carriers.  There was a significant assocn. between being a Met/Met carrier and having a higher prevalence of hypertension (odds ratio = 2.448, 95% confidence interval = 1.426-4.205, P = 0.001).  When salt and energy intakes were dichotomized, the effect of Val158Met on hypertension was obsd. only in the high-energy intake group, and was equiv. between low- and high-salt groups.  Conclusion The Met allele of COMT Val158Met is assocd. with higher blood pressure and higher prevalence of hypertension in Japanese men, and energy intake may interact with this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY3VrATIhDDrVg90H21EOLACvtfcHk0lisQdsDhBNzAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVegt7rF&md5=2a22ae7361d6b48ea7b6a0c8f2dfb0b5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fajh.2011.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajh.2011.93%26sid%3Dliteratum%253Aachs%26aulast%3DHtun%26aufirst%3DN.%2BC.%26aulast%3DMiyaki%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DShimbo%26aufirst%3DT.%26aulast%3DMuramatsu%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520the%2520catechol-O-methyl%2520transferase%2520gene%2520Val158Met%2520polymorphism%2520with%2520blood%2520pressure%2520and%2520prevalence%2520of%2520hypertension%253A%2520interaction%2520with%2520dietary%2520energy%2520intake%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2011%26volume%3D24%26spage%3D1022%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Friese, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid-Schonbein, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, D. T.</span><span> </span><span class="NLM_article-title">Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension</span> <span class="citation_source-journal">Blood Press.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F08037051.2011.566012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21428728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlyks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=222-231&author=R.+S.+Frieseauthor=G.+W.+Schmid-Schonbeinauthor=D.+T.+O%E2%80%99Connor&title=Systematic+polymorphism+discovery+after+genome-wide+identification+of+potential+susceptibility+loci+in+a+hereditary+rodent+model+of+human+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension</span></div><div class="casAuthors">Friese, Ryan S.; Schmid-Schoeoenbein, Geert W.; O'Connor, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Pressure</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">BLPREG</span>;
        ISSN:<span class="NLM_cas:issn">0803-7051</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Genetic strategies such as linkage anal. and quant. trait locus (QTL) mapping have identified a multi-tude of loci implicated in the pathogenesis of hypertension in the spontaneously hypertensive rat (SHR).  While several candidate genetic regions have been identified in the SHR and its control, the Wistar-Kyoto rat (WKY), systematic follow-up of candidate identification with polymorphism discovery has not been widespread.  In the current report, we develop a data-mining strategy to identify candidate genes for hypertension in the SHR, and then sequence each gene in the SHR and WKY strains.  We integrate blood pressure QTL data, microarray data and data-mining methods.  First, we detd. the set of genes differentially expressed in SHR and WKY adrenal glands.  Next, the chromosomal position of all differentially expressed genes was compared with peak marker position of all reported SHR blood pressure QTLs.  We also identified the set of differentially expressed genes with the most extreme fold-change.  Finally, the QTL positional candidates and the genes with extreme differential expression were proposed as candidate genes if they had biol. plausible roles in hypertensive pathol.  We identified seven candidate genes that merit resequencing (catechol-O-methyltransferase [Comt], chromogranin A [Chga], dopamine beta-hydroxylase [Dbh], electron transferring flavoprotein dehydrogenase [Etfdh], endothelin receptor type B [Ednrb], neuropeptide Y [Npy] and phenylethanolamine-N-methyltransferase [Pnmt]), and then discovered polymorphism in four of these seven candidate genes.  Chga is proposed as the strongest candidate for addnl. functional investigation.  Our method for candidate gene identification is portable and can be applied to microarray data from any tissue, in any disease model with a QTL database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo11DcQP31SHrVg90H21EOLACvtfcHk0ljBbIS2iAC3vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlyks7o%253D&md5=f14a375ea099d66fb11c76ef3b20ce05</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3109%2F08037051.2011.566012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08037051.2011.566012%26sid%3Dliteratum%253Aachs%26aulast%3DFriese%26aufirst%3DR.%2BS.%26aulast%3DSchmid-Schonbein%26aufirst%3DG.%2BW.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DD.%2BT.%26atitle%3DSystematic%2520polymorphism%2520discovery%2520after%2520genome-wide%2520identification%2520of%2520potential%2520susceptibility%2520loci%2520in%2520a%2520hereditary%2520rodent%2520model%2520of%2520human%2520hypertension%26jtitle%3DBlood%2520Press.%26date%3D2011%26volume%3D20%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Flemström, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Safsten, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedstedt, G.</span><span> </span><span class="NLM_article-title">Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1993&pages=825-833&author=G.+Flemstr%C3%B6mauthor=B.+Safstenauthor=G.+Jedstedt&title=Stimulation+of+mucosal+alkaline+secretion+in+rat+duodenum+by+dopamine+and+dopaminergic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlemstr%25C3%25B6m%26aufirst%3DG.%26aulast%3DSafsten%26aufirst%3DB.%26aulast%3DJedstedt%26aufirst%3DG.%26atitle%3DStimulation%2520of%2520mucosal%2520alkaline%2520secretion%2520in%2520rat%2520duodenum%2520by%2520dopamine%2520and%2520dopaminergic%2520compounds%26jtitle%3DGastroenterology%26date%3D1993%26volume%3D104%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Li, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. X.</span><span> </span><span class="NLM_article-title">Entacapone promotes cAMP-dependent colonic Cl(−) secretion in rats</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">e277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1365-2982.2011.01715.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21501335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWntLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=657-e277&author=L.+S.+Liauthor=L.+F.+Zhengauthor=J.+D.+Xuauthor=T.+Jiauthor=H.+Guoauthor=X.+F.+Liauthor=Y.+Liauthor=Y.+Zhangauthor=J.+X.+Zhu&title=Entacapone+promotes+cAMP-dependent+colonic+Cl%28%E2%88%92%29+secretion+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone promotes cAMP-dependent colonic C1- secretion in rats</span></div><div class="casAuthors">Li, L.-S.; Zheng, L.-F.; Xu, J.-D.; Ji, T.; Guo, H.; Li, X.-F.; Li, Y.; Zhang, Y.; Zhu, J.-X.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">657-665</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Entacapone is a promising drug used widely for the treatment of Parkinson's disease (PD) as a catechol-O-Me transferase (COMT) inhibitor.  However, entacapone has gastrointestinal side effects.  The aim of this study was to investigate the effects of entacapone on the epithelial ion transport in rat distal colon, and explore the underlying mechanism.  The study was performed on freshly isolated colonic mucosa-only, submucosa-only and mucosa-submucosa prepns. in rat.  The short circuit current (ISC) was measured to det. electrogenic ion transport, and a scanning ion-selective electrode technique (SIET) was used to directly measure Cl- flux across the epithelium.  The content of intracellular cAMP was measured with RIA.  Entacapone increased mucosal ISC in the rat distal colon.  ISC was inhibited significantly by apical addn. of diphenylamine-2,2'-dicarboxylic acid (DPC), a blocker of the Cl- channel, basolateral application of bumetanide, an inhibitor of Na+-K+-2Cl- co-transporter (NKCC), removal of Cl- from the bathing soln., and pretreatment with MDL 12330A, an inhibitor of adenylate cyclase.  Inhibiting endogenous prostaglandin (PG) synthesis with indomethacin, and eliminating submucosal enteric neural activity with tetrodotoxin (TTX)-inhibited entacapone-evoked ISC increases.  Similar results were also obtained when Cl- flux was measured with SIET.  Entacapone significantly increased intracellular cAMP content, which was greatly inhibited by either indomethacin or TTX in the tissues contg. submucosal plexus, and by only indomethacin in the mucosa-only prepns.  Entacapone stimulates cAMP-dependent Cl- secretion in the rat colon, and this process is regulated by endogenous PG and the submucosal enteric nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe7U-leAKt2rVg90H21EOLACvtfcHk0ljBbIS2iAC3vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWntLnE&md5=23ca263ab8f0965a58661b8fd7336775</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2982.2011.01715.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2982.2011.01715.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DZheng%26aufirst%3DL.%2BF.%26aulast%3DXu%26aufirst%3DJ.%2BD.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%2BF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%2BX.%26atitle%3DEntacapone%2520promotes%2520cAMP-dependent%2520colonic%2520Cl%2528%25E2%2588%2592%2529%2520secretion%2520in%2520rats%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2011%26volume%3D23%26spage%3D657%26epage%3De277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Tahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arisawa, T.</span><span> </span><span class="NLM_article-title">COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in <i>H. pylori</i> infected older subjects</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=19579610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD1MvmslCntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=411-415&author=T.+Taharaauthor=T.+Shibataauthor=M.+Nakamuraauthor=D.+Yoshiokaauthor=M.+Okuboauthor=N.+Maruyamaauthor=T.+Kamanoauthor=Y.+Kamiyaauthor=H.+Fujitaauthor=M.+Nagasakaauthor=M.+Iwataauthor=K.+Takahamaauthor=M.+Watanabeauthor=H.+Yamashitaauthor=H.+Nakanoauthor=I.+Hirataauthor=T.+Arisawa&title=COMT+gene+Val158Met+polymorphism+influences+the+severity+of+intestinal+metaplasia+in+H.+pylori+infected+older+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in H. pylori infected older subjects</span></div><div class="casAuthors">Tahara Tomomitsu; Shibata Tomoyuki; Nakamura Masakatsu; Yoshioka Daisuke; Okubo Masaaki; Maruyama Naoko; Kamano Toshiaki; Kamiya Yoshio; Fujita Hiroshi; Nagasaka Mitsuo; Iwata Masami; Takahama Kazuya; Watanabe Makoto; Yamashita Hiromi; Nakano Hiroshi; Hirata Ichiro; Arisawa Tomiyasu</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-gastroenterology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">90</span>),
    <span class="NLM_cas:pages">411-5</span>
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    </div><div class="casAbstract">BACKGROUND/AIMS:  A complex interaction of host genetic and environmental factors may be relevant in the development of Helocobacter pylori (H. pylori) related gastroduodenal diseases.  Catechol-O-methyltransferase (COMT) is expressed catalyzes the methylation of various endobiotic and xenobiotic substances and thus might protect DNA from oxidative damage.  We aimed to clarify the effect of COMT functional polymorphism on the severity of histological gastritis in a Japanese population.  METHODOLOGY:  203 subjects were included in this study.  Restriction fragment length polymorphism analysis was performed for polymorphisms at codon 158 in the COMT gene.  Gastritis scores of antral gastric mucosa were assessed according to the updated Sydney system.  RESULTS:  COMT genotype distribution in the study subjects was 158Val/Val (51.2%), 84Val/Met (41.4%), and 15Met/Met (7.4%).  It was within the Hardy-Weinberg equilibrium (p = 0.73).  In over all subjects, the degree of intestinal metaplasia tended to be lower among 158Met/Met when compared to Val/Val (Val/Val vs.  Met/Met; 0.59 +/- 0.93 vs. 0.13 +/- 0.52, p = 0.052).  Among H. pylori infected subjects, the degree of intestinal metaplasia was significantly lower among 158Met carriers in 50 years or older age (Val/Val vs.  Met carriers; 1.20 +/- 1.06 vs. 0.75 +/- 1.08, p = 0.0436).  No significant association was found between COMT genotypes and the degree of gastritis in different gender  CONCLUSION:  Our data suggest that COMT gene 158Met polymorphism is associate with a reduced risk of developing more severe intestinal metaplasia in H. pylori infected older subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJk4gHGS1_CyM8MEzWGjS9fW6udTcc2eYEG-rtLu7Aq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvmslCntA%253D%253D&md5=f8ce07c73e5f8a761b452e859a4a255e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahara%26aufirst%3DT.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DN.%26aulast%3DKamano%26aufirst%3DT.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DNagasaka%26aufirst%3DM.%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DTakahama%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DH.%26aulast%3DNakano%26aufirst%3DH.%26aulast%3DHirata%26aufirst%3DI.%26aulast%3DArisawa%26aufirst%3DT.%26atitle%3DCOMT%2520gene%2520Val158Met%2520polymorphism%2520influences%2520the%2520severity%2520of%2520intestinal%2520metaplasia%2520in%2520H.%2520pylori%2520infected%2520older%2520subjects%26jtitle%3DHepatogastroenterology%26date%3D2009%26volume%3D56%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Palma, P. N.; Kiss, L. E.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyl-transferase inhibitors: Present problems and relevance of the new ones</span>. In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1039%2F9781849737357-00083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=83-109&author=P.+N.+Palma&author=L.+E.+Kiss&author=P.+Soares-da-Silvaauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00083%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26atitle%3DCatechol-O-methyl-transferase%2520inhibitors%253A%2520Present%2520problems%2520and%2520relevance%2520of%2520the%2520new%2520ones%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRSC%2520Publishing%26date%3D2013%26spage%3D83%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Learmonth, D. A.; Kiss, L. E.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Chemistry of COMT Inhibitors</span>. In  <span class="citation_source-book">Basic Aspects of Catechol-O-methyltransferase and the Clinical Applications of Its Inhibitors</span>; <span class="NLM_contrib-group">Nissinen, E.</span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FB978-0-12-381326-8.00006-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=119-162&author=D.+A.+Learmonth&author=L.+E.+Kiss&author=P.+Soares-da-Silvaauthor=E.+Nissinen&title=Basic+Aspects+of+Catechol-O-methyltransferase+and+the+Clinical+Applications+of+Its+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-381326-8.00006-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-381326-8.00006-5%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26atitle%3DChemistry%2520of%2520COMT%2520Inhibitors%26btitle%3DBasic%2520Aspects%2520of%2520Catechol-O-methyltransferase%2520and%2520the%2520Clinical%2520Applications%2520of%2520Its%2520Inhibitors%26aulast%3DNissinen%26aufirst%3DE.%26pub%3DElsevier%26date%3D2010%26spage%3D119%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Masri, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">O-Methylation in vitro of dihydroxy- and trihydroxy-phenolic compounds by liver slices</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1962&pages=495-505&author=M.+S.+Masriauthor=A.+N.+Boothauthor=F.+Deeds&title=O-Methylation+in+vitro+of+dihydroxy-+and+trihydroxy-phenolic+compounds+by+liver+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasri%26aufirst%3DM.%2BS.%26aulast%3DBooth%26aufirst%3DA.%2BN.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DO-Methylation%2520in%2520vitro%2520of%2520dihydroxy-%2520and%2520trihydroxy-phenolic%2520compounds%2520by%2520liver%2520slices%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1962%26volume%3D65%26spage%3D495%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Gugler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, H. J.</span><span> </span><span class="NLM_article-title">Inhibition of liver catechol-O-methyltransferase by flavanoids</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF00501194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=4268471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaE3sXhtVOmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1973&pages=223-233&author=R.+Guglerauthor=H.+J.+Dengler&title=Inhibition+of+liver+catechol-O-methyltransferase+by+flavanoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human liver catechol O-methyltransferase by flavonoids</span></div><div class="casAuthors">Gugler, R.; Dengler, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">All of 19 tested flavonoids having flavone, flavonol, flavanone, flavanol, flavanonol, and chalcone structures inhibited liver catechol O-methyltransferase in vitro to various degrees, the glycosides being weaker inhibitors than the corresponding genins.  The most effective inhibitors were those with a catechol configuration, esp. quercetin and fisetin.  The inhibition by quercetin and rutin was competitive, that by isorhamnetin of the mixed type.  The Km of the enzyme for norepinephrine was 3.3 × 10-4M, and the inhibitor consts. for quercetin and rutin were 5.3 × 10-6 and 10.8 × 10-6M, resp.  The inhibition was more pronounced at lower pH values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7G8vIuYIMVLVg90H21EOLACvtfcHk0liXc2iqEFZwZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtVOmsLc%253D&md5=45c2808075fb6a02e9b344d923d61343</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1007%2FBF00501194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00501194%26sid%3Dliteratum%253Aachs%26aulast%3DGugler%26aufirst%3DR.%26aulast%3DDengler%26aufirst%3DH.%2BJ.%26atitle%3DInhibition%2520of%2520liver%2520catechol-O-methyltransferase%2520by%2520flavanoids%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1973%26volume%3D276%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Giles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, J. W.</span><span> </span><span class="NLM_article-title">The catechol-O-methyltransferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3,4-dihydroxy-2-methylpropiophenone)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=5625691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaF2sXltFGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=1967&pages=189-194&author=R.+E.+Gilesauthor=J.+W.+Miller&title=The+catechol-O-methyltransferase+activity+and+endogenous+catecholamine+content+of+various+tissues+in+the+rat+and+the+effect+of+administration+of+U-0521+%283%2C4-dihydroxy-2-methylpropiophenone%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol O-methyl transferase activity and endogenous catecholamine content of various tissues in the rat and the effect of administration of U-0521 (3',4'-dihydroxy-2-methyl propiophenone)</span></div><div class="casAuthors">Giles, Ralph E.; Miller, Jack W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-94</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The regulatory influence of COMT (catechol O-methyl transferase) on the catechol amine content of various tissues was investigated.  The COMT activity of the heart, brain, uterus, and liver was inhibited by administration of U-0521.  This agent increased the epinephrine but not the norepinephrine content of the uterus within a period of 1 hr.  The norepinephrine concn. in the brain was also elevated, but no significant changes occurred in the catechol amine content of the heart.  The increases in catechol amines were probably due to the localized inhibition of COMT in the tissues where these changes occurred.  The COMT activity of the uterus was greater during estrus than during diestrus and it increased after estrogen administration to ovariectomized rats.  The cyclic variation of the catechol amine content in the uterus could not be explained on the basis of these changes in COMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhASzJnVbk7bVg90H21EOLACvtfcHk0liXc2iqEFZwZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXltFGlsbc%253D&md5=eadd2690f2e0a51e405ae75962f69843</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiles%26aufirst%3DR.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BW.%26atitle%3DThe%2520catechol-O-methyltransferase%2520activity%2520and%2520endogenous%2520catecholamine%2520content%2520of%2520various%2520tissues%2520in%2520the%2520rat%2520and%2520the%2520effect%2520of%2520administration%2520of%2520U-0521%2520%25283%252C4-dihydroxy-2-methylpropiophenone%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1967%26volume%3D158%26spage%3D189%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Ross, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haljasmaa, O.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase inhibitors. In vivo inhibition in mice</span> <span class="citation_source-journal">Acta. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1964.tb01786.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=14209613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaF2MXhtVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1964&pages=215-225&author=S.+B.+Rossauthor=O.+Haljasmaa&title=Catechol-O-methyltransferase+inhibitors.+In+vivo+inhibition+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition in mice</span></div><div class="casAuthors">Ross, S. B.; Haljasmaa, O.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-25</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">Inhibitors of the enzyme activity in peripheral organs and brains in mice were investigated.  Tropolones had the highest inhibition potency in peripheral organs but were less effective in brain.  Pyrogallol, iso-Pr ester of gallate, and 2,3,4-trihydroxyacetophenone were the most effective compds. inhibiting the enzyme in the brain.  Many of the compds. interfered with other adrenergic mechanisms such as stimulation or blockade of adrenergic β-receptor blocking capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWGP5lxv1f7Vg90H21EOLACvtfcHk0lieD9JRJfX7qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXhtVagsA%253D%253D&md5=a4ffb4be646e9ffb4660db5b3dd9ab60</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1964.tb01786.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1964.tb01786.x%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DS.%2BB.%26aulast%3DHaljasmaa%26aufirst%3DO.%26atitle%3DCatechol-O-methyltransferase%2520inhibitors.%2520In%2520vivo%2520inhibition%2520in%2520mice%26jtitle%3DActa.%2520Pharmacol.%2520Toxicol.%26date%3D1964%26volume%3D21%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Angel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, K. J.</span><span> </span><span class="NLM_article-title">Convulsant action of polyphenols</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1968&pages=84-85&author=A.+Angelauthor=K.+J.+Rogers&title=Convulsant+action+of+polyphenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngel%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DK.%2BJ.%26atitle%3DConvulsant%2520action%2520of%2520polyphenols%26jtitle%3DNature%26date%3D1968%26volume%3D217%26spage%3D84%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Reches, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahn, S.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase and Parkinson’s disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=6695593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL2cXhtFCrtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1984&pages=171&author=A.+Rechesauthor=S.+Fahn&title=Catechol-O-methyltransferase+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase and Parkinson's disease</span></div><div class="casAuthors">Reches, Avinoam; Fahn, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">Parkinson-Specific Mot. Ment. Disord.:  Role Pallidum</span>),
    <span class="NLM_cas:pages">171-9</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">U-0521 (I)  [5466-89-7], a potent inhibitor of catechol-O-methyltransferase (COMT)  [9012-25-3], when given i.p. (200 mg/kg) to rats blocked the accumulation of 3-O-methyldopa  [300-48-1] in plasma and enhanced L-DOPA  [59-92-7] metab. in the striatum.  I was not active, however, when given orally to rats or to a patient with Parkinson's disease.  The use of L-DOPA plus a COMT-inhibitor which is active when taken orally, may be useful in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd00xaqkHu9rVg90H21EOLACvtfcHk0lieD9JRJfX7qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtFCrtro%253D&md5=c161876690f7eb118db3b09e3fae78cf</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReches%26aufirst%3DA.%26aulast%3DFahn%26aufirst%3DS.%26atitle%3DCatechol-O-methyltransferase%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1984%26volume%3D40%26spage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullnig, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wylie, D.</span><span> </span><span class="NLM_article-title">The enzymic methylation of pyrogallol</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1960&pages=53-154&author=S.+Archerauthor=A.+Arnoldauthor=R.+K.+Kullnigauthor=D.+Wylie&title=The+enzymic+methylation+of+pyrogallol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DArnold%26aufirst%3DA.%26aulast%3DKullnig%26aufirst%3DR.%2BK.%26aulast%3DWylie%26aufirst%3DD.%26atitle%3DThe%2520enzymic%2520methylation%2520of%2520pyrogallol%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1960%26volume%3D87%26spage%3D53%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Axelrod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRoche, M.-J.</span><span> </span><span class="NLM_article-title">Inhibitor of O-methylation of epinephrine and norepinephrine in vitro and in vivo</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=1959&pages=800&author=J.+Axelrodauthor=M.-J.+LaRoche&title=Inhibitor+of+O-methylation+of+epinephrine+and+norepinephrine+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxelrod%26aufirst%3DJ.%26aulast%3DLaRoche%26aufirst%3DM.-J.%26atitle%3DInhibitor%2520of%2520O-methylation%2520of%2520epinephrine%2520and%2520norepinephrine%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DScience%26date%3D1959%26volume%3D130%26spage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Booth, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, O. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeds, F.</span><span> </span><span class="NLM_article-title">The metabolic fate of gallic acid and related compounds</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1959&pages=3014-3016&author=A.+N.+Boothauthor=M.+Masriauthor=D.+J.+Robbinsauthor=O.+H.+Emersonauthor=F.+T.+Jonesauthor=F.+Deeds&title=The+metabolic+fate+of+gallic+acid+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBooth%26aufirst%3DA.%2BN.%26aulast%3DMasri%26aufirst%3DM.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26aulast%3DJones%26aufirst%3DF.%2BT.%26aulast%3DDeeds%26aufirst%3DF.%26atitle%3DThe%2520metabolic%2520fate%2520of%2520gallic%2520acid%2520and%2520related%2520compounds%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1959%26volume%3D234%26spage%3D3014%26epage%3D3016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Ericson, A. D.</span><span> </span><span class="NLM_article-title">Potentiation of the L-dopa effect in man by the use of catechol-<i>O</i>-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0022-510X%2871%2990088-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1971&pages=193-197&author=A.+D.+Ericson&title=Potentiation+of+the+L-dopa+effect+in+man+by+the+use+of+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0022-510X%2871%2990088-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-510X%252871%252990088-8%26sid%3Dliteratum%253Aachs%26aulast%3DEricson%26aufirst%3DA.%2BD.%26atitle%3DPotentiation%2520of%2520the%2520L-dopa%2520effect%2520in%2520man%2520by%2520the%2520use%2520of%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D1971%26volume%3D24%26spage%3D193%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Simpson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, V.</span><span> </span><span class="NLM_article-title">An investigation of the clinical effect of GPA-1714, a catechol-O-methyl transferase inhibitor</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgslWqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1972&pages=417-421&author=G.+M.+Simpsonauthor=V.+Varga&title=An+investigation+of+the+clinical+effect+of+GPA-1714%2C+a+catechol-O-methyl+transferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation of the clinical effect of GPA-1714, a catechol-O-methyl transferase inhibitor</span></div><div class="casAuthors">Simpson G M; Varga V</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical pharmacology and new drugs</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">417-21</span>
        ISSN:<span class="NLM_cas:issn">0021-9754</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbUW91mHQ8a6qcneEtCi92fW6udTcc2eZCK0AZIJVym7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgslWqtA%253D%253D&md5=5ba992765dd89098c218bd1168146658</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DG.%2BM.%26aulast%3DVarga%26aufirst%3DV.%26atitle%3DAn%2520investigation%2520of%2520the%2520clinical%2520effect%2520of%2520GPA-1714%252C%2520a%2520catechol-O-methyl%2520transferase%2520inhibitor%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D1972%26volume%3D12%26spage%3D417%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Bäckström, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honkanen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippuri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairisalo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pystynen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindén, I.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohto, P.</span><span> </span><span class="NLM_article-title">Synthesis of some novel potent and selective catechol <i>O</i>-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00124a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=841-846&author=R.+B%C3%A4ckstr%C3%B6mauthor=E.+Honkanenauthor=A.+Pippuriauthor=P.+Kairisaloauthor=J.+Pystynenauthor=K.+Heinolaauthor=E.+Nissinenauthor=I.-B.+Lind%C3%A9nauthor=P.+T.+M%C3%A4nnist%C3%B6author=S.+Kaakkolaauthor=P.+Pohto&title=Synthesis+of+some+novel+potent+and+selective+catechol+O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm00124a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00124a017%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26aulast%3DHonkanen%26aufirst%3DE.%26aulast%3DPippuri%26aufirst%3DA.%26aulast%3DKairisalo%26aufirst%3DP.%26aulast%3DPystynen%26aufirst%3DJ.%26aulast%3DHeinola%26aufirst%3DK.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLind%25C3%25A9n%26aufirst%3DI.-B.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DPohto%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520some%2520novel%2520potent%2520and%2520selective%2520catechol%2520O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Bäckström, R. J.; Heinola, K. E.; Honkanen, E. J.; Kaakkola, S. K.; Kairisalo, P. J.; Linden, I.-B. Y.; Männistö, P. T.; Nissinen, E. A. O.; Pohto, P.; Pippuri, A. K.; Pystynen, J. J.</span><span> </span><span class="NLM_article-title">Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same</span>. U.S. Patent US4963590,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=K.+E.+Heinola&author=E.+J.+Honkanen&author=S.+K.+Kaakkola&author=P.+J.+Kairisalo&author=I.-B.+Y.+Linden&author=P.+T.+M%C3%A4nnist%C3%B6&author=E.+A.+O.+Nissinen&author=P.+Pohto&author=A.+K.+Pippuri&author=J.+J.+Pystynen&title=Pharmacologically+active+compounds%2C+methods+for+the+preparation+thereof+and+compositions+containing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%2BJ.%26atitle%3DPharmacologically%2520active%2520compounds%252C%2520methods%2520for%2520the%2520preparation%2520thereof%2520and%2520compositions%2520containing%2520the%2520same%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0014-2999%2888%2990614-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=3181288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaL1cXmtVCkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1988&pages=263-269&author=E.+Nissinenauthor=I.+B.+Lindenauthor=E.+Schultzauthor=S.+Kaakkolaauthor=P.+M%C3%A4nnist%C3%B6&title=Inhibition+of+catechol-O-methyltransferase+activity+by+two+novel+disubstituted+catechols+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat</span></div><div class="casAuthors">Nissinen, Erkki; Linden, Inge Britt; Schultz, Eija; Kaakkola, Seppo; Mannisto, Pekka T.; Pohto, Pentti</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">263-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Catechol-O-methyltransferase (COMT) has an important role in the extraneuronal inactivation of catecholamine neurotransmitters and drugs with a catechol structure.  Two novel COMT inhibitors, OR-462 and OR-486, were highly effective (50% inhibitory concns. (IC50) = 18 and 12 nM, resp.) and selective in inhibiting COMT activity in vitro.  Tyrosine hydroxylase was not inhibited until micromolar concns. of these compds. were used: the IC50 values for OR-462 and OR-486 were 10 and 14 μM, resp.  The IC50 values for dopamine β-hydroxylase, dopa decarboxylase and monoamine oxidase forms A and B were >50 μM.  In studies ex vivo in rats, oral OR-462 inhibited mainly the COMT activity in the duodenum, while OR-486 inhibited COMT activity in the liver and red cells as well.  Oral OR-462 did not penetrate into the brain in doses of ≤30 mg/kg, while the same doses of OR-486 had some effect on striatal COMT activity.  When tested in combination with levodopa-carbidopa, orally administered OR-462 and OR-486 were more effective in reducing the formation of 3-O-methyldopa from levodopa than was the levodopa-carbidopa treatment alone.  Thus, OR-462 and OR-486 are effective and long-lasting inhibitors of COMT activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz879OV4z61LVg90H21EOLACvtfcHk0lgrXARSFsAK9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXmtVCkt74%253D&md5=c1a228d9538369802233db62c470bc94</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2888%2990614-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252888%252990614-0%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520activity%2520by%2520two%2520novel%2520disubstituted%2520catechols%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D153%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span> </span><span class="NLM_article-title">Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3953</span><span class="NLM_x">–</span> <span class="NLM_lpage">3956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0006-2952%2889%2990673-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2597177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3cXjt1Gmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1989&pages=3953-3956&author=E.+Schultzauthor=E.+Nissinen&title=Inhibition+of+rat+liver+and+duodenum+soluble+catechol-O-methyltransferase+by+a+tight-binding+inhibitor+OR-462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462</span></div><div class="casAuthors">Schultz, Eija; Nissinen, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3953-6</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The inhibition kinetics of rat liver and duodenum sol. catechol O-methyltransferase (COMT) with the disubstituted catechol, OR-462, was studied.  After preincubation of the enzyme and inhibitor in the presence of Mg2+ and S-adenosylmethionine, an inhibition ∼30-fold greater than that without preincubation was obsd.  Reversible tight-binding inhibition was demonstrated with Ki values of 0.7 and 1.0 nM for the liver and duodenum enzymes, resp.  The Km values of 53.4 and 56.9 μM for 3,4-dihydroxybenzoic acid and 23.0 and 17.5 μM for S-adenosylmethionine were calcd. for liver and duodenum enzyme, resp.  A catalytic no. of 24 min-1 for liver sol. COMT was calcd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSurcO5KL2r7Vg90H21EOLACvtfcHk0lhcmBRyPnGU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjt1Gmug%253D%253D&md5=c1f0690d8f0607f8bde3d96a18502ec2</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2889%2990673-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252889%252990673-4%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DNissinen%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520rat%2520liver%2520and%2520duodenum%2520soluble%2520catechol-O-methyltransferase%2520by%2520a%2520tight-binding%2520inhibitor%2520OR-462%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1989%26volume%3D38%26spage%3D3953%26epage%3D3956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Männistö, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuomainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuomainen, R. K.</span><span> </span><span class="NLM_article-title">Different in vivo properties of three new inhibitors of catechol-O-methyltransferase in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1476-5381.1992.tb09020.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1628144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XitVOltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1992&pages=569-574&author=P.+M%C3%A4nnist%C3%B6author=T.+Tuomainenauthor=R.+K.+Tuomainen&title=Different+in+vivo+properties+of+three+new+inhibitors+of+catechol-O-methyltransferase+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat</span></div><div class="casAuthors">Mannisto, Pekka T.; Tuomainen, Paivi; Tuominen, Raimo K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-74</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The authors compared three new catechol O-methyltransferase (COMT) inhibitors (OR-611, Ro 40-7592 and CGP 28014; 10 and 30 mg kg-1, i.p.) in male rats given levodopa (L-DOPA, 50 mg kg-1, i.p.) and carbidopa ((-)-L-α-Me dopa, 50 mg kg-1, i.p.).  In some studies pretreatment with pargyline (80 mg kg-1, i.p.) was used to block the function of monoamine oxidase (MAO).  Decreases of hypothalamic and striatal 3-O-methyl-dopa (3-OMD) levels were used as measures of the inhibition of peripheral COMT.  The inhibition of brain COMT activity was estd. by decreases of hypothalamic and striatal homovanillic acid (HVA) and 3-methoxytyramine (3-MT; after pargyline) levels.  The three COMT inhibitors studied had different individual characteristics.  OR-611 was primarily a peripherally acting COMT inhibitor, decreasing 3-OMD levels in the striatum (to 31-52%) and in the hypothalamus (to 16-27%) both in the control and pargyline-treated animals at 1 and 3 h.  It did not have any effect on brain HVA and 3-MT.  Ro 40-7592 was a broad spectrum COMT inhibitor decreasing striatal and hypothalamic 3-OMD (always to <30%), HVA (to <50%) and 3-MT levels (to <23%) significantly both at 1 and 3 h.  It was more potent than OR-611.  CGP 28014 functioned as a weak COMT inhibitor in the periphery inhibiting 3-OMD formation only at 3 h.  In contrast, it was fairly potent in decreasing the brain HVA and 3-MT levels at 1 h (to 37-22% and 42-35% in the striatum, and to 57-33% and 64-35% in the hypothalamus, resp.) but not at 3 h.  Since CGP 28014, unlike OR-611 and Ro 40-7592, did not generally increase the brain DOPA, dopamine or DOPAC levels, it was not a typical COMT inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGDBh5WX2SbVg90H21EOLACvtfcHk0lhcmBRyPnGU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitVOltbw%253D&md5=907c08efd59e6cbed4c221aba7bca69f</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1992.tb09020.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1992.tb09020.x%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%26aulast%3DTuomainen%26aufirst%3DT.%26aulast%3DTuomainen%26aufirst%3DR.%2BK.%26atitle%3DDifferent%2520in%2520vivo%2520properties%2520of%2520three%2520new%2520inhibitors%2520of%2520catechol-O-methyltransferase%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1992%26volume%3D105%26spage%3D569%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Cedarbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reches, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, M.</span><span> </span><span class="NLM_article-title">Effect of nitecapone (OR-462) on the pharmacokinetics of levodopa and 3-O-methyldopa formation in cynomolgus monkeys</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=544-552&author=J.+Cedarbaumauthor=G.+Legerauthor=A.+Rechesauthor=M.+Guttman&title=Effect+of+nitecapone+%28OR-462%29+on+the+pharmacokinetics+of+levodopa+and+3-O-methyldopa+formation+in+cynomolgus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCedarbaum%26aufirst%3DJ.%26aulast%3DLeger%26aufirst%3DG.%26aulast%3DReches%26aufirst%3DA.%26aulast%3DGuttman%26aufirst%3DM.%26atitle%3DEffect%2520of%2520nitecapone%2520%2528OR-462%2529%2520on%2520the%2520pharmacokinetics%2520of%2520levodopa%2520and%25203-O-methyldopa%2520formation%2520in%2520cynomolgus%2520monkeys%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D1990%26volume%3D13%26spage%3D544%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohto, P.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF00173538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1407012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1992&pages=262-266&author=E.+Nissinenauthor=I.+B.+Lindenauthor=E.+Schultzauthor=P.+Pohto&title=Biochemical+and+pharmacological+properties+of+a+peripherally+acting+catechol-O-methyltransferase+inhibitor+entacapone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone</span></div><div class="casAuthors">Nissinen, Erkki; Linden, Inge Britt; Schultz, Eija; Pohto, Pentti</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">262-6</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">Entacapone, OR-611, was found to be a potent peripherally acting inhibitor of catechol-O-methyl-transferase (COMT).  IC50 values of 10 nmol/L and 160 nmol/L were obtained for rat duodenum and liver-sol. COMT, resp.  There were not effects on other catecholamine metabolizing enzymes.  Entacapone showed reversible, tight-binding type of inhibition of sol. rat liver COMT with a Ki-value of 14 nmol/L and it also caused 50% inhibition of rat duodenal, erythrocyte, liver and striatal COMT activity 1 h after oral dosing with 1.1, 5.4, 6.7 and 24.2 mg/kg, resp.  However, penetration of entacapone into the brain was poor, since the formation of homovanillic acid (HVA), the O-Me metabolite of dopamine in the striatum, was not reduced, even after the highest dose of 30 mg/kg.  In rat blood serum, the concn. of 3-O-methyldopa (3OMD), the O-methylated product of L-dopa, was reduced in a dose-dependent manner, and the concn. of L-dopa was increased after the administration of entacapone (3-30 mg/kg p.o.) together with L-dopa + carbidopa.  These changes were reflected, in the striatum, by a significant rise in the dopamine concn. and a redn. in the 3OMD concn.  Consequently, when entacapone was added to the treatment with L-dopa + carbidopa, the dose of L-dopa could be lowered from 50 to 15 mg/kg in order to produce the same striatal dopamine concns. as with 50 + 50 mg/kg of L-dopa + carbidopa alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_2UnG4ReArrVg90H21EOLACvtfcHk0lhcmBRyPnGU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGnt7w%253D&md5=6590cfbde047e5c9b4ec19ebdb3b8532</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2FBF00173538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00173538%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DPohto%26aufirst%3DP.%26atitle%3DBiochemical%2520and%2520pharmacological%2520properties%2520of%2520a%2520peripherally%2520acting%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1992%26volume%3D346%26spage%3D262%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Keranen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korpela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentikainen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikberg, T.</span><span> </span><span class="NLM_article-title">Inhibition of soluble catechol-<i>O</i>-methyltransferase and single dose pharmacokinetics after oral and intraveneous administration of entacapone</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=151-157&author=T.+Keranenauthor=A.+Gordinauthor=M.+Karlssonauthor=K.+Korpelaauthor=P.+J.+Pentikainenauthor=H.+Ritaauthor=E.+Schultzauthor=L.+Seppalaauthor=T.+Wikberg&title=Inhibition+of+soluble+catechol-O-methyltransferase+and+single+dose+pharmacokinetics+after+oral+and+intraveneous+administration+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeranen%26aufirst%3DT.%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DM.%26aulast%3DKorpela%26aufirst%3DK.%26aulast%3DPentikainen%26aufirst%3DP.%2BJ.%26aulast%3DRita%26aufirst%3DH.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DSeppala%26aufirst%3DL.%26aulast%3DWikberg%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520soluble%2520catechol-O-methyltransferase%2520and%2520single%2520dose%2520pharmacokinetics%2520after%2520oral%2520and%2520intraveneous%2520administration%2520of%2520entacapone%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doulakas, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span> </span><span class="NLM_article-title">The lipophilicity behaviour of three catechol-O-methyltransferase (COMT) inhibitors and simple analogues</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=144-152&author=L.+Novaroliauthor=G.+B.+Doulakasauthor=M.+Reistauthor=B.+Rolandoauthor=R.+Frutteroauthor=A.+Gascoauthor=P.-A.+Carrupt&title=The+lipophilicity+behaviour+of+three+catechol-O-methyltransferase+%28COMT%29+inhibitors+and+simple+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDoulakas%26aufirst%3DG.%2BB.%26aulast%3DReist%26aufirst%3DM.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26atitle%3DThe%2520lipophilicity%2520behaviour%2520of%2520three%2520catechol-O-methyltransferase%2520%2528COMT%2529%2520inhibitors%2520and%2520simple%2520analogues%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D144%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Effects of aqueous solubility and dissolution characteristics on oral bioavailability of entacapone</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=238-244&author=J.+Savolainenauthor=M.+Forsbergauthor=H.+Taipaleauthor=P.+T.+Mannist%C3%B6author=K.+J%C3%A4rvinenauthor=J.+Gyntherauthor=P.+Jarhoauthor=T.+J%C3%A4rvinen&title=Effects+of+aqueous+solubility+and+dissolution+characteristics+on+oral+bioavailability+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DK.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DJarho%26aufirst%3DP.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DEffects%2520of%2520aqueous%2520solubility%2520and%2520dissolution%2520characteristics%2520on%2520oral%2520bioavailability%2520of%2520entacapone%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2000%26volume%3D49%26spage%3D238%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Wikberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottoila, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span> </span><span class="NLM_article-title">Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1993&pages=81-92&author=T.+Wikbergauthor=A.+Vuorelaauthor=P.+Ottoilaauthor=J.+Taskinen&title=Identification+of+major+metabolites+of+the+catechol-O-methyltransferase+inhibitor+entacapone+in+rats+and+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWikberg%26aufirst%3DT.%26aulast%3DVuorela%26aufirst%3DA.%26aulast%3DOttoila%26aufirst%3DP.%26aulast%3DTaskinen%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520major%2520metabolites%2520of%2520the%2520catechol-O-methyltransferase%2520inhibitor%2520entacapone%2520in%2520rats%2520and%2520humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1993%26volume%3D21%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Bäckström, R. J.; Kalevi, E.; Heinola, K. E.; Honkanen, E. J.; Kaakkola, S. K.; Kairisalo, P. J.; Linden, I.-B. Y.; Männistö, P. T.; Nissinen, E. A. O.; Pohto, P.; Pippuri, A. K.; Pystynen, J. J.</span><span> </span><span class="NLM_article-title">Pharmacologically active catechol derivatives</span>. U.S. Patent US5446194,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=E.+Kalevi&author=K.+E.+Heinola&author=E.+J.+Honkanen&author=S.+K.+Kaakkola&author=P.+J.+Kairisalo&author=I.-B.+Y.+Linden&author=P.+T.+M%C3%A4nnist%C3%B6&author=E.+A.+O.+Nissinen&author=P.+Pohto&author=A.+K.+Pippuri&author=J.+J.+Pystynen&title=Pharmacologically+active+catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%2BJ.%26atitle%3DPharmacologically%2520active%2520catechol%2520derivatives%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Aho, P.; Pohto, P.; Linden, I.-B. Y.; Bäckström, R. J.; Honkanen, E.; Nissinen, E.</span><span> </span><span class="NLM_article-title">New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters</span>. European Patent EP0323162,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=P.+Aho&author=P.+Pohto&author=I.-B.+Y.+Linden&author=R.+J.+B%C3%A4ckstr%C3%B6m&author=E.+Honkanen&author=E.+Nissinen&title=New+use+of+catechol-o-methyl+transferase+%28comt%29+inhibitors+and+their+physiologically+acceptable+salts+and+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAho%26aufirst%3DP.%26atitle%3DNew%2520use%2520of%2520catechol-o-methyl%2520transferase%2520%2528comt%2529%2520inhibitors%2520and%2520their%2520physiologically%2520acceptable%2520salts%2520and%2520esters%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Linden, I.-B. Y.; Ranta, S. H.; Heinonen, E. O.; Kaakkola, S. K.; Nissinen, E. A. O.; Pohlo, P.</span><span> </span><span class="NLM_article-title">Use of catechol-o·methyl transferase (COMT) inhibitors as anti-cancer agents</span>. U.K. Patent GB2220569,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=I.-B.+Y.+Linden&author=S.+H.+Ranta&author=E.+O.+Heinonen&author=S.+K.+Kaakkola&author=E.+A.+O.+Nissinen&author=P.+Pohlo&title=Use+of+catechol-o%C2%B7methyl+transferase+%28COMT%29+inhibitors+as+anti-cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DI.-B.%2BY.%26atitle%3DUse%2520of%2520catechol-o%25C2%25B7methyl%2520transferase%2520%2528COMT%2529%2520inhibitors%2520as%2520anti-cancer%2520agents%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Aperia, A. C.; Linden, I.-B. Y.</span><span> </span><span class="NLM_article-title">Use of COMT Inhibitors for the manufacture of a medicament for the prevention of Diabetic Vascular Dysfunctions</span>. International Patent WO199827973,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=A.+C.+Aperia&author=I.-B.+Y.+Linden&title=Use+of+COMT+Inhibitors+for+the+manufacture+of+a+medicament+for+the+prevention+of+Diabetic+Vascular+Dysfunctions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAperia%26aufirst%3DA.%2BC.%26atitle%3DUse%2520of%2520COMT%2520Inhibitors%2520for%2520the%2520manufacture%2520of%2520a%2520medicament%2520for%2520the%2520prevention%2520of%2520Diabetic%2520Vascular%2520Dysfunctions%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Aho, P.; Linden, I.-B. Y.</span><span> </span><span class="NLM_article-title">Use of COMT inhibitors as analgesics</span>. International Patent WO200168083,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=P.+Aho&author=I.-B.+Y.+Linden&title=Use+of+COMT+inhibitors+as+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAho%26aufirst%3DP.%26atitle%3DUse%2520of%2520COMT%2520inhibitors%2520as%2520analgesics%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Ellimen, J.; Karvinen, J.; Vahteristo, M.</span><span> </span><span class="NLM_article-title">Treatment of restless leg syndrome</span>. International Patent WO2006051154,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+Ellimen&author=J.+Karvinen&author=M.+Vahteristo&title=Treatment+of+restless+leg+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllimen%26aufirst%3DJ.%26atitle%3DTreatment%2520of%2520restless%2520leg%2520syndrome%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Nissinen, H.; Vahteristo, M.; Kuoppamaki, M.; Ellmen, J.; Leionen, M.</span><span> </span><span class="NLM_article-title">Treatment of symptoms of motor dysfunction</span>. International Patent WO2007034024,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Nissinen&author=M.+Vahteristo&author=M.+Kuoppamaki&author=J.+Ellmen&author=M.+Leionen&title=Treatment+of+symptoms+of+motor+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DH.%26atitle%3DTreatment%2520of%2520symptoms%2520of%2520motor%2520dysfunction%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Eremadzadeh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S. K.</span><span> </span><span class="NLM_article-title">Computerized rotometer apparatus for recording circling behaviour</span> <span class="citation_source-journal">Methods Find. Exp. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2501597" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1989&pages=399-407&author=E.+Eremadzadehauthor=L.+Koskinenauthor=S.+K.+Kaakkola&title=Computerized+rotometer+apparatus+for+recording+circling+behaviour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEremadzadeh%26aufirst%3DE.%26aulast%3DKoskinen%26aufirst%3DL.%26aulast%3DKaakkola%26aufirst%3DS.%2BK.%26atitle%3DComputerized%2520rotometer%2520apparatus%2520for%2520recording%2520circling%2520behaviour%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D1989%26volume%3D11%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Bernauer, K.; Borgulya, J.; Bruderer, H.; Da Prada, M.; Zürcher, G.</span><span> </span><span class="NLM_article-title">Catechol derivatives</span>. U.S. Patent US5236952,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=K.+Bernauer&author=J.+Borgulya&author=H.+Bruderer&author=M.+Da+Prada&author=G.+Z%C3%BCrcher&title=Catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBernauer%26aufirst%3DK.%26atitle%3DCatechol%2520derivatives%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherschlicht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlappi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span> </span><span class="NLM_article-title">Ro 40-7592. Catechol-<i>O</i>-methyltransferase (COMT) inhibitor</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=719-721&author=J.+Borgulyaauthor=M.+Da+Pradaauthor=J.+Dingemanseauthor=R.+Scherschlichtauthor=B.+Schlappiauthor=G.+Z%C3%BCrcher&title=Ro+40-7592.+Catechol-O-methyltransferase+%28COMT%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DScherschlicht%26aufirst%3DR.%26aulast%3DSchlappi%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26atitle%3DRo%252040-7592.%2520Catechol-O-methyltransferase%2520%2528COMT%2529%2520inhibitor%26jtitle%3DDrugs%2520Future%26date%3D1991%26volume%3D16%26spage%3D719%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtman, R. J.</span><span> </span><span class="NLM_article-title">Effects of COMT inhibitors on striatal dopamine metabolism a microdialysis study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0006-8993%2892%2991003-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1381981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK38XlvVGgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=1992&pages=241-249&author=S.+Kaakkolaauthor=R.+J.+Wurtman&title=Effects+of+COMT+inhibitors+on+striatal+dopamine+metabolism+a+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of COMT inhibitors on striatal dopamine metabolism:  a microdialysis study</span></div><div class="casAuthors">Kaakkola, S.; Wurtman, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-9</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">In vivo microdialysis was used to examine the effect of 2 catechol-O-methyltransferase (COMT) inhibitors, Ro 40-7592 and OR-611, on extracellular levels of dopamine, DOPAC, HVA, and 5-HIAA in rat striatum.  The interactions of the COMT inhibitors with nomifensine, clorgyline, and deprenyl were also studied.  Ro 40-7592 (3-30 mg/kg, i.p.) decreased dose-dependently the efflux of HVA, increased that of DOPAC, and tended to increase that of dopamine.  Higher doses of OR-611 (30-100 mg/kg i.p.) also decreased the dialyzate level of HVA, increased that of DOPAC, and tended to increase that of dopamine.  Ro 40-7592 was about 10-fold as potent as OR-611.  Neither of the COMT inhibitors changed dialyzate levels of 5-HIAA.  An OR-611 dose of 10 mg/kg i.p. had no effect, in contrast to Ro-7592, on any of the parameters studied; this dose was thus used to differentiate between the effects of central and peripheral COMT inhibition.  Both nomifensine (15 mg/kg, i.p.) and clorgyline (4 mg/kg, i.p.) alone elevated extracellular dopamine levels, and lowered those of DOPAC and HVA, though there were quant. and temporal differences between the drugs.  L-Deprenyl (1 mg/kg, i.p.) alone had no effect on any of the compds. measured.  Ro 40-7592 (10 mg/kg, i.p.) potentiated the effect of nomifensine on dopamine efflux, and it tended to increase clorgyline-induced dopamine efflux.  DOPAC levels in dialyzates were increased by combinations of Ro 40-7592 and nomifensine or clorgyline, whereas HVA levels remained about as low as they were after Ro 40-7592 alone.  Ro 40-7592 had no interaction with L-deprenyl.  OR-611 (10 mg/kg, i.p.) did not modify the effects on dopamine metab. of nomifensine, clorgyline, or L-deprenyl.  Thus, Ro 40-7592 is a potent centrally active COMT inhibitor, whereas OR-611 is principally a peripherally active inhibitor.  Use of drugs which inhibit brain COMT can considerable modify dopamine metab.  COMT inhibitors may be of clin. significance in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0DCkRazKLLVg90H21EOLACvtfcHk0liJt9txoEnk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVGgtL4%253D&md5=191b4e677e3c68efcea6381e7efabc60</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2892%2991003-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252892%252991003-W%26sid%3Dliteratum%253Aachs%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DWurtman%26aufirst%3DR.%2BJ.%26atitle%3DEffects%2520of%2520COMT%2520inhibitors%2520on%2520striatal%2520dopamine%2520metabolism%2520a%2520microdialysis%2520study%26jtitle%3DBrain%2520Res.%26date%3D1992%26volume%3D587%26spage%3D241%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Prada, M.</span><span> </span><span class="NLM_article-title">Potent COMT inhibition by Ro40-7592 in the periphery and in the brain: preclinical and clinical findings</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=8420203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1SgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=641-647&author=G.+Z%C3%BCrcherauthor=J.+Dingemanseauthor=M.+Da+Prada&title=Potent+COMT+inhibition+by+Ro40-7592+in+the+periphery+and+in+the+brain%3A+preclinical+and+clinical+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings</span></div><div class="casAuthors">Zuercher, Gerhard; Dingemanse, Jasper; Da Prada, Mose</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">641-7</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">The amino acid 3,4-dihydroxyphenyl-L-alanine (levodopa, DOPA) administered in combination with inhibitors of extracerebral arom. L-amino acid decarboxylase (AADC; i.e., benserazide in Madopar and carbidopa in Sinemet) are still the std. treatments for the therapy of Parkinson's disease (PD).  The administration of DOPA together with AADC inhibitors, which poorly penetrate into the brain, results in a blockade of the decarboxylation of DOPA in the periphery, i.e., gastrointestinal tract, kidney, and brain capillaries.  As a consequence, a dramatic redn. of the conversion of DOPA into dopamine (DA) occurs in extra-cerebral tissues and thereby several side effects produced by the formation of DA in the periphery (nausea, vomiting, and orthostatic hypotension) are eliminated.  Moreover, the inhibition of the AADC restricted to the extracerebral tissues results in an improved access of DOPA into the brain, where the amino acid can easily be converted into DA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbc5ZFqKg9IbVg90H21EOLACvtfcHk0liJt9txoEnk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1SgsbY%253D&md5=a3610c5dcbd75a015e47f792c6722ba2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DDingemanse%26aufirst%3DJ.%26aulast%3DDa%2BPrada%26aufirst%3DM.%26atitle%3DPotent%2520COMT%2520inhibition%2520by%2520Ro40-7592%2520in%2520the%2520periphery%2520and%2520in%2520the%2520brain%253A%2520preclinical%2520and%2520clinical%2520findings%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D641%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonetti, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da parada, M.</span><span> </span><span class="NLM_article-title">Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol O-methyltransferase: a pharmacological study in rats</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=2239490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1990&pages=497-503&author=G.+Z%C3%BCrcherauthor=H.+H.+Kellerauthor=R.+Kettlerauthor=J.+Borgulyaauthor=E.+P.+Bonettiauthor=R.+Eigenmannauthor=M.+Da+parada&title=Ro+40-7592%2C+a+novel%2C+very+potent%2C+and+orally+active+inhibitor+of+catechol+O-methyltransferase%3A+a+pharmacological+study+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DKeller%26aufirst%3DH.%2BH.%26aulast%3DKettler%26aufirst%3DR.%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DBonetti%26aufirst%3DE.%2BP.%26aulast%3DEigenmann%26aufirst%3DR.%26aulast%3DDa%2Bparada%26aufirst%3DM.%26atitle%3DRo%252040-7592%252C%2520a%2520novel%252C%2520very%2520potent%252C%2520and%2520orally%2520active%2520inhibitor%2520of%2520catechol%2520O-methyltransferase%253A%2520a%2520pharmacological%2520study%2520in%2520rats%26jtitle%3DAdv.%2520Neurol.%26date%3D1990%26volume%3D53%26spage%3D497%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgulya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span> </span><span class="NLM_article-title">Tolcapone: A potential new antidepressant detected in a novel animal model of depression</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=344-350&author=J.+L.+Moreauauthor=J.+Borgulyaauthor=F.+Jenckauthor=J.+R.+Martin&title=Tolcapone%3A+A+potential+new+antidepressant+detected+in+a+novel+animal+model+of+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DBorgulya%26aufirst%3DJ.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26atitle%3DTolcapone%253A%2520A%2520potential%2520new%2520antidepressant%2520detected%2520in%2520a%2520novel%2520animal%2520model%2520of%2520depression%26jtitle%3DBehav.%2520Pharmacol.%26date%3D1994%26volume%3D5%26spage%3D344%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauhala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, E.</span><span> </span><span class="NLM_article-title">Beneficial effects of co-administration of catechol O-methyltransferase inhibitors and L-dihydroxypheylalanine in rat models of depression</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2F0014-2999%2894%2900776-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7768276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaK2M3osFyktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=229-233&author=P.+T.+M%C3%A4nnist%C3%B6author=A.+Langauthor=P.+Rauhalaauthor=E.+Vasar&title=Beneficial+effects+of+co-administration+of+catechol+O-methyltransferase+inhibitors+and+L-dihydroxypheylalanine+in+rat+models+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression</span></div><div class="casAuthors">Mannisto P T; Lang A; Rauhala P; Vasar E</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">229-33</span>
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The administration of catechol-O-methyltransferase inhibitors alone changed neither the behavior of the rats in two animal models of depression, the forced swimming test (entacapone and tolcapone) or in the learned helplessness paradigm (tolcapone), nor the locomotor activity.  L-Dihydroxyphenylalanine (L-DOPA) and carbidopa treatment as such decreased motility but did not improve the behavior in the antidepressant tests.  Co-administration of catechol-O-methyltransferase inhibitors and L-DOPA/carbidopa increased the performance of rats in both tests without increasing locomotor activity.  Catechol-O-methyltransferase inhibitors could be beneficial as adjunct drugs of L-DOPA not only in Parkinson's disease but also in the coincident depressive illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRefyru2M4boe2qxNLjzXe8fW6udTcc2eZrNKSv70gZfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3osFyktQ%253D%253D&md5=9472278a0074e4f8a6771fabba57a9ef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2900776-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252900776-4%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DLang%26aufirst%3DA.%26aulast%3DRauhala%26aufirst%3DP.%26aulast%3DVasar%26aufirst%3DE.%26atitle%3DBeneficial%2520effects%2520of%2520co-administration%2520of%2520catechol%2520O-methyltransferase%2520inhibitors%2520and%2520L-dihydroxypheylalanine%2520in%2520rat%2520models%2520of%2520depression%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D274%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Maj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogóz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skuza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowinska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superata, J.</span><span> </span><span class="NLM_article-title">Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinsons disease</span> <span class="citation_source-journal">J. Neural Transm.: Parkinson’s Dis. Dementia Sect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1007%2FBF02260898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1977408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3MXlt1Kku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=101-112&author=J.+Majauthor=Z.+Rog%C3%B3zauthor=G.+Skuzaauthor=H.+Sowinskaauthor=J.+Superata&title=Behavioural+and+neurochemical+effects+of+Ro+40-7592%2C+a+new+COMT+inhibitor+with+a+potential+therapeutic+activity+in+Parkinsons+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease</span></div><div class="casAuthors">Maj, J.; Rogoz, Z.; Skuza, G.; Sowinska, H.; Superata, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission:  Parkinson's Disease and Dementia Section</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-12</span>CODEN:
                <span class="NLM_cas:coden">JNPSEJ</span>;
        ISSN:<span class="NLM_cas:issn">0936-3076</span>.
    </div><div class="casAbstract">Behavioral and neurochem. effects of Ro 40-7592 (I), a new catechol-O-methyltransferase (COMI) inhibitor, were studied in rats and mice.  I increased the effect of L-DOPA (plus benserazide) on locomotor activity, reserpine-induced hypothermia, and catalepsy induced by pimozide, haloperidol and fluphenazine.  Locomotor hyperactivity induced by amphetamine or nomifensine, as well as stereotypy induced by amphetamine (but not apomorphine), were also increased by I.  The drug stimulated exploratory activity in the open field test.  It decreased the levels of HFA and 3-MT, increased the level of DOPAC but did not change the levels of dopamine in the striatum, nucleus accumbens and frontal cortex.  These results indicate that I may improve therapy with L-DOPA (plus decarboxylase inhibitor) of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGa4QWw3HnLVg90H21EOLACvtfcHk0ljIQLUB0yLc-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt1Kku7o%253D&md5=718bd38b92436031ac4982ae554d96c3</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2FBF02260898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02260898%26sid%3Dliteratum%253Aachs%26aulast%3DMaj%26aufirst%3DJ.%26aulast%3DRog%25C3%25B3z%26aufirst%3DZ.%26aulast%3DSkuza%26aufirst%3DG.%26aulast%3DSowinska%26aufirst%3DH.%26aulast%3DSuperata%26aufirst%3DJ.%26atitle%3DBehavioural%2520and%2520neurochemical%2520effects%2520of%2520Ro%252040-7592%252C%2520a%2520new%2520COMT%2520inhibitor%2520with%2520a%2520potential%2520therapeutic%2520activity%2520in%2520Parkinsons%2520disease%26jtitle%3DJ.%2520Neural%2520Transm.%253A%2520Parkinson%25E2%2580%2599s%2520Dis.%2520Dementia%2520Sect.%26date%3D1990%26volume%3D2%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Törnwall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span> </span><span class="NLM_article-title">Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission</span> <span class="citation_source-journal">Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1991.tb00412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=1658768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK3MXltVGnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1991&pages=64-70&author=M.+T%C3%B6rnwallauthor=P.+T.+Mannist%C3%B6&title=Acute+toxicity+of+three+new+selective+COMT+inhibitors+in+mice+with+special+emphasis+on+interactions+with+drugs+increasing+catecholaminergic+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission</span></div><div class="casAuthors">Tornwall, M.; Mannisto, P. T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Toxicology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">PHTOEH</span>;
        ISSN:<span class="NLM_cas:issn">0901-9928</span>.
    </div><div class="casAbstract">3-Nitropyrocatechols are very potent and selective inhibitors of catechol O-methyltransferase (COMT).  LD50 of 3 of these compds. were assessed after i.p. administration with a special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.  LD50 of the inhibitors varied from 137 mg/kg (Ro 41-0960) (I) to 507 mg/kg (OR 462) (II) and 544 mg/kg (OR 611) (III).  The LD50 of Ro 41-0960 was significantly lower than II and III.  At toxic dose levels all inhibitors caused convulsions and hypomotility.  II and III had statistically significant mortality increasing interaction with 20 mg/kg of nomifensine and the former also with 10 mg of amphetamine.  Owing to their high therapeutic indexes, these compds. can be considered useful new tools in pharmacol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSVfCG6R6Co7Vg90H21EOLACvtfcHk0lh-ZgFIWYBvag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltVGnur4%253D&md5=b7b9f61a49070072239e5b4cb8f3dcf3</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1991.tb00412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1991.tb00412.x%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25B6rnwall%26aufirst%3DM.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DAcute%2520toxicity%2520of%2520three%2520new%2520selective%2520COMT%2520inhibitors%2520in%2520mice%2520with%2520special%2520emphasis%2520on%2520interactions%2520with%2520drugs%2520increasing%2520catecholaminergic%2520neurotransmission%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1991%26volume%3D69%26spage%3D64%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">Tolcapone and hepatotoxic effects</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1001%2Farchneur.57.2.263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10681087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADC%252BD3c7ktlehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=263-267&author=C.+W.+Olanow&title=Tolcapone+and+hepatotoxic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Tolcapone and hepatotoxic effects. Tasmar Advisory Panel</span></div><div class="casAuthors">Olanow C W</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-7</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">Four patients with Parkinson disease have recently been described in whom severe hepatic dysfunction developed in association with tolcapone therapy.  These reports led to the introduction of a "black box" warning and more intensive monitoring requirements in the United States.  A review of these cases and all clinical trials indicates that liver dysfunction did not develop in any patient who had received monitoring of liver function according to the original prescribing information.  Virtually all instances of liver enzyme abnormality and clinical liver dysfunction occurred within 6 months of initiating treatment.  To assess the current role of tolcapone therapy in Parkinson disease, a panel of neurologists and hepatologists was convened.  Consensus was reached with respect to the following: (1) Tolcapone is an effective agent in the treatment of patients with fluctuating Parkinson disease. (2) The risk of developing irreversible liver injury is negligible with appropriate monitoring. (3) It may be possible to reduce the frequency of monitoring after 6 months of treatment. (4) The requirement that tolcapone be withdrawn if liver enzymes are elevated above the upper limit of normal on a single occasion is unnecessarily restrictive.  It was concluded that tolcapone, when used as an adjunct to levodopa, is an effective anti-parkinsonian agent and that less frequent monitoring after 6 months, with an action limit of 2 to 3 times the upper limit of normal, is sufficient to ensure safety in patients who are deriving benefit from the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSvLil8Il-hnRxY89Cm6SyfW6udTcc2eaBQ3KAcMKMFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7ktlehsA%253D%253D&md5=bf1f26ab7b6132952888840225f92417</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1001%2Farchneur.57.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.57.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DTolcapone%2520and%2520hepatotoxic%2520effects%26jtitle%3DArch.%2520Neurol.%26date%3D2000%26volume%3D57%26spage%3D263%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Assal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spahr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadengue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubbici-Brandt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhard, P. R.</span><span> </span><span class="NLM_article-title">Tolcapone and fulminant hepaptitis</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=958&author=F.+Assalauthor=L.+Spahrauthor=A.+Hadengueauthor=L.+Rubbici-Brandtauthor=P.+R.+Burkhard&title=Tolcapone+and+fulminant+hepaptitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAssal%26aufirst%3DF.%26aulast%3DSpahr%26aufirst%3DL.%26aulast%3DHadengue%26aufirst%3DA.%26aulast%3DRubbici-Brandt%26aufirst%3DL.%26aulast%3DBurkhard%26aufirst%3DP.%2BR.%26atitle%3DTolcapone%2520and%2520fulminant%2520hepaptitis%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Jorga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotteler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heizmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, R.</span><span> </span><span class="NLM_article-title">Metabolism and excretion of tolcapone, a novel inhibitor of catechol O-methyltransferase</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1046%2Fj.1365-2125.1999.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10583021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=513-520&author=K.+M.+Jorgaauthor=B.+Fottelerauthor=P.+Heizmannauthor=R.+Gasser&title=Metabolism+and+excretion+of+tolcapone%2C+a+novel+inhibitor+of+catechol+O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase</span></div><div class="casAuthors">Jorga, Karin; Fotteler, Barbel; Heizmann, Peter; Gasser, Rodolfo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The rate of excretion and routes of metab. of tolcapone, a novel inhibitor of catechol-O-methyltransferase (COMT) were studied.  Six healthy male volunteers were given 200 mg [14C]-tolcapone (approx. 50 μCi) orally.  To assess excretion balance and to identify metabolites, urine and feces were collected before administration and until radioactivity fell below 75 d min-1 ml-1 (urine) and 100 d min-1 mg-1 (feces).  Blood samples were collected frequently before and after administration to det. plasma radioactivity, to identify tolcapone metabolites and to measure plasma tolcapone and its methylated deriv. 3-O-methyltolcapone (3-OMT).  The mean proportion of the dose excreted in urine was 57.3% and in feces 40.5%.  Excretion was almost complete (more than 95%) in all participants after 9 days.  The major early metabolite present in plasma was the 3-O-β,D-glucuronide conjugate, which was detectable within 2 h after dosing.  The major late metabolite in plasma was 3-OMT.  The 3-O-β,D-glucuronide was also the most abundant metabolite in urine and feces, accounting for 27% and 33%, resp., of the total radioactivity excreted by these routes and for 26% of the original dose.  Redn. of the nitro moiety yields an amine deriv., detected in both urine and feces, with subsequent modifications, such as acetylation of the amine group and conjugation with glucuronic acid or sulfate, or both.  Oxidative reactions due to cytochrome P 450 enzymes are of small significance, as is 3-O-methylation by COMT.  Tolcapone is almost completely metabolized and excreted in urine and feces (only 0.5% of tolcapone was excreted unchanged); glucuronidation is the most important route of metab.  The relatively long duration of excretion is caused by the long half-life of 3-OMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomxbJ3foHx37Vg90H21EOLACvtfcHk0ljCL1jG2KUnzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFalu7k%253D&md5=53200da79657f3560fc6de831654cd86</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2125.1999.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2125.1999.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorga%26aufirst%3DK.%2BM.%26aulast%3DFotteler%26aufirst%3DB.%26aulast%3DHeizmann%26aufirst%3DP.%26aulast%3DGasser%26aufirst%3DR.%26atitle%3DMetabolism%2520and%2520excretion%2520of%2520tolcapone%252C%2520a%2520novel%2520inhibitor%2520of%2520catechol%2520O-methyltransferase%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1999%26volume%3D48%26spage%3D513%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Smith, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heady, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trugman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harman, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. L.</span><span> </span><span class="NLM_article-title">In vitro metabolism of tolcapone to reactive intermediates relevance to tolcapone liver toxicity</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx025569n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=123-128&author=K.+S.+Smithauthor=P.+L.+Smithauthor=T.+N.+Headyauthor=J.+M.+Trugmanauthor=W.+D.+Harmanauthor=T.+L.+McDonald&title=In+vitro+metabolism+of+tolcapone+to+reactive+intermediates+relevance+to+tolcapone+liver+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Ftx025569n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx025569n%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DK.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DHeady%26aufirst%3DT.%2BN.%26aulast%3DTrugman%26aufirst%3DJ.%2BM.%26aulast%3DHarman%26aufirst%3DW.%2BD.%26aulast%3DMcDonald%26aufirst%3DT.%2BL.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520tolcapone%2520to%2520reactive%2520intermediates%2520relevance%2520to%2520tolcapone%2520liver%2520toxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2003%26volume%3D16%26spage%3D123%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Haasio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koponen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentilla, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span> </span><span class="NLM_article-title">Effects of entacapone and tolcapone on mitochondrial membrane potential</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0014-2999%2802%2902383-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12393055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2002&pages=21-26&author=K.+Haasioauthor=A.+Koponenauthor=K.+E.+Pentillaauthor=E.+Nissinen&title=Effects+of+entacapone+and+tolcapone+on+mitochondrial+membrane+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of entacapone and tolcapone on mitochondrial membrane potential</span></div><div class="casAuthors">Haasio, Kristiina; Koponen, Anita; Penttila, Kai E.; Nissinen, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-26</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Catechol-O-Me transferase (COMT) inhibitors, entacapone and tolcapone, are used as an adjunctive treatment to L-dopa in Parkinson's disease.  Based on their catechol structure, both inhibitors are potential uncoupling agents, but only tolcapone shows this effect in vitro at clin. relevant concns.  This study was designed to evaluate the direct uncoupling effects of the two COMT inhibitors in vitro and in vivo.  In isolated rat liver mitochondria, entacapone had no effect on the membrane potential at therapeutical concns., but both tolcapone and the ref. compd. 2,4-dinitrophenol disrupted the potential at low μM concns.  Since protein binding is speculated to decrease the uncoupling effects in vivo, the COMT inhibitory effect of entacapone and tolcapone as a surrogate for the overall activity of these inhibitors was evaluated in vitro with or without serum.  The COMT inhibitory activity of entacapone was reduced to half, while tolcapone had only about 1/10 of its activity left in the presence of serum.  Further, uncoupling is known to induce an increase in the body temp. in vivo, and these effects were evaluated in the rat by a possible hyperthermic response to the treatment with entacapone or tolcapone in combination with L-dopa (10 mg/kg) and carbidopa (20 mg/kg).  This combination with entacapone (400 mg/kg) had no effect on the rectal body temp.  In contrast, tolcapone (50 mg/kg) caused an elevation in the body temp. together with L-dopa and carbidopa (P<0.01).  Both in vitro and in vivo results indicate that entacapone does not impair energy metab. related to uncoupling of oxidative phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRip7eAsgAabVg90H21EOLACvtfcHk0ljCL1jG2KUnzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCht7Y%253D&md5=8a649045794a303d435cf67fef4fdcb9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902383-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902383-X%26sid%3Dliteratum%253Aachs%26aulast%3DHaasio%26aufirst%3DK.%26aulast%3DKoponen%26aufirst%3DA.%26aulast%3DPentilla%26aufirst%3DK.%2BE.%26aulast%3DNissinen%26aufirst%3DE.%26atitle%3DEffects%2520of%2520entacapone%2520and%2520tolcapone%2520on%2520mitochondrial%2520membrane%2520potential%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D453%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaheinen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentilla, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaivola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, I. B.</span><span> </span><span class="NLM_article-title">Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson’s disease, does not impair mitochondrial energy production</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0014-2999%2897%2901431-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=9537825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2sXotVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1997&pages=287-294&author=E.+Nissinenauthor=P.+Kaheinenauthor=K.+E.+Pentillaauthor=K.+Kaivolaauthor=I.+B.+Linden&title=Entacapone%2C+a+novel+catechol-O-methyltransferase+inhibitor+for+Parkinson%E2%80%99s+disease%2C+does+not+impair+mitochondrial+energy+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production</span></div><div class="casAuthors">Nissinen, Erkki; Kaheinen, Petri; Penttila, Kai E.; Kaivola, Juha; Linden, Inge-Britt</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Entacapone, a novel mainly peripherally acting catechol-O-methyltransferase inhibitor used in the treatment of Parkinson's disease, was evaluated for its possible uncoupling activity in cell culture, in rat liver mitochondria, and in isolated guinea-pig heart.  Entacapone did not stimulate respiration in the L1210 murine T cell lymphoma cell line at the concns. studied (5-40 μM).  Furthermore, entacapone neither increased mitochondrial respiration nor impaired cardiac function at pharmacol. relevant concns. (<10 μM).  In fact, the threshold concn. for increased mitochondrial oxygen consumption was 20 μM and half-maximal stimulation of respiration was not detected until 58 μM.  Surprisingly, tolcapone, another catechol-O-methyltransferase inhibitor, which acts both peripherally and centrally, stimulated respiration in L1210 cells at the lowest concn. studied (5 μM).  In addn., 1 μM tolcapone increased mitochondrial respiration, indicating that it caused uncoupling at a much lower concn. than that of 2,4-dinitrophenol, a well-known uncoupler of oxidative phosphorylation.  Tolcapone also impaired the mech. function and oxygen consumption of the isolated guinea-pig heart at 1 μM. These results show that peripherally acting entacapone, unlike the brain-penetrating tolcapone, is a safe catechol-O-methyltransferase inhibitor for the treatment of Parkinson's disease, since it does not interfere with mitochondrial energy metab. at pharmacol. effective concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNVpzZyM4Ek7Vg90H21EOLACvtfcHk0lj_31vA9VAo1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVyjsbY%253D&md5=441064c55e00ba634bc3b3657e55ade8</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901431-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901431-3%26sid%3Dliteratum%253Aachs%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DKaheinen%26aufirst%3DP.%26aulast%3DPentilla%26aufirst%3DK.%2BE.%26aulast%3DKaivola%26aufirst%3DK.%26aulast%3DLinden%26aufirst%3DI.%2BB.%26atitle%3DEntacapone%252C%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520for%2520Parkinson%25E2%2580%2599s%2520disease%252C%2520does%2520not%2520impair%2520mitochondrial%2520energy%2520production%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D340%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Korlipara, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H.</span><span> </span><span class="NLM_article-title">Differencies in toxicity of catechol O-methyltransferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=562-569&author=L.+P.+Korliparaauthor=J.+M.+Cooperauthor=A.+H.+Schapira&title=Differencies+in+toxicity+of+catechol+O-methyltransferase+inhibitors%2C+tolcapone+and+entacapone+to+cultured+human+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorlipara%26aufirst%3DL.%2BP.%26aulast%3DCooper%26aufirst%3DJ.%2BM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26atitle%3DDifferencies%2520in%2520toxicity%2520of%2520catechol%2520O-methyltransferase%2520inhibitors%252C%2520tolcapone%2520and%2520entacapone%2520to%2520cultured%2520human%2520neuroblastoma%2520cells%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D56%26spage%3D562%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Benes, J.; Soares-da-Silva, P.; Learmonth, D.</span><span> </span><span class="NLM_article-title">Substituted 2-Phenyl-l-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical composition containing them</span>. International Patent WO200037423,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=J.+Benes&author=P.+Soares-da-Silva&author=D.+Learmonth&title=Substituted+2-Phenyl-l-%283%2C4-dihydroxy-5-nitrophenyl%29-1-ethanones%2C+their+use+in+the+treatment+of+some+central+and+peripheral+nervous+system+disorders+and+pharmaceutical+composition+containing+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DJ.%26atitle%3DSubstituted%25202-Phenyl-l-%25283%252C4-dihydroxy-5-nitrophenyl%2529-1-ethanones%252C%2520their%2520use%2520in%2520the%2520treatment%2520of%2520some%2520central%2520and%2520peripheral%2520nervous%2520system%2520disorders%2520and%2520pharmaceutical%2520composition%2520containing%2520them%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109964" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=685-695&author=D.+A.+Learmonthauthor=M.+A.+Vieira-Coelhoauthor=J.+Benesauthor=P.+C.+Alvesauthor=N.+Borgesauthor=A.+P.+Freitasauthor=P.+Soares-da-Silva&title=Synthesis+of+1-%283%2C4-dihydroxy-5-nitrophenyl%29-2-phenyl-ethanone+and+derivatives+as+potent+and+long-acting+peripheral+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm0109964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109964%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DBenes%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DP.%2BC.%26aulast%3DBorges%26aufirst%3DN.%26aulast%3DFreitas%26aufirst%3DA.%2BP.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%2520of%25201-%25283%252C4-dihydroxy-5-nitrophenyl%2529-2-phenyl-ethanone%2520and%2520derivatives%2520as%2520potent%2520and%2520long-acting%2520peripheral%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D685%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">250</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=250-258&author=P.+N.+Palmaauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=L.+C.+Wrightauthor=D.+A.+Learmonthauthor=P.+Soares-da-Silva&title=Molecular+modeling+and+metabolic+studies+of+the+interaction+of+catechol-O-methyltransferase+and+a+new+nitrocatechol+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DMolecular%2520modeling%2520and%2520metabolic%2520studies%2520of%2520the%2520interaction%2520of%2520catechol-O-methyltransferase%2520and%2520a%2520new%2520nitrocatechol%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D250%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Learmonth, D.; Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them</span>. International Patent WO200198251,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+Learmonth&author=P.+Soares-da-Silva&title=Substituted+nitrated+catechols%2C+their+use+in+the+treatment+of+some+central+and+peripheral+nervous+system+disorders+and+pharmaceutical+compositions+containing+them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%26atitle%3DSubstituted%2520nitrated%2520catechols%252C%2520their%2520use%2520in%2520the%2520treatment%2520of%2520some%2520central%2520and%2520peripheral%2520nervous%2520system%2520disorders%2520and%2520pharmaceutical%2520compositions%2520containing%2520them%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira-Coelho, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6207</span><span class="NLM_x">–</span> <span class="NLM_lpage">6217</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040848o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6207-6217&author=D.+A.+Learmonthauthor=P.+N.+Palmaauthor=M.+A.+Vieira-Coelhoauthor=P.+Soares-da-Silva&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+studies+of+a+novel%2C+peripherally+selective+inhibitor+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm040848o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040848o%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DVieira-Coelho%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520studies%2520of%2520a%2520novel%252C%2520peripherally%2520selective%2520inhibitor%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6207%26epage%3D6217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matias, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-Da-Silva, P.</span><span> </span><span class="NLM_article-title">Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=795-805&author=M.+J.+Bonif%C3%A1cioauthor=M.+Archerauthor=M.+L.+Rodriguesauthor=P.+M.+Matiasauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-Da-Silva&title=Kinetics+and+crystal+structure+of+catechol-O-methyltransferase+complex+with+co-substrate+and+a+novel+inhibitor+with+potential+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DMatias%26aufirst%3DP.%2BM.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-Da-Silva%26aufirst%3DP.%26atitle%3DKinetics%2520and%2520crystal%2520structure%2520of%2520catechol-O-methyltransferase%2520complex%2520with%2520co-substrate%2520and%2520a%2520novel%2520inhibitor%2520with%2520potential%2520therapeutic%2520application%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D62%26spage%3D795%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Kiss, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span> </span><span class="NLM_article-title">Discovery of a long-acting, peripherally selective inhibitor of catechol-<i>O</i>-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3396</span><span class="NLM_x">–</span> <span class="NLM_lpage">3411</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1001524" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3396-3411&author=L.+E.+Kissauthor=H.+S.+Ferreiraauthor=L.+Torr%C3%A3oauthor=M.+J.+Bonif%C3%A1cioauthor=P.+N.+Palmaauthor=P.+Soares-da-Silvaauthor=D.+A.+Learmonth&title=Discovery+of+a+long-acting%2C+peripherally+selective+inhibitor+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm1001524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1001524%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DL.%2BE.%26aulast%3DFerreira%26aufirst%3DH.%2BS.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520long-acting%252C%2520peripherally%2520selective%2520inhibitor%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3396%26epage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Computation of the binding affinities of catechol-<i>O</i>-methyltransferase inhibitors: Multisubstate relative free energy calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=970-986&author=P.+N.+Palmaauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=P.+Soares-da-Silva&title=Computation+of+the+binding+affinities+of+catechol-O-methyltransferase+inhibitors%3A+Multisubstate+relative+free+energy+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DComputation%2520of%2520the%2520binding%2520affinities%2520of%2520catechol-O-methyltransferase%2520inhibitors%253A%2520Multisubstate%2520relative%2520free%2520energy%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2012%26volume%3D33%26spage%3D970%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Opicapone: Characterization of a novel peripheral long-acting catechol-<i>O</i>-methyltransferase inhibitior</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">S2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S125&issue=S2&author=M.+J.+Bonif%C3%A1cioauthor=L.+Torr%C3%A3oauthor=A.+I.+Loureiroauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Opicapone%3A+Characterization+of+a+novel+peripheral+long-acting+catechol-O-methyltransferase+inhibitior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DOpicapone%253A%2520Characterization%2520of%2520a%2520novel%2520peripheral%2520long-acting%2520catechol-O-methyltransferase%2520inhibitior%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DS2%26spage%3DS125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Brain and peripheral levodopa pharmacokinetics in the cynomolgus monkey following administration of opicapone, a novel catechol-<i>O</i>-methyltransferase inhibitor</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">S2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=S125&issue=S2&author=M.+J.+Bonif%C3%A1cioauthor=J.+S.+Sutcliffeauthor=L.+Torr%C3%A3oauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Brain+and+peripheral+levodopa+pharmacokinetics+in+the+cynomolgus+monkey+following+administration+of+opicapone%2C+a+novel+catechol-O-methyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DBrain%2520and%2520peripheral%2520levodopa%2520pharmacokinetics%2520in%2520the%2520cynomolgus%2520monkey%2520following%2520administration%2520of%2520opicapone%252C%2520a%2520novel%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2012%26volume%3D18%26issue%3DS2%26spage%3DS125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Takehiro, I.; Toshihiro, N.; Hitoshi, I.; Nobuyuki, T.; Hideyuki, M.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and uses of those</span>. International Patent WO2007063789,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=I.+Takehiro&author=N.+Toshihiro&author=I.+Hitoshi&author=T.+Nobuyuki&author=M.+Hideyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+uses+of+those"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520uses%2520of%2520those%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: Synthesis and biological activity as catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4584</span><span class="NLM_x">–</span> <span class="NLM_lpage">4588</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4584-4588&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Dihydroxynitrobenzaldehydes+and+hydroxymethoxynitrobenzaldehydes%3A+Synthesis+and+biological+activity+as+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a011%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DDihydroxynitrobenzaldehydes%2520and%2520hydroxymethoxynitrobenzaldehydes%253A%2520Synthesis%2520and%2520biological%2520activity%2520as%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4584%26epage%3D4588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1973</span><span class="NLM_x">–</span> <span class="NLM_lpage">1981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=1973-1981&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Inhibition+of+catechol-O-methyltransferase+by+1-vinyl+derivatives+of+nitrocatechols+and+nitroguaiacols.+Kinetics+of+the+irreversible+inhibition+by+3-%283-hydroxy-4-methoxy-5-nitro+benzylidene%29-2%2C4-pentanedione"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DInhibition%2520of%2520catechol-O-methyltransferase%2520by%25201-vinyl%2520derivatives%2520of%2520nitrocatechols%2520and%2520nitroguaiacols.%2520Kinetics%2520of%2520the%2520irreversible%2520inhibition%2520by%25203-%25283-hydroxy-4-methoxy-5-nitro%2520benzylidene%2529-2%252C4-pentanedione%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D1973%26epage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Pérez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedrafita, F. J.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible tight-binding inhibition of pig liver catechol-<i>O</i>-methyltransferase by [2-(3,4-dihydroxy-2-nitrophenyl) vinyl]phenyl ketone</span> <span class="citation_source-journal">Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.3109%2F14756369409020195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=7539072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK2MXis1Cjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=123-131&author=R.+A.+P%C3%A9rezauthor=E.+Fern%C3%A1ndez-Alvarezauthor=O.+Nietoauthor=F.+J.+Piedrafita&title=Kinetics+of+the+reversible+tight-binding+inhibition+of+pig+liver+catechol-O-methyltransferase+by+%5B2-%283%2C4-dihydroxy-2-nitrophenyl%29+vinyl%5Dphenyl+ketone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenyl ketone</span></div><div class="casAuthors">Perez, Rosa A.; Fernandez-Alvarez, Eldiberto; Nieto, Ofelia; Piedrafita, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-31</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">The inactivation of partially purified pig liver catechol-O-methyltransferase (COMT) by [2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenylketone has been studied.  The results demonstrated that COMAT is inhibited in a reversible tight-binding fashion with an apparent Ki of 0.2 μM.  IC50 values were detd. at different concns. of both substrates of the enzymic reaction, pyrocatechol and S-adenosyl-L-methionine (AdoMet).  The plot of IC50 vs. pyrocatechol concn. gave a straight line, suggesting competitive inhibition.  However the nitrocatechol deriv. showed an uncompetitive inhibition pattern when measured as a function of AdoMet concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom2bJxWnRCH7Vg90H21EOLACvtfcHk0ljjyBGqnJQSAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXis1Cjt7s%253D&md5=a20073cab8993056859d7c5d7fa6a610</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.3109%2F14756369409020195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756369409020195%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DR.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DE.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DPiedrafita%26aufirst%3DF.%2BJ.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520tight-binding%2520inhibition%2520of%2520pig%2520liver%2520catechol-O-methyltransferase%2520by%2520%255B2-%25283%252C4-dihydroxy-2-nitrophenyl%2529%2520vinyl%255Dphenyl%2520ketone%26jtitle%3DEnzyme%2520Inhib.%26date%3D1994%26volume%3D8%26spage%3D123%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Rivas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ceballos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontenla, J. A.</span><span> </span><span class="NLM_article-title">In vivo effects of new inhibitors of catechol-O-methyltransferase</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1038%2Fsj.bjp.0702474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10323601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADyaK1MXislGku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=1667-1673&author=E.+Rivasauthor=M.+L.+de+Ceballosauthor=O.+Nietoauthor=J.+A.+Fontenla&title=In+vivo+effects+of+new+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of new inhibitors of catechol-O-methyl transferase</span></div><div class="casAuthors">Rivas, Emilia; De Ceballos, Maria L.; Nieto, Ofelia; Fontenla, Jose Angel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1667-1673</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The effects of two new synthetic compds. showing in vitro catechol-O-Me transferase (COMT) inhibitor properties were studied in vivo and compared with the effects of nitecapone and Ro-41-0960.  QO IA (3-(3-hydroxy-4-methoxy-5-nitrobenzylidene)-2,4-pentanedione), QO IIR ([2-(3,4-dihydroxy-2-nitrophenyl)vinyl]phenyl ketone), nitecapone and Ro-41-0960 (30 mg kg-1, i.p.) were given to reserpinized rats 1 h before the administration of L-DOPA/carbidopa (LD/CD, 50: 50 mg kg-1, i.p.).  Locomotor activity was assessed 1 h later.  All the COMT inhibitors (COMTI), with the exception of QO IA, markedly potentiated LD/CD reversal of reserpine-induced akinesia.  Similar results were obtained when the COMTI were coadministered with LD/CD.  The effect of compd. QO IIR was dose-dependent (7.5-30 mg kg-1, i.p.).  The COMTI (30 mg kg-1, i.p.) potentiated LD/CD reversal of both catalepsy and hypothermia of reserpinized mice.  QO IIR, nitecapone and Ro-41-0960 (30 mg kg-1, i.p.) reduced striatal 3-methyl-DOPA (3-OMD) levels and increased dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) levels.  Compd. QO IA was devoid of any effect on striatal amine levels.  In contrast to the other inhibitors, Ro-41-0961 reduced HVA levels as well.  The effect of QO IIR on striatal amine levels was dose-dependent (7.5-60 mg kg-1, i.p.).  These results suggest that the new compd. QO IIR is an effective peripherally acting COMT inhibitor in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhPwwT8u4ILVg90H21EOLACvtfcHk0lhmekVi2dp9UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGku7s%253D&md5=5f23c89adf3d9f53280fa873c245d250</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702474%26sid%3Dliteratum%253Aachs%26aulast%3DRivas%26aufirst%3DE.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26aulast%3DNieto%26aufirst%3DO.%26aulast%3DFontenla%26aufirst%3DJ.%2BA.%26atitle%3DIn%2520vivo%2520effects%2520of%2520new%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D1667%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel series of “ortho-nitrated” inhibitors of catechol-O-methyltransferase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8070</span><span class="NLM_x">–</span> <span class="NLM_lpage">8078</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0580454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=8070-8078&author=D.+A.+Learmonthauthor=M.+J.+Bonif%C3%A1cioauthor=P.+Soares-da-Silva&title=Synthesis+and+biological+evaluation+of+a+novel+series+of+%E2%80%9Cortho-nitrated%E2%80%9D+inhibitors+of+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjm0580454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0580454%26sid%3Dliteratum%253Aachs%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520%25E2%2580%259Cortho-nitrated%25E2%2580%259D%2520inhibitors%2520of%2520catechol-O-methyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D8070%26epage%3D8078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span> </span><span class="NLM_article-title">Crystallization and preliminary X-ray diffraction studies of a catechol-<i>O</i>-methyltransferase/inhibitor complex</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">F61</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=F61&publication_year=2005&pages=118-120&author=M.+L.+Rodriguesauthor=M.+J.+Bonif%C3%A1cioauthor=P.+Soares-da-Silvaauthor=M.+A.+Carrondoauthor=M.+Archer&title=Crystallization+and+preliminary+X-ray+diffraction+studies+of+a+catechol-O-methyltransferase%2Finhibitor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DArcher%26aufirst%3DM.%26atitle%3DCrystallization%2520and%2520preliminary%2520X-ray%2520diffraction%2520studies%2520of%2520a%2520catechol-O-methyltransferase%252Finhibitor%2520complex%26jtitle%3DActa%2520Crystallogr.%26date%3D2005%26volume%3DF61%26spage%3D118%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifácio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learmonth, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrondo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase. Interactions with the active site and regioselectivity of <i>O</i>-methylation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=143-153&author=P.+N.+Palmaauthor=M.+L.+Rodriguesauthor=M.+Archerauthor=M.+J.+Bonif%C3%A1cioauthor=A.+I.+Loureiroauthor=D.+A.+Learmonthauthor=M.+A.+Carrondoauthor=P.+Soares-da-Silva&title=Comparative+study+of+ortho-+and+meta-nitrated+inhibitors+of+catechol-O-methyltransferase.+Interactions+with+the+active+site+and+regioselectivity+of+O-methylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DRodrigues%26aufirst%3DM.%2BL.%26aulast%3DArcher%26aufirst%3DM.%26aulast%3DBonif%25C3%25A1cio%26aufirst%3DM.%2BJ.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DLearmonth%26aufirst%3DD.%2BA.%26aulast%3DCarrondo%26aufirst%3DM.%2BA.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DComparative%2520study%2520of%2520ortho-%2520and%2520meta-nitrated%2520inhibitors%2520of%2520catechol-O-methyltransferase.%2520Interactions%2520with%2520the%2520active%2520site%2520and%2520regioselectivity%2520of%2520O-methylation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Pystynen, J.; Luiro, A.; Lotta, T.; Ovaska, M.; Vidgren, J.</span><span> </span><span class="NLM_article-title">New catechol derivatives</span>. International Patent WO199637456,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=J.+Pystynen&author=A.+Luiro&author=T.+Lotta&author=M.+Ovaska&author=J.+Vidgren&title=New+catechol+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPystynen%26aufirst%3DJ.%26atitle%3DNew%2520catechol%2520derivatives%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Ahlmark, M.; Din Belle, D.; Kauppala, M.; Luiro, A.; Pajunen, T.; Pystynen, J.; Tiainen, E.; Vaismaa, M.</span><span> </span><span class="NLM_article-title">Catechol O-methyltransferase activity inhibiting compounds</span>. International Patent WO2013175053,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Ahlmark&author=D.+Din+Belle&author=M.+Kauppala&author=A.+Luiro&author=T.+Pajunen&author=J.+Pystynen&author=E.+Tiainen&author=M.+Vaismaa&title=Catechol+O-methyltransferase+activity+inhibiting+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhlmark%26aufirst%3DM.%26atitle%3DCatechol%2520O-methyltransferase%2520activity%2520inhibiting%2520compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Takehiro, I.; Inoue, H.; Kobayashi, S.; Yoshida, M.; Shiohara, H.; Ueno, Y.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and use of the catechol derivative and use of the pharmaceutical composition</span>. International Patent WO2009081891,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Takehiro&author=H.+Inoue&author=S.+Kobayashi&author=M.+Yoshida&author=H.+Shiohara&author=Y.+Ueno&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+use+of+the+catechol+derivative+and+use+of+the+pharmaceutical+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520use%2520of%2520the%2520catechol%2520derivative%2520and%2520use%2520of%2520the%2520pharmaceutical%2520composition%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Hiroaki, S.; Satoko, K.; Hitoshi, I.; Masako, Y.; Yasunori, U.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and uses of those</span>. International Patent WO2009081892,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Hiroaki&author=K.+Satoko&author=I.+Hitoshi&author=Y.+Masako&author=U.+Yasunori&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+uses+of+those"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHiroaki%26aufirst%3DS.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520uses%2520of%2520those%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Takehiro, I.; Satoko, K.; Hitoshi, I.; Yasunori, U.; Masako, Y.; Nobuyuki, T.</span><span> </span><span class="NLM_article-title">Novel catechol derivative, pharmaceutical composition containing the same, and use of the catechol derivative and use of the pharmaceutical composition</span>. International Patent WO2010001821,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=I.+Takehiro&author=K.+Satoko&author=I.+Hitoshi&author=U.+Yasunori&author=Y.+Masako&author=T.+Nobuyuki&title=Novel+catechol+derivative%2C+pharmaceutical+composition+containing+the+same%2C+and+use+of+the+catechol+derivative+and+use+of+the+pharmaceutical+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakehiro%26aufirst%3DI.%26atitle%3DNovel%2520catechol%2520derivative%252C%2520pharmaceutical%2520composition%2520containing%2520the%2520same%252C%2520and%2520use%2520of%2520the%2520catechol%2520derivative%2520and%2520use%2520of%2520the%2520pharmaceutical%2520composition%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Pystynen, J.; Ovaska, M.; Vidgren, J.; Lotta, T.; Yliperttula-ikonen, M.</span><span> </span><span class="NLM_article-title">Coumarin derivatives with COMT inhibiting activity</span>. International Patent WO200202548,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+Pystynen&author=M.+Ovaska&author=J.+Vidgren&author=T.+Lotta&author=M.+Yliperttula-ikonen&title=Coumarin+derivatives+with+COMT+inhibiting+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPystynen%26aufirst%3DJ.%26atitle%3DCoumarin%2520derivatives%2520with%2520COMT%2520inhibiting%2520activity%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Bäckström, R.; Pystynen, J.; Lotta, T.; Ovaska, M.; Taskinen, J.</span><span> </span><span class="NLM_article-title">Derivatives of naphthalene with COMT inhibiting activity</span>. International Patent WO200222551,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+B%C3%A4ckstr%C3%B6m&author=J.+Pystynen&author=T.+Lotta&author=M.+Ovaska&author=J.+Taskinen&title=Derivatives+of+naphthalene+with+COMT+inhibiting+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26atitle%3DDerivatives%2520of%2520naphthalene%2520with%2520COMT%2520inhibiting%2520activity%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Ahlmark, M.; Bäckström, R.; Luiro, A.; Pystynen, J.; Tiainen, E.</span><span> </span><span class="NLM_article-title">New pharmaceutical compounds</span>. International Patent WO2007010085,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+Ahlmark&author=R.+B%C3%A4ckstr%C3%B6m&author=A.+Luiro&author=J.+Pystynen&author=E.+Tiainen&title=New+pharmaceutical+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhlmark%26aufirst%3DM.%26atitle%3DNew%2520pharmaceutical%2520compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pystynen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sairanen, M.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-<i>O</i>-methyltransferase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2614</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2614-2616&author=J.+Rautioauthor=J.+Lepp%C3%A4nenauthor=M.+Lehtonenauthor=K.+Laineauthor=M.+Koskinenauthor=J.+Pystynenauthor=J.+Savolainenauthor=M.+Sairanen&title=Design%2C+synthesis+and+in+vitro%2Fin+vivo+evaluation+of+orally+bioavailable+prodrugs+of+a+catechol-O-methyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DKoskinen%26aufirst%3DM.%26aulast%3DPystynen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DSairanen%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520evaluation%2520of%2520orally%2520bioavailable%2520prodrugs%2520of%2520a%2520catechol-O-methyltransferase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2614%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Belleau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burba, J.</span><span> </span><span class="NLM_article-title">Tropolones: A unique class of potent non-competitive inhibitors of S-adenosylmethionine-catechol methyltransferase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1961&pages=195-196&author=B.+Belleauauthor=J.+Burba&title=Tropolones%3A+A+unique+class+of+potent+non-competitive+inhibitors+of+S-adenosylmethionine-catechol+methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelleau%26aufirst%3DB.%26aulast%3DBurba%26aufirst%3DJ.%26atitle%3DTropolones%253A%2520A%2520unique%2520class%2520of%2520potent%2520non-competitive%2520inhibitors%2520of%2520S-adenosylmethionine-catechol%2520methyltransferase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1961%26volume%3D54%26spage%3D195%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Broch, O. J.</span><span> </span><span class="NLM_article-title">The in vivo effect of tropolone on noradrenaline metabolism and catechol-O-methyltransferase activity in the striatum of the rat</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fj.1600-0773.1973.tb01543.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=4801086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A280%3ADyaE2c%252FntFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1973&pages=417-428&author=O.+J.+Broch&title=The+in+vivo+effect+of+tropolone+on+noradrenaline+metabolism+and+catechol-O-methyltransferase+activity+in+the+striatum+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The in vivo effect of tropolone on noradrenaline metabolism and catechol-O-methyl transferase activity in tissues of the rat</span></div><div class="casAuthors">Broch O J Jr</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica et toxicologica</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-28</span>
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfqbUGvdtxZUNHe_gFldTbfW6udTcc2eZyVQqv9-v8n7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2c%252FntFamsQ%253D%253D&md5=ff3d27d81628e8825787b70b41ffe604</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1973.tb01543.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1973.tb01543.x%26sid%3Dliteratum%253Aachs%26aulast%3DBroch%26aufirst%3DO.%2BJ.%26atitle%3DThe%2520in%2520vivo%2520effect%2520of%2520tropolone%2520on%2520noradrenaline%2520metabolism%2520and%2520catechol-O-methyltransferase%2520activity%2520in%2520the%2520striatum%2520of%2520the%2520rat%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1973%26volume%3D33%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Borchardt, R. T.</span><span> </span><span class="NLM_article-title">Catechol-O-methyltransferase. 4. In vitro inhibition by 3-hydroxy-4-pyrones, 3-hydroxy-2-pyridones and 3-hydroxy-4-pyridones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00263a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1973&pages=581-583&author=R.+T.+Borchardt&title=Catechol-O-methyltransferase.+4.+In+vitro+inhibition+by+3-hydroxy-4-pyrones%2C+3-hydroxy-2-pyridones+and+3-hydroxy-4-pyridones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm00263a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00263a047%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DCatechol-O-methyltransferase.%25204.%2520In%2520vitro%2520inhibition%2520by%25203-hydroxy-4-pyrones%252C%25203-hydroxy-2-pyridones%2520and%25203-hydroxy-4-pyridones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1973%26volume%3D16%26spage%3D581%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Wolkenberg, S.; Barrow, J. C.; Poslusney, S. T.; Harrison, S. T.; Trotter, B. W.; Mulhearn, J.; Nanda, K. K.; Manley, P. J.; Zhao, Z.; Scubert, J. W.; Kett, N.; Zartman, A.</span><span> </span><span class="NLM_article-title">Inhibitors of Catechol-O-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109254,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=J.+C.+Barrow&author=S.+T.+Poslusney&author=S.+T.+Harrison&author=B.+W.+Trotter&author=J.+Mulhearn&author=K.+K.+Nanda&author=P.+J.+Manley&author=Z.+Zhao&author=J.+W.+Scubert&author=N.+Kett&author=A.+Zartman&title=Inhibitors+of+Catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520Catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Wolkenberg, S.; Barrow, J. C.; Harrison, S. T.; Trotter, B. W.; Nanda, K. K.; Manley, P. J.; Zhao, Z.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-<i>O</i>-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109261,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=J.+C.+Barrow&author=S.+T.+Harrison&author=B.+W.+Trotter&author=K.+K.+Nanda&author=P.+J.+Manley&author=Z.+Zhao&title=Inhibitors+of+catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Wolkenberg, S.; Harrison, S. T.; Barrow, J. C.; Zhao, Z.; Kett, N.; Zartman, A.</span><span> </span><span class="NLM_article-title">Inhibitors of catechol-O-methyltransferase and their use in the treatment of psychotic disorders</span>. International Patent WO2011109267,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Wolkenberg&author=S.+T.+Harrison&author=J.+C.+Barrow&author=Z.+Zhao&author=N.+Kett&author=A.+Zartman&title=Inhibitors+of+catechol-O-methyltransferase+and+their+use+in+the+treatment+of+psychotic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWolkenberg%26aufirst%3DS.%26atitle%3DInhibitors%2520of%2520catechol-O-methyltransferase%2520and%2520their%2520use%2520in%2520the%2520treatment%2520of%2520psychotic%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Brevitt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. W.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of two progressive series of bifunctional polyhdroxybenzamide catechol-O-methyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2035</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9605187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2035-2039&author=S.+E.+Brevittauthor=E.+W.+Tan&title=Synthesis+and+in+vitro+evaluation+of+two+progressive+series+of+bifunctional+polyhdroxybenzamide+catechol-O-methyltransferase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm9605187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9605187%26sid%3Dliteratum%253Aachs%26aulast%3DBrevitt%26aufirst%3DS.%2BE.%26aulast%3DTan%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520two%2520progressive%2520series%2520of%2520bifunctional%2520polyhdroxybenzamide%2520catechol-O-methyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2035%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Bailey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. W.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5740</span><span class="NLM_x">–</span> <span class="NLM_lpage">5749</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=5740-5749&author=K.+Baileyauthor=E.+W.+Tan&title=Synthesis+and+evaluation+of+bifunctional+nitrocatechol+inhibitors+of+pig+liver+catechol-O-methyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520bifunctional%2520nitrocatechol%2520inhibitors%2520of%2520pig%2520liver%2520catechol-O-methyltransferase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D5740%26epage%3D5749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT)</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2F%28SICI%291521-3765%2820000317%296%3A6%3C971%3A%3AAID-CHEM971%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10785817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=971-982&author=B.+Masjostauthor=P.+Ballmerauthor=E.+Borroniauthor=G.+Z%C3%BCrcherauthor=F.+K.+Winklerauthor=R.+Jakob-Roetneauthor=F.+Diederich&title=Structure-based+design%2C+synthesis%2C+and+in+vitro+evaluation+of+bisubstrate+inhibitors+for+catechol+O-methyltransferase+%28COMT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and in vitro evaluation of bi-substrate inhibitors for catechol O-methyltransferase (COMT)</span></div><div class="casAuthors">Masjost, Birgit; Ballmer, Patrick; Borroni, Edilio; Zurcher, Gerhard; Winkler, Fritz K.; Jakob-Roetne, Roland; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">971-982</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The enzyme catechol O-methyltransferase (COMT) catalyzes the Me group transfer from the cofactor S-adenosylmethionine (SAM) to the hydroxy group of catechol substrates.  Potential bisubstrate inhibitors of COMT were developed by structure-based design and synthesized.  The compds. were tested for in vitro inhibitory activity against COMT obtained from rat liver, and the inhibition kinetics were examd. with regard to the binding sites of cofactor and substrate.  One of the designed mols. was found to be a bisubstrate inhibitor of COMT with an IC50 = 2 μM.  It exhibits competitive kinetics for the SAM and non-competitive kinetics for the catechol binding site.  Useful structure-activity relationships were established which provide important guidelines for the design of future generations of bisubstrate inhibitors of COMT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3n0QtsrURUbVg90H21EOLACvtfcHk0lhitXoxEWVUMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFCjt7s%253D&md5=42e749bce69de74dbb6e6382f3e56534</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2820000317%296%3A6%3C971%3A%3AAID-CHEM971%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252820000317%25296%253A6%253C971%253A%253AAID-CHEM971%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DBallmer%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520bisubstrate%2520inhibitors%2520for%2520catechol%2520O-methyltransferase%2520%2528COMT%2529%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2000%26volume%3D6%26spage%3D971%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of a bisubstrate inhibitor bound to the enzyme catechol-<i>O</i>-methyltransferase: A dramatic effect of inhibitor preorganization on binding affinity</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=4040-4042&author=C.+Lernerauthor=A.+Rufauthor=V.+Gramlichauthor=B.+Masjostauthor=G.+Z%C3%BCrcherauthor=R.+Jakob-Roetneauthor=E.+Borroniauthor=F.+Diederich&title=X-ray+crystal+structure+of+a+bisubstrate+inhibitor+bound+to+the+enzyme+catechol-O-methyltransferase%3A+A+dramatic+effect+of+inhibitor+preorganization+on+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520a%2520bisubstrate%2520inhibitor%2520bound%2520to%2520the%2520enzyme%2520catechol-O-methyltransferase%253A%2520A%2520dramatic%2520effect%2520of%2520inhibitor%2520preorganization%2520on%2520binding%2520affinity%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D4040%26epage%3D4042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masjost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors for the enzyme catechol-<i>O</i>-methyltransferase (COMT): Influence of inhibitor preorganisation and linker length between two substrate moieties on binding affinity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=42-49&author=C.+Lernerauthor=B.+Masjostauthor=A.+Rufauthor=V.+Gramlichauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+inhibitors+for+the+enzyme+catechol-O-methyltransferase+%28COMT%29%3A+Influence+of+inhibitor+preorganisation+and+linker+length+between+two+substrate+moieties+on+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DMasjost%26aufirst%3DB.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DGramlich%26aufirst%3DV.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520inhibitors%2520for%2520the%2520enzyme%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Influence%2520of%2520inhibitor%2520preorganisation%2520and%2520linker%2520length%2520between%2520two%2520substrate%2520moieties%2520on%2520binding%2520affinity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2003%26volume%3D1%26spage%3D42%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors of the enzyme catechol-O-methyltransferase (COMT): Efficient inhibition despite the lack of a nitro group</span> <span class="citation_source-journal">Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1270-1274&author=R.+Pauliniauthor=C.+Lernerauthor=R.+Jakob-Roetneauthor=G.+Z%C3%BCrcherauthor=E.+Borroniauthor=F.+Diederich&title=Bisubstrate+inhibitors+of+the+enzyme+catechol-O-methyltransferase+%28COMT%29%3A+Efficient+inhibition+despite+the+lack+of+a+nitro+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DZ%25C3%25BCrcher%26aufirst%3DG.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBisubstrate%2520inhibitors%2520of%2520the%2520enzyme%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Efficient%2520inhibition%2520despite%2520the%2520lack%2520of%2520a%2520nitro%2520group%26jtitle%3DChem.%2520Biochem.%26date%3D2004%26volume%3D5%26spage%3D1270%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Diedrich, F.; Jakob-Roetne, R.; Lerner, C.; Paulini, R.</span><span> </span><span class="NLM_article-title">COMT inhibitors</span>. International Patent WO2005058228,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Diedrich&author=R.+Jakob-Roetne&author=C.+Lerner&author=R.+Paulini&title=COMT+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDiedrich%26aufirst%3DF.%26atitle%3DCOMT%2520inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allemann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tissot, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span> </span><span class="NLM_article-title">Catechol-<i>O</i>-methyltransferase in complex with substituted 3′-deoxyribose bisubstrate inhibitors</span> <span class="citation_source-journal">Acta Crystallogr. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1107%2FS0907444912001138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=22349227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=253-260&author=M.+Ellermannauthor=C.+Lernerauthor=G.+Burgyauthor=A.+Ehlerauthor=C.+Bissantzauthor=R.+Jakob-Roetneauthor=R.+Pauliniauthor=O.+Allemannauthor=H.+Tissotauthor=D.+Grunsteinauthor=M.+Stihleauthor=F.+Diederichauthor=M.+G.+Rudolph&title=Catechol-O-methyltransferase+in+complex+with+substituted+3%E2%80%B2-deoxyribose+bisubstrate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Lerner, Christian; Burgy, Guillaume; Ehler, Andreas; Bissantz, Caterina; Jakob-Roetne, Roland; Paulini, Ralph; Allemann, Oliver; Tissot, Heloise; Gruenstein, Dan; Stihle, Martine; Diederich, Francois; Rudolph, Markus G.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">High-resoln. structures of catechol-O-methyltransferase with ribose-modified inhibitors and Mg2+ identify the side chain of Glu90 as crucial for hydrogen bonding to the ribose hydroxyl groups.  Glu90 subtly aligns with the 2'-hydroxyl, but not the 3'-hydroxyl, group to increase binding affinity, explaining the obsd. activities of bisubstrate inhibitors with a 3'-desoxyribose moiety.  The biol. activity of catechol neurotransmitters such as dopamine in the synapse is modulated by transporters and enzymes.  Catechol-O-methyltransferase (COMT; EC 2.1.1.6) inactivates neurotransmitters by catalyzing the transfer of a Me group from S-adenosylmethionine to catechols in the presence of Mg2+.  This pathway also inactivates L-DOPA, the std. therapeutic for Parkinson's disease.  Depletion of catechol neurotransmitters in the prefrontal cortex has been linked to schizophrenia.  The inhibition of COMT therefore promises improvements in the treatment of these diseases.  The concept of bisubstrate inhibitors for COMT has been described previously.  Here, ribose-modified bisubstrate inhibitors were studied.  Three high-resoln. crystal structures of COMT in complex with novel ribose-modified bisubstrate inhibitors confirmed the predicted binding mode but displayed subtle alterations at the ribose-binding site.  The high affinity of the inhibitors can be convincingly rationalized from the structures, which document the possibility of removing and/or replacing the ribose 3'-hydroxyl group and provide a framework for further inhibitor design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocHxOEL-zuzLVg90H21EOLACvtfcHk0ljc_HKl65QL0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFWksrY%253D&md5=2b1b40fde37e8eae240dd4a1c2c58c4f</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001138%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DAllemann%26aufirst%3DO.%26aulast%3DTissot%26aufirst%3DH.%26aulast%3DGrunstein%26aufirst%3DD.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26atitle%3DCatechol-O-methyltransferase%2520in%2520complex%2520with%2520substituted%25203%25E2%2580%25B2-deoxyribose%2520bisubstrate%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26spage%3D253%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Ellermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Molecular recognition at the active site of catechol-O-methyltransferase (COMT): Adenine replacements in bisubstrate inhibitors</span> <span class="citation_source-journal">Chemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6369</span><span class="NLM_x">–</span> <span class="NLM_lpage">6381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1002%2Fchem.201003648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=21538606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6369-6381&author=M.+Ellermannauthor=R.+Pauliniauthor=R.+Jakob-Roetneauthor=C.+Lernerauthor=E.+Borroniauthor=D.+Rothauthor=A.+Ehlerauthor=W.+B.+Schweizerauthor=D.+Schlatterauthor=M.+G.+Rudolphauthor=F.+Diederich&title=Molecular+recognition+at+the+active+site+of+catechol-O-methyltransferase+%28COMT%29%3A+Adenine+replacements+in+bisubstrate+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors</span></div><div class="casAuthors">Ellermann, Manuel; Paulini, Ralph; Jakob-Roetne, Roland; Lerner, Christian; Borroni, Edilio; Roth, Doris; Ehler, Andreas; Schweizer, W. Bernd; Schlatter, Daniel; Rudolph, Markus G.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6369-6381, S6369/1-S6369/95</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">L-Dopa, the std. therapeutic for Parkinson's disease, is inactivated by the enzyme catechol-O-methyltransferase (COMT).  COMT catalyzes the transfer of an activated Me group from S-adenosylmethionine (SAM) to its catechol substrates, such as L-dopa, in the presence of magnesium ions.  The mol. recognition properties of the SAM-binding site of COMT have been investigated only sparsely.  Here, we explore this site by structural alterations of the adenine moiety of bisubstrate inhibitors.  The mol. recognition of adenine is of special interest due to the great abundance and importance of this nucleobase in biol. systems.  Novel bisubstrate inhibitors with adenine replacements were developed by structure-based design and synthesized using a nucleosidation protocol introduced by Vorbrueggen and co-workers.  Key interactions of the adenine moiety with COMT were measured with a radiochem. assay.  Several bisubstrate inhibitors, most notably the adenine replacements thiopyridine, purine, N-methyladenine, and 6-methylpurine, displayed nanomolar IC50 values (median inhibitory concn.) for COMT down to 6 nM.  A series of six cocrystal structures of the bisubstrate inhibitors in ternary complexes with COMT and Mg2+ confirm our predicted binding mode of the adenine replacements.  The cocrystal structure of an inhibitor bearing no nucleobase can be regarded as an intermediate along the reaction coordinate of bisubstrate inhibitor binding to COMT.  Our studies show that solvation varies with the type of adenine replacement, whereas among the adenine derivs., the nitrogen atom at position 1 is essential for high affinity, while the exocyclic amino group is most efficiently substituted by a Me group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo1pH4WO4rXLVg90H21EOLACvtfcHk0ljc_HKl65QL0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsLY%253D&md5=2e3849c0801ab409dd4e41b9a5957a8b</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003648%26sid%3Dliteratum%253Aachs%26aulast%3DEllermann%26aufirst%3DM.%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DLerner%26aufirst%3DC.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DD.%26aulast%3DEhler%26aufirst%3DA.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DMolecular%2520recognition%2520at%2520the%2520active%2520site%2520of%2520catechol-O-methyltransferase%2520%2528COMT%2529%253A%2520Adenine%2520replacements%2520in%2520bisubstrate%2520inhibitors%26jtitle%3DChemistry%26date%3D2011%26volume%3D17%26spage%3D6369%26epage%3D6381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Lanier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davenport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fosbeary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadotani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saikatendu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hixon, M. S.</span><span> </span><span class="NLM_article-title">A fragment-based approach to identifying S-adenosyl-L-methionine -competitive inhibitors of catechol-<i>O</i>-methyl transferase (COMT)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500475k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5459-5463&author=M.+Lanierauthor=G.+Ambrusauthor=D.+C.+Coleauthor=R.+Davenportauthor=J.+Elleryauthor=R.+Fosbearyauthor=A.+J.+Jenningsauthor=A.+Kadotaniauthor=Y.+Kamadaauthor=R.+Kamranauthor=S.-I.+Matsumotoauthor=A.+Mizukamiauthor=S.+Okuboauthor=K.+Okadaauthor=K.+Saikatenduauthor=L.+Walshauthor=H.+Wuauthor=M.+S.+Hixon&title=A+fragment-based+approach+to+identifying+S-adenosyl-L-methionine+-competitive+inhibitors+of+catechol-O-methyl+transferase+%28COMT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm500475k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500475k%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DAmbrus%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DEllery%26aufirst%3DJ.%26aulast%3DFosbeary%26aufirst%3DR.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DKadotani%26aufirst%3DA.%26aulast%3DKamada%26aufirst%3DY.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DS.-I.%26aulast%3DMizukami%26aufirst%3DA.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DK.%26aulast%3DSaikatendu%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHixon%26aufirst%3DM.%2BS.%26atitle%3DA%2520fragment-based%2520approach%2520to%2520identifying%2520S-adenosyl-L-methionine%2520-competitive%2520inhibitors%2520of%2520catechol-O-methyl%2520transferase%2520%2528COMT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5459%26epage%3D5463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vepsäläinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis of a water-soluble prodrug of entacapone</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1016%2FS0960-894X%2800%2900384-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=10987428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1967-1969&author=J.+Lepp%C3%A4nenauthor=J.+Huuskonenauthor=J.+Savolainenauthor=T.+Nevalainenauthor=H.+Taipaleauthor=J.+Veps%C3%A4l%C3%A4inenauthor=J.+Gyntherauthor=T.+J%C3%A4rvinen&title=Synthesis+of+a+water-soluble+prodrug+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a water-soluble prodrug of entacapone</span></div><div class="casAuthors">Leppanen, Jukka; Huuskonen, Juhani; Savolainen, Jouko; Nevalainen, Tapio; Taipale, Hannu; Vepsalainen, Jouko; Gynther, Jukka; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1967-1969</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Entacapone reacted with phosphorous oxychloride in dry pyridine yielding a phosphate ester.  The phosphate promoiety increased aq. soly. of the parent drug by more than 1700- and 20-fold at pH 1.2 and 7.4, resp.  The phosphate ester provides adequate stability (t1/2=2227 h; pH 7.4) towards chem. hydrolysis, and allowed for release of the parent drug via enzymic hydrolysis in liver homogenate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeadkHp-iAr7Vg90H21EOLACvtfcHk0ljc_HKl65QL0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFGmsro%253D&md5=69c20cc5a6d807b2574becee373af46b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2800%2900384-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252800%252900384-X%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DVeps%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520a%2520water-soluble%2520prodrug%2520of%2520entacapone%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1967%26epage%3D1969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1489</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1211%2F0022357011778025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=11732751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Sgsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=1489-1498&author=J.+Lepp%C3%A4nenauthor=J.+Savolainenauthor=T.+Nevalainenauthor=M.+Forsbergauthor=J.+Huuskonenauthor=H.+Taipaleauthor=J.+Gyntherauthor=P.+T.+Mannist%C3%B6author=T.+J%C3%A4rvinen&title=Synthesis+and+in-vitro%2Fin-vivo+evaluation+of+orally+administered+entacapone+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs</span></div><div class="casAuthors">Leppanen, Jukka; Savolainen, Jouko; Nevalainen, Tapio; Forsberg, Markus; Huuskonen, Juhani; Taipale, Hannu; Gynther, Jukka; Mannisto, Pekka T.; Jarvinen, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1489-1498</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Entacapone is a new inhibitor of catechol-O-methyltransferase (COMT) that is used as an adjunct to L-dopa therapy in the treatment of Parkinson's disease.  The bioavailability of orally administered entacapone is, however, relatively low (29-46%).  In this study we have prepd. more lipophilic acyl and acyloxyacyl esters, an acyloxy alkyl ether and an alkyloxycarbonyl ester of entacapone, and we have evaluated them as potential prodrugs to enhance the oral bioavailability of entacapone.  All the derivs. fulfilled prodrug criteria and released entacapone in human serum in-vitro.  The oral bioavailability of monopivaloyl (I) and dipivaloyl (II) esters of entacapone were investigated further in rats.  The lipophilicity of II was high (log Papp 4.0 at pH 7.4) but its oral bioavailability was low (F = 0.6%), most probably due to its low aq. soly.  The monopivaloyl ester I had a higher lipophilicity (log Papp 0.80) than entacapone (log Papp 0.18) at pH 7.4 while maintaining an aq. soly. equal to entacapone.  However, oral bioavailability was not increased when compared with the parent drug entacapone (F = 7.0% and 10.4%, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9kFE8zCmxcrVg90H21EOLACvtfcHk0lihvNgF8dLC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Sgsr0%253D&md5=896ef764cd519975146b5c57127a510d</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1211%2F0022357011778025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011778025%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in-vitro%252Fin-vivo%2520evaluation%2520of%2520orally%2520administered%2520entacapone%2520prodrugs%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D1489%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Savolainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl and N,N-dialkyl-carbamate esters of entacapone</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2000&pages=205-206&author=J.+Savolainenauthor=J.+Lepp%C3%A4nenauthor=M.+Forsbergauthor=H.+Taipaleauthor=T.+Nevalainenauthor=J.+Huuskonenauthor=J.+Gyntherauthor=P.+T.+Mannist%C3%B6author=T.+J%C3%A4rvinen&title=Synthesis+and+in+vitro%2Fin+vivo+evaluation+of+novel+oral+N-alkyl+and+N%2CN-dialkyl-carbamate+esters+of+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavolainen%26aufirst%3DJ.%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DForsberg%26aufirst%3DM.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DMannist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252Fin%2520vivo%2520evaluation%2520of%2520novel%2520oral%2520N-alkyl%2520and%2520N%252CN-dialkyl-carbamate%2520esters%2520of%2520entacapone%26jtitle%3DLife%2520Sci.%26date%3D2000%26volume%3D67%26spage%3D205%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Leppänen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taipale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of a novel L-Dopa-entacapone codrug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1379</span><span class="NLM_x">–</span> <span class="NLM_lpage">1382</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010980d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1379-1382&author=J.+Lepp%C3%A4nenauthor=J.+Huuskonenauthor=T.+Nevalainenauthor=J.+Gyntherauthor=H.+Taipaleauthor=T.+J%C3%A4rvinen&title=Design+and+synthesis+of+a+novel+L-Dopa-entacapone+codrug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm010980d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010980d%26sid%3Dliteratum%253Aachs%26aulast%3DLepp%25C3%25A4nen%26aufirst%3DJ.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DTaipale%26aufirst%3DH.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520L-Dopa-entacapone%2520codrug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1379%26epage%3D1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarpila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nissinen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bäckström, R.</span><span> </span><span class="NLM_article-title">Inhibition of soluble COMT activity in healty volunteers by OR-462, a potential drug for Parkinson’s disease</span> <span class="citation_source-journal">Neurol. India</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1989&pages=286&issue=suppl&author=A.+Gordinauthor=S.+Tarpilaauthor=S.+Kaakkolaauthor=E.+Nissinenauthor=E.+Schultzauthor=R.+B%C3%A4ckstr%C3%B6m&title=Inhibition+of+soluble+COMT+activity+in+healty+volunteers+by+OR-462%2C+a+potential+drug+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DTarpila%26aufirst%3DS.%26aulast%3DKaakkola%26aufirst%3DS.%26aulast%3DNissinen%26aufirst%3DE.%26aulast%3DSchultz%26aufirst%3DE.%26aulast%3DB%25C3%25A4ckstr%25C3%25B6m%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520soluble%2520COMT%2520activity%2520in%2520healty%2520volunteers%2520by%2520OR-462%252C%2520a%2520potential%2520drug%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurol.%2520India%26date%3D1989%26volume%3D37%26issue%3Dsuppl%26spage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Borges, N.</span><span> </span><span class="NLM_article-title">Tolcapone in Parkinson’s disease: Liver toxicity and clinical efficacy</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1517%2F14740338.4.1.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=15709899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=69-73&author=N.+Borges&title=Tolcapone+in+Parkinson%E2%80%99s+disease%3A+Liver+toxicity+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Tolcapone in Parkinson's disease: liver toxicity and clinical efficacy</span></div><div class="casAuthors">Borges, Nuno</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-73</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease patients treated with a combination of levodopa and an arom. L-amino acid decarboxylase inhibitor usually develop motor complications after some years.  To minimise this problem, selective catechol-O-methyltransferase (COMT) inhibitors were developed in order to improve the poor pharmacokinetic profile of levodopa.  Tolcapone and entacapone are the two marketed drugs in this class, and both increase the half-life of levodopa and improve clin. parameters, such as the increase in the duration of 'on' and decrease of 'off' time.  Soon after its release, tolcapone was suspended in the EU due to its implication in the deaths of three Parkinsonian patients.  The cause of death in these patients was fulminant hepatitis.  The mechanism by which tolcapone induces liver damage has been studied.  Results show that this drug induces uncoupling of oxidative phosphorylation in mitochondria, thus significantly reducing the cell's capacity to generate ATP.  This toxic effect was demonstrated both in vitro and in vivo in several models but the concns. required to induce it are significantly higher than those needed to inhibit COMT.  Inter-individual differences in the capacity to metabolise tolcapone may yield higher plasma levels and may explain its toxic effects in a small sample of patients.  Recently, the suspension on tolcapone was lifted, based on new clin. data and ongoing monitoring of its use in other countries.  The European Agency for the Evaluation of Medicinal Products concluded that, in some situations, tolcapone has a clin. efficacy that is superior to entacapone and that an adequate level of safety could be achieved with appropriate liver function monitoring and other measures.  It is concluded that tolcapone can be safely used in Parkinsonian patients who do not respond or cannot, for other reasons, be prescribed with other COMT inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocg8m3WMSA0LVg90H21EOLACvtfcHk0lihvNgF8dLC5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yrsbY%253D&md5=d3ffbf4427aa75a41fe36370a9a750e2</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1517%2F14740338.4.1.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.4.1.69%26sid%3Dliteratum%253Aachs%26aulast%3DBorges%26aufirst%3DN.%26atitle%3DTolcapone%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520Liver%2520toxicity%2520and%2520clinical%2520efficacy%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2005%26volume%3D4%26spage%3D69%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of BIA3-202, a novel COMT inhibitor, during first administration to humans</span> <span class="citation_source-journal">Drugs R&D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.2165%2F00126839-200304040-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=12848585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=207-217&author=L.+Almeidaauthor=P.+Soares-da-Silva&title=Pharmacokinetics+and+pharmacodynamics+of+BIA3-202%2C+a+novel+COMT+inhibitor%2C+during+first+administration+to+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of BIA 3-202, a novel COMT inhibitor, during first administration to humans</span></div><div class="casAuthors">Almeida, Luis; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in R&D</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-217</span>CODEN:
                <span class="NLM_cas:coden">DRDDFD</span>;
        ISSN:<span class="NLM_cas:issn">1174-5886</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">Objective: To det. the tolerability, pharmacodynamics and pharmacokinetics of single oral doses of BIA 3-202, a novel catechol-O-methyltransferase (COMT) inhibitor, in healthy male volunteers.  Methods: Single increasing oral doses of BIA 3-202 (10, 30, 50, 100, 200, 400 and 800mg) were administered under fasting conditions to seven sequential groups of nine subjects, under a double-blind, randomized, placebo-controlled design.  In an addnl. group of eight subjects (group 8), a single dose of BIA 3-202 400mg was administered on two occasions, once under fasting conditions and once with a high-fat meal, under an open-label, two-way crossover design.  Results: BIA 3-202 was well tolerated at all doses tested.  Most adverse events were mild in severity and their incidence was similar between BIA 3-202 and placebo.  Maximum plasma concns. (Cmax) of BIA 3-202 were attained at 0.5-2.5h (tmax) and thereafter declined with an apparent terminal half-life (t1/2) of 1.5-5h.  Over the, dose range of 10-800mg, there was an approx. dose-proportional increase in the area under the plasma concn.-time curve (AUC) values of BIA 3-202: for a dose level increase in the ratio 3.0:1.7:2.0:2.0:2.0:2.0, AUC increased in the ratio 3.1:1.7:1.9:2.2:2.1:1.7.  Plasma concns. of the O-methylated deriv., BIA 3-270, increased markedly less than predicted from a proportional relationship: for a dose level increase in the ratio 1:80, AUC0-t increased in the ratio 1:5.  In most subjects, the tmax of BIA 3-270 was attained at the last sampling time and, therefore, t1/2 could not be estd.  Urine assays showed that less than 1% of the total dose administered was excreted in urine as BIA 3-202.  Urine concns. of BIA 3-270 were below the limit of quantification.  In group 8, the rate and extent of systemic availability (tmax, AUC and Cmax) of BIA 3-202 and BIA 3-270 after a high-fat meal were similar, to those under fasting conditions.  Inhibition of COMT activity in erythrocytes reached max. levels at 2-2.5h post dose, with sustained inhibition up to approx. 4-6 h, returning to baseline by about 16 h.  Conclusion: BIA 3-202 was well tolerated at single 10-800mg oral doses and presented dose-proportional kinetics.  It effectively inhibited COMT activity and the presence of food did not affect its pharmacokinetics or COMT inhibitory activity.  The results provide a basis for further clin. studies with BIA 3-202.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYK3Wkddgk1rVg90H21EOLACvtfcHk0ljneGyw-u-pfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFygsLc%253D&md5=fee139ce13401d6e955807a6d92bed4a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2165%2F00126839-200304040-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00126839-200304040-00001%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520BIA3-202%252C%2520a%2520novel%2520COMT%2520inhibitor%252C%2520during%2520first%2520administration%2520to%2520humans%26jtitle%3DDrugs%2520R%2526D%26date%3D2003%26volume%3D4%26spage%3D207%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Silveira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz-Da-Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=603-609&author=P.+Silveiraauthor=M.+Vaz-Da-Silvaauthor=L.+Almeidaauthor=J.+Maiaauthor=A.+Falc%C3%A3oauthor=A.+Loureiroauthor=L.+Torr%C3%A3oauthor=R.+Machadoauthor=L.+C.+Wrightauthor=P.+Soares-da-Silva&title=Pharmacokinetic-pharmacodynamic+interaction+between+BIA+3-202%2C+a+novel+COMT+inhibitor%2C+and+levodopa%2Fbenserazide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilveira%26aufirst%3DP.%26aulast%3DVaz-Da-Silva%26aufirst%3DM.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DMaia%26aufirst%3DJ.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DLoureiro%26aufirst%3DA.%26aulast%3DTorr%25C3%25A3o%26aufirst%3DL.%26aulast%3DMachado%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DPharmacokinetic-pharmacodynamic%2520interaction%2520between%2520BIA%25203-202%252C%2520a%2520novel%2520COMT%2520inhibitor%252C%2520and%2520levodopa%252Fbenserazide%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol%26date%3D2003%26volume%3D59%26spage%3D603%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palma, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Opicapone: A short lived and very long acting novel catechol-<i>O</i>-methyltransferase inhibitor following multiple-dose administration in healthy subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm500572b&amp;key=10.1111%2Fbcp.12081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm500572b&amp;key=23336248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm500572b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&pages=763-775&author=J.+F.+Rochaauthor=L.+Almeidaauthor=A.+Falcaoauthor=P.+N.+Palmaauthor=A.+I.+Loureiroauthor=R.+Pintoauthor=M.+J.+Bonifacioauthor=L.+C.+Wrightauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=Opicapone%3A+A+short+lived+and+very+long+acting+novel+catechol-O-methyltransferase+inhibitor+following+multiple-dose+administration+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects</span></div><div class="casAuthors">Rocha, Jose Francisco; Almeida, Luis; Falcao, Amilcar; Palma, P. Nuno; Loureiro, Ana I.; Pinto, Roberto; Bonifacio, Maria Joao; Wright, Lyndon C.; Nunes, Teresa; Soares-da-Silva, Patricio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">763-775</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : The aim of this study was to assess the tolerability, pharmacokinetics and inhibitory effect on erythrocyte sol. catechol-O-methyltransferase (S-COMT) activity following repeated doses of opicapone.  Methods : This randomized, placebo-controlled, double-blind study enrolled healthy male subjects who received either once daily placebo or opicapone 5, 10, 20 or 30 mg for 8 days.  Results : Opicapone was well tolerated.  Its systemic exposure increased in an approx. dose-proportional manner with an apparent terminal half-life of 1.0 to 1.4 h.  Sulphation was the main metabolic pathway.  Opicapone metabolites recovered in urine accounted for less than 3% of the amt. of opicapone administered suggesting that bile is likely the main route of excretion.  Maximum S-COMT inhibition (Emax) ranged from 69.9% to 98.0% following the last dose of opicapone.  The opicapone-induced S-COMT inhibition showed a half-life in excess of 100 h, which was dose-independent and much longer than plasma drug exposure.  Such a half-life translates into a putative underlying rate const. that is comparable with the estd. dissocn. rate const. of the COMT-opicapone complex.  Conclusion : Despite its short elimination half-life, opicapone markedly and sustainably inhibited erythrocyte S-COMT activity making it suitable for a once daily regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLkdVAbBdZHrVg90H21EOLACvtfcHk0ljneGyw-u-pfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Orsr7F&md5=a65d6b1c3442a858b607b1cfc2d8efb0</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1111%2Fbcp.12081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.12081%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DFalcao%26aufirst%3DA.%26aulast%3DPalma%26aufirst%3DP.%2BN.%26aulast%3DLoureiro%26aufirst%3DA.%2BI.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DBonifacio%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DOpicapone%253A%2520A%2520short%2520lived%2520and%2520very%2520long%2520acting%2520novel%2520catechol-O-methyltransferase%2520inhibitor%2520following%2520multiple-dose%2520administration%2520in%2520healthy%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D76%26spage%3D763%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcão, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz-da-Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=1059-1071&author=J.+F.+Rochaauthor=A.+Falc%C3%A3oauthor=A.+Santosauthor=R.+Pintoauthor=N.+Lopesauthor=T.+Nunesauthor=L.+C.+Wrightauthor=M.+Vaz-da-Silvaauthor=P.+Soares-da-Silva&title=Effect+of+opicapone+and+entacapone+upon+levodopa+pharmacokinetics+during+three+daily+levodopa+administrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DPinto%26aufirst%3DR.%26aulast%3DLopes%26aufirst%3DN.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DL.%2BC.%26aulast%3DVaz-da-Silva%26aufirst%3DM.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DEffect%2520of%2520opicapone%2520and%2520entacapone%2520upon%2520levodopa%2520pharmacokinetics%2520during%2520three%2520daily%2520levodopa%2520administrations%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D70%26spage%3D1059%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The design of a double-blind, placebo-controlled, multi-national phase-III trial in patients with Parkinson’s disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=S127&author=A.+Leesauthor=R.+Costaauthor=C.+Oliveiraauthor=N.+Lopesauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=The+design+of+a+double-blind%2C+placebo-controlled%2C+multi-national+phase-III+trial+in+patients+with+Parkinson%E2%80%99s+disease+and+end-of-dose+motor+fluctuations%3A+Opicapone+superiority+vs.+placebo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%26aulast%3DCosta%26aufirst%3DR.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DLopes%26aufirst%3DN.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520design%2520of%2520a%2520double-blind%252C%2520placebo-controlled%252C%2520multi-national%2520phase-III%2520trial%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520end-of-dose%2520motor%2520fluctuations%253A%2520Opicapone%2520superiority%2520vs.%2520placebo%26jtitle%3DMov.%2520Disord.%26date%3D2012%26volume%3D27%26spage%3DS127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Ferreira, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares-da-Silva, P.</span><span> </span><span class="NLM_article-title">The design of a double-blind, placebo- and active-controlled, multi-national phase-III trial in patients with Parkinson’s disease and end-of-dose motor fluctuations: Opicapone superiority vs. placebo and non-inferiority vs. entacapone</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">S118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=S118&author=J.+J.+Ferreiraauthor=J.+F.+Rochaauthor=A.+Santosauthor=T.+Nunesauthor=P.+Soares-da-Silva&title=The+design+of+a+double-blind%2C+placebo-+and+active-controlled%2C+multi-national+phase-III+trial+in+patients+with+Parkinson%E2%80%99s+disease+and+end-of-dose+motor+fluctuations%3A+Opicapone+superiority+vs.+placebo+and+non-inferiority+vs.+entacapone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DJ.%2BJ.%26aulast%3DRocha%26aufirst%3DJ.%2BF.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DT.%26aulast%3DSoares-da-Silva%26aufirst%3DP.%26atitle%3DThe%2520design%2520of%2520a%2520double-blind%252C%2520placebo-%2520and%2520active-controlled%252C%2520multi-national%2520phase-III%2520trial%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520end-of-dose%2520motor%2520fluctuations%253A%2520Opicapone%2520superiority%2520vs.%2520placebo%2520and%2520non-inferiority%2520vs.%2520entacapone%26jtitle%3DMov.%2520Disord.%26date%3D2012%26volume%3D27%26spage%3DS118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500572b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm500572b%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-21" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500572b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67c735f02d543bf8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
